Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3015399	p-tfr	mg/l (mg/l)	66751	148084	0.02%
3015399	s-tfr	mg/l (mg/l)	36798	75725	0.00%
3015399	p-tfr	— (—)	30838	51636	100.00%	Distribution not available
3015399	s-tfr	— (—)	2453	3397	100.00%	Distribution not available
3015399	p-tfr	mg/l______ (mg/l)	2219	4508	0.00%
3015399	p-transferriinireseptori	mg/l______ (mg/l)	903	1417	0.00%
3015399	transferriinireseptori,liukoinen	mg/l (mg/l)	147	196	0.00%
3015399	p-transferriinireseptori	— (—)	147	176	100.00%	Distribution not available
3015399	s-transferriinireseptori,liukoinen	mg/l (mg/l)	95	125	0.00%
3015399	transferriinireseptori,liukoinen	— (—)	36	48	100.00%	Distribution not available
3015399	p-transferriinireseptori	mg/l (mg/l)	25	32	0.00%
3015399	p-tfr	MG/L (mg/l)	24	33	0.00%
3015399	s-transferriinireseptori,liukoinen(ko)	mg/l (mg/l)	24	26	0.00%
3015399	transferriinireseptori,liukoinen(p-tfr)	mg/l (mg/l)	18	24	0.00%
3015399	transferriinireseptori,liukoinen(tfr)	mg/l (mg/l)	13	17	0.00%
3015399	s-tfr	mg/l______ (mg/l)	10	10	0.00%
3015399	p-transferriinireseptori,liukoinen(pi)	mg/l (mg/l)	9	12	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

17640

84327

1.45

323.31

2.7

2.3

2.97

2.77

mg/l

20.04

15493

72883

Diseases of pulp and periapical tissues, including avohilmo

19715

77999

1.43

320.83

2.5

2.3

2.78

2.79

mg/l

0.18

17024

67577

Injuries to the abdomen, lower back, lumbar spine and pelvis

8103

53878

1.75

320.77

2.7

2.4

2.91

2.84

mg/l

1.54

6990

46555

Poisoning by drugs, medicaments and biological substances

4428

25726

2.13

320.27

2.6

2.3

2.80

2.65

mg/l

4.27

3858

22463

Generalized anxiety disorder

3312

17564

2.40

319.51

2.5

2.2

2.51

2.58

mg/l

1.17

2841

15305

Colon adenocarcinoma

2725

13898

2.84

318.41

2.5

3.85

2.84

mg/l

40.22

2437

11898

Asthma, hospital admissions , main diagnosis only

15332

99837

1.48

317.48

2.6

2.3

2.87

2.76

mg/l

6.70

13606

86209

Colorectal adenocarcinoma

4141

23660

2.25

316.87

2.4

3.62

2.82

mg/l

42.23

3657

20291

Mental and behavioural disorders due to alcohol

9063

59182

1.66

316.78

2.5

2.3

2.87

2.77

mg/l

3.28

7836

51268

Vitamin B12 deficiency anaemia

2309

11057

3.09

315.88

3.4

2.1

3.07

2.77

mg/l

5.65

2079

9334

Symptoms and signs involving the skin and subcutaneous tissue

13598

94884

1.52

314.55

2.6

2.4

2.75

2.79

mg/l

1.44

11905

82125

Diseases of the respiratory system

11708

41197

1.58

314.41

2.5

2.1

2.79

2.71

mg/l

2.64

10250

35276

Volume depletion

2235

10610

3.13

312.18

3.3

2.3

3.33

2.98

mg/l

7.55

1983

9064

Cholelithiasis, broad definition with cholecystitis

16198

81260

1.47

310.01

2.7

2.3

2.98

2.79

mg/l

18.55

14207

70024

Hyperkinetic disorders, excluding more controls

2462

10912

2.67

308.87

2.4

2.2

2.37

2.45

mg/l

1.49

2149

9614

External causes of morbidity and mortality

11897

42087

1.56

308.51

2.4

2.2

2.76

2.71

mg/l

1.22

10314

36586

Angina pectoris

10112

43760

1.80

307.65

2.7

2.2

2.93

2.82

mg/l

4.36

8991

36980

Crohn disease

3470

12810

4.88

307.65

4.7

2.2

2.72

2.71

mg/l

0.14

3270

11126

Asthma (only as main-diagnosis)

14063

48514

1.88

307.65

2.6

2.1

2.85

2.69

mg/l

11.83

12488

41624

Coxarthrosis

9284

39085

1.77

307.65

2.6

2.2

2.95

2.85

mg/l

3.28

8096

33321

Complications of medical and surgical care

16129

90041

1.97

307.65

2.8

2.3

2.96

2.79

mg/l

15.93

14272

77668

Unspecified kidney failure

2664

11917

3.74

307.65

3.6

2.3

3.08

2.94

mg/l

1.76

2411

10057

All-cause Heart Failure

14333

49875

2.86

307.65

3.1

2.2

3.38

2.77

mg/l

103.84

12908

42209

Disorders of gallbladder, biliary tract and pancreas

19397

85772

1.59

307.65

2.7

2.3

2.95

2.78

mg/l

17.09

17102

74014

Asthma, including avohilmo

22810

94358

1.47

307.65

2.5

2.3

2.81

2.77

mg/l

2.01

20088

81373

Non-rheumatic valve diseases

10085

36509

2.59

307.65

2.9

2.2

3.15

2.69

mg/l

52.86

8967

30875

Renal failure

13543

52501

3.52

307.65

3.4

2.3

3.10

2.90

mg/l

15.50

12203

44706

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

7333

26272

2.04

307.65

2.7

2.0

2.93

2.55

mg/l

29.46

6603

22471

Symptoms and signs involving the digestive system and abdomen

19863

66032

1.71

307.65

2.6

2.2

2.79

2.78

mg/l

0.16

17394

56809

Caries of dentine, including avohilmo

15102

54337

1.60

307.65

2.5

2.3

2.81

2.86

mg/l

1.79

13075

46907

ILD differential diagnosis

14680

48896

1.70

307.65

2.5

2.1

2.78

2.69

mg/l

4.10

12864

41954

Hypothyroidism, levothyroxine purchases

5059

9281

3.95

307.65

2.4

1.8

2.60

2.32

mg/l

20.17

4427

8001

Asthma-related infections

12263

78702

1.79

307.65

2.8

2.4

2.94

2.79

mg/l

8.80

10927

67762

Insulin, combination of fast acting with intermediate-acting or long-acting

12759

73863

1.88

307.65

3.0

2.3

3.24

2.80

mg/l

69.42

11328

63541

Persons encountering health services for specific procedures and health care

23452

84668

1.95

307.65

2.7

2.3

2.79

2.75

mg/l

1.60

20823

72740

Calcific aortic valvular stenosis, diagnosis (helper)

6459

38598

2.09

307.65

3.0

2.4

3.19

2.99

mg/l

7.98

5728

32854

Dental operations

11690

40101

1.71

307.65

2.4

2.3

2.84

2.94

mg/l

4.38

10085

34352

Cerebrovascular diseases (FINNGEN)

5522

17824

2.70

307.65

2.7

2.0

2.88

2.58

mg/l

16.12

4912

15095

Dental caries, including avohilmo

14004

50073

1.61

307.65

2.5

2.3

2.82

2.89

mg/l

2.81

12098

43164

Care involving dialysis

1967

7384

4.94

307.65

4.2

2.3

2.90

2.77

mg/l

1.68

1822

6330

Ischemic heart diseases

15809

58638

1.90

307.65

2.8

2.3

2.95

2.76

mg/l

16.50

14105

50136

Inflammatory bowel disease treatment related agents

27110

84488

2.21

307.65

3.0

2.1

2.90

2.71

mg/l

28.60

24282

72301

Calcific aortic valvular stenosis

6469

38656

2.09

307.65

3.0

2.4

3.19

2.99

mg/l

7.92

5736

32903

Hyperlipidaemia, other/unspecified

7575

42354

1.96

307.65

2.7

2.3

3.11

2.94

mg/l

6.62

6593

36162

Type 2 diabetes

19984

74459

1.81

307.65

2.7

2.2

3.02

2.68

mg/l

70.62

17683

63968

Cerebrovascular diseases

13870

67532

1.64

307.65

2.7

2.4

2.99

2.86

mg/l

6.88

12105

58080

Heart failure and antihypertensive medication

6106

11744

5.45

307.65

3.3

2.0

3.23

2.70

mg/l

33.62

5564

9907

Ulcerative colitis (strict definition, require KELA)

4124

17013

3.88

307.65

4.1

2.2

2.67

2.69

mg/l

0.27

3838

14849

Operations 2 for CAVS

6459

38598

2.09

307.65

3.0

2.4

3.19

2.99

mg/l

7.98

5728

32854

Condition for Implicit Sepsis (Organ dysfunction codes)

19355

75614

2.21

307.65

2.9

2.2

2.91

2.75

mg/l

15.02

16991

65033

Bacterial Sepsis

12291

49722

2.92

307.65

3.2

2.3

3.15

2.84

mg/l

29.80

10908

42426

Implicit bacterial Sepsis

10941

45374

3.02

307.65

3.2

2.3

3.14

2.86

mg/l

22.52

9733

38635

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

13163

78245

1.71

307.65

2.7

2.4

3.01

2.84

mg/l

10.84

11565

67356

Hypothyreosis and Thyroxine purchase for inclusion criteria

18316

85741

1.59

307.65

2.5

2.3

2.81

2.77

mg/l

1.44

15965

74108

Hypertensive heart and/or renal disease

5498

20177

2.63

307.65

3.0

2.2

3.29

2.88

mg/l

20.37

4867

16877

Calcific aortic valvular stenosis, including rheumatic fever

6475

38695

2.08

307.65

3.0

2.4

3.19

2.99

mg/l

8.19

5743

32937

Neurotic, stress-related and somatoform disorders

17950

80042

1.80

307.65

2.6

2.3

2.65

2.76

mg/l

7.71

15634

69642

Certain infectious and parasitic diseases

19463

63591

1.75

307.65

2.6

2.2

2.83

2.68

mg/l

14.44

17052

54692

Diseases of arteries, arterioles and capillaries

13827

64596

1.91

307.65

3.0

2.3

3.16

2.84

mg/l

32.31

12176

55358

Antihypertensive medication - note that there are other indications

11186

34682

1.94

307.65

2.5

2.1

2.67

2.52

mg/l

9.84

9881

29848

Inflammatory bowel disease

8111

35272

3.52

307.65

4.1

2.2

2.72

mg/l

0.11

7530

30597

Certain infectious and parasitic diseases, including avohilmo

13769

44666

1.75

307.65

2.5

2.1

2.81

2.71

mg/l

4.73

12061

38361

IBD patients in KELA-register

6244

23748

4.44

307.65

4.3

2.1

2.64

2.68

mg/l

0.88

5858

20633

Other specific joint derangements/joint disorders

14464

59199

1.75

307.65

2.6

2.2

2.66

2.69

mg/l

0.82

12664

50937

ILD medications: prednisolone, methylprednisolone, prednisone

25216

79584

2.17

307.65

2.9

2.1

2.92

2.71

mg/l

33.80

22427

68144

Other heart diseases, wide

18307

67291

1.94

307.65

2.7

2.2

2.84

2.62

mg/l

28.30

16210

57943

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2000

4767

4.00

307.65

2.8

2.0

3.04

2.83

mg/l

2.63

1789

4006

Presence of other functional implants

11624

51651

1.82

307.65

2.7

2.3

3.10

2.83

mg/l

23.59

9839

44186

10519

64493

1.66

307.65

2.6

2.3

2.92

2.77

mg/l

7.20

9124

55818

Fever of other and unknown origin

13395

58844

2.56

307.65

3.0

2.2

3.10

2.75

mg/l

45.85

12013

50403

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

21137

88506

1.89

307.65

2.8

2.3

2.96

2.71

mg/l

39.43

18765

76350

Malignant neoplasm of colon

3424

17841

2.72

307.65

2.5

3.79

2.83

mg/l

48.92

3054

15309

Pneumonia, organism unspecified

19854

82659

1.98

307.65

2.8

2.3

3.01

2.71

mg/l

49.50

17607

71257

Erysipelas

12043

59436

2.18

307.65

2.9

2.3

3.17

2.77

mg/l

48.50

10682

50764

Anaemias

9004

8971

16.37

307.65

3.8

1.8

3.28

2.32

mg/l

148.36

8292

7738

Liquid cancers

6058

33226

2.21

307.65

2.6

2.4

3.43

2.80

mg/l

33.61

5345

28548

Malignant neoplasm of digestive organs

7962

36734

2.06

307.65

2.5

2.4

3.46

2.81

mg/l

61.33

7065

31481

Valvular operations

2886

13885

2.88

307.65

3.0

2.2

3.20

2.71

mg/l

23.37

2579

11624

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

11886

76906

1.86

307.65

2.9

2.3

2.95

2.82

mg/l

7.67

10525

66284

Medical observation and evaluation for suspected diseases and conditions

13733

37930

2.23

307.65

2.7

2.1

2.83

2.77

mg/l

1.73

11842

32402

Continuous positive airway pressure

3556

11511

3.44

307.65

2.9

2.0

3.34

2.64

mg/l

36.52

2979

9687

Autoimmune diseases related-to ILD

19637

95111

2.15

307.65

3.2

2.2

2.80

2.78

mg/l

0.68

17632

81781

Septicaemia

10449

48839

2.70

307.65

3.2

2.3

3.25

2.79

mg/l

53.91

9324

41656

Symptoms and signs involving the urinary system

15667

77113

1.81

307.65

2.6

2.4

2.85

2.84

mg/l

0.24

13524

66633

Implicit Sepsis

18418

71024

2.52

307.65

3.0

2.2

2.99

2.76

mg/l

24.87

16180

60943

Hypothyroidism and >3 levothyroxin purchases

5059

9281

3.95

307.65

2.4

1.8

2.60

2.32

mg/l

20.17

4427

8001

Hypertensive diseases (excluding secondary)

9514

28112

2.38

307.65

2.7

2.0

2.77

2.54

mg/l

16.79

8522

24118

General symptoms and signs

23086

67193

2.06

307.65

2.6

2.2

2.80

2.72

mg/l

4.84

20317

57715

Crohn's disease NAS

1641

5846

5.29

307.65

5.3

2.1

2.74

2.72

mg/l

0.14

1546

5055

Injuries to the hip and thigh

9710

59976

1.69

307.65

2.7

2.4

2.98

2.88

mg/l

3.02

8411

51633

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

31859

79131

4.52

307.65

3.4

1.9

3.27

2.57

mg/l

313.26

28795

67337

GI-bleeding

7750

41474

2.59

307.65

3.5

2.3

3.39

2.89

mg/l

42.83

6982

35476

Dental caries

5464

24420

2.83

307.65

3.2

2.3

2.96

2.87

mg/l

1.87

4815

21155

Hypertensive diseases

14520

49456

1.93

307.65

2.7

2.1

2.81

2.70

mg/l

6.25

12927

42521

Crohn disease (strict definition, require KELA)

1785

5917

6.46

307.65

5.0

2.2

2.56

2.67

mg/l

1.59

1708

5149

General examination and investigation of persons without complaint and reported diagnosis

12906

37821

2.10

307.65

2.6

2.1

2.90

2.77

mg/l

6.46

11487

32314

Abnormalities of breathing

19551

64627

2.08

307.65

2.7

2.2

2.88

2.72

mg/l

14.94

17279

55682

Insulin, fast-acting

7261

43843

2.06

307.65

3.1

2.3

3.22

2.75

mg/l

43.63

6482

37900

Asthma (diagnoses ohter than nonallergic)

17713

99769

1.64

307.65

2.7

2.3

2.86

2.77

mg/l

5.20

15700

86042

Obesity

13847

76653

2.12

307.65

2.8

2.3

3.06

2.67

mg/l

63.52

12398

66349

Implicit bacterial Sepsis, including avohilmo

12024

48479

2.99

307.65

3.2

2.3

3.11

2.85

mg/l

21.60

10689

41337

Type 2 diabetes, strict (exclude DM1)

18914

72087

1.76

307.65

2.7

2.2

3.05

2.69

mg/l

69.74

16710

61922

Insulin medication

12733

62816

2.06

307.65

3.0

2.3

3.24

2.74

mg/l

87.87

11307

53876

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

5325

27670

2.36

307.65

2.6

2.2

2.73

2.63

mg/l

3.15

4661

24252

21986

83553

1.47

307.65

2.6

2.3

2.88

2.76

mg/l

11.34

19114

72018

Caries of dentine

4899

21747

2.96

307.65

3.2

2.3

3.00

2.87

mg/l

2.85

4313

18873

STROKE

10056

39556

2.04

307.65

2.6

2.1

2.88

2.69

mg/l

12.27

8925

33578

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1864

6353

6.04

307.65

5.0

2.2

2.57

2.68

mg/l

1.65

1782

5542

Asthma (mode)

15063

48896

1.88

307.65

2.6

2.1

2.79

2.69

mg/l

5.28

13378

41954

Major coronary heart disease event excluding revascularizations

11071

47377

1.82

307.65

2.8

2.3

3.06

2.83

mg/l

17.13

9751

40077

Disorders of lens

11995

48492

1.77

307.65

2.7

2.2

2.90

2.80

mg/l

3.99

10418

41985

Implicit viral Sepsis

5031

24979

2.90

307.65

3.3

2.3

3.07

2.82

mg/l

8.82

4543

21379

Hypotension

4005

23108

2.39

307.65

2.9

2.4

2.97

3.01

mg/l

0.46

3437

19745

Other symptoms and signs involving cognitive functions and awareness

9726

54872

1.90

307.65

2.6

2.4

2.71

2.93

mg/l

15.78

8382

47087

Pneumonias (Asthma/COPD co-morbidities)

21530

88541

1.88

307.65

2.8

2.3

2.95

2.70

mg/l

37.42

19118

76352

Explicit Sepsis, including avohilmo

11140

52458

2.63

307.65

3.1

2.3

3.22

2.80

mg/l

48.53

9952

44827

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

18709

71501

1.80

307.65

2.8

2.2

3.08

2.69

mg/l

82.14

16557

61492

Cardiomyopathies, Primary/intrinsic

2480

11237

3.16

307.65

3.1

2.1

2.93

2.69

mg/l

4.42

2237

9450

Complications of surgical and medical care, not elsewhere classified

22340

91401

1.98

307.65

2.8

2.3

2.97

2.75

mg/l

31.10

19763

78758

Nutritional anaemias

18004

61329

6.01

307.65

4.1

2.1

3.71

2.69

mg/l

313.08

16470

52224

Explicit Sepsis

10897

51665

2.63

307.65

3.1

2.3

3.23

2.81

mg/l

49.15

9727

44149

Other systemic involvement of connective tissue

5640

34693

2.06

307.65

2.9

2.4

2.87

2.85

mg/l

0.30

4982

29885

Other CVD (FINNGEN)

2713

6988

4.71

307.65

3.0

1.9

2.92

2.63

mg/l

6.81

2350

5738

Vascular disorders of the intestines

1725

7057

4.24

307.65

4.8

2.2

3.69

2.91

mg/l

25.11

1603

5981

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

20162

77394

2.17

307.65

2.8

2.2

2.87

2.73

mg/l

12.23

17727

66627

Diseases of arteries, arterioles and capillaries (FINNGEN)

4929

12570

3.75

307.65

3.0

1.9

3.07

2.61

mg/l

27.07

4396

10511

Persons encountering health services for examination and investigation

12101

37945

1.82

307.65

2.5

2.1

2.81

2.77

mg/l

0.90

10596

32412

ILD medications: immunosuppressive drugs

15732

70204

2.73

307.65

3.3

2.1

2.88

2.69

mg/l

22.14

14370

60299

Asthma

15375

48514

1.91

307.65

2.6

2.1

2.82

2.69

mg/l

8.30

13649

41624

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

20751

83195

1.86

307.65

2.8

2.2

2.91

2.70

mg/l

28.19

18228

71890

Ulcer of lower limb, not elsewhere classified

3616

17153

3.40

307.65

3.5

2.4

3.29

2.92

mg/l

11.23

3225

14733

Infections, IBD-co-morbidities

3583

7716

4.72

307.65

3.3

2.0

2.86

2.71

mg/l

2.57

3229

6558

Emergency coronary revascularization (for ACS)

17338

63155

2.00

307.65

2.8

2.3

2.99

2.81

mg/l

16.76

15453

53875

Other diseases of intestine

3267

15974

2.84

307.65

3.4

2.2

2.83

2.80

mg/l

0.27

2940

13697

ILD medications: azathioprine

3826

14118

4.60

307.65

4.2

2.1

2.87

2.64

mg/l

9.14

3569

12163

Anxiety disorders

18111

80731

1.79

307.65

2.6

2.3

2.65

2.76

mg/l

7.81

15768

70217

Heart failure, not strict

18581

56093

3.22

307.65

3.1

2.1

3.12

2.68

mg/l

87.32

16737

47619

Other bacterial intestinal infections, including avohilmo

4906

28385

2.21

307.65

3.1

2.3

2.91

2.83

mg/l

1.48

4368

24403

Diabetes mellitus

20774

78167

1.78

307.65

2.7

2.2

3.00

2.66

mg/l

72.32

18375

67251

10978

66308

1.64

307.65

2.6

2.3

2.91

2.77

mg/l

7.07

9531

57423

Cardiovascular diseases

11284

34253

2.03

307.65

2.5

2.1

2.66

2.49

mg/l

13.13

10028

29483

Specific personality disorders

4508

25524

2.22

307.65

2.5

2.2

2.64

2.61

mg/l

0.42

3920

22297

Sleep disorders (combined)

22319

80746

1.64

307.65

2.5

2.3

2.78

2.79

mg/l

0.40

19349

69845

Opioids

20539

63756

1.96

307.65

2.6

2.1

2.79

2.69

mg/l

7.82

17906

54811

Spondylosis

10259

52470

1.78

307.65

2.6

2.3

2.83

2.88

mg/l

1.30

8977

45034

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

5348

32368

1.99

307.65

2.8

2.2

3.20

2.65

mg/l

52.33

4785

28070

Other arthritis (FG)

5946

35505

2.04

307.65

2.8

2.2

2.91

2.75

mg/l

5.57

5288

30404

Other (not insulin) diabetes medications

19224

77010

1.67

307.65

2.7

2.2

3.06

2.71

mg/l

70.13

16988

66268

Used for control exclusion in common control thyroid runs

22978

68678

2.01

307.65

2.8

2.1

2.79

2.74

mg/l

2.47

20368

58668

Oedema, not elsewhere classified

7540

37218

2.67

307.65

3.0

2.2

3.02

2.83

mg/l

8.57

6659

31798

Crohn's disease of small intestine

1859

6345

5.86

307.65

4.9

2.1

2.73

2.68

mg/l

0.37

1762

5499

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3016

15511

2.74

307.65

3.4

2.4

3.62

2.81

mg/l

39.40

2752

13401

Other systemic involvement of connective tissue (FG)

5545

29521

2.42

307.65

2.9

2.2

2.87

2.80

mg/l

1.57

4898

25105

Neurological diseases, wide definition

5447

13370

2.41

307.65

2.4

2.1

2.67

2.58

mg/l

2.13

4773

11482

Colorectal cancer, including Hilmo

5635

30064

2.27

307.65

2.5

2.4

3.51

2.83

mg/l

45.80

4978

25790

Hypothyroidism, other/unspecified

17700

82370

1.61

307.65

2.5

2.3

2.80

2.77

mg/l

1.19

15430

71179

Dysphagia

5154

29947

2.17

307.65

2.7

2.3

2.79

2.86

mg/l

1.27

4484

25637

Benzodiazepine use

21477

95055

1.78

307.65

2.6

2.3

2.84

2.77

mg/l

3.72

18394

82523

Glomerular diseases

3660

19932

2.49

307.65

3.5

2.4

3.00

2.81

mg/l

5.04

3327

17254

Endocrine, nutritional and metabolic diseases

15844

45253

2.07

307.65

2.5

2.1

2.74

2.62

mg/l

8.00

13943

38738

Dizziness and giddiness

15612

78766

1.82

307.65

2.6

2.3

2.76

2.83

mg/l

3.68

13592

68038

Cough

7664

45877

1.82

307.65

2.7

2.2

2.84

2.77

mg/l

1.66

6684

39466

Liquid cancers, including Hilmo

7346

38092

2.15

307.65

2.6

2.4

3.37

2.79

mg/l

38.03

6511

32717

Second line medication for Crohn's disease

12990

71875

2.34

307.65

3.2

2.3

2.88

2.74

mg/l

11.42

11841

62091

Hypokalaemia

2661

13116

2.90

307.65

3.1

2.3

3.13

2.90

mg/l

4.18

2374

11290

5-aminosalicylic acid

5510

21299

4.12

307.65

4.1

2.1

2.63

2.65

mg/l

0.17

5122

18314

Gout, FINNGEN

6208

36266

2.21

307.65

3.0

2.3

3.23

2.90

mg/l

14.93

5545

30809

Retention of urine

7001

35549

1.95

307.65

2.6

2.4

2.96

2.91

mg/l

0.89

6055

30512

Anxiety (asthma-related co-morbidities)

12580

53741

2.17

307.65

2.5

2.3

2.57

2.69

mg/l

7.80

10924

47041

Hypothyroidism, strict autoimmune, 3 medication purchases required

16384

80007

1.55

307.65

2.5

2.3

2.84

2.77

mg/l

3.04

14243

69165

Any gastric operation

16880

43926

2.32

307.65

2.7

1.9

2.85

2.50

mg/l

59.96

14835

37355

Gout, idiopatic and unspecified

5280

31033

2.26

307.65

3.1

2.4

3.18

2.90

mg/l

10.12

4707

26548

Other septicaemia

9330

45098

2.71

307.65

3.2

2.3

3.27

2.80

mg/l

49.53

8334

38416

Colectomy operation

3923

19442

3.10

307.65

3.2

2.4

3.47

2.85

mg/l

26.51

3555

16733

Gout

6208

27567

2.61

307.65

3.0

2.3

3.23

2.92

mg/l

13.40

5545

23402

Other pulmonary diagnosis

14837

48927

1.72

307.65

2.5

2.1

2.78

2.70

mg/l

4.22

13002

41981

Other/unspecified dorsalgia

7256

45275

1.87

307.65

2.6

2.3

2.80

2.84

mg/l

0.81

6373

38925

Other antidepressants

22548

67985

2.03

307.65

2.5

2.3

2.74

2.82

mg/l

4.89

19547

58987

Other arthrosis

9475

42223

1.72

307.65

2.6

2.2

2.77

2.81

mg/l

0.69

8295

36188

Mucosal proctocolitis

3283

12258

4.63

307.65

4.0

2.1

2.67

2.69

mg/l

0.19

3052

10660

Hernia of abdominal wall, postoperative

4077

16303

3.50

307.65

3.0

1.9

3.03

2.50

mg/l

33.92

3611

13787

Neurological diseases

16376

54553

1.70

307.65

2.4

2.3

2.73

2.75

mg/l

0.28

14268

47142

Alcohol use disorder, Swedish definition

9993

60856

1.72

307.65

2.6

2.3

2.91

2.78

mg/l

5.87

8704

52654

Obesity related asthma

7119

41059

2.20

307.65

2.8

2.3

3.07

2.75

mg/l

21.57

6393

35528

Cystitis

16810

71038

1.59

307.65

2.6

2.3

2.76

2.79

mg/l

0.95

14619

61319

Asthma, unspecified (mode)

11652

46401

2.23

307.65

2.7

2.1

2.92

2.70

mg/l

15.02

10269

39775

Asthma-related pneumonia

7649

48150

1.94

307.65

3.0

2.4

3.08

2.87

mg/l

9.36

6855

41296

Alcohol use disorder, ICD-based

7330

47766

1.79

307.65

2.5

2.3

2.87

2.78

mg/l

2.65

6369

41396

Chronic kidney disease

9072

39237

3.70

307.65

3.5

2.3

3.09

2.92

mg/l

7.90

8206

33367

Other disorders of skin and subcutaneous tissue

15019

84522

1.77

307.65

2.9

2.3

2.95

2.82

mg/l

8.77

13236

72837

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

19273

69035

1.95

307.65

2.8

2.2

2.93

2.70

mg/l

29.32

17097

59413

Pacemaker

8216

45382

2.23

307.65

3.0

2.4

3.12

2.95

mg/l

7.51

7298

38680

Obesity and other hyperalimentation

13902

76904

2.11

307.65

2.8

2.3

3.06

2.67

mg/l

63.48

12444

66566

Use of pramipexole

4435

26153

2.22

307.65

2.8

2.4

2.83

2.88

mg/l

0.82

3808

22623

Cardiomyopathy (excluding other)

2543

11808

3.04

307.65

3.1

2.1

2.93

2.68

mg/l

4.83

2293

9937

Other headache syndromes

7856

50738

1.80

307.65

2.5

2.3

2.65

2.74

mg/l

3.09

6907

43909

Viral Sepsis

5038

25021

2.90

307.65

3.3

2.3

3.07

2.82

mg/l

8.91

4549

21416

Conduction disorders

6127

26359

2.39

307.65

2.8

2.2

3.05

2.69

mg/l

20.69

5343

22177

Implicit viral Sepsis, including avohilmo

7357

37928

2.70

307.65

3.1

2.3

2.96

2.82

mg/l

4.85

6565

32503

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

4374

18347

3.76

307.65

4.0

2.2

2.65

2.69

mg/l

0.57

4073

16006

Asthma, hospital admissions 3, pneumonia

7656

48268

1.93

307.65

3.0

2.4

3.08

2.87

mg/l

9.36

6862

41397

ILD medications

26162

80865

2.13

307.65

2.9

2.1

2.88

2.71

mg/l

24.19

23303

69262

Sleep disorders

16903

86202

1.50

307.65

2.4

2.3

2.61

2.79

mg/l

23.13

14700

74796

Myocardial infarction

9005

39655

1.90

307.65

2.8

2.2

3.06

2.83

mg/l

13.60

7907

33510

Nonorganic sleeping disorders, excluding more controls

3931

20892

2.36

307.65

2.6

2.2

2.50

2.68

mg/l

5.48

3433

18299

Biguanides

18800

77681

1.67

307.65

2.7

2.3

3.08

2.71

mg/l

70.97

16551

66878

Excluding asthma or asthma-COPD overlap

14778

48927

1.71

307.65

2.5

2.1

2.78

2.70

mg/l

3.77

12945

41981

Reimbursement for rheumatic diseases

11084

73073

1.78

307.65

2.8

2.3

2.97

2.79

mg/l

14.05

9990

63021

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

20246

92226

1.58

307.65

2.8

2.3

2.81

2.78

mg/l

1.04

17794

79536

Metabolic disorders

20173

72249

2.01

307.65

2.7

2.3

2.80

2.81

mg/l

0.24

17747

62354

Calcific aortic valvular stenosis, operated

6469

38656

2.09

307.65

3.0

2.4

3.19

2.99

mg/l

7.92

5736

32903

Hypothyroidism, strict autoimmune

14910

62845

1.82

307.65

2.5

2.1

2.82

2.74

mg/l

3.56

12997

53604

Cardiomyopathy

3545

16878

2.89

307.65

3.0

2.1

2.92

2.69

mg/l

5.57

3164

14210

Bacterial infection, other or unspecified, including avohilmo

14733

60883

2.73

307.65

3.0

2.3

3.18

2.76

mg/l

62.38

13105

51945

Myocardial infarction, strict

8189

37686

1.81

307.65

2.8

2.2

3.02

2.83

mg/l

8.90

7184

31834

Atrial fibrillation and flutter

5831

15587

3.11

307.65

2.7

1.9

3.00

2.59

mg/l

23.96

5215

13118

Diarrhoea and gastroenteritis of presumed infectious origin

14511

86293

1.74

307.65

2.9

2.3

2.89

2.76

mg/l

7.80

12819

74455

Other arrhythmias

12332

56130

1.93

307.65

2.6

2.2

2.72

2.64

mg/l

3.26

10780

48105

Other noninfective gastroenteritis and colitis

5295

28933

2.41

307.65

3.5

2.3

2.85

2.80

mg/l

0.80

4793

24966

Erysipelas, including avohilmo

15814

67263

2.15

307.65

2.8

2.2

3.14

2.73

mg/l

65.73

14050

57567

Other or unspecified ileus, impaction or obstruction

3790

20395

2.43

307.65

3.3

2.2

3.09

2.88

mg/l

5.41

3390

17395

Mental and behavioural disorders due to alcohol, excluding acute intoxication

7874

51434

1.76

307.65

2.5

2.3

2.87

2.78

mg/l

2.38

6841

44536

Percutaneous Coronary Intervention

15764

56586

2.06

307.65

2.8

2.3

2.97

2.77

mg/l

19.09

14085

48329

Major coronary heart disease event

16215

60819

1.89

307.65

2.8

2.3

2.97

2.78

mg/l

17.62

14471

51927

Atrial fibrillation and flutter with reimbursement

5053

12111

3.56

307.65

2.8

1.9

3.00

2.62

mg/l

18.83

4497

10078

Dyspnoea

20736

88095

2.11

307.65

2.8

2.3

3.05

2.74

mg/l

53.31

18315

75891

Atherosclerosis, excluding cerebral and coronary sclerosis

8259

43064

1.82

307.65

3.1

2.3

3.32

2.91

mg/l

30.52

7230

36688

AV-block

3998

16924

2.75

307.65

2.9

2.1

3.09

2.73

mg/l

15.70

3495

14071

Constipation

19769

82205

1.98

307.65

2.7

2.3

2.78

2.83

mg/l

2.07

17094

71243

Coronary revascularization (ANGIO or CABG)

15625

56609

2.03

307.65

2.8

2.3

2.97

2.77

mg/l

19.16

13971

48348

Heart failure,strict

13210

41302

3.33

307.65

3.2

2.1

3.34

2.71

mg/l

102.56

11954

34738

Mood disorders, excluding more controls

20052

70188

2.01

307.65

2.6

2.3

2.74

2.80

mg/l

2.61

17398

60999

Mood disorders

21777

88683

1.85

307.65

2.5

2.3

2.73

2.79

mg/l

3.04

18906

76916

Heart failure, strict

14594

50495

2.89

307.65

3.2

2.2

3.38

2.77

mg/l

106.12

13148

42750

Colorectal cancer

4999

27685

2.25

307.65

2.5

2.4

3.58

2.83

mg/l

47.05

4417

23729

Malignant neoplasm of colon, including Hilmo

4114

21730

2.63

307.65

2.6

2.4

3.66

2.82

mg/l

46.92

3672

18647

Presence of cardiac and vascular implants and grafts

10035

40152

2.45

307.65

3.0

2.3

3.07

2.87

mg/l

11.88

8939

34258

Persons encountering health services for other counselling and medical advice, not elsewhere classified

23582

80012

1.84

307.65

2.7

2.3

2.73

2.78

mg/l

2.91

20851

68931

Persons encountering health services in other circumstances, wide

24487

80651

1.82

307.65

2.7

2.3

2.80

2.79

mg/l

0.14

21563

69409

Secondary hypertension

1594

5728

4.01

307.65

3.3

2.0

2.95

2.57

mg/l

7.34

1452

4812

Hypertension, essential

14657

47954

2.05

307.65

2.6

2.1

2.81

2.71

mg/l

5.48

13034

41185

Follow-up examination after treatment for conditions other than malignant neoplasms

8173

33124

1.91

307.65

2.6

2.0

2.67

2.76

mg/l

3.05

7111

28304

Intestinal stricture

6356

39059

2.05

307.65

3.3

2.4

3.07

2.88

mg/l

6.43

5691

33576

Asthma, hospital admission 2, infections

12263

78702

1.79

307.65

2.8

2.4

2.94

2.79

mg/l

8.80

10927

67762

Malignant neoplasm of digestive organs, including Hilmo

8919

38680

2.13

307.65

2.5

2.4

3.40

2.80

mg/l

59.77

7940

33152

Gastro-oesophageal reflux disease

14714

72624

2.11

307.65

2.8

2.2

2.86

2.75

mg/l

6.26

12760

62618

Any mental disorder

22426

71836

1.82

307.65

2.5

2.3

2.74

2.81

mg/l

3.63

19410

62422

Persons encountering health services in other circumstances

8443

50247

2.02

307.65

2.7

2.2

3.07

2.75

mg/l

27.84

7365

43328

Examination and observation for other reasons

13628

37462

2.62

307.65

3.0

2.1

2.83

2.77

mg/l

2.01

12004

32025

Diseases of liver

7161

40984

2.25

307.65

3.1

2.3

3.15

2.80

mg/l

22.85

6428

35492

Hypothyroidism (congenital or acquired)

5093

9308

3.96

307.65

2.4

1.8

2.61

2.31

mg/l

21.39

4455

8027

Myocardial infarction, without ST-elevation

8093

48172

1.84

307.65

2.9

2.4

3.12

2.95

mg/l

6.85

7097

41146

Paralytic ileus and intestinal obstruction

5396

29570

2.35

307.65

3.1

2.2

3.06

2.86

mg/l

6.13

4796

25230

First line medication for Crohn's disease

25621

77873

2.17

307.65

2.9

2.1

2.88

2.70

mg/l

27.08

22896

66575

Autoimmune diseases excluding thyroid diseases, strict definition

23226

71411

2.16

307.65

3.0

2.1

2.82

2.74

mg/l

5.75

20851

61005

Insulin, intermediate and long-acting

11692

68656

2.04

307.65

3.0

2.3

3.24

2.80

mg/l

63.77

10392

59118

Care involving use of rehabilitation procedures

12680

72526

1.85

307.65

2.7

2.3

2.61

2.79

mg/l

15.78

11443

62241

Crohn disease (strict definition, all UC cases excluded)

1390

4554

6.57

307.65

4.9

2.1

2.59

2.70

mg/l

1.50

1331

3936

Diseases of pulp and periapical tissues and dental caries

12748

44882

1.65

307.65

2.5

2.3

2.83

2.90

mg/l

2.31

11025

38638

Abnormal findings on examination of blood, without diagnosis

9589

55213

1.92

307.65

2.8

2.4

2.85

2.86

mg/l

0.19

8611

47479

Other anxiety disorders

9799

47229

2.17

307.65

2.6

2.2

2.53

2.66

mg/l

7.48

8491

41290

Pain in joint

12042

42257

2.09

307.65

2.6

2.2

2.65

2.79

mg/l

9.45

10505

36178

All anxiety disorders

12915

58911

2.05

307.65

2.5

2.3

2.57

2.70

mg/l

8.89

11210

51466

Insulin, fast-acting or short human

7291

45644

1.95

307.65

3.1

2.4

3.22

2.78

mg/l

39.25

6507

39449

Ischaemic heart disease, wide definition

14129

57122

1.78

307.65

2.7

2.3

2.94

2.81

mg/l

8.00

12495

48827

Any reimbursement code in KELA

11119

28898

2.28

307.65

2.6

1.8

2.68

2.45

mg/l

21.66

9920

24329

Substance abuse, excluding more controls

10671

54198

1.94

307.65

2.6

2.3

2.87

2.79

mg/l

2.59

9215

47099

Mood [affective] disorders

21733

88612

1.85

307.65

2.5

2.3

2.73

2.79

mg/l

3.07

18866

76862

Spinal stenosis

10239

46800

1.95

307.65

2.7

2.3

2.91

2.93

mg/l

0.28

8968

39919

Acute renal failure

5924

26514

3.69

307.65

3.5

2.3

3.16

2.90

mg/l

11.45

5375

22576

Other special examinations and investigations of persons without complaint or reported diagnosis

12752

37944

1.98

307.65

2.6

2.1

2.77

mg/l

0.00

11325

32412

Adjustment and management of implanted device

4075

21977

2.58

307.65

3.0

2.4

2.72

2.94

mg/l

6.00

3544

18607

Other medical care

10613

52641

2.13

307.65

2.5

2.3

3.26

2.86

mg/l

44.06

9435

44779

Other CVD

4469

26498

2.26

307.65

2.9

2.4

2.97

2.99

mg/l

0.19

3852

22700

Personality disorders

5218

29475

2.22

307.65

2.6

2.2

2.64

2.61

mg/l

0.34

4529

25777

Non-invasive ventilation

4978

17196

3.29

307.65

2.6

1.9

2.26

2.57

mg/l

16.36

4714

14639

Factors influencing health status and contact with health services

5149

12940

2.31

307.65

2.4

1.9

2.82

2.74

mg/l

1.16

4444

10968

Hernia

17995

83155

1.63

307.65

2.7

2.3

2.95

2.78

mg/l

14.60

15830

71774

Other external causes of accidental injury

14984

53677

1.55

307.65

2.5

2.2

2.75

2.76

mg/l

0.11

12906

46825

Depression or dysthymia

13401

41579

2.11

307.65

2.5

2.3

2.77

2.87

mg/l

4.31

11534

36213

Migraine

9629

48670

1.78

307.65

2.5

2.2

2.55

2.66

mg/l

5.80

8459

42215

Heart failure and coronary heart disease

10380

36147

2.92

307.65

3.2

2.3

3.38

2.86

mg/l

57.87

9397

30383

Hypothyroidism, drug reimbursement

2442

5621

3.89

307.65

2.5

1.7

2.63

2.35

mg/l

8.75

2139

4837

Diverticular disease of intestine

15504

53423

2.26

307.65

2.8

2.1

2.98

2.82

mg/l

11.97

13623

45755

Ulcerative colitis (strict definition, all Crohn cases excluded)

3366

14256

3.66

307.65

3.9

2.2

2.65

2.71

mg/l

0.95

3118

12413

Other reaction to severe stress, and adjustment disorders

6772

40982

1.96

307.65

2.7

2.2

2.75

2.65

mg/l

3.02

5925

35841

Gonarthrosis

11545

44383

1.66

307.65

2.5

2.2

2.91

2.82

mg/l

3.42

10109

38010

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

12935

80386

1.92

307.65

2.9

2.3

2.95

2.80

mg/l

9.30

11457

69251

Use of hypnotics and sedatives

20738

83538

1.60

307.65

2.6

2.3

2.79

mg/l

0.03

18015

72436

Iron deficiency

1039

3218

9.39

307.65

3.9

2.1

2.67

2.53

mg/l

1.11

957

2787

Iron deficiency anaemia secondary to blood loss (chronic)

4553

18147

4.64

307.65

4.7

2.1

4.04

2.73

mg/l

118.53

4191

15398

Iron deficiency anaemia

16133

53825

7.05

307.65

4.3

2.1

3.82

2.69

mg/l

307.65

14812

45826

Other and unspecified anaemias

15605

50880

6.70

307.65

3.8

2.2

3.25

2.86

mg/l

48.06

14187

43203

Hypertensive Heart Disease

4843

19203

2.47

307.65

3.0

2.2

3.33

2.89

mg/l

19.87

4267

16045

Bleeding

17994

75642

2.05

307.65

3.0

2.3

3.12

2.77

mg/l

51.60

15946

64999

Ulcerative colitis

6002

26337

3.43

307.65

4.0

2.2

2.72

mg/l

0.02

5554

22799

Inflammatory bowel disease, strict (require KELA)

6244

24244

4.33

307.65

4.3

2.2

2.64

2.69

mg/l

1.25

5858

21082

Diabetes, insulin treatment (Kela reimbursement)

20062

79851

1.72

307.65

2.8

2.3

3.10

2.71

mg/l

84.30

17733

68812

Asthma/COPD (KELA code 203)

17963

90962

1.45

307.65

2.6

2.3

2.87

2.74

mg/l

9.30

15848

78484

Gastrointestinal diseases

11731

31477

2.20

307.65

2.6

1.8

2.74

2.58

mg/l

9.98

10317

26608

Missing teeth due to accident, extraction or parodontitis

12076

73200

1.73

307.65

2.7

2.4

2.85

mg/l

0.04

10326

63346

Exposure to unspecified factor

19850

99353

1.51

307.65

2.6

2.3

2.74

2.78

mg/l

1.37

16960

86367

Neoplasms

13469

50274

1.55

307.65

2.4

2.2

2.75

2.58

mg/l

13.35

11859

43421

Chronic apical periodontitis

21188

89979

1.45

307.65

2.5

2.3

2.77

2.78

mg/l

0.44

18286

78079

Gastroduodenal ulcer

5727

30770

2.48

307.65

3.3

2.2

3.47

2.89

mg/l

36.28

5103

26230

Gastric ulcer

4007

20028

2.84

307.65

3.4

2.2

3.51

2.90

mg/l

28.99

3581

17093

Other disorders of urethra and urinary system

14670

68161

1.74

307.65

2.6

2.3

2.80

mg/l

0.06

12794

58810

Low back pain

16478

69872

1.88

307.65

2.6

2.3

2.78

mg/l

0.06

14474

60134

Myalgia

4676

27391

2.10

307.65

2.7

2.2

2.67

2.77

mg/l

2.30

4027

23688

Pain in limb

18523

70313

2.03

307.65

2.7

2.3

2.78

2.79

mg/l

0.26

16253

60573

Malaise and fatigue

13960

50210

3.09

307.65

2.9

2.2

2.84

2.78

mg/l

1.64

12181

42914

Falls/tendency to fall

19952

73579

1.49

307.65

2.5

2.3

2.76

2.74

mg/l

0.54

17219

64116

Implicit Sepsis, including avohilmo

19400

75118

2.36

307.65

2.9

2.2

2.94

2.75

mg/l

19.40

17033

64573

All kidney diseases

22651

87047

2.16

307.65

2.9

2.2

2.95

2.70

mg/l

40.46

20095

74871

Codeine or tramadol medication

24355

84168

1.85

307.65

2.7

2.2

2.84

2.76

mg/l

4.81

21272

72571

Asthma-related pneumonia or sepsis

7656

48268

1.93

307.65

3.0

2.4

3.08

2.87

mg/l

9.36

6862

41397

Other disorders of fluid, electrolyte and acid-base balance

8087

35928

3.15

307.65

3.2

2.3

3.08

2.95

mg/l

3.97

7135

30731

Other gastritis (incl. Duodenitis)

4621

24852

2.47

307.65

3.3

2.2

3.14

2.83

mg/l

12.41

4183

21329

Nerve, nerve root and plexus disorders

20609

90654

1.52

307.65

2.6

2.3

2.79

2.80

mg/l

0.18

18174

78158

Pure hypercholesterolaemia

15040

58965

1.92

307.65

2.5

2.3

2.64

2.87

mg/l

26.07

13138

50688

All pneumoniae

21578

88666

1.87

307.65

2.8

2.3

2.95

2.70

mg/l

37.95

19164

76466

Shoulder lesions

13825

58974

1.57

307.65

2.5

2.3

2.75

2.86

mg/l

5.93

12149

50756

Diseases of the eye and adnexa

13965

49976

1.54

307.65

2.4

2.2

2.66

2.72

mg/l

2.55

12242

43504

Hypertension

14503

49423

1.93

307.65

2.7

2.1

2.81

2.70

mg/l

6.26

12910

42491

Other diseases of hard tissues of teeth

10622

37010

1.69

307.65

2.5

2.3

2.70

2.97

mg/l

24.84

9161

31866

Glucagon-like peptide-1 (GLP-1) analogues

5348

32368

1.99

307.65

2.8

2.2

3.20

2.65

mg/l

52.33

4785

28070

Other dorsopathies, not elsewhere classified

20098

71486

1.65

307.65

2.5

2.3

2.71

2.78

mg/l

4.05

17588

61527

Other joint disorders

16421

61223

1.55

307.65

2.5

2.2

2.70

mg/l

0.04

14347

52599

Accidents

14814

53677

1.52

307.65

2.5

2.2

2.75

2.76

mg/l

0.07

12788

46825

Behavioural syndromes associated with physiological disturbances and physical factors

17698

88225

1.51

307.65

2.4

2.61

2.79

mg/l

23.07

15421

76543

Non-ischemic cardiomyopathy

7320

28296

2.96

307.65

3.0

2.2

3.38

2.75

mg/l

51.47

6534

23726

Coronary atherosclerosis

12269

47375

1.97

307.65

2.8

2.2

2.97

2.80

mg/l

9.77

10869

40164

Fall on same level

22400

84756

1.58

307.65

2.5

2.3

2.79

2.74

mg/l

2.96

19310

73757

Valvular heart disease excluding rheumatic fever

10152

36727

2.59

307.65

2.9

2.2

3.15

2.69

mg/l

52.56

9032

31073

Dorsalgia

20256

71356

1.72

307.65

2.5

2.3

2.75

2.78

mg/l

0.87

17737

61415

All chronic kidney diseases

14395

54930

2.99

307.65

3.2

2.2

3.04

2.80

mg/l

24.37

12941

46820

Polyarthropathies

15049

53767

2.23

307.65

2.9

2.2

3.00

2.75

mg/l

27.44

13475

46167

Disorders of other endocrine glands

8602

56769

1.75

307.65

2.9

2.4

2.95

2.78

mg/l

8.45

7580

49138

Lower back pain or/and sciatica

22184

95170

1.66

307.65

2.6

2.3

2.77

2.79

mg/l

0.48

19505

82127

Pain (limb, back, neck, head abdominally)

13858

44406

1.77

307.65

2.5

2.2

2.78

2.81

mg/l

0.95

12115

37904

Other and unspecified dermatitis

10056

69904

1.66

307.65

2.7

2.3

2.85

2.79

mg/l

1.51

8895

60526

Bronchitis

21125

95622

1.46

307.65

2.7

2.3

2.90

2.76

mg/l

12.74

18441

82585

L04AX Other immunosuppressants

12247

69992

2.23

307.65

3.2

2.3

2.91

2.74

mg/l

14.54

11137

60469

Provisional assignment of new diseases of uncertain etiology

11799

72362

2.00

307.65

2.9

2.3

2.82

2.79

mg/l

0.54

10489

62522

Noninfective enteritis and colitis

11664

57210

2.86

307.65

3.8

2.2

2.77

2.78

mg/l

0.17

10703

49333

COPD/asthma related infections

19637

69035

1.60

307.65

2.6

2.2

2.84

2.70

mg/l

12.38

17174

59413

Other neurological diseases

13727

76845

1.57

307.65

2.7

2.4

2.91

2.86

mg/l

1.44

12109

66023

Dermatitis and eczema

21468

95874

1.46

307.65

2.6

2.3

2.76

2.79

mg/l

1.24

18702

82968

Gout, strict definition

3916

21896

2.49

307.65

3.1

2.4

3.25

2.90

mg/l

11.56

3499

18742

Acute tubulo-interstitial nephritis

13868

71209

2.02

307.65

2.8

2.2

3.00

2.75

mg/l

25.54

12170

60896

Gonarthrosis [arthrosis of knee](FG)

13495

53700

1.63

307.65

2.5

2.2

2.92

2.79

mg/l

6.77

11811

45953

Codes for special purposes

11816

72425

2.01

307.65

2.9

2.3

2.82

2.79

mg/l

0.54

10500

62579

Transplanted organ and tissue status

2303

8788

4.51

307.65

3.9

2.3

2.98

2.71

mg/l

6.50

2143

7633

Sleep apnoea

18050

79514

1.63

307.65

2.6

2.3

2.92

2.77

mg/l

13.44

15733

68945

Dermatitis

12068

83410

1.61

307.65

2.7

2.3

2.84

2.80

mg/l

1.21

10661

72140

Substance abuse

10671

67337

1.69

307.65

2.6

2.3

2.87

2.76

mg/l

4.15

9215

58361

Type 2 diabetes, definitions combined

18842

71725

1.77

307.65

2.7

2.2

3.05

2.69

mg/l

70.45

16648

61604

Other bacterial diseases, including avohilmo

22898

81946

2.15

307.65

2.8

2.2

3.05

2.68

mg/l

80.77

20357

70467

Open wound of head

10326

67401

1.64

307.65

2.6

2.4

2.87

2.85

mg/l

0.32

8757

58383

Disorders of thyroid, IBD co-morbidities

3400

10056

2.90

307.65

2.6

1.9

2.67

2.62

mg/l

0.53

2970

8566

Personality disorders, excluding more controls

5218

24546

2.77

307.65

2.6

2.2

2.64

2.61

mg/l

0.37

4529

21520

Covid-19 confirmed case

8836

49909

2.39

307.65

3.0

2.4

2.83

2.85

mg/l

0.28

7892

42998

8764

57090

1.79

307.65

2.8

2.3

2.88

2.75

mg/l

5.38

7807

49336

Other soft tissue disorders, not elsewhere classified

20816

71382

2.00

307.65

2.6

2.3

2.75

2.79

mg/l

1.36

18258

61499

Heart failure and bmi 25plus

7884

25913

2.89

307.65

3.2

2.3

3.50

2.91

mg/l

50.22

7064

21789

Type 2 diabetes, definitions combined, including avohilmo

18673

71613

1.73

307.65

2.7

2.2

3.04

2.68

mg/l

69.22

16469

61566

Coxarthrosis [arthrosis of hip](FG)

10169

46220

1.75

307.65

2.6

2.2

2.96

2.82

mg/l

6.20

8859

39329

Arthrosis

12698

48529

1.60

307.65

2.5

2.2

2.84

2.79

mg/l

1.74

11145

41636

Other intervertebral disc disorders

15666

64863

1.62

307.65

2.5

2.3

2.71

2.81

mg/l

7.05

13802

55822

Rheumatoid arthritis

6400

32610

2.16

307.65

2.8

2.2

3.14

2.82

mg/l

20.22

5765

27848

COPD (mode)

5716

27066

1.99

307.65

2.7

2.2

3.25

2.82

mg/l

23.97

4956

22974

Renal tubulo-interstitial diseases

21494

84443

2.44

307.65

3.0

2.2

2.98

2.73

mg/l

39.90

19084

72508

Intracranial trauma

11280

46077

1.92

307.65

2.5

2.2

2.81

2.71

mg/l

3.96

9814

39843

Other cataract

8339

38381

1.93

307.65

2.7

2.3

2.95

2.84

mg/l

3.29

7188

33052

Other specified/unspecified arthritis

5241

30387

2.13

307.65

2.8

2.2

2.90

2.77

mg/l

3.71

4646

26070

Intracranial injury

11541

74488

1.65

307.65

2.6

2.4

2.88

2.81

mg/l

2.05

9958

64471

Episodal and paroxysmal disorders

21874

76646

1.63

307.65

2.5

2.3

2.78

2.77

mg/l

0.08

19124

66111

COPD differential diagnosis

14690

48915

1.70

307.65

2.5

2.1

2.78

2.69

mg/l

4.07

12874

41972

19273

69035

1.95

307.65

2.8

2.2

2.93

2.70

mg/l

29.32

17097

59413

Asthma, unspecified (mode), excluding more controls

11175

41893

2.37

307.65

2.7

2.1

2.90

2.64

mg/l

22.17

9863

35800

Senile cataract

11024

43853

1.77

307.65

2.7

2.2

2.92

2.83

mg/l

3.02

9523

37859

Other Crohn's disease

1886

6134

6.30

307.65

5.0

2.1

2.59

2.70

mg/l

1.56

1794

5335

Diseases of the skin and subcutaneous tissue

19181

67630

1.59

307.65

2.6

2.2

2.76

2.79

mg/l

0.63

16725

58294

Crohn's disease of large intestine

1310

4406

5.91

307.65

5.1

2.1

2.63

2.71

mg/l

0.78

1240

3818

Soft tissue disorders

20068

71957

1.60

307.65

2.5

2.3

2.72

2.79

mg/l

3.97

17535

61974

Genitourinary diseases

9660

31263

1.73

307.65

2.5

2.2

2.73

mg/l

0.01

8429

27062

Other heart diseases

9205

28687

2.59

307.65

2.8

2.1

2.86

2.53

mg/l

27.99

8220

24614

Cardiac arrhythmias

11381

40533

2.14

307.65

2.6

2.1

2.78

2.52

mg/l

23.85

10102

34790

Disorders of choroid and retina

15259

76471

1.58

307.65

2.7

2.3

2.91

2.84

mg/l

2.77

13132

66019

Schizophrenia or delusion, excluding more controls

5085

29672

1.99

307.65

2.4

2.2

2.71

2.76

mg/l

0.87

4433

25946

Hard cardiovascular diseases

15794

57877

1.90

307.65

2.7

2.2

2.92

2.73

mg/l

16.52

14090

49570

Infections of the skin and subcutaneous tissue

11166

75273

1.68

307.65

2.9

2.3

2.85

2.75

mg/l

4.51

9930

65218

Intestinal infectious diseases, including avohilmo, including avohilmo

23432

91152

1.62

307.65

2.7

2.3

2.81

2.78

mg/l

0.92

20582

78601

COPD/asthma/ILD related infections

19637

69035

1.60

307.65

2.6

2.2

2.84

2.70

mg/l

12.38

17174

59413

Gout, unspecified

4343

24938

2.36

307.65

3.1

2.4

3.21

2.89

mg/l

10.94

3863

21336

Other bacterial diseases

22104

79686

2.34

307.65

2.9

2.2

3.10

2.71

mg/l

83.72

19653

68508

Other diseases of intestines

23461

76671

2.05

307.65

2.8

2.1

2.83

2.70

mg/l

12.27

20704

66008

Disorders of eyelid, lacrimal system and orbit

16602

90770

1.49

307.65

2.6

2.4

2.74

2.82

mg/l

4.54

14432

78523

Influenza and pneumonia

22248

88000

1.83

307.65

2.8

2.2

2.93

2.69

mg/l

39.19

19729

75863

Other and unspecified iron deficiency

13457

42745

9.01

307.65

4.4

2.1

3.84

2.69

mg/l

282.23

12380

36491

Complications of procedures, not elsewhere classified

17531

88500

1.92

307.65

2.8

2.3

2.97

2.75

mg/l

23.58

15546

76267

Injuries to the head

22072

95041

1.54

307.65

2.5

2.3

2.80

2.77

mg/l

0.93

18975

82523

GASTRO-related operations

16880

43926

2.32

307.65

2.7

1.9

2.85

2.50

mg/l

59.96

14835

37355

Autoimmune diseases

24574

74000

2.02

307.65

2.8

2.1

2.80

2.74

mg/l

4.06

21822

63245

Insomnia

16529

85692

1.48

307.65

2.4

2.3

2.59

2.78

mg/l

25.12

14370

74397

Chronic lower respiratory diseases

22971

91059

1.46

307.65

2.6

2.3

2.85

2.74

mg/l

8.01

20245

78565

Autoimmune diseases excluding thyroid diseases

23947

73564

2.16

307.65

3.0

2.1

2.83

2.74

mg/l

6.99

21505

62872

Other diseases of anus and rectum

6482

35741

2.32

307.65

3.0

2.2

3.03

2.83

mg/l

7.83

5624

30546

Arthropathies

16849

61336

1.53

307.65

2.5

2.2

2.74

2.70

mg/l

1.55

14810

52708

Bacterial infection, other or unspecified

13532

57298

2.77

307.65

3.0

2.3

3.21

2.78

mg/l

60.53

12022

48819

Diseases of oesophagus, stomach and duodenum

24782

82834

2.20

307.65

2.9

2.2

2.92

2.73

mg/l

26.60

21839

71422

Cardiovascular diseases (excluding rheumatic etc)

11739

38785

2.02

307.65

2.6

2.1

2.72

2.50

mg/l

22.13

10491

33326

Diseases of oral cavity, salivary glands and jaws

11136

37662

1.74

307.65

2.5

2.3

2.80

2.98

mg/l

11.28

9630

32368

Osteopathies and chondropathies

11778

67673

1.93

307.65

2.9

2.3

2.95

2.82

mg/l

7.02

10313

58432

Asthma (only as main-diagnosis), excluding more controls

13491

43907

1.99

307.65

2.6

2.1

2.84

2.63

mg/l

18.61

11984

37558

Systemic connective tissue disorders

7349

44956

2.07

307.65

2.9

2.4

2.90

2.85

mg/l

1.06

6524

38715

Biological medication for rheuma

3743

18037

2.87

307.65

3.8

2.3

2.75

2.65

mg/l

2.34

3509

15771

Benign neoplasms

18647

73811

1.52

307.65

2.6

2.2

2.84

2.71

mg/l

11.61

16350

63774

Irritable bowel syndrome

5524

30977

2.24

307.65

2.6

2.1

2.56

2.72

mg/l

6.54

4765

26695

Asthma, excluding more controls

14660

43907

2.02

307.65

2.6

2.1

2.81

2.63

mg/l

14.14

13019

37558

Anxiety disorders, excluding more controls

16771

64781

1.96

307.65

2.6

2.3

2.66

2.78

mg/l

8.10

14583

56417

Peripheral artery disease

8884

45574

1.88

307.65

3.1

2.3

3.31

2.90

mg/l

33.74

7798

38876

Depression

20378

84697

1.91

307.65

2.6

2.3

2.71

2.77

mg/l

2.73

17697

73560

Diseases of the digestive system

11191

60194

2.51

307.65

3.4

2.3

3.18

2.83

mg/l

32.94

10040

51663

Polyarthrosis

4114

20239

2.36

307.65

2.8

2.3

3.01

2.90

mg/l

2.19

3629

17194

Intestinal infectious diseases

19466

99014

1.68

307.65

2.9

2.3

2.86

2.76

mg/l

6.16

17208

85424

Recurrent or chronic depression

8123

27014

2.62

307.65

2.5

2.2

2.66

2.78

mg/l

5.07

7079

23729

Disorders of the thyroid gland

18818

87140

1.58

307.65

2.5

2.3

2.81

2.77

mg/l

1.41

16380

75305

Osteoporosis

5806

31135

2.27

307.65

3.1

2.4

3.11

2.96

mg/l

4.35

5061

26663

Unspecified haematuria

8267

43884

1.83

307.65

2.7

2.4

2.93

2.89

mg/l

0.97

7160

37829

Other diseases of urinary system

19809

77084

1.64

307.65

2.5

2.3

2.76

2.78

mg/l

0.61

17143

66659

Other septicaemia, including avohilmo

9542

45859

2.72

307.65

3.2

2.3

3.26

2.80

mg/l

50.16

8530

39062

Other diseases of the digestive system

7790

41440

2.63

307.65

3.5

2.3

3.38

2.88

mg/l

43.60

7007

35465

Symptoms and signs concerning food and fluid intake

2462

11164

3.26

307.65

2.8

2.2

2.74

2.78

mg/l

0.33

2143

9588

Syncope and collapse

9640

45756

2.17

307.65

2.7

2.2

2.83

2.81

mg/l

0.47

8294

39017

Spondylopathies

15647

59610

1.81

307.65

2.6

2.3

2.85

mg/l

0.03

13722

51206

Dorsopathies

19585

71765

1.53

307.65

2.5

2.3

2.72

2.78

mg/l

2.93

17108

61790

Seropositive rheumatoid arthritis

4721

27560

2.12

307.65

2.8

2.2

3.21

2.82

mg/l

22.53

4277

23405

Other retinal disorders

12594

66272

1.67

307.65

2.7

2.4

2.98

2.88

mg/l

4.02

10829

57001

Symptoms and signs involving the nervous and musculoskeletal systems

11249

78855

1.65

307.65

2.6

2.4

2.71

2.82

mg/l

5.58

10005

68018

Pain in throat and chest

17574

62922

1.95

307.65

2.6

2.2

2.74

2.73

mg/l

0.14

15350

54209

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6472

16181

2.33

307.65

2.3

1.9

2.71

2.67

mg/l

0.60

5651

13819

Sulfasalazine

5594

31277

2.24

307.65

3.0

2.1

2.97

2.71

mg/l

14.29

5073

26816

Headache

13639

62485

2.00

307.65

2.6

2.2

2.70

2.71

mg/l

0.07

12049

53750

Finngen Rheumatological endpoints

19059

71874

1.72

307.65

2.6

2.2

2.82

2.70

mg/l

10.04

16882

61738

Crohn disease (strict definition, require KELA, min 2 HDR)

1770

5830

6.58

307.65

5.1

2.2

2.56

2.66

mg/l

1.46

1693

5075

Symptoms and signs involving the circulatory and respiratory systems

20194

64724

1.80

307.65

2.6

2.2

2.75

2.72

mg/l

0.72

17722

55766

Diseases of the musculoskeletal system and connective tissue

9960

32450

1.72

307.65

2.4

2.2

2.71

2.70

mg/l

0.06

8728

27788

Haemorrhage from respiratory passages

7582

36252

2.38

307.65

3.0

2.2

3.10

2.85

mg/l

11.58

6671

30906

Symptoms and signs involving cognition, perception, emotional state and behaviour

20437

88329

1.82

307.65

2.6

2.3

2.74

2.80

mg/l

3.63

17793

76451

Pain, not elsewhere classified

6026

31603

2.46

307.65

2.8

2.2

2.70

2.73

mg/l

0.46

5364

27250

Abnormalities of heart beat

7457

42085

2.11

307.65

2.7

2.2

2.76

2.79

mg/l

0.37

6495

36094

Non-selective monoamine reuptake inhibitors

7036

40417

2.03

307.65

2.7

2.3

2.92

2.89

mg/l

0.39

6102

35050

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

4036

16454

3.98

307.65

4.1

2.2

2.67

2.69

mg/l

0.25

3763

14361

Nausea and vomiting

6229

32460

2.46

307.65

3.1

2.3

2.92

2.85

mg/l

1.73

5537

27873

Abdominal and pelvic pain

19596

66026

1.69

307.65

2.6

2.2

2.77

2.78

mg/l

0.11

17173

56803

Obesity, other/unspecified

7446

39269

2.50

307.65

2.9

2.2

3.04

2.65

mg/l

33.06

6728

34103

Diaphragmatic hernia

8070

44404

2.46

307.65

3.2

2.3

3.09

2.86

mg/l

10.23

7181

38033

Obesity due to excess calories

10519

58464

2.32

307.65

2.8

2.3

3.06

2.65

mg/l

60.50

9465

50725

Disorders of lipoprotein metabolism and other lipidaemias

16443

62242

1.89

307.65

2.6

2.3

2.73

2.86

mg/l

8.42

14387

53544

L04AD Calcineurin inhibitors

2525

10202

4.17

307.65

3.9

2.4

2.90

2.71

mg/l

4.12

2351

8929

Hypo-osmolality and hyponatraemia

4318

20194

3.22

307.65

3.1

2.3

2.98

2.99

mg/l

0.01

3780

17283

6-mercaptopurine

1008

2867

7.96

307.65

4.0

2.0

2.50

2.54

mg/l

0.28

951

2473

Oxycodone

9442

38935

2.85

307.65

2.9

2.2

3.32

2.82

mg/l

57.34

8341

33137

Benign neoplasm of colon, rectum, anus and anal canal

14165

70310

2.18

307.65

3.0

2.3

3.10

2.85

mg/l

24.43

12539

60284

Chronic gastritis

6059

32009

2.61

307.65

3.2

2.2

3.01

2.88

mg/l

3.57

5270

27366

Benign neoplasm: Colon

11898

66537

2.15

307.65

3.0

2.3

3.12

2.86

mg/l

23.45

10570

57019

Dialysis, with operation codes

3067

12501

4.24

307.65

4.1

2.2

2.96

2.79

mg/l

3.65

2835

10732

Concussion

9838

45488

1.96

307.65

2.5

2.2

2.80

2.72

mg/l

2.59

8521

39324

Selective serotonin reuptake inhibitors

19915

68296

1.73

307.65

2.4

2.3

2.76

2.81

mg/l

2.49

17079

59270

Aplastic and other anaemias

16576

53672

6.28

307.65

3.8

2.2

3.25

2.85

mg/l

52.54

15061

45568

Mental and behavioural disorders due to psychoactive substance use

10989

68742

1.67

307.65

2.6

2.3

2.87

2.76

mg/l

4.86

9478

59597

Diabetes medication

20794

82768

1.67

307.65

2.7

2.2

3.02

2.68

mg/l

73.37

18372

71308

L04AA Selective immunosuppressants

4811

24120

2.80

307.65

3.5

2.3

2.97

2.73

mg/l

11.28

4461

20947

Other functional intestinal disorders

10347

51738

2.31

307.65

2.7

2.2

2.76

2.79

mg/l

0.53

9050

44302

All influenza

5098

30523

2.05

307.65

3.0

2.3

3.09

2.76

mg/l

13.28

4503

26238

Budesonide

3886

14460

4.73

307.65

4.2

2.1

2.60

2.68

mg/l

1.40

3598

12413

Vocal cord dysfunction

2432

8072

3.41

307.65

2.5

1.7

2.75

2.53

mg/l

5.15

2087

6822

Ulcerative rectosigmoiditis

1809

7663

3.67

307.65

3.9

2.1

2.67

2.71

mg/l

0.38

1686

6641

Other bacterial intestinal infections

3824

21449

2.35

307.65

3.3

2.3

3.02

2.86

mg/l

3.70

3440

18431

Glomerular disorders in diseases classified elsewhere

2513

12313

3.05

307.65

3.7

2.3

3.01

2.81

mg/l

4.23

2280

10640

Dipeptidyl peptidase 4 (DPP-4) inhibitors

12413

53878

2.39

307.65

2.9

2.3

3.27

2.80

mg/l

69.40

10926

46010

Ulcerative colitis, NAS

3439

13970

4.02

307.65

4.3

2.2

2.75

2.72

mg/l

0.34

3199

12130

Depression medications

5435

9604

3.54

307.65

2.4

1.8

2.62

2.32

mg/l

20.24

4745

8289

Type 2 diabetes, wide definition

17069

60508

2.22

307.65

2.9

2.2

3.11

2.73

mg/l

63.29

15211

51771

Azathioprine

3826

14327

4.52

307.65

4.2

2.1

2.87

2.65

mg/l

8.58

3569

12326

Parasetamol

14957

39856

2.26

307.65

2.5

2.1

2.80

2.61

mg/l

17.22

13160

34074

Diabetes, varying definitions

20648

78110

1.77

307.65

2.7

2.2

3.00

2.66

mg/l

71.28

18263

67207

Nephropathy related operations

2861

12419

3.87

307.65

4.1

2.3

2.98

2.81

mg/l

3.57

2638

10746

Tumor necrosis factor alpha inhibitors

3281

16133

2.78

307.65

3.7

2.3

2.72

2.64

mg/l

1.48

3071

14117

Tramadol

18007

56725

2.40

307.65

2.8

2.1

2.87

2.73

mg/l

11.64

15806

48746

Disorders of adult personality and behaviour

5477

31421

2.16

307.65

2.5

2.2

2.64

2.60

mg/l

0.71

4746

27479

Other nutritional deficiencies

15389

78768

2.28

307.65

2.8

2.3

3.02

2.67

mg/l

57.97

13802

68117

Codeine

20065

62762

2.08

307.65

2.6

2.1

2.81

2.69

mg/l

9.62

17518

53946

Sleep apnoea, including avohilmo

19012

81849

1.58

307.65

2.6

2.3

2.88

2.76

mg/l

9.22

16580

70997

Sciatica+with lumbago

10011

57069

1.82

307.65

2.5

2.3

2.73

2.80

mg/l

2.68

8893

49224

Paroxysmal tachycardia

3991

16293

2.53

307.65

2.8

2.0

2.86

2.56

mg/l

11.60

3518

13761

Psychiatric diseases

19276

62206

1.78

307.65

2.5

2.3

2.74

2.82

mg/l

4.02

16724

54013

Oral corticosteroids

24800

82159

2.20

307.65

2.9

2.2

2.98

2.72

mg/l

47.51

22137

70293

Other anaemias

15705

51179

6.64

307.65

3.8

2.2

3.25

2.86

mg/l

48.66

14275

43449

Mycoses, including avohilmo

17143

99619

1.44

304.45

2.6

2.3

2.77

mg/l

0.10

14813

86449

Convulsions, not elsewhere classified

4277

24434

2.07

303.95

2.6

2.2

2.79

2.71

mg/l

1.49

3694

21031

Noninfectious colitis NAS

2852

14886

2.62

302.80

3.6

2.2

2.85

2.80

mg/l

0.56

2595

12851

Fibromyalgia

1979

8951

3.18

301.81

2.7

2.2

2.64

2.72

mg/l

0.95

1785

7743

Haemorrhoids and perianal venous thrombosis

6280

40093

1.83

301.55

2.7

2.2

2.98

2.81

mg/l

6.48

5543

34255

Rotator cuff syndrome

11004

53906

1.58

299.90

2.6

2.3

2.77

2.87

mg/l

4.31

9688

46372

Bipolar affective disorders

3426

18732

2.28

299.36

2.4

2.2

2.66

2.64

mg/l

0.29

2989

16408

Lumbar disc prolapse

11332

60100

1.56

298.46

2.5

2.3

2.71

2.80

mg/l

4.44

10024

51830

Hyperkalaemia

1476

6056

4.26

296.31

3.8

2.3

3.39

3.02

mg/l

5.26

1342

5201

Poisoning by medicine

4007

23155

2.15

295.96

2.6

2.3

2.80

2.64

mg/l

4.36

3501

20235

Other extrapyramidal and movement disorders in other diseases

4908

30341

2.04

295.74

2.6

2.4

2.66

2.85

mg/l

7.96

4188

26332

Bacterial intestinal infections, IBD co-morbidities

3806

22075

2.25

291.27

3.3

2.4

3.02

2.88

mg/l

2.94

3420

19038

Organic, including symptomatic, mental disorders

9923

49583

1.64

290.82

2.5

2.4

2.89

2.96

mg/l

1.71

8467

42509

Unspecified fall

9819

68589

1.60

289.13

2.6

2.4

2.82

2.84

mg/l

0.20

8388

59349

Restless leg syndrome

2980

16205

2.53

285.82

2.7

2.4

2.58

2.82

mg/l

8.72

2558

14067

Cholelithiasis

15503

80268

1.46

285.07

2.7

2.3

2.97

2.79

mg/l

15.70

13581

69158

Gonarthrosis,primary

15911

72855

1.45

284.96

2.5

2.4

2.93

2.85

mg/l

3.95

13885

62812

Rheumatoid arthritis, including avohilmo

7052

47514

1.76

284.15

2.8

2.4

3.10

2.83

mg/l

16.56

6343

40823

2755

14392

2.49

281.67

2.9

2.2

2.45

2.69

mg/l

7.64

2398

12485

Extrapyramidal and movement disorders

7438

50897

1.73

280.15

2.5

2.4

2.72

2.89

mg/l

9.37

6324

43920

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

5325

33612

1.88

279.05

2.6

2.3

2.73

2.62

mg/l

3.72

4661

29360

Venous thromboembolism

10056

69726

1.59

278.52

2.8

2.4

3.15

2.86

mg/l

20.89

8860

59886

Gingivitis and periodontal diseases

18266

72798

1.41

278.34

2.5

2.4

2.71

2.86

mg/l

14.24

15766

63255

Stroke, excluding SAH

10930

57241

1.57

277.65

2.7

2.4

3.06

2.90

mg/l

7.69

9486

49045

Implicit fungal Sepsis, including avohilmo

1686

7572

3.64

277.37

3.4

2.2

3.08

2.78

mg/l

4.37

1487

6499

Polyneuropathies and other disorders of the peripheral nervous system

4266

25910

2.11

276.97

2.9

2.4

2.88

mg/l

0.05

3748

22299

Stroke, including SAH

11368

59624

1.55

274.54

2.7

2.4

3.06

2.88

mg/l

9.16

9876

51125

Other diseases of liver

3447

19626

2.25

274.30

3.1

2.3

2.99

2.76

mg/l

6.22

3080

17036

Acute upper respiratory infections of multiple and unspecified sites

14179

77947

1.46

271.23

2.6

2.3

2.83

2.76

mg/l

2.57

12428

67508

Other ulcerative colitis

1297

5141

4.16

271.03

4.4

2.1

2.93

2.71

mg/l

3.08

1223

4440

Bacterial pneumoniae

7567

45408

1.69

270.34

2.8

2.3

2.79

mg/l

0.01

6796

38891

Ischaemic Stroke, excluding all haemorrhages

10358

55168

1.58

269.61

2.7

2.4

3.06

2.91

mg/l

6.46

8976

47228

Functional dyspepsia

4904

30644

1.92

269.05

2.7

2.2

2.58

2.75

mg/l

7.35

4289

26424

Abnormal findings on diagnostic imaging of lung

9023

60841

1.62

268.63

2.8

2.4

3.08

2.88

mg/l

10.53

7891

52183

Peripheral arterial reconstruction

3571

21051

2.28

266.72

3.2

2.4

3.36

2.97

mg/l

13.64

3154

17980

Visual disturbances and blindness

9841

71159

1.57

265.14

2.6

2.4

2.71

2.83

mg/l

6.02

8534

61506

Other and unspecified polyneuropathies, also in other diseases

3771

22490

2.18

263.70

2.9

2.4

2.88

mg/l

0.03

3314

19366

Kidney transplant status

1165

4468

4.58

263.68

3.9

2.3

2.85

2.76

mg/l

0.82

1076

3877

Other diseases of blood and blood-forming organs, wide

4162

25347

2.07

263.63

2.9

2.4

3.22

2.79

mg/l

14.52

3680

21957

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

16667

100632

1.41

263.44

2.6

2.3

2.77

mg/l

0.15

14513

87212

Fracture of femur

5626

33090

1.86

262.86

2.7

2.4

3.05

3.00

mg/l

0.82

4839

28263

KRA_PSY_EATING, excluding more controls

1776

7995

3.05

262.53

2.8

2.1

2.52

2.46

mg/l

0.68

1551

6981

Fibrosis and cirrhosis of liver

1726

8020

3.45

262.43

3.8

2.3

3.59

2.83

mg/l

19.21

1601

6914

Candidiasis, including avohilmo

5870

38711

1.81

261.97

2.8

2.3

2.88

2.73

mg/l

4.63

5090

33611

Sequelae of external causes of morbidity and mortality

4934

31416

1.93

260.01

2.9

2.4

2.97

2.82

mg/l

3.81

4444

27171

Other degenerative diseases of the nervous system

5229

24020

1.86

259.74

2.4

2.2

2.77

2.86

mg/l

1.65

4433

20523

Complications of internal orthopaedic prosthetic devices, implants and grafts

4407

27420

2.02

258.61

2.8

2.3

3.06

2.89

mg/l

4.57

3898

23444

Persistent mood disorders

3563

20761

2.13

256.37

2.7

2.3

2.72

2.76

mg/l

0.51

3099

18050

Unstable angina pectoris

6572

34712

1.75

255.22

2.8

2.3

3.05

2.86

mg/l

7.54

5825

29247

Extracorporeal dialysis

1367

5834

4.07

254.75

4.6

2.4

3.01

2.83

mg/l

2.06

1273

5027

Malignant neoplasm, including Hilmo

14760

65311

1.43

254.24

2.4

2.94

2.69

mg/l

25.61

12994

56663

Undetermined asthma, excluding more controls

2462

12738

2.46

253.79

2.7

2.1

2.81

2.67

mg/l

2.10

2177

10909

Laparoscopic right hemicolectomy

1407

6254

4.38

252.97

2.7

2.4

3.92

2.89

mg/l

18.76

1271

5352

Chronic pancreatitis

2398

12549

2.61

252.85

2.9

2.3

2.89

2.79

mg/l

1.02

2152

10818

Bacterial pneumonia, not elsewhere classified

7164

43220

1.68

249.71

2.8

2.3

2.77

2.80

mg/l

0.29

6448

36991

Colon adenocarcinoma, helper endpoint

2725

15172

2.53

249.26

2.5

2.4

3.85

2.89

mg/l

36.23

2437

12985

Statin medication

11081

45295

1.50

248.87

2.5

2.2

2.75

mg/l

0.04

9702

39268

Benign neoplasm: Colon, unspecified

4802

30841

1.93

248.20

3.1

2.4

3.05

2.89

mg/l

4.26

4162

26582

Excessive, frequent and irregular menstruation

7167

25889

1.71

247.36

2.6

2.3

2.79

2.73

mg/l

1.42

6250

22390

Adalimumab

1948

9474

2.83

247.17

3.9

2.2

2.74

2.66

mg/l

0.88

1813

8270

Other diseases of pleura

8469

52551

1.62

247.00

2.9

2.4

3.34

2.88

mg/l

40.35

7364

45101

Disorders of mineral metabolism

1795

8554

3.05

246.34

3.2

2.2

3.00

2.85

mg/l

1.50

1602

7390

Artrosis, including avohilmo

14313

59419

1.44

246.27

2.4

2.3

2.83

2.79

mg/l

1.24

12515

51363

Emotionally unstable personality disorder

2418

12701

2.50

246.13

2.5

2.2

2.63

2.56

mg/l

0.71

2098

11095

Malignant neoplasm, wide definition

14729

65452

1.42

245.12

2.4

2.95

2.69

mg/l

25.66

12963

56786

Injuries to the thorax

8456

60378

1.59

243.81

2.6

2.4

2.93

2.86

mg/l

1.64

7336

52138

Other disorders of lacrimal gland

6776

46681

1.69

242.01

2.7

2.4

2.73

2.83

mg/l

2.91

5923

40374

Other disorders of ear

16350

82292

1.40

241.79

2.5

2.4

2.85

2.79

mg/l

2.43

14072

71382

Coagulation defects, purpura and other haemorrhagic conditions

3773

22921

2.08

241.36

3.2

2.4

3.06

2.77

mg/l

8.62

3397

19846

Disease of hard tissues of teeth, NOS

9439

35189

1.56

240.55

2.5

2.3

2.66

2.95

mg/l

27.64

8141

30362

Malignant neoplasm

14335

64042

1.43

240.38

2.3

2.4

2.96

2.69

mg/l

25.86

12613

55533

Cutaneous abscess, furuncle and carbuncle

4721

30041

1.87

240.20

3.0

2.3

2.88

2.72

mg/l

4.71

4193

26102

Fracture of lumbar spine and pelvis

4564

29185

1.94

237.77

2.8

2.4

2.99

2.94

mg/l

0.49

3931

25096

Benign neoplasm of other and ill-defined parts of digestive system

3451

20680

2.17

237.63

3.3

2.4

3.20

2.85

mg/l

10.71

3081

17840

Type 1 diabetes

4292

26571

1.90

237.51

3.0

2.3

2.86

2.65

mg/l

7.58

3822

22961

Sequelae with surgical and medical care as external cause

3931

24313

2.04

237.22

2.9

2.4

3.01

2.83

mg/l

4.08

3545

21032

Type 1 diabetes, wide definition, subgroup 1

3585

21218

2.03

237.06

2.9

2.2

2.86

2.60

mg/l

9.40

3169

18388

Malignant neoplasm

14320

64119

1.42

236.35

2.3

2.4

2.96

2.69

mg/l

26.44

12604

55598

Panic disorder

2768

15264

2.26

236.24

2.5

2.2

2.52

2.61

mg/l

1.53

2384

13330

Menorrhagia

6115

22595

1.76

235.74

2.6

2.3

2.90

2.78

mg/l

2.78

5311

19557

Viral hepatitis, IBD co-morbidity

931

3140

3.95

235.33

2.6

1.9

2.82

2.53

mg/l

2.62

816

2693

Urinary track infection

10712

39228

1.52

234.69

2.5

2.2

2.67

2.70

mg/l

0.59

9342

33919

Substance use, excluding alcohol

3392

19880

2.06

233.98

2.6

2.3

2.88

2.67

mg/l

5.61

2885

17373

Unspecified mental disorder

6807

46883

1.65

233.96

2.4

2.3

2.71

2.72

mg/l

0.12

5979

40807

Nonischemic cardiomyopathy

1955

9758

2.78

233.96

3.0

2.3

3.10

2.81

mg/l

3.98

1740

8291

Transient ischemic attack

9481

55274

1.55

232.81

2.7

2.4

2.91

mg/l

0.01

8363

47280

Disorders of lacrimal system

8094

56986

1.60

232.18

2.7

2.4

2.74

2.84

mg/l

3.70

7070

49288

Injury, poisoning and certain other consequences of external causes

9563

34233

1.54

231.54

2.4

2.2

2.75

2.72

mg/l

0.89

8324

29635

Collagenous colitis

1928

9730

2.87

231.07

3.6

2.3

2.88

2.81

mg/l

0.67

1743

8399

Visual disturbances

8938

65164

1.56

230.39

2.6

2.4

2.65

2.81

mg/l

9.86

7813

56366

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

5740

23863

1.77

230.16

2.4

2.2

2.41

2.51

mg/l

4.19

5024

20870

Cirrhosis of liver, NAS

1262

5488

4.06

228.39

3.8

2.3

3.79

2.84

mg/l

22.71

1174

4713

Pulmonary heart disease, diseases of pulmonary circulation

5978

40820

1.73

226.89

3.0

2.4

3.34

2.90

mg/l

24.80

5348

35038

Ulcerative ileocolitis

911

3305

4.88

226.72

4.8

2.1

2.74

mg/l

0.04

859

2871

Polycystic ovarian syndrome, consortium definition

13069

57204

1.45

225.95

2.5

2.3

2.83

2.70

mg/l

7.30

11384

49547

Streptococcal septicaemia, including avohilmo

1913

9662

2.80

225.54

3.2

2.3

3.23

2.76

mg/l

11.15

1702

8228

Other obstetric conditions, not elsewhere classified

5812

24373

1.75

225.42

2.4

2.2

2.41

2.51

mg/l

4.53

5089

21337

Deforming dorsopathies

4944

32192

1.80

225.23

2.7

2.3

2.74

2.81

mg/l

1.22

4363

27728

Explicit bacterial Sepsis, including avohilmo

2207

11682

2.54

223.65

3.1

2.2

3.22

2.76

mg/l

13.02

1961

9993

Infliximab

579

1610

8.25

223.41

4.1

2.1

2.39

2.60

mg/l

1.99

553

1401

Preparatory care for dialysis

1032

4144

4.85

223.33

4.7

2.3

2.77

2.85

mg/l

0.55

953

3571

Primary gonarthrosis, bilateral

9257

56935

1.54

223.02

2.6

2.4

3.00

2.89

mg/l

3.69

8061

48850

Chronic periodontitis, including avohilmo

17548

88900

1.36

222.84

2.5

2.4

2.74

2.81

mg/l

3.46

15054

77304

Periodontitis

17575

88952

1.36

222.76

2.5

2.4

2.74

2.81

mg/l

3.43

15084

77346

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2815

16198

2.27

220.81

3.3

2.4

3.32

2.85

mg/l

15.74

2469

13985

Other acute lower respiratory infections

9919

70175

1.50

220.63

2.8

2.4

2.98

2.80

mg/l

9.87

8677

60664

Acute upper respiratory infections

19164

92069

1.34

220.49

2.6

2.3

2.81

2.79

mg/l

0.71

16671

79512

Undetermined asthma

2462

13380

2.31

220.41

2.7

2.1

2.81

2.73

mg/l

0.96

2177

11529

Degeneration of macula and posterior pole

9047

51290

1.55

219.32

2.7

2.4

3.02

2.95

mg/l

1.58

7713

43877

DVT of lower extremities and pulmonary embolism

7659

54777

1.60

218.28

2.8

2.4

3.22

2.88

mg/l

20.58

6778

47017

Combinations of oral blood glucose lowering drugs

4766

31227

1.81

216.38

2.8

2.3

3.27

2.75

mg/l

36.00

4280

26844

Suicide or other Intentional self-harm

4152

26236

1.87

215.66

2.6

2.3

2.82

2.67

mg/l

4.73

3620

22932

Streptococcal septicaemia

1855

9415

2.77

215.57

3.2

2.3

3.27

2.76

mg/l

12.71

1649

8011

Enterocolitis due to Clostridium difficile

2274

12461

2.52

214.17

3.4

2.4

3.12

2.92

mg/l

3.23

2054

10728

Hernia of abdominal wall

8003

57971

1.57

214.05

2.7

2.4

3.02

2.82

mg/l

9.77

7097

50109

Diseases of the ear and mastoid process

20392

82334

1.33

214.03

2.5

2.3

2.75

2.76

mg/l

0.34

17666

71470

Explicit bacterial Sepsis

2142

11400

2.51

213.39

3.1

2.2

3.26

2.76

mg/l

14.78

1902

9744

Gonarthrosis, primary, with knee surgery

10262

59927

1.50

213.33

2.6

2.4

3.07

2.89

mg/l

9.76

8952

51434

Somatoform disorder

2954

17225

2.13

212.86

2.8

2.3

2.60

2.73

mg/l

2.39

2587

15017

Fitting and adjustment of other devices

6735

41605

1.64

212.79

2.6

2.3

3.02

2.91

mg/l

2.79

5891

35237

Kela-code for severe mental illness

6014

41250

1.66

211.55

2.4

2.3

2.76

2.73

mg/l

0.40

5294

35892

Cellulitis

4032

25546

1.90

211.51

3.0

2.3

2.92

2.77

mg/l

3.65

3584

22118

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2902

16838

2.13

211.26

2.6

2.3

2.81

2.62

mg/l

5.07

2534

14751

Carpal tunnel syndrome

10667

69724

1.47

210.97

2.6

2.3

2.84

2.82

mg/l

0.49

9478

60209

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3863

20840

1.90

210.93

2.5

2.3

2.47

2.48

mg/l

0.07

3390

18216

Migraine with aura

4450

28657

1.81

210.69

2.5

2.2

2.51

2.63

mg/l

3.22

3884

24904

Superficial injury of head

4586

29945

1.82

210.10

2.6

2.4

2.76

2.85

mg/l

1.83

3937

26003

Other symptoms and signs involving the nervous and musculoskeletal systems

7454

53511

1.58

209.24

2.6

2.4

2.70

2.79

mg/l

3.18

6738

46305

Pain and other conditions associated with female genital organs and menstrual cycle

3840

19938

1.91

208.13

2.4

2.2

2.48

2.61

mg/l

3.91

3266

17368

Post-traumatic stress disorder

1737

8597

2.69

206.97

2.6

2.1

2.45

2.54

mg/l

1.14

1522

7512

Sensorineural hearing loss

13162

67952

1.41

206.77

2.5

2.4

3.01

2.85

mg/l

9.74

11254

58678

Nonorganic sleeping disorders

3931

24898

1.89

205.49

2.6

2.3

2.50

2.69

mg/l

6.66

3433

21744

Any operation in hilmo

580

628

5.49

205.28

2.1

1.4

2.78

2.35

mg/l

2.70

508

538

Coronary artery bypass grafting

4632

22487

1.83

204.76

2.8

2.2

3.17

2.87

mg/l

11.99

4109

18817

Osteoporosis with pathological fracture (FG)

1566

7694

3.05

204.08

3.2

2.3

3.20

2.99

mg/l

2.11

1371

6487

Dilated cardiomyopathy

2249

12480

2.46

203.29

3.1

2.4

2.92

2.86

mg/l

0.56

2033

10731

Conductive and sensorineural hearing loss

13729

71132

1.40

202.29

2.5

2.4

2.98

2.84

mg/l

8.51

11769

61509

Cardiomyopathy, other and unspecified

1462

6887

2.97

201.52

3.0

2.1

2.83

2.67

mg/l

1.63

1303

5801

Ulcerative proctitis

1276

5727

3.31

201.31

3.6

2.1

2.49

2.70

mg/l

2.97

1178

4975

Amputation

2095

11443

2.53

199.40

3.4

2.3

3.36

2.91

mg/l

12.93

1868

9752

Rheumatism, unspecified

2401

13459

2.27

199.32

2.8

2.3

2.74

2.85

mg/l

1.70

2137

11568

Irregular menses

8424

46373

1.52

197.31

2.5

2.2

2.70

2.62

mg/l

2.94

7419

40361

Other diseases of lip and oral mucosa

7317

52893

1.57

197.20

2.7

2.4

2.74

2.78

mg/l

0.74

6390

45910

Persons encountering health services for specific procedures, not carried out

1714

8647

2.68

197.02

3.1

2.2

2.73

2.70

mg/l

0.16

1465

7457

Ascites

1520

7408

2.93

196.43

3.4

2.3

3.47

2.88

mg/l

12.40

1392

6346

Intestinal adhesions without obstruction

1692

8554

2.73

196.24

3.3

2.2

3.07

2.81

mg/l

3.54

1499

7317

Phobic anxiety disorders

2370

13111

2.21

195.88

2.6

2.2

2.59

2.57

mg/l

0.15

2062

11476

Polyuria

4158

27168

1.85

195.72

2.7

2.4

2.65

2.86

mg/l

8.23

3547

23462

Alcohol dependence

4363

28502

1.78

195.51

2.6

2.3

2.98

2.79

mg/l

5.36

3799

24728

Viral pneumonia

2465

14039

2.23

195.22

3.1

2.3

3.02

2.76

mg/l

5.10

2200

12093

Ventral hernia

4292

28154

1.82

195.16

2.9

2.3

3.11

2.84

mg/l

9.32

3813

24209

Soft tissue disorders related to use, overuse and pressure

4731

31497

1.74

194.55

2.6

2.3

2.68

2.86

mg/l

7.60

4154

27093

Diabetic nephropathy, excluding more controls

3048

15218

2.17

194.31

3.5

2.5

3.01

2.96

mg/l

0.62

2781

13164

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

4604

30798

1.79

194.29

2.8

2.4

3.22

2.84

mg/l

20.83

4175

26529

Seropositive rheumatoid arthritis, wide

4719

31735

1.77

193.70

2.8

2.4

3.21

2.84

mg/l

20.38

4276

27323

Type 1 diabetes, wide definition

3657

22916

1.87

192.85

2.9

2.3

2.86

2.63

mg/l

7.94

3234

19834

Any event in cancer register

15472

71646

1.36

192.33

2.3

2.4

2.90

2.68

mg/l

21.05

13569

62149

Solid cancers, including Hilmo

14091

64348

1.38

191.93

2.3

2.4

2.92

2.69

mg/l

21.53

12374

55804

Seronegative rheumatoid arthritis

2120

11604

2.36

191.03

2.8

2.2

3.08

2.80

mg/l

6.35

1900

9877

Migraine without aura

3557

22221

1.88

191.02

2.5

2.2

2.53

2.59

mg/l

1.03

3145

19358

Other/unspecified seropositive rheumatoid arthritis

4663

31378

1.77

190.87

2.8

2.4

3.21

2.84

mg/l

20.25

4223

27024

Oesophageal varices

939

3849

4.35

190.50

4.2

2.3

4.10

2.81

mg/l

29.13

881

3313

Injuries to the shoulder and upper arm

15105

92897

1.35

189.98

2.5

2.4

2.78

2.82

mg/l

0.98

13077

80426

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1675

8694

2.84

189.74

3.3

2.4

3.05

2.94

mg/l

1.29

1516

7427

Weight loss

2099

11692

2.49

189.74

2.7

2.4

2.65

2.82

mg/l

3.16

1807

10111

Benign neoplasm: Sigmoid colon

3477

22048

1.97

189.71

3.0

2.4

3.21

2.87

mg/l

11.74

3116

19011

Cardiodefibrillation

6282

44776

1.64

189.63

2.9

2.4

3.19

2.90

mg/l

14.22

5559

38343

Primary_lymphoid and hematopoietic malignant neoplasms

4399

29356

1.81

189.50

2.5

2.4

3.06

2.88

mg/l

4.60

3903

25236

Early onset COPD, excluding more controls

3223

19646

1.93

188.86

2.8

2.2

3.12

2.74

mg/l

11.76

2829

16801

Pulmonary embolism

5353

37065

1.69

188.61

2.9

2.4

3.27

2.89

mg/l

18.52

4782

31815

Acute bronchitis

7523

53902

1.54

188.54

2.9

2.4

3.02

2.83

mg/l

8.98

6542

46508

Alcohol abuse, main dg, excluding more controls

2397

13470

2.15

188.35

2.6

2.2

2.75

2.71

mg/l

0.43

2109

11767

Other symptoms and signs involving the digestive system and abdomen

3055

18563

1.99

187.38

2.9

2.2

3.08

2.82

mg/l

8.37

2662

16009

Mycoses

4988

34042

1.71

186.97

2.9

2.3

2.99

2.77

mg/l

7.23

4379

29523

Acute sinusitis

8976

60950

1.47

186.89

2.6

2.3

2.76

2.71

mg/l

1.36

7825

53003

Methotrexate

2489

14353

2.17

186.78

3.1

2.2

3.24

2.73

mg/l

21.46

2255

12268

Special screening examination for infectious and parasitic diseases

3778

17086

1.80

186.64

2.2

2.0

2.34

2.57

mg/l

9.22

3027

14830

Fissure and fistula of anal and rectal regions

3964

25553

1.80

186.32

2.8

2.1

2.68

2.74

mg/l

0.92

3450

22038

Pulmonary heart disease

5353

37157

1.69

186.26

2.9

2.4

3.27

2.90

mg/l

17.50

4782

31908

Enlarged lymph nodes

2715

15942

2.05

185.96

2.6

2.2

2.95

2.72

mg/l

4.98

2402

13732

Alzheimer disease, excluding more controls

3289

12955

1.97

185.77

2.4

2.3

2.76

2.99

mg/l

5.64

2768

11018

Anaemia in chronic diseases classified elsewhere

630

2145

6.70

184.74

4.3

2.1

3.10

2.81

mg/l

2.27

589

1821

Fracture of rib(s), sternum and thoracic spine

5544

38728

1.66

184.38

2.7

2.4

2.94

2.88

mg/l

1.03

4793

33405

Disturbances of skin sensation

4816

32615

1.71

184.24

2.5

2.3

2.55

2.71

mg/l

6.03

4205

28420

Disorders of synovium and tendon

9073

57607

1.46

184.18

2.6

2.3

2.70

2.79

mg/l

3.25

8004

49769

Benign neoplasm: Stomach

1918

10520

2.56

182.92

3.6

2.4

3.30

2.89

mg/l

8.01

1708

9075

Coxibs

5121

17902

1.70

182.46

2.4

2.82

2.88

mg/l

0.98

4414

15463

Bacterial pneumonia (organism specified)

8083

54318

1.51

182.32

2.8

2.4

2.81

2.87

mg/l

1.26

7248

46544

Schizophrenia or delusion

5085

34727

1.67

182.22

2.4

2.3

2.71

2.72

mg/l

0.19

4433

30245

Other diseases of upper respiratory tract

19722

84134

1.30

181.12

2.5

2.4

2.71

2.83

mg/l

10.00

17071

72724

Peripheral artery operations in Hilmo

2484

14571

2.19

181.10

3.3

2.3

3.36

2.91

mg/l

12.68

2214

12390

Dialysis

851

3374

4.29

180.22

4.4

2.3

2.79

2.82

mg/l

0.15

793

2898

Disturbance of activity and attention

2429

13616

2.13

180.01

2.4

2.3

2.37

2.47

mg/l

2.17

2118

11925

Schizophrenia, schizotypal and delusional disorders

5098

34936

1.66

179.50

2.4

2.3

2.71

2.73

mg/l

0.20

4443

30434

COPD

7865

47317

1.52

179.06

2.8

2.4

3.23

2.87

mg/l

22.31

6820

40455

Chronic ulcer of skin, not elsewhere classified

1455

7302

2.94

179.00

3.6

2.3

3.39

2.92

mg/l

8.61

1323

6249

Delirium, not induced by alcohol and other psychoactive substances

2537

15074

2.19

178.97

2.7

2.5

2.98

3.03

mg/l

0.37

2201

12927

Disorders of skin appendages

8586

64062

1.47

178.97

2.6

2.3

2.69

2.71

mg/l

0.23

7563

55640

Other disorders of veins

7109

51159

1.54

178.29

2.6

2.3

2.86

2.78

mg/l

1.63

6059

44227

Hyperkinetic disorders

2528

14379

2.08

177.55

2.4

2.36

2.47

mg/l

2.69

2207

12614

Other (seronegative) rheumatoid arthritis, wide

3421

21919

1.92

177.01

2.9

2.4

3.13

2.85

mg/l

9.09

3073

18915

Exclusions for E4_PCOS_CONSORTIUM

12586

61608

1.39

176.98

2.5

2.3

2.84

2.71

mg/l

8.03

10896

53663

Coxarthrosis, primary

10489

67369

1.43

176.79

2.6

2.4

3.00

2.91

mg/l

3.36

9155

57780

Chronic sinusitis

7159

52218

1.52

176.72

2.6

2.3

2.63

2.79

mg/l

8.21

6225

45350

Diabetic maculopathy, excluding more controls

1957

10689

2.36

176.68

3.2

2.2

2.94

2.68

mg/l

5.44

1731

9186

Solid cancers

13608

62932

1.36

176.09

2.3

2.4

2.94

2.70

mg/l

21.90

11943

54555

Paracetamol or NSAID medication

2877

8298

1.97

175.49

2.3

2.83

2.68

mg/l

2.30

2490

7126

Other diseases of stomach and duodenum

1300

6241

3.01

175.01

3.7

2.2

3.10

2.84

mg/l

3.69

1186

5326

Later onset COPD, excluding more controls

3908

19549

1.84

173.43

2.8

2.2

3.32

2.87

mg/l

15.76

3374

16479

Abnormal weight loss

1918

10711

2.49

172.68

2.7

2.4

2.63

2.83

mg/l

3.58

1648

9244

Chronic periodontitis, complicated

9399

70088

1.44

172.25

2.5

2.4

2.78

2.83

mg/l

1.13

8058

60777

Pain in thoracic spine

2682

16091

2.01

171.34

2.5

2.2

2.74

2.78

mg/l

0.42

2382

13932

Sequelae of cerebrovascular disease

6645

41369

1.57

171.31

2.8

2.4

3.06

2.94

mg/l

3.09

5751

35429

Spondyloarthritis

3068

19069

1.91

170.68

2.9

2.2

2.87

2.79

mg/l

1.34

2736

16447

Purpura and other haemorrhagic conditions

2526

15153

2.13

170.63

3.1

2.4

3.15

2.79

mg/l

8.64

2302

13153

Problems related to lifestyle

1840

9901

2.33

169.22

2.6

2.1

2.88

2.67

mg/l

3.65

1623

8591

Fungal Sepsis

959

4181

3.82

169.00

3.7

2.2

3.25

2.77

mg/l

5.70

861

3579

Cholecystectomy

12466

84003

1.37

168.77

2.6

2.4

2.92

2.83

mg/l

3.90

10958

72525

Acute pancreatitis

3396

21799

1.86

168.73

2.8

2.3

2.93

2.82

mg/l

1.80

2971

18752

Temporomandibular joint disorders, including avohilmo

7711

55609

1.49

168.46

2.4

2.3

2.51

2.66

mg/l

9.55

6760

48433

Oter anti-inflammatory and antirheumatic agents, non-steroids

4000

14201

1.79

168.44

2.6

2.4

2.97

3.01

mg/l

0.44

3465

12233

Benign neoplasm: Ascending colon

2649

16260

2.11

168.28

3.1

2.4

3.12

2.87

mg/l

5.98

2405

13977

Cervicalgia

3591

23278

1.81

167.71

2.6

2.3

2.78

2.84

mg/l

0.90

3150

20038

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1058

4847

3.57

167.64

3.2

2.4

2.89

2.83

mg/l

0.35

943

4139

Exclusions for E4_PCOS_BROAD

3014

18860

1.93

166.61

2.9

2.4

2.87

2.72

mg/l

3.32

2692

16478

Traumatic subdural haemorrhage

2483

13785

2.07

165.78

2.6

2.3

3.06

2.97

mg/l

0.83

2132

11806

Dentofacial anomalies [including malocclusion]

11641

71473

1.38

165.50

2.4

2.3

2.55

2.71

mg/l

13.91

10176

62267

Heartburn

2039

11465

2.22

165.30

2.7

2.2

2.55

2.77

mg/l

4.52

1775

9865

Other chronic obstructive pulmonary disease

7528

45951

1.51

164.33

2.8

2.4

3.26

2.88

mg/l

23.52

6519

39265

Artificial opening status

1126

5289

3.24

163.62

3.4

2.3

3.12

2.79

mg/l

3.09

1017

4544

5817

36123

1.62

162.50

2.7

2.5

3.14

3.00

mg/l

3.25

4952

30777

Nonalcoholic fatty liver disease

1788

9772

2.37

162.28

3.1

2.3

2.90

2.74

mg/l

1.83

1615

8544

Other postsurgical states

1283

6312

2.89

161.88

3.2

2.3

3.42

2.74

mg/l

14.61

1187

5458

Polymyalgia rheumatica

2631

16333

2.09

161.12

2.9

2.4

2.99

2.98

mg/l

0.12

2298

13978

Supplementary factors related to causes of morbidity and mortality classified elsewhere

5445

38735

1.60

161.09

2.7

2.4

3.10

2.76

mg/l

19.22

4786

33632

Total colectomy operation

887

3795

3.81

160.82

4.7

2.2

3.16

2.77

mg/l

4.64

832

3272

Total colectomy

887

3795

3.81

160.82

4.7

2.2

3.16

2.77

mg/l

4.64

832

3272

Chronic rhinitis, nasopharyngitis and pharyngitis

5414

38347

1.59

160.79

2.5

2.3

2.52

2.77

mg/l

13.49

4650

33382

Any death

10600

58072

1.41

158.97

2.6

2.4

3.55

2.69

mg/l

146.88

9360

50020

Alcoholic liver disease

1783

9836

2.37

158.90

3.0

2.3

3.53

2.81

mg/l

18.31

1595

8503

Allergic asthma (mode), excluding more controls

3681

23388

1.73

158.88

2.5

2.1

2.62

2.60

mg/l

0.34

3290

20169

Implicit fungal Sepsis

888

3851

3.88

158.84

3.6

2.2

3.21

2.76

mg/l

4.92

797

3289

Spondylopathies (FG)

2251

13156

2.07

156.92

2.8

2.2

2.77

2.67

mg/l

1.51

2008

11327

Other dialysis

689

2679

4.88

156.54

4.7

2.4

2.74

2.84

mg/l

0.64

643

2316

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

5730

41391

1.57

155.86

2.6

2.4

2.79

2.77

mg/l

0.18

5033

35922

Benign neoplasm: Rectum, anus and anal canal

3561

23692

1.82

155.81

2.9

2.4

3.07

2.87

mg/l

4.44

3118

20401

Other chronic obstructive pulmonary disease, including avohilmo

9229

58621

1.43

155.40

2.7

2.4

3.17

2.87

mg/l

20.50

7957

50401

L04AC Interleukin inhibitors

1211

5866

2.84

155.37

4.2

2.2

2.90

2.66

mg/l

3.58

1143

5120

Eating disorder

1784

9918

2.36

155.13

2.8

2.2

2.52

2.50

mg/l

0.23

1558

8665

Amputation of toe

1456

7714

2.72

154.95

3.4

2.4

3.28

2.91

mg/l

6.62

1299

6614

Dementia, including avohilmo

8511

44459

1.47

154.85

2.5

2.93

2.99

mg/l

1.35

7131

38130

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

8541

62875

1.43

154.81

2.5

2.3

2.68

2.80

mg/l

5.06

7399

54591

Exposure to other specified factors

13868

96347

1.33

154.32

2.6

2.3

2.75

mg/l

0.06

11931

83752

Zoster [herpes zoster], including avohilmo

9151

68459

1.43

154.14

2.6

2.4

2.87

2.85

mg/l

0.45

7952

59014

Decubitus ulcer and pressure area

1337

6888

2.83

153.57

3.3

2.4

3.14

2.96

mg/l

1.41

1169

5874

Injuries to the knee and lower leg

21125

95754

1.26

152.87

2.5

2.3

2.80

2.77

mg/l

0.74

18368

82903

Endocarditis

752

3015

3.97

152.37

3.5

2.1

3.28

2.73

mg/l

5.02

686

2535

Artificial joint operation, meniscal resection

15271

79684

1.31

152.04

2.5

2.4

2.95

2.83

mg/l

7.13

13324

68787

Subjective visual disturbances

4477

31162

1.67

151.91

2.6

2.4

2.52

2.79

mg/l

15.91

3897

27023

Other malignant neoplasms of skin (=non-melanoma skin cancer)

7680

39150

1.47

151.77

2.5

2.4

2.94

2.80

mg/l

4.31

6590

33579

Disorders resulting from impaired renal tubular function

801

3393

4.10

151.73

3.5

2.3

2.85

2.84

mg/l

0.03

746

2920

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

7926

40354

1.46

151.14

2.5

2.4

2.92

2.80

mg/l

4.04

6807

34623

Any dementia, excluding more controls

6679

34013

1.54

151.04

2.4

2.87

3.02

mg/l

4.56

5633

29141

Psoriatic and enteropathic arthropathies

1924

10916

2.17

149.78

3.1

2.2

2.86

2.71

mg/l

2.05

1743

9357

Benign neoplasm: Rectum

3185

20897

1.86

149.68

2.9

2.4

3.09

2.87

mg/l

4.79

2807

18025

Viral infections characterized by skin and mucous membrane lesions

7153

53681

1.48

149.56

2.8

2.4

2.87

2.78

mg/l

2.94

6314

46601

Oxicams

4130

15685

1.70

148.39

2.5

2.4

2.93

2.95

mg/l

0.14

3631

13525

Coeliac disease

2164

12888

2.11

147.81

2.8

2.3

2.63

2.72

mg/l

1.38

1942

11163

Other disorders of kidney and ureter

2352

14413

2.07

147.42

3.1

2.4

2.96

2.84

mg/l

1.65

2121

12471

Haemolytic anaemias

793

3411

4.06

146.32

3.7

2.3

3.86

2.83

mg/l

14.00

724

2945

Ulcerative enterocolitis

672

2624

4.31

145.68

4.4

2.1

2.93

2.77

mg/l

0.89

615

2277

Meniscus derangement

8616

43681

1.42

145.01

2.5

2.2

2.81

2.80

mg/l

0.16

7494

37458

Sulfonylureas

5940

34631

1.55

144.37

3.0

2.3

3.36

2.88

mg/l

34.69

5148

29350

Atopic dermatitis

9761

60667

1.38

144.15

2.4

2.3

2.52

2.67

mg/l

11.37

8391

52954

Other blood glucose lowering drugs, excl. Insulins

2729

17368

1.92

143.66

2.9

2.3

3.26

2.82

mg/l

14.07

2423

14829

Malignant neoplasm of skin

8237

42584

1.44

143.43

2.5

2.4

2.92

2.79

mg/l

4.86

7079

36579

Acute pancreatitis (for exclusion)

3396

22630

1.77

143.43

2.8

2.4

2.93

2.84

mg/l

1.22

2971

19562

Mixed and other personality disorders

1370

7112

2.50

142.93

2.8

2.2

2.65

2.64

mg/l

0.04

1172

6240

Cervical disc disorders

5668

41261

1.53

142.39

2.6

2.3

2.80

2.85

mg/l

0.78

4948

35496

Benign neoplasm: Transverse colon

2014

12040

2.20

141.91

3.2

2.4

3.34

2.86

mg/l

13.52

1834

10396

Disorders of parathyroid gland

3696

24928

1.74

141.64

3.1

2.4

3.19

2.95

mg/l

5.68

3239

21446

Eating disorders

2015

11895

2.13

141.21

2.8

2.2

2.55

2.56

mg/l

0.03

1769

10360

Type of accident

5008

35941

1.58

141.04

2.7

2.4

3.10

2.77

mg/l

16.70

4397

31219

Barrett oesophagus

978

4597

3.16

140.27

3.1

2.2

2.95

2.79

mg/l

1.20

871

3922

Misadventures to patients during surgical and medical care

2576

16280

1.94

139.93

3.0

2.3

3.09

2.77

mg/l

9.15

2305

14106

Disorders of calcium metabolism

1252

6446

2.69

139.59

2.9

2.3

3.24

2.89

mg/l

3.40

1112

5563

Benign neoplasm: Caecum

2017

12144

2.19

139.43

3.1

2.4

3.19

2.86

mg/l

6.83

1823

10451

Idiopathic gout

1768

10229

2.30

139.31

3.1

2.3

3.04

2.87

mg/l

1.88

1581

8770

Disorders of sclera, cornea, iris and ciliary body

9193

72089

1.39

138.92

2.6

2.4

2.80

2.79

mg/l

0.07

8097

62442

Primary Sclerosing Cholangitis, IBD and UDCA required

500

1707

5.41

138.83

4.9

2.0

2.89

2.75

mg/l

0.62

465

1464

Non-allergic asthma (mode), excluding more controls

2979

18987

1.78

138.71

2.6

2.1

2.83

2.67

mg/l

3.29

2679

16180

Alzheimer’s disease (Late onset), excluding more controls

2750

11223

1.90

138.66

2.4

2.3

2.74

3.03

mg/l

7.75

2301

9538

Malignant neoplasm of skin, including Hilmo

8570

44262

1.42

138.42

2.5

2.4

2.89

2.78

mg/l

4.07

7368

38047

Status post-ami

4391

23323

1.65

138.29

2.9

2.2

3.34

2.87

mg/l

25.20

3832

19552

Dementia

7970

42010

1.45

138.16

2.5

2.91

3.00

mg/l

2.32

6679

35935

Allergic asthma (mode)

3682

24151

1.66

137.59

2.5

2.1

2.62

2.63

mg/l

0.02

3291

20886

Injuries to the elbow and forearm

12272

85094

1.33

137.50

2.5

2.4

2.79

2.78

mg/l

0.34

10577

73803

Disorders of conjunctiva

14383

91546

1.30

136.76

2.5

2.4

2.65

2.77

mg/l

8.93

12471

79537

COPD related to multimorbidity

6917

44429

1.48

136.10

2.8

2.4

3.33

2.89

mg/l

28.68

6004

38086

Fracture of shoulder and upper arm

6162

45907

1.49

135.50

2.6

2.4

2.78

2.87

mg/l

2.16

5307

39647

7459

51711

1.46

135.35

2.6

2.4

2.89

2.98

mg/l

2.36

6412

44238

Basal cell carcinoma, including Hilmo

7630

39398

1.44

135.34

2.5

2.4

2.92

2.80

mg/l

3.50

6534

33790

Basal cell carcinoma

7407

38383

1.45

135.12

2.5

2.4

2.93

2.81

mg/l

3.27

6326

32906

Other specified and unspecified personality disorders

1540

8482

2.31

134.82

2.7

2.2

2.73

2.68

mg/l

0.45

1338

7393

Certain disorders involving the immune mechanism

3080

20358

1.79

134.58

3.1

2.4

2.98

2.78

mg/l

4.83

2801

17713

Diabetic retinopathy, excluding more controls

4758

19045

1.66

134.45

3.1

2.5

3.03

2.94

mg/l

1.56

4209

16553

Injuries to the ankle and foot

12010

82921

1.32

133.81

2.6

2.3

2.67

2.71

mg/l

1.59

10405

72321

Other necrotizing vasculopathies (FG)

1140

5771

2.77

133.58

3.0

2.2

3.06

2.85

mg/l

1.89

1011

4888

Enteropathic arthropathies

521

1866

4.93

132.61

4.6

2.0

2.73

2.67

mg/l

0.30

497

1587

Migraine with aura and triptan purchases

2787

18020

1.82

132.46

2.5

2.3

2.50

2.59

mg/l

1.95

2426

15760

Other eating disorders

1047

5131

2.85

131.93

2.8

2.2

2.61

2.50

mg/l

0.99

931

4481

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

10512

76470

1.35

131.86

2.6

2.3

2.74

2.70

mg/l

1.09

9175

66632

Special screening examination for other diseases and disorders

1964

11528

2.01

131.85

2.9

2.0

2.59

2.74

mg/l

2.71

1812

9843

Elevated blood glucose level

1562

8807

2.33

131.11

3.1

2.3

3.14

2.80

mg/l

4.71

1403

7596

Spondylolisthesis/Spondylolysis

2933

19222

1.78

130.32

2.7

2.3

2.75

2.85

mg/l

1.45

2604

16538

Candidiasis

2549

16346

1.90

130.08

3.2

2.3

3.04

2.75

mg/l

6.01

2223

14177

Myelodysplastic syndrome, including Hilmo

698

2990

4.08

129.87

3.3

2.4

2.94

2.87

mg/l

0.32

632

2540

Cervicobrachial syndrome

3501

23763

1.68

129.45

2.5

2.2

2.66

2.80

mg/l

3.46

3153

20520

Fracture of lower leg, including ankle

9136

70789

1.37

129.38

2.5

2.4

2.82

2.80

mg/l

0.32

7959

61352

Thiazolidinediones

1943

11704

2.11

129.24

2.9

2.3

3.30

2.78

mg/l

15.88

1701

10015

Cholangitis (primary sclerosing, PSC)

1235

6523

2.62

129.14

3.6

2.4

3.11

2.81

mg/l

3.30

1104

5583

Osteomyelitis

1236

6531

2.62

129.08

3.6

2.3

3.17

2.83

mg/l

4.69

1105

5619

Transport accidents

7642

48796

1.41

128.20

2.4

2.2

2.73

2.74

mg/l

0.13

6623

42640

Other and unspecified nonorganic psychotic disorders

2957

19395

1.75

127.88

2.3

2.60

2.65

mg/l

0.82

2560

16964

Hypertensive Renal Disease

768

3369

3.40

127.57

3.3

2.1

3.13

2.92

mg/l

1.38

696

2796

Other disorders of glucose regulation and pancreatic internal secretion

1542

8749

2.28

125.77

3.2

2.4

2.89

2.77

mg/l

1.03

1381

7562

Intestinal malabsorption

921

4418

3.05

125.39

3.7

2.2

2.73

2.75

mg/l

0.09

819

3774

Internal derangement of knee

5789

42566

1.47

125.31

2.4

2.2

2.84

2.75

mg/l

2.08

4980

36576

Excessive attrition of teeth

9944

78723

1.35

125.30

2.5

2.3

2.59

2.72

mg/l

8.32

8621

68596

Stomatitis and related lesions

3382

23139

1.70

124.98

2.7

2.4

2.78

2.75

mg/l

0.29

2943

20129

Amiodarone users

1810

10888

2.18

124.85

3.2

2.4

3.04

2.89

mg/l

1.65

1631

9380

Skin changes due to chronic exposure to nonionizing radiation

7052

49421

1.45

124.56

2.6

2.5

2.89

2.99

mg/l

2.75

6056

42267

Epilepsy

5011

36431

1.52

124.38

2.4

2.3

2.79

2.80

mg/l

0.10

4306

31409

Thrombocytopenia, unspecified

1373

7613

2.45

124.38

3.0

2.3

3.22

2.81

mg/l

5.61

1254

6554

Hydronephrosis

2018

12331

2.02

124.37

2.6

2.2

3.08

2.81

mg/l

4.63

1783

10517

Diseases of the myoneural junction and muscle

2188

13723

1.98

124.16

2.7

2.4

3.08

2.86

mg/l

3.94

1845

11907

Urticaria and erythema

6011

45224

1.47

124.09

2.6

2.4

2.75

2.72

mg/l

0.64

5229

39407

Abnormalities of gait and mobility

2245

14258

1.99

123.76

2.7

2.4

2.74

2.87

mg/l

1.43

1937

12279

Actinic keratosis

6879

48352

1.46

123.58

2.6

2.5

2.89

2.99

mg/l

2.59

5908

41333

Symptoms and signs involving speech and voice

5668

42495

1.50

123.38

2.6

2.4

2.70

2.84

mg/l

4.43

4866

36789

Haemorrhage, not elsewhere classified

814

3751

3.25

122.51

3.6

2.2

3.42

2.87

mg/l

4.95

732

3205

Trochanteric bursitis

2473

15871

1.85

122.44

2.7

2.3

2.65

2.89

mg/l

7.12

2157

13630

Viral and other specified intestinal infections, including avohilmo

4671

32408

1.54

122.21

2.8

2.2

2.70

2.64

mg/l

0.90

4167

28094

Cardiac arrest

1036

4244

2.56

121.81

2.9

1.9

3.12

2.64

mg/l

7.24

916

3480

Parkinson's disease, excluding more controls

2208

12597

1.91

121.71

2.4

2.3

2.82

2.96

mg/l

1.93

1857

10755

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1640

9573

2.19

121.46

2.9

2.3

3.07

2.76

mg/l

4.28

1476

8279

Other disorders of eyelid

7637

56300

1.41

121.43

2.5

2.4

2.81

2.93

mg/l

4.30

6598

48361

Myeloproliferative diseases

1535

8884

2.31

121.35

2.8

2.4

4.59

2.87

mg/l

25.96

1344

7637

Congenital malformations, deformations and chromosomal abnormalities

9411

71050

1.35

121.35

2.6

2.3

2.77

2.68

mg/l

3.10

8262

61901

Adrenocortical insufficiency

759

3445

3.48

120.87

3.6

2.3

3.10

2.82

mg/l

2.84

703

2963

Other abnormal uterine and vaginal bleeding

3824

19139

1.64

120.56

2.6

2.3

3.03

2.84

mg/l

5.08

3248

16491

Pleural effusion

2800

18728

1.81

120.19

2.9

2.4

3.24

2.89

mg/l

10.41

2465

16023

Social phobias

1432

7899

2.21

120.12

2.5

2.2

2.54

2.56

mg/l

0.11

1225

6903

Extreme obesity with alveolar hypoventilation

809

3771

3.26

119.77

3.2

2.3

4.19

2.79

mg/l

21.95

709

3255

Migraine without aura and triptan purchases

2800

18502

1.76

119.75

2.5

2.3

2.49

2.59

mg/l

2.27

2456

16197

Acute posthaemorrhagic anaemia

735

3292

3.44

118.94

4.2

2.1

3.54

2.87

mg/l

7.59

664

2769

ILD, hospital admission 2, with pulmonary infections

1785

10742

2.10

118.49

2.9

2.3

3.11

2.86

mg/l

3.91

1601

9173

Obsessive-compulsive disorder

1206

6353

2.39

118.20

2.5

2.2

2.51

2.54

mg/l

0.17

1052

5555

Other enthesopathies

4581

33145

1.53

117.92

2.5

2.2

2.69

2.80

mg/l

2.81

4014

28665

Triptan medication for migraine, single purchase ok

11878

65587

1.30

117.32

2.4

2.3

2.58

2.70

mg/l

8.27

10345

57106

Migraine, single triptan purchase ok & required. ICD-code if available is included

11878

65587

1.30

117.32

2.4

2.3

2.58

2.70

mg/l

8.27

10345

57106

Duodenal ulcer

1876

11396

2.02

117.23

3.1

2.2

3.49

2.89

mg/l

11.74

1661

9688

Other diseases of pericardium

839

3945

3.00

117.16

2.9

2.1

3.19

2.69

mg/l

7.62

757

3331

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

3965

27413

1.61

116.94

2.1

2.4

3.35

2.77

mg/l

33.84

3522

23579

Disorder of lipoprotein metabolism, unspecified

2235

14248

1.90

116.11

2.8

2.3

3.03

2.95

mg/l

0.73

1920

12188

Ovarian cyst

5727

24385

1.49

115.83

2.5

2.2

2.71

2.74

mg/l

0.38

4974

21092

4163

28211

1.61

115.52

2.7

2.5

3.12

3.04

mg/l

1.30

3516

24019

Monoamine oxidase A inhibitors

1818

10927

2.00

115.49

2.7

2.3

2.68

2.81

mg/l

1.75

1572

9538

Dental pulpitis, including avohilmo

14856

79399

1.27

115.15

2.4

2.3

2.72

2.70

mg/l

0.71

12955

69194

Acetic acid derivatives and related substances

4756

17620

1.54

114.96

2.4

2.82

2.89

mg/l

0.88

4077

15217

Pruritus

2084

13133

1.94

114.08

3.0

2.3

2.71

2.78

mg/l

0.74

1841

11346

Myeloproliferative diseases (CML excluded)

1399

8039

2.35

113.84

2.8

2.4

4.79

2.87

mg/l

27.12

1215

6892

Diabetic nephropathy

3074

21247

1.79

113.78

3.5

2.6

3.01

3.09

mg/l

0.97

2805

18526

Inflammatory diseases of female pelvic organs

10644

59158

1.33

113.71

2.5

2.3

2.70

2.72

mg/l

0.35

9212

51365

Vitamin deficiency

950

4778

2.81

113.70

3.2

2.3

3.04

2.77

mg/l

2.93

851

4117

Vitamin deficiency, wide

950

4778

2.81

113.70

3.2

2.3

3.04

2.77

mg/l

2.93

851

4117

Other complications of surgical and medical care, not elsewhere classified

1706

10232

2.07

112.91

2.9

2.2

3.05

2.76

mg/l

4.57

1541

8848

Hallux valgus (acquired)

5135

27094

1.49

112.49

2.4

2.2

2.73

2.82

mg/l

1.64

4387

23179

Psychotic depression

991

4939

2.53

112.45

2.7

2.2

2.89

2.76

mg/l

1.14

872

4316

Parkinson's disease, strict definition, excluding more controls

2065

12000

1.90

112.41

2.4

2.3

2.79

2.97

mg/l

2.93

1734

10248

Open wound of lower leg

2662

17769

1.77

111.76

2.9

2.4

3.07

2.80

mg/l

5.34

2328

15419

Papulosquamous disorders

6268

48182

1.43

111.54

2.6

2.4

2.84

2.80

mg/l

0.69

5514

41743

Hyperplasia of prostate

5419

22593

1.48

111.38

2.4

2.3

2.78

2.89

mg/l

2.68

4639

19468

Other hammer toe(s) (acquired)

2748

16704

1.74

111.14

2.6

2.3

2.83

2.91

mg/l

1.14

2353

14151

COPD, hospital admissions

7555

50172

1.40

111.06

2.8

2.4

3.25

2.88

mg/l

23.22

6543

43040

Alzheimer’s disease (Atypical or mixed), excluding more controls

1739

7762

2.07

110.97

2.4

2.3

2.93

3.09

mg/l

1.75

1467

6602

Conjunctivitis

12674

84520

1.28

110.93

2.5

2.4

2.61

2.76

mg/l

12.56

10962

73537

COPD, early/later onset

7626

50522

1.39

110.87

2.8

2.4

3.26

2.88

mg/l

24.41

6599

43347

Acquired haemolytic anaemia

564

2377

4.42

110.85

3.8

2.3

3.86

2.93

mg/l

8.65

522

2048

Other and unspecified myopathies

1614

9694

2.14

110.09

2.7

2.4

3.10

2.90

mg/l

2.52

1351

8350

Postprocedural disorders of digestive system, not elsewhere classified

688

3122

3.49

109.87

4.7

2.3

3.14

2.80

mg/l

2.15

620

2666

Abnormal serum enzyme levels

4973

35923

1.51

109.50

2.5

2.4

2.66

2.88

mg/l

9.33

4459

30778

Dermatophytosis, including avohilmo

10809

86772

1.30

109.09

2.5

2.3

2.73

2.77

mg/l

1.05

9335

75334

Left ventricular outflow tract obstruction (LVOTO), broad definition

1537

8992

2.10

108.93

2.8

2.4

3.01

2.70

mg/l

5.80

1387

7881

Faecal incontinence

1639

9843

2.08

108.83

2.8

2.3

2.76

2.93

mg/l

1.87

1386

8453

Non-allergic asthma (mode)

2979

20049

1.66

108.48

2.6

2.2

2.83

2.74

mg/l

1.43

2679

17185

Other disorders of adrenal gland

896

4516

2.87

108.21

3.5

2.3

3.02

2.77

mg/l

2.86

827

3890

Mental and behavioural disorders due to sedatives or hypnotics

1126

6051

2.38

106.07

2.8

2.3

2.81

2.72

mg/l

0.57

972

5279

Umbilical hernia

4221

30814

1.53

106.06

2.6

2.3

2.95

2.76

mg/l

4.69

3746

26707

Other diseases of oesophagus

1624

9771

2.06

105.82

2.9

2.2

2.94

2.83

mg/l

0.94

1413

8379

Injuries to the neck

3768

27033

1.57

105.52

2.5

2.3

2.67

2.71

mg/l

0.45

3264

23565

Alcohol-induced chronic pancreatitis

1049

5562

2.49

105.15

2.7

2.3

2.88

2.80

mg/l

0.45

927

4821

Vasomotor and allergic rhinitis

5950

44525

1.42

104.83

2.5

2.3

2.62

2.70

mg/l

2.75

5202

38812

Other and unspecified effects of external causes

4396

32347

1.51

104.64

2.6

2.3

2.62

2.69

mg/l

1.37

3850

28193

Other metabolic disorders

2161

13911

1.83

104.58

2.6

2.2

2.78

2.76

mg/l

0.16

1911

12105

Disorders of tooth development and eruption

2495

13256

1.73

104.41

2.6

2.2

2.57

2.79

mg/l

5.27

2198

11546

Triptan medication for migraine, min. 3 purchases

8816

52798

1.34

104.33

2.4

2.3

2.55

2.63

mg/l

3.55

7733

46136

Other diseases of pancreas

1465

8670

2.16

104.17

2.8

2.3

2.87

2.81

mg/l

0.38

1295

7429

Zoster [herpes zoster]

3222

22720

1.65

103.83

2.9

2.4

3.02

2.87

mg/l

2.55

2834

19581

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4517

33046

1.50

103.59

2.6

2.3

2.70

2.60

mg/l

2.30

3942

28950

Aortic valve malfunction, age under 60 years

1417

8219

2.12

103.53

2.8

2.3

3.04

2.71

mg/l

5.95

1276

7200

Ankylosing spondylitis

1386

7967

2.12

103.31

2.8

2.2

2.85

2.75

mg/l

1.11

1230

6935

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1734

10768

2.02

103.27

2.9

2.4

2.93

2.80

mg/l

1.44

1567

9329

Superficial injury of lower leg

4381

32326

1.51

103.19

2.7

2.4

2.82

2.75

mg/l

1.21

3791

28091

Other necrotizing vasculopathies

1313

7617

2.30

102.96

3.0

2.4

3.03

2.90

mg/l

1.06

1169

6555

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2743

18120

1.70

102.80

2.9

2.5

2.90

2.70

mg/l

3.74

2445

15843

Arthropathies in other diseases classified elsewhere

679

3100

3.19

102.80

3.6

2.2

2.99

2.81

mg/l

1.37

610

2651

Urticaria

4805

35959

1.48

102.78

2.6

2.3

2.70

2.69

mg/l

0.17

4184

31370

Diseases of salivary glands

5263

39974

1.46

102.71

2.5

2.4

2.80

2.77

mg/l

0.40

4612

34753

Any dementia

7198

39404

1.40

102.37

2.5

2.88

3.02

mg/l

4.56

6076

33674

Endometriosis

5415

23691

1.46

102.19

2.4

2.2

2.67

2.75

mg/l

1.60

4653

20512

Alcohol abuse, main dg

2397

15853

1.75

102.06

2.6

2.3

2.75

2.71

mg/l

0.46

2109

13840

Superficial injury of hip and thigh

2719

18585

1.72

102.05

2.7

2.4

3.00

2.88

mg/l

1.36

2370

16001

Hypoglycaemia, other or unspecified

1222

6896

2.30

101.71

3.3

2.4

2.90

2.76

mg/l

1.06

1103

5972

Familial hypercholesterolemia

2515

16954

1.75

101.40

2.7

2.3

3.09

2.97

mg/l

1.73

2199

14455

Presence of other devices

4244

30836

1.53

101.38

2.5

2.3

2.87

2.88

mg/l

0.05

3754

26350

Myocarditis

698

3121

2.80

101.34

2.8

1.8

2.88

2.59

mg/l

2.07

624

2602

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2572

16792

1.73

101.32

2.9

2.5

2.91

2.68

mg/l

4.45

2302

14691

Asthma and allergy, excluding more controls

1988

12335

1.81

100.75

2.6

2.1

2.48

2.55

mg/l

0.87

1767

10686

Thoracic aortic aneurysm

2353

15714

1.79

100.28

2.6

2.3

3.00

2.81

mg/l

2.49

2051

13495

Other/unspecified rheumatoid arthritis

2125

13941

1.86

100.10

3.0

2.4

3.29

2.91

mg/l

9.07

1920

11986

Other hearing loss

4984

36609

1.48

100.05

2.5

2.4

2.78

2.93

mg/l

4.27

4191

31451

Charcot foot

375

1303

5.03

99.98

3.7

1.9

3.06

2.73

mg/l

1.95

338

1098

Other and unspecified nerve root and plexus disorders, also in other diseases

3199

22475

1.61

99.98

2.4

2.3

2.49

2.75

mg/l

10.68

2809

19500

Other and unspecified drugs and medicaments

1513

9147

2.10

99.70

2.9

2.3

3.09

2.79

mg/l

3.50

1367

7928

Disorders of vestibular function (Vertigo)

7833

61234

1.36

99.67

2.5

2.4

2.76

2.88

mg/l

4.19

6749

52824

Hyperparathyroidism

3138

21945

1.65

99.50

3.0

2.4

3.14

2.96

mg/l

3.04

2747

18888

Sicca syndrome [Sjögren]

1456

8723

2.13

99.32

2.8

2.3

2.90

2.85

mg/l

0.36

1274

7544

Malignant neoplasm of stomach, including Hilmo

1088

5961

2.39

99.08

2.8

2.4

3.29

2.85

mg/l

5.76

992

5074

Diseases of male genital organs

6987

27241

1.38

98.83

2.4

2.76

2.84

mg/l

2.08

6069

23652

Necrosis of pulp, including avohilmo

9101

73076

1.31

98.59

2.5

2.3

2.75

2.71

mg/l

1.25

7896

63779

Coxarthrosis, primary, with hip surgery

7797

58137

1.36

98.33

2.5

2.4

3.04

2.93

mg/l

3.28

6805

49752

Other symptoms and signs involving the circulatory and respiratory systems

1147

6350

2.27

98.22

2.6

2.2

2.94

2.74

mg/l

1.93

999

5467

Leisure time condition

3046

21405

1.64

98.21

2.6

2.4

3.06

2.79

mg/l

8.74

2627

18622

Other sleep disorders

1862

11764

1.88

97.96

2.6

2.2

2.86

2.73

mg/l

1.43

1666

10199

Essential (haemorrhagic) thrombocythaemia

731

3553

3.06

97.71

2.8

2.3

3.40

2.80

mg/l

4.03

635

3034

Colonic or urogenital fistula

4213

31221

1.51

97.30

2.8

2.3

2.70

2.79

mg/l

1.86

3664

27136

COPD, hospital admission 2, with asthma infections

5474

36314

1.45

97.03

2.9

2.4

3.31

2.88

mg/l

21.32

4763

31125

ILD, hospital admissions 3, with pneumonia sepsis

1538

9415

2.06

96.85

2.9

2.3

3.16

2.89

mg/l

3.92

1384

8023

Anosmia

320

910

4.37

96.73

2.5

1.6

2.70

2.42

mg/l

1.64

278

747

Unspecific neurodegenerative disorder

7587

41658

1.38

96.31

2.4

2.5

2.87

3.04

mg/l

7.20

6334

35615

Non-Hodgkin lymphoma, all, including Hilmo

2124

13971

1.81

95.89

2.4

3.13

2.78

mg/l

7.65

1884

12017

Ulcer of oesophagus

1174

6672

2.28

95.53

3.3

2.2

3.34

2.82

mg/l

7.19

1055

5705

Cholangitis (primary sclerosing, PSC), with reimbursement 202

409

1549

4.68

95.38

4.8

2.3

2.92

2.86

mg/l

0.19

381

1336

Aortic aneurysm

3847

27707

1.54

95.33

2.6

2.3

3.12

2.87

mg/l

6.63

3356

23611

UC patients in KELA-register (code 208), prior to 1994

763

3779

2.87

95.25

4.2

2.2

2.90

2.86

mg/l

0.18

704

3249

Other general symptoms and signs

932

4822

2.46

95.23

2.8

2.2

2.63

2.68

mg/l

0.24

813

4185

All influenza (not pneumonia)

2291

15193

1.73

95.22

2.8

2.3

3.07

2.71

mg/l

7.42

2016

13191

Seropositive rheumatoid arthritis, strict definition

2422

16426

1.74

95.20

2.7

2.4

3.18

2.79

mg/l

12.45

2207

14198

Noninflammatory disorders of female genital tract

6654

25995

1.39

95.12

2.4

2.3

2.69

2.73

mg/l

0.79

5764

22481

Acute alcohol intoxication, ICD10

3032

21274

1.61

95.10

2.5

2.3

2.84

2.72

mg/l

1.91

2631

18548

Glomerulonephritis

1610

9970

1.99

94.96

3.2

2.4

2.93

2.80

mg/l

1.51

1474

8639

Fentanyl

1745

10903

1.90

94.80

2.8

2.2

3.41

2.95

mg/l

9.17

1500

9233

Psoriasis

4365

32638

1.48

94.17

2.7

2.4

2.88

2.77

mg/l

2.18

3847

28369

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2280

15206

1.78

93.92

2.7

2.5

3.10

2.90

mg/l

2.50

1983

12963

Recurrent aphthous stomatitis , including avohilmo

2438

16596

1.73

93.90

2.8

2.4

2.79

2.77

mg/l

0.16

2137

14411

Thyroiditis, ILD-related definition

1878

12043

1.86

93.80

2.6

2.2

2.65

2.73

mg/l

0.86

1652

10372

Benign neoplasm: Descending colon

1270

7504

2.24

93.68

3.0

2.4

3.23

2.86

mg/l

6.12

1164

6457

Asthma and allergy

1988

12554

1.77

93.61

2.6

2.1

2.48

2.57

mg/l

1.29

1767

10901

Multiple myeloma, including Hilmo

851

4439

2.71

93.43

2.5

2.4

2.76

2.81

mg/l

0.25

749

3783

Agranulocytosis

1831

11770

1.89

92.96

2.6

2.4

3.00

2.80

mg/l

2.38

1639

10180

Acute gastritis

1250

7253

2.16

92.87

3.3

2.2

3.32

2.84

mg/l

8.01

1120

6216

Use of disulfiram, acamprosate or naltrexone

1274

7362

2.10

92.78

2.5

2.2

2.72

2.71

mg/l

0.04

1109

6479

Speech and linguistic disorders, excluding more controls

1244

6628

2.08

92.37

2.8

2.4

2.69

2.59

mg/l

0.64

1100

5797

Atopic dermatitis, strict definition with reimbursement

4706

34110

1.45

92.20

2.5

2.3

2.50

2.60

mg/l

2.98

4076

29785

Abnormal involuntary movements

2257

15181

1.76

92.17

2.6

2.4

2.70

2.79

mg/l

1.13

1951

13167

Abscess of anal and rectal regions

1277

7375

2.07

91.97

3.1

2.1

2.89

2.67

mg/l

2.23

1124

6402

In situ neoplasms

6949

55684

1.37

91.76

2.6

2.4

2.87

2.86

mg/l

0.11

5986

47947

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1978

12859

1.80

91.76

2.6

2.2

2.74

2.76

mg/l

0.14

1748

11181

Emotional disorders starting during childhood or adolecense, excluding more controls

773

3669

2.60

91.67

2.7

2.4

2.59

2.39

mg/l

2.05

677

3210

Other viral diseases, including avohilmo

5913

45661

1.39

91.66

2.6

2.3

2.67

2.65

mg/l

0.29

5267

39893

Glucosamine medication

7705

49710

1.35

91.58

2.5

2.4

2.96

2.95

mg/l

0.02

6544

42621

Thyrotoxicosis, other and/or unspecified

3203

22919

1.58

91.53

2.6

2.3

2.79

2.78

mg/l

0.15

2802

19914

Other diseases of arteries and capillaries

1556

9652

1.99

91.45

4.0

2.3

3.22

2.80

mg/l

7.01

1411

8305

Unspecified urinary incontinence

1589

9964

2.00

91.33

2.8

2.4

3.08

2.90

mg/l

1.93

1281

8609

Phlebitis and thrombophlebitis (not including DVT)

3606

26373

1.54

91.18

2.7

2.3

3.06

2.79

mg/l

7.62

3152

22790

Hepatic failure, not elsewhere classified

714

3527

2.95

91.05

3.3

2.3

3.51

2.88

mg/l

6.35

654

3011

Colitis, primary sclerosing

318

1072

5.64

90.97

5.3

2.2

3.01

2.81

mg/l

0.66

294

941

Abnormal results of function studies

1505

9249

2.00

90.94

3.0

2.3

2.95

2.73

mg/l

2.49

1332

8022

Diagnoses used for exclusion with ILD

4105

30671

1.50

90.67

2.8

2.4

3.13

2.87

mg/l

7.63

3623

26415

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2982

21188

1.62

90.53

2.1

2.4

3.44

2.78

mg/l

27.96

2669

18256

Other and unspecified mood [affective] disorders

1170

6639

2.14

90.48

2.5

2.1

2.55

2.59

mg/l

0.25

1026

5809

Other skin changes

3389

24684

1.57

90.35

2.8

2.4

2.90

2.85

mg/l

0.57

2996

21328

Other diseases of blood and blood-forming organs

1199

6993

2.22

90.26

3.0

2.3

3.73

2.82

mg/l

9.74

1037

6033

Osteonecrosis

1094

6215

2.31

90.23

2.9

2.3

2.80

2.84

mg/l

0.19

1000

5353

Other and unspecified local infections of skin and subcutaneous tissue

1654

10448

1.92

89.49

3.2

2.3

2.86

2.78

mg/l

0.80

1487

9048

Chronic laryngitis and laryngotracheitis

2268

15316

1.73

89.42

2.8

2.3

2.96

2.83

mg/l

2.03

1910

13262

Acute peritonitis

1118

6410

2.27

89.17

3.8

2.4

3.17

2.87

mg/l

3.50

1030

5515

Other local infections of skin and subcutaneous tissue

1735

11089

1.89

89.02

3.2

2.3

2.88

2.77

mg/l

1.13

1557

9610

Voice disturbances

4312

32585

1.48

88.89

2.5

2.4

2.61

2.82

mg/l

7.10

3738

28298

Diseases of peritoneum

1691

10783

1.92

88.88

3.5

2.4

3.11

2.85

mg/l

3.96

1524

9322

Drug-induced adrenocortical insufficiency

412

1646

4.57

88.66

4.0

2.3

3.39

2.86

mg/l

4.45

382

1429

Other mental disorders due to brain damage and dysfunction and to physical disease

2097

14094

1.80

88.60

2.8

2.4

2.90

2.97

mg/l

0.65

1827

12130

Postmenopausal osteoporosis with pathological fracture

1260

7622

2.25

88.49

3.1

2.5

3.07

3.04

mg/l

0.10

1091

6507

Unspecified privation

1788

11546

1.87

88.42

2.9

2.4

2.65

2.78

mg/l

1.40

1558

10021

Schizophrenia

2261

15174

1.70

88.12

2.3

2.74

2.71

mg/l

0.27

2009

13296

Fall on same level involving ice and snow

9480

78386

1.29

88.05

2.4

2.71

2.80

mg/l

3.76

8206

67982

Neuromuscular dysfunction of bladder

1513

9392

1.97

87.85

2.8

2.3

2.55

2.85

mg/l

6.20

1333

8152

Sub-endpoint used in defining T1D endpoints

4578

34178

1.44

87.67

3.0

2.4

2.92

2.81

mg/l

2.35

4074

29545

Conjunctivitis (acute, non atopic), including avohilmo

16915

88185

1.21

87.20

2.4

2.70

2.80

mg/l

7.36

14564

76637

Abnormal findings on diagnostic imaging of other body structures

2378

16353

1.70

87.01

2.6

2.3

2.88

2.79

mg/l

0.89

2125

14161

Other respiratory disorders and diseases

3436

25219

1.55

86.89

3.0

2.4

3.62

2.91

mg/l

30.72

2999

21627

Other diseases of the respiratory system

3436

25219

1.55

86.89

3.0

2.4

3.62

2.91

mg/l

30.72

2999

21627

Primary biliary cholangitis, wide definition

452

1865

3.81

86.83

4.1

2.2

3.04

2.83

mg/l

0.99

422

1597

Malignant neoplasm of stomach

941

5137

2.39

86.59

2.8

2.4

3.33

2.85

mg/l

5.56

859

4361

Other and unspecified injuries of head

1336

8097

2.07

86.57

2.8

2.4

2.58

2.83

mg/l

4.34

1151

7008

Cytomegalovirus infection, IBD co-morbidity

455

1904

3.86

86.10

3.8

2.2

2.93

2.85

mg/l

0.28

420

1642

Other shoulder lesions

1519

9409

1.92

85.94

2.7

2.2

2.68

2.78

mg/l

0.98

1293

8130

Diseases of inner ear

8882

70107

1.30

85.91

2.5

2.4

2.77

2.87

mg/l

4.11

7646

60576

Other symptoms and signs involving the urinary system

1734

11202

1.86

85.33

2.5

2.3

2.84

2.83

mg/l

0.05

1572

9678

Squamous cell neoplasms and carcinomas of the skin

1845

12159

1.85

84.96

2.7

2.5

3.13

2.91

mg/l

2.66

1610

10333

Other problems related to primary support group, including family circumstances

1829

11568

1.81

84.88

3.0

2.4

2.80

2.58

mg/l

4.41

1624

10171

Failure and rejection of transplanted organs and tissues

299

1015

5.52

84.37

3.7

2.4

3.17

2.81

mg/l

1.83

272

890

Other abnormal findings of blood chemistry

877

4763

2.50

84.22

2.8

2.2

3.08

2.80

mg/l

2.52

794

4090

Hypopituitarism

1125

6476

2.14

84.17

2.8

2.4

2.88

2.69

mg/l

1.91

1015

5671

Other/unspecified cytomegaloviral diseases

405

1628

4.23

84.16

3.7

2.2

2.94

2.85

mg/l

0.33

377

1412

Pain associated with micturition

2013

13472

1.77

84.04

2.7

2.3

2.77

2.83

mg/l

0.47

1762

11687

Other respiratory diseases principally affecting the interstitium

3049

22143

1.59

83.89

2.8

2.4

3.05

2.93

mg/l

2.14

2716

18952

Immunodeficiencies

843

4523

2.53

83.84

3.8

2.3

3.02

2.76

mg/l

2.53

784

3903

Iridocyclitis

3520

25976

1.52

83.66

2.7

2.4

2.88

2.79

mg/l

1.39

3148

22525

SLE (Finngen)

616

2931

2.92

83.32

3.2

2.1

2.88

2.76

mg/l

0.53

560

2517

Secondary right heart disease

817

4407

2.66

83.13

4.2

2.4

3.87

2.88

mg/l

9.84

748

3761

Viral and other specified intestinal infections

3331

23639

1.52

82.97

2.9

2.2

2.75

2.64

mg/l

2.16

2983

20450

Acute alcohol intoxication

3833

28585

1.48

82.92

2.6

2.3

2.88

2.78

mg/l

1.91

3329

24755

Disorders of psychological development

1877

11359

1.76

82.81

2.6

2.4

2.64

2.57

mg/l

0.62

1645

9938

Fracture of skull and facial bones

3237

23511

1.53

82.56

2.5

2.3

2.71

2.77

mg/l

0.96

2779

20515

Diseases of external ear

5752

45515

1.38

82.46

2.6

2.4

2.76

2.80

mg/l

0.74

4803

39568

Left bundle-branch block

1194

7051

2.08

82.29

2.6

2.1

2.85

2.69

mg/l

1.43

1028

5938

Other pulmonary heart/vessel disease

884

4898

2.52

82.17

4.2

2.4

3.81

2.89

mg/l

9.69

810

4179

Mental and behavioural disorders due to opioids

623

2955

2.77

82.07

2.8

2.2

2.96

2.60

mg/l

2.60

538

2621

Diabetic retinopathy

6096

30308

1.41

82.04

3.0

2.7

3.09

3.06

mg/l

0.35

5345

26639

Disorders of iron metabolism

343

1275

4.60

81.67

3.8

2.1

2.38

3.00

mg/l

6.44

309

1114

Oesophagitis

925

5117

2.34

81.55

3.0

2.2

2.98

2.81

mg/l

1.19

823

4375

Autoimmune hepatitis, wide definition

760

3915

2.53

81.40

3.3

2.1

2.91

2.75

mg/l

1.01

678

3350

Scoliosis

1444

9009

1.93

81.10

2.8

2.3

2.69

2.72

mg/l

0.17

1263

7762

Cytomegaloviral disease, including avohilmo

466

2023

3.59

80.97

3.7

2.2

2.92

2.84

mg/l

0.30

430

1745

Cytomegaloviral disease

461

1997

3.61

80.60

3.7

2.2

2.94

2.84

mg/l

0.35

426

1722

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

1018

5715

2.14

80.47

2.5

2.2

2.83

2.61

mg/l

1.95

865

5018

Erosion of teeth , including avohilmo

4134

31342

1.45

80.35

2.5

2.3

2.49

2.65

mg/l

5.64

3545

27369

malignant neoplasm of male genital organs, including Hilmo

4281

19358

1.45

80.26

2.3

2.4

2.87

2.74

mg/l

3.00

3659

16556

Varicose veins

9807

61811

1.28

80.25

2.6

2.3

2.98

2.84

mg/l

6.74

8618

53149

Alcohol withdrawal state with delirium

1059

6118

2.17

79.93

2.7

2.3

2.85

2.81

mg/l

0.20

909

5309

DVT of lower extremities

3027

22015

1.56

79.88

2.7

2.3

3.14

2.85

mg/l

6.53

2634

18947

Other bursopathies

2024

13626

1.72

79.75

2.7

2.3

2.83

2.85

mg/l

0.16

1772

11689

Other coagulation defects

1302

8016

2.03

79.64

3.5

2.3

2.88

2.73

mg/l

1.12

1155

6968

Familial hypercholesterolemia, with ischemic heart disease

1564

10110

1.91

79.22

2.9

2.3

3.13

2.90

mg/l

3.49

1359

8529

Other viral diseases

4394

33521

1.43

78.90

2.8

2.3

2.72

2.67

mg/l

0.95

3914

29286

Need for other prophylactic measures

967

5494

2.27

78.68

2.8

2.4

2.39

2.79

mg/l

5.54

863

4763

malignant neoplasm of male genital organs

4210

19102

1.45

78.63

2.2

2.4

2.86

2.74

mg/l

2.83

3597

16326

Mouth breathing

5695

45074

1.37

78.59

2.5

2.4

2.53

2.77

mg/l

16.65

5034

39290

Periapical abscess

6978

56592

1.32

78.17

2.5

2.4

2.82

2.75

mg/l

1.79

6045

49299

L01XX Other antineoplastic agents

1045

6169

2.27

78.16

2.7

2.4

4.89

2.89

mg/l

21.61

929

5293

Impingement syndrome of shoulder

3330

24510

1.50

78.16

2.5

2.3

2.74

2.84

mg/l

1.65

2889

21127

COPD, hospital admissions 3, with asthma pneumonia sepsis

4624

30771

1.43

77.82

2.9

2.4

3.34

2.89

mg/l

19.31

4024

26340

Diseases of tongue

992

5643

2.18

77.56

2.5

2.3

2.79

2.97

mg/l

1.39

851

4848

IBD (strict) with PSC

224

665

6.64

77.47

5.6

2.0

2.86

2.82

mg/l

0.09

209

581

Radiculopathy

2513

17738

1.61

77.47

2.7

2.3

2.85

2.91

mg/l

0.74

2180

15175

Enthesopathies of lower limb, excluding foot

3334

24545

1.49

77.41

2.5

2.3

2.72

2.78

mg/l

0.78

2903

21222

Acidosis

431

1853

3.72

77.27

3.6

2.2

3.33

3.01

mg/l

1.50

380

1586

Disorders of continuity of bone

1581

10186

1.84

77.00

2.8

2.3

2.75

2.73

mg/l

0.15

1383

8863

Assault

1854

12258

1.71

76.54

2.3

2.65

2.63

mg/l

0.12

1586

10770

Other pleural conditions

1773

11853

1.81

76.51

3.0

2.4

3.35

2.90

mg/l

8.96

1551

10120

Adverse effects, not elsewhere classified

3086

22629

1.53

76.38

2.6

2.3

2.59

2.72

mg/l

2.71

2708

19694

Other disorders of the musculoskeletal system and connective tissue

2341

16450

1.65

76.32

2.7

2.4

2.67

2.85

mg/l

3.35

2070

14232

Other disorders of eye and adnexa

2306

16125

1.65

76.32

2.5

2.4

2.49

2.75

mg/l

6.72

2005

14025

Disorders of vitreous body and globe

8145

63759

1.30

76.20

2.6

2.4

2.76

2.87

mg/l

3.57

7040

55076

Malnutrition

474

2177

3.65

75.99

3.4

2.6

3.25

2.93

mg/l

1.39

429

1868

Other specified/unspecified bacterial intestinal infections

1134

6831

2.11

75.83

3.2

2.3

2.81

2.83

mg/l

0.10

1018

5895

Caries of enamel

15374

87196

1.21

75.70

2.5

2.3

2.51

2.78

mg/l

49.02

13235

76020

Disorders of oesophagus in diseases classified elsewhere

435

1906

3.67

75.33

3.8

2.2

3.56

2.96

mg/l

3.76

404

1599

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

576

2739

2.74

75.10

3.0

2.2

2.50

2.68

mg/l

1.85

509

2431

Psoriatic arthropathies

1463

9252

1.84

75.04

2.6

2.2

2.90

2.75

mg/l

1.51

1306

7961

Colitis, primary sclerosing, strict definition

242

776

6.07

75.02

5.2

2.1

3.10

2.80

mg/l

0.86

221

683

Respiratory insufficiency

1343

8348

1.92

74.95

3.0

2.2

4.21

2.85

mg/l

28.62

1165

7079

Keratitis

5559

44225

1.36

74.71

2.5

2.4

2.76

2.77

mg/l

0.20

4874

38375

ILD, hospital admissions

2537

18257

1.62

74.55

2.7

2.4

3.04

2.91

mg/l

1.85

2259

15676

Early onset COPD

3223

23892

1.51

74.40

2.8

2.3

3.12

2.79

mg/l

9.15

2829

20667

Disorders of vitreous body

7899

62176

1.30

74.32

2.6

2.4

2.76

2.86

mg/l

3.81

6823

53716

Glaucoma

9298

66280

1.27

74.17

2.5

2.4

2.89

2.91

mg/l

0.57

8054

56856

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

2383

16846

1.62

74.16

2.2

2.4

3.17

2.75

mg/l

10.62

2125

14540

Malignant neoplasm of prostate

4132

18556

1.44

73.87

2.3

2.4

2.86

2.74

mg/l

2.62

3521

15853

Malignant neoplasm of prostate, including Hilmo

4184

18763

1.44

73.81

2.2

2.4

2.86

2.74

mg/l

2.44

3573

16035

Use of memantine

5175

33141

1.40

73.74

2.4

2.5

2.90

3.07

mg/l

5.05

4282

28346

Use of other anti-dementia drugs

5175

33141

1.40

73.74

2.4

2.5

2.90

3.07

mg/l

5.05

4282

28346

Fracture of foot, except ankle

3750

28390

1.45

73.41

2.6

2.3

2.69

2.70

mg/l

0.06

3272

24769

Artificial joint re-operation

1208

7525

2.07

73.39

2.9

2.4

3.11

2.92

mg/l

2.11

1075

6471

Bulimia nervosa (incl. atypical)

648

3308

2.66

73.31

2.6

2.2

2.56

2.49

mg/l

0.47

558

2898

Folate deficiency anaemia

260

910

6.21

72.84

3.5

2.1

3.06

2.76

mg/l

1.28

239

790

Fracture of forearm

8916

66981

1.27

72.42

2.5

2.4

2.78

2.80

mg/l

0.30

7678

57999

Thyrotoxicosis

3986

30636

1.44

72.39

2.6

2.4

2.82

2.79

mg/l

0.21

3477

26583

Localized swelling, mass and lump of skin and subcutaneous tissue

5029

39748

1.38

72.31

2.6

2.4

2.84

2.80

mg/l

0.48

4409

34435

Other inflammatory liver diseases

1076

6461

2.09

71.93

3.3

2.3

2.92

2.77

mg/l

1.32

956

5584

Flat foot [pes planus] (acquired)

1438

9172

1.83

71.75

2.6

2.2

2.72

2.78

mg/l

0.47

1253

7854

Other interstitial pulmonary diseases

2565

18618

1.60

71.48

2.7

2.4

3.06

2.92

mg/l

2.17

2281

15981

Other diseases of biliary tract

1480

9638

1.86

71.40

3.2

2.4

3.18

2.86

mg/l

4.44

1332

8278

Ankylosing spondylitis, ICD10

1322

8323

1.90

71.34

2.9

2.3

2.85

2.73

mg/l

1.46

1177

7250

Other viral hepatitis

918

5215

2.15

71.09

2.5

2.2

2.77

2.65

mg/l

0.79

807

4582

Interstitial lung disease

2565

18636

1.60

71.09

2.7

2.4

3.06

2.92

mg/l

2.10

2281

15997

Interstitial lung disease endpoints

2565

18636

1.60

71.09

2.7

2.4

3.06

2.92

mg/l

2.10

2281

15997

Other viral diseases, not elsewhere classified, including avohilmo

4080

31184

1.42

71.02

2.7

2.3

2.66

2.67

mg/l

0.03

3662

27283

Primary coxarthrosis, bilateral

4677

36910

1.40

71.00

2.6

2.4

3.03

2.94

mg/l

1.59

4066

31642

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

8613

68912

1.27

70.58

2.4

2.3

2.54

2.73

mg/l

13.17

7397

59983

Infections with a predominantly sexual mode of transmission, including avohilmo

5991

44075

1.33

70.55

2.3

2.57

2.60

mg/l

0.57

5085

38608

Benign paroxysmal vertigo

4723

37302

1.39

70.32

2.6

2.4

2.72

2.87

mg/l

4.38

4054

32252

Unspecified acute lower respiratory infection

2381

16933

1.59

70.25

2.8

2.4

2.93

2.79

mg/l

2.02

2133

14756

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1098

6635

2.03

70.25

2.6

2.3

2.77

2.72

mg/l

0.31

964

5760

Immunodeficiency with predominantly antibody defects

493

2332

3.14

70.17

3.7

2.3

3.11

2.80

mg/l

2.15

468

2028

Anorexia (incl.atypical)

1025

6082

2.08

70.12

2.8

2.3

2.50

2.60

mg/l

0.87

897

5281

Right hemicolectomy

1030

6223

2.16

70.02

3.1

2.4

3.57

2.90

mg/l

9.38

928

5337

Redundant prepuce, phimosis and paraphimosis

2643

18630

1.52

70.00

2.6

2.3

2.85

2.82

mg/l

0.19

2318

16275

Sequelae of injuries, of poisoning and of other consequences of external causes

3403

25594

1.46

69.81

2.5

2.3

2.66

2.74

mg/l

1.27

2957

22310

Arthropathy in ulcerative colitis

286

1061

4.91

69.80

4.3

2.2

2.74

2.81

mg/l

0.20

267

924

Cervicocranial syndrome

1681

11193

1.74

69.78

2.5

2.3

2.64

2.81

mg/l

2.28

1491

9637

Fibroblastic disorders

3541

26809

1.45

69.77

2.5

2.3

2.68

2.90

mg/l

8.20

3076

22984

Other viral hepatitis, including avohilmo

963

5577

2.08

69.65

2.5

2.2

2.77

2.64

mg/l

0.87

841

4900

Postmenopausal bleeding

3924

15589

1.45

69.24

2.5

2.4

2.97

2.96

mg/l

0.02

3334

13428

Insulin, fast-acting (human)

2070

14343

1.63

69.15

3.0

2.2

2.72

2.68

mg/l

0.34

1836

12480

Other embolism and thrombosis

2030

14130

1.66

69.11

2.9

2.3

3.09

2.81

mg/l

4.41

1804

12199

severe traumatic brain injury, does not include concussion

3659

28032

1.45

68.93

2.6

2.4

3.06

2.93

mg/l

2.00

3144

24058

Wide developmental disorders, excluding more controls

511

2316

2.71

68.56

2.3

2.6

2.51

2.45

mg/l

0.32

442

2057

Acute and subacute iridocyclitis

2856

21044

1.52

68.49

2.7

2.4

2.90

2.78

mg/l

2.03

2565

18262

Amputation of foot

522

2585

3.11

68.48

3.6

2.3

3.32

2.96

mg/l

2.57

470

2226

Myelodysplastic syndrome

307

1216

4.89

68.47

3.2

2.3

2.89

2.86

mg/l

0.08

274

1033

Anterior Iridocyclitis

3029

22543

1.50

68.28

2.7

2.4

2.90

2.78

mg/l

1.91

2718

19567

Lung transplantation

193

586

8.27

68.03

4.2

2.2

3.09

2.97

mg/l

0.25

186

511

Trigger finger

2118

14785

1.61

68.03

2.6

2.2

2.71

2.79

mg/l

0.97

1860

12760

Superficial injury of abdomen, lower back and pelvis

2525

18265

1.56

68.01

2.7

2.3

2.78

2.76

mg/l

0.24

2169

15900

Lung transplant status

192

582

8.31

67.88

4.1

2.2

3.08

2.97

mg/l

0.21

185

509

Pyogenic arthritis

1048

6289

2.02

67.84

3.0

2.3

3.24

2.83

mg/l

5.47

953

5391

Other disorders starting during childhood or adolecense, excluding more controls

722

3648

2.29

67.52

2.5

2.57

2.41

mg/l

1.44

643

3220

Other disorders of bladder

1894

13088

1.69

67.42

2.7

2.3

2.75

2.88

mg/l

1.79

1572

11285

Unspecified/other endometriosis

1465

9319

1.78

67.28

2.3

2.2

2.53

2.60

mg/l

0.55

1270

8147

Fall on and from stairs and steps

4156

32411

1.41

67.26

2.6

2.4

2.80

2.81

mg/l

0.15

3600

28104

Drug-induced osteoporosis with pathological fracture

361

1562

4.17

67.16

4.1

2.4

3.76

3.06

mg/l

4.69

329

1337

Excessive earwax

10300

79709

1.24

66.62

2.5

2.4

2.76

2.85

mg/l

4.19

8876

68893

Vitreous haemorrhage

1620

10902

1.76

66.55

3.1

2.4

2.85

2.86

mg/l

0.07

1419

9423

Diabetes mellitus in pregnancy

4860

24290

1.37

66.52

2.3

2.2

2.58

2.52

mg/l

1.56

4285

21304

Allergic conjunctivitis

8964

72749

1.25

66.05

2.4

2.3

2.54

2.72

mg/l

12.76

7707

63404

Acute myeloid leukaemia and myelodysplastic syndromes

474

2271

3.13

66.02

2.9

2.3

2.92

2.82

mg/l

0.36

414

1928

Endometriosis of pelvic peritoneum

2320

14999

1.57

66.01

2.4

2.2

2.54

2.67

mg/l

2.24

2000

13087

Other and unspecified coagulation defects

862

4995

2.21

65.93

3.6

2.2

2.74

2.72

mg/l

0.05

767

4353

Multiple myeloma and malignant plasma cell neoplasms

869

5121

2.29

65.92

2.5

2.4

2.79

2.93

mg/l

0.92

765

4376

Herpesviral [herpes simplex] infections, including avohilmo

3986

30947

1.41

65.70

2.6

2.3

2.63

2.68

mg/l

0.73

3466

26953

COPD-related respiratory insufficiency

1942

13611

1.68

65.61

2.9

2.4

3.66

2.89

mg/l

19.13

1683

11603

ILD, hospital admissions 1, main diag only

2240

16151

1.62

65.33

2.7

2.4

3.03

2.91

mg/l

1.62

1993

13865

Viral hepatitis

1048

6340

1.97

65.05

2.6

2.2

2.82

2.67

mg/l

0.98

917

5545

Adhesive capsulitis of shoulder

2398

17266

1.55

65.05

2.6

2.3

2.79

2.86

mg/l

0.80

2059

14901

Degenerative diseases of the nervous system

6456

38198

1.32

64.98

2.4

2.5

2.81

3.05

mg/l

12.12

5433

32683

Other and unspecified diseases of blood and blood-forming organs

499

2456

3.00

64.87

3.2

2.2

3.07

2.89

mg/l

0.49

441

2103

Malignant neoplasm of rectum, including Hilmo

1866

12944

1.67

64.64

2.4

3.17

2.81

mg/l

5.75

1614

11122

Maternal care for other conditions predominantly related to pregnancy

3076

22474

1.47

64.37

2.4

2.2

2.54

2.53

mg/l

0.01

2664

19649

Covid-19 suspected case

3258

24664

1.45

64.27

2.6

2.3

2.80

2.68

mg/l

2.34

2867

21484

Conjunctivitis (acute, non atopic)

4322

33827

1.38

64.12

2.5

2.4

2.73

2.72

mg/l

0.07

3778

29485

Alzheimer disease, including avohilmo

6643

37986

1.32

64.10

2.4

2.5

2.84

3.06

mg/l

10.79

5581

32413

Viral hepatitis, including avohilmo

1097

6738

1.93

64.07

2.5

2.2

2.81

2.68

mg/l

0.89

957

5884

Disorders of ocular muscles, binocular movement, accommodation and refraction

7472

61706

1.27

63.82

2.5

2.4

2.68

2.71

mg/l

0.59

6510

53716

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2972

22298

1.48

63.62

2.5

2.3

2.61

2.63

mg/l

0.27

2593

19379

Paralytic ileus

636

3374

2.46

63.55

3.4

2.2

3.08

2.81

mg/l

1.45

565

2863

Allergic rhinitis

4580

35769

1.36

63.33

2.5

2.3

2.55

2.63

mg/l

2.47

4008

31283

Malignant neoplasm of urinary organs, including Hilmo

1770

12207

1.68

63.30

2.5

2.4

3.12

2.80

mg/l

5.97

1545

10477

Other autoimmune haemolytic anaemias

291

1179

4.98

63.26

2.8

2.3

4.11

3.00

mg/l

7.22

267

1020

Open wound of forearm

1564

10520

1.74

63.26

2.8

2.3

2.94

2.79

mg/l

1.66

1342

9112

Chronic viral hepatitis

756

4194

2.21

63.22

2.4

2.2

2.85

2.63

mg/l

1.43

659

3695

Propionic acid derivatives

4731

18613

1.37

63.15

2.3

2.5

2.77

2.86

mg/l

1.77

4102

16109

Other follicular disorders

1177

7420

1.89

63.12

2.9

2.2

2.94

2.65

mg/l

3.42

1050

6476

Chronic hepatitis, not elsewhere classified

594

3112

2.60

63.08

3.1

2.2

2.99

2.80

mg/l

1.13

539

2684

Benign neoplasm: Small intestine

713

4021

2.46

62.97

3.5

2.3

3.43

2.93

mg/l

4.06

648

3442

Persons with potential health hazards related to communicable diseases

5557

44561

1.32

62.90

2.6

2.3

2.68

2.60

mg/l

1.86

4931

38927

Follow-up examination after treatment for malignant neoplasms

1536

10239

1.73

62.90

2.4

2.2

3.11

2.93

mg/l

1.70

1339

8637

Hypocalcemia

456

2205

3.15

62.78

3.3

2.3

3.09

2.89

mg/l

0.75

419

1880

Superficial injury of thorax

2356

17082

1.55

62.63

2.6

2.3

2.92

2.80

mg/l

1.32

2056

14813

Other specified/unspecified systemic involvement of connective tissue

934

5615

2.10

62.59

3.0

2.3

2.85

2.80

mg/l

0.21

846

4869

Autism spe, excluding more controls

390

1681

2.98

62.32

2.3

2.5

2.60

2.47

mg/l

0.83

331

1490

Deficiency of other B group vitamins

427

2009

3.22

62.28

3.3

2.2

2.98

2.91

mg/l

0.24

375

1730

Bronchiectasis

1313

8619

1.87

62.26

2.8

2.4

3.00

2.86

mg/l

1.28

1132

7387

Other symptoms and signs involving general sensations and perceptions

759

4336

2.30

61.86

2.7

2.4

3.01

2.88

mg/l

0.63

660

3721

False labour

4346

21106

1.38

61.73

2.1

2.2

2.46

2.55

mg/l

2.45

3835

18488

Ulcerative colitis (strict) with PSC

174

505

6.55

61.64

5.3

2.0

3.07

2.86

mg/l

0.40

160

438

Convalescence

860

5046

2.12

61.61

2.7

2.2

2.91

2.75

mg/l

1.15

733

4333

Schizoaffective disorder

1110

6922

1.90

61.52

2.3

2.2

2.76

2.68

mg/l

0.58

993

6035

Lesion of ulnar nerve

2017

14252

1.60

61.47

2.7

2.3

2.89

2.76

mg/l

1.72

1780

12390

Wet age-related macular degeneration

3141

23226

1.49

61.47

2.8

2.5

3.17

3.06

mg/l

1.24

2684

19802

Atopic dermatitis, strict definition

4420

34183

1.36

61.38

2.5

2.3

2.47

2.59

mg/l

4.11

3839

29887

Cerebral palsy and other paralytic syndromes

1729

11930

1.68

61.33

2.7

2.4

2.89

2.80

mg/l

0.75

1504

10363

Vascular diseases of the intestine

722

4092

2.36

61.20

3.7

2.3

3.32

2.92

mg/l

3.78

652

3478

Malignant neoplasm of bladder, including Hilmo

1872

12968

1.64

60.78

2.5

2.4

2.97

2.83

mg/l

1.66

1605

11063

Suppurative and necrotic conditions of lower respiratory tract

919

5548

2.09

60.77

2.8

2.3

2.97

2.89

mg/l

0.45

810

4780

Polyp of the female genital tract

4472

19917

1.38

60.72

2.4

2.3

2.82

2.83

mg/l

0.08

3863

17244

Lichen simplex chronicus and prurigo

1023

6331

1.99

60.65

2.9

2.3

2.84

2.82

mg/l

0.10

908

5456

Primary biliary cholangitis (PBC)

394

1793

3.20

60.46

3.7

2.2

2.98

2.82

mg/l

0.54

364

1536

Dissociative [conversion] disorders

660

3597

2.35

60.46

2.7

2.1

2.72

2.61

mg/l

0.68

582

3144

Amenorrhoea

1104

6906

1.89

60.26

2.8

2.2

2.63

2.55

mg/l

0.70

988

6018

Malignant neoplasm of small intestine, including Hilmo

540

2796

2.69

60.12

2.9

2.3

3.21

2.79

mg/l

2.90

496

2373

Unspecified misadventure during surgical and medical care

970

5987

2.05

59.97

3.0

2.3

3.16

2.82

mg/l

4.10

868

5185

Arthropathy in Crohn disease

233

844

5.22

59.83

5.4

2.1

2.69

2.73

mg/l

0.08

228

735

Other and unspecified disorders of skin and subcutaneous tissue

1033

6452

1.98

59.69

2.9

2.3

3.41

2.83

mg/l

11.63

846

5551

Ocular pain

1377

9149

1.78

59.64

2.5

2.3

2.47

2.72

mg/l

5.11

1206

7955

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

523

2696

2.76

59.64

2.4

2.76

2.86

mg/l

0.44

456

2291

Multiple myeloma

523

2696

2.76

59.64

2.4

2.76

2.86

mg/l

0.44

456

2291

Laparoscopic left hemicolectomy

358

1621

3.72

59.42

2.2

2.73

2.93

mg/l

0.48

309

1395

Other viral diseases, not elsewhere classified

2725

20272

1.48

59.38

2.9

2.4

2.76

2.71

mg/l

0.48

2452

17712

Diplopia

2049

14698

1.60

59.36

2.7

2.4

2.82

mg/l

0.02

1816

12740

Disorders of muscles

1544

10435

1.70

59.35

2.7

2.2

2.75

2.79

mg/l

0.31

1368

8997

Presbycusis

2537

18674

1.53

59.25

2.5

2.78

3.05

mg/l

7.36

2065

15947

Giant cell arteritis

759

4442

2.32

59.22

2.9

2.4

2.96

2.98

mg/l

0.08

667

3790

Other disorders of white blood cells

897

5430

2.09

59.17

3.1

2.4

3.02

2.80

mg/l

1.78

793

4702

Benign neoplasm of other and unspecified endocrine glands

2012

14404

1.60

59.10

2.7

2.4

2.95

2.80

mg/l

1.91

1787

12497

Injuries to unspecified part of trunk, limb or body region

1656

11453

1.69

59.08

2.9

2.4

2.84

2.80

mg/l

0.20

1445

9933

Other and unspecified urticaria

2950

22329

1.46

59.04

2.6

2.3

2.76

2.71

mg/l

0.67

2574

19457

Attention to artificial openings

708

4004

2.30

59.00

3.0

2.3

3.26

2.83

mg/l

4.56

626

3413

Injuries to the wrist and hand

16780

98688

1.17

58.99

2.4

2.67

2.78

mg/l

8.64

14483

85674

Reactive arthropathies

1258

8139

1.79

58.97

2.6

2.2

2.71

2.74

mg/l

0.21

1120

7013

Benign thyroid growths and nodules

4994

37511

1.34

58.68

2.4

2.89

2.86

mg/l

0.27

4325

32339

Postprocedural musculoskeletal disorders, not elsewhere classified

1171

7596

1.90

58.65

2.9

2.4

2.81

2.89

mg/l

0.55

1059

6566

Infections with a predominantly sexual mode of transmission

4425

35129

1.35

58.52

2.4

2.3

2.62

2.61

mg/l

0.13

3744

30790

Childhood asthma (age<16), excluding more controls

1836

9860

1.59

58.31

2.4

2.0

2.52

2.43

mg/l

1.17

1623

8526

Deviated nasal septum

4612

36860

1.34

58.10

2.4

2.3

2.60

2.81

mg/l

9.77

3988

32024

Pericarditis

556

2884

2.46

57.98

2.9

2.1

2.95

2.70

mg/l

1.76

486

2437

Inflammatory disease of uterus

2154

15606

1.56

57.84

2.6

2.2

2.64

2.63

mg/l

0.03

1878

13600

Systemic lupus erythematosus

616

3368

2.45

57.82

3.2

2.2

2.88

2.78

mg/l

0.41

560

2916

Non-follicular lymphoma

1508

10345

1.74

57.49

2.4

3.17

2.87

mg/l

3.86

1330

8914

Other specified/unspecified inflammatory spondylopathies

717

4035

2.17

57.45

2.7

2.2

2.71

2.69

mg/l

0.09

640

3497

Anti-inflammatory and antirheumatic products, non-steroids

4682

18616

1.35

57.37

2.3

2.5

2.77

2.86

mg/l

1.62

4040

16112

Diseases of spleen

358

1626

3.46

57.28

3.3

2.2

3.74

2.87

mg/l

5.17

318

1406

Agoraphobia

525

2678

2.49

57.00

2.6

2.1

2.48

2.53

mg/l

0.24

459

2360

Golimumab

566

2982

2.44

56.99

3.1

2.1

2.72

2.68

mg/l

0.17

525

2602

Spontaneous rupture of synovium and tendon

1242

8113

1.80

56.94

2.8

2.3

2.97

2.87

mg/l

0.79

1086

6958

Visual impairment including blindness (binocular or monocular)

1194

7809

1.86

56.94

3.0

2.4

3.36

2.92

mg/l

6.16

969

6701

Unknown and unspecified causes of morbidity

1030

6406

1.88

56.67

2.8

2.1

2.91

2.73

mg/l

1.74

975

5508

Secondary and unspecified malignant neoplasm of lymph nodes

1293

8564

1.78

56.59

2.3

2.4

3.15

2.76

mg/l

5.68

1140

7362

Disorders of magnesium metabolism

195

671

6.51

56.57

3.7

2.1

2.99

3.03

mg/l

0.07

182

595

Mental and behavioural disorders due to tobacco

1303

8632

1.77

56.52

2.6

2.3

3.10

2.72

mg/l

6.40

1099

7528

Other disorders involving the immune mechanism, not elsewhere classified

529

2760

2.58

56.46

3.3

2.4

2.88

2.77

mg/l

0.46

487

2401

Hypoparathyroidism

645

3634

2.42

56.44

3.3

2.4

3.53

2.90

mg/l

5.42

568

3120

Psoriasis vulgaris

2683

20174

1.47

56.12

2.7

2.3

2.86

2.76

mg/l

1.42

2366

17529

Childhood asthma (age<16)

1837

9954

1.57

55.81

2.4

2.0

2.52

2.43

mg/l

1.09

1624

8613

Open wound of ankle and foot

1586

10948

1.66

55.69

2.9

2.3

2.74

mg/l

0.03

1395

9538

Benign neoplasm: Duodenum

486

2532

2.87

55.69

3.6

2.3

3.57

2.97

mg/l

3.52

436

2177

Viral pneumonia (unknown virus, not influenza)

1058

6722

1.88

55.43

3.0

2.3

2.95

2.73

mg/l

1.92

941

5807

Progressive vascular leukoencephalopathy

792

4818

2.26

55.42

2.8

2.5

2.39

3.05

mg/l

14.08

693

4102

Invasive ventilation

1159

7562

1.85

55.36

2.9

2.4

3.14

2.81

mg/l

3.27

1025

6539

Hypercalcemia

770

4597

2.22

55.34

2.8

2.4

3.39

2.91

mg/l

3.30

674

3933

Dermatophytosis

2099

15288

1.56

55.24

2.7

2.4

2.93

2.80

mg/l

1.81

1852

13264

Cardiac murmurs and other cardiac sounds

1451

9698

1.69

55.17

2.8

2.3

2.72

2.68

mg/l

0.25

1299

8415

Dislocation, sprain and strain of joints and ligaments at neck level

2289

16833

1.51

55.11

2.4

2.3

2.58

2.65

mg/l

0.92

1961

14724

Congenital malformations of the circulatory system

2072

14577

1.55

54.98

2.9

2.5

2.94

2.68

mg/l

4.07

1856

12766

Smoking dependency

1303

8688

1.76

54.90

2.6

2.3

3.10

2.73

mg/l

6.30

1099

7571

Emotional disorders and disorders of social functioning with onset specific to childhood

839

4913

2.03

54.90

2.8

2.6

2.60

2.45

mg/l

1.42

736

4300

Reactive arthropathies, FINNGEN

1018

6395

1.87

54.43

2.6

2.2

2.59

2.70

mg/l

0.94

913

5447

Hypermobility syndrome

865

5264

2.02

54.43

2.7

2.2

2.58

mg/l

0.00

778

4601

Other juvenile arthritis

647

3609

2.24

54.39

3.6

2.3

2.92

2.53

mg/l

5.28

599

3140

Pneumonitis due to solids and liquids

1376

9336

1.74

54.37

2.9

2.4

3.27

2.95

mg/l

3.36

1178

7977

Blepharochalasis

4478

36212

1.35

54.26

2.5

2.4

2.75

2.93

mg/l

6.36

3858

31175

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

493

2548

2.61

54.06

3.3

2.4

2.84

2.78

mg/l

0.19

451

2216

Striking against or struck by other objects

4854

39295

1.32

54.04

2.6

2.4

2.68

2.70

mg/l

0.34

4155

34304

Other enthesopathy of foot (+metatarsalgia)

1518

10413

1.66

53.89

2.5

2.2

2.54

2.76

mg/l

4.30

1316

8958

Other inflammation of eyelid

2208

16270

1.53

53.86

2.5

2.3

2.53

2.81

mg/l

8.33

1906

14099

Maternal care for other known or suspected fetal problems

3581

17487

1.39

53.65

2.2

2.47

2.51

mg/l

0.59

3151

15320

Retinal vascular occlusion

1954

14218

1.59

53.55

2.8

2.4

3.04

2.95

mg/l

0.86

1705

12155

Malignant neoplasm of small intestine

419

2073

2.94

53.51

3.0

2.3

3.25

2.80

mg/l

2.59

380

1758

Etanercept

984

6188

1.90

53.46

2.8

2.3

2.86

2.68

mg/l

1.82

905

5391

Cholecystitis

2240

16575

1.52

53.38

2.8

2.4

3.19

2.90

mg/l

6.01

1966

14149

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

5680

46219

1.29

53.37

2.5

2.3

2.63

2.64

mg/l

0.16

4882

40453

SLE, ICD10

578

3190

2.43

53.03

3.0

2.2

2.90

2.79

mg/l

0.45

526

2765

SLE, strict definition

578

3190

2.43

53.03

3.0

2.2

2.90

2.79

mg/l

0.45

526

2765

Otitis externa

3429

26871

1.39

52.99

2.7

2.4

2.73

2.74

mg/l

0.11

2917

23380

Diabetic neuropathy

1945

14262

1.63

52.96

3.2

2.7

3.03

3.05

mg/l

0.17

1749

12498

Metatarsalgia

1414

9607

1.68

52.88

2.5

2.2

2.51

2.76

mg/l

5.29

1221

8251

Fenamates

2287

11398

1.51

52.74

2.5

2.4

2.76

2.87

mg/l

1.23

1995

9917

Congenital malformations of heart and great arteries

1824

12639

1.58

52.55

2.8

2.5

2.99

2.68

mg/l

5.27

1648

11083

Viral pneumonia (known virus, not influenza)

527

2854

2.58

52.40

3.5

2.4

2.95

2.87

mg/l

0.29

482

2432

Primary hyperparathyroidism

1707

12181

1.63

52.35

2.8

2.4

3.12

2.88

mg/l

2.56

1482

10532

Corns and callosities

1044

6729

1.87

52.29

3.1

2.3

2.97

2.84

mg/l

1.17

933

5782

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1504

10447

1.66

51.86

2.5

2.4

3.14

2.81

mg/l

5.25

1320

8988

Other disorders of bone

2776

21179

1.43

51.73

2.7

2.3

2.76

2.71

mg/l

0.46

2401

18443

Nephrotic syndrome

525

2829

2.50

51.64

3.5

2.4

2.79

2.82

mg/l

0.11

477

2437

D07AA Corticosteroids, weak (group I)

2310

17187

1.49

51.25

2.7

2.4

2.61

2.68

mg/l

0.82

2069

14966

Retinal vascular disorders

1975

14492

1.57

51.22

2.8

2.4

3.04

2.95

mg/l

0.86

1723

12381

Small fibre neuropathy

528

2880

2.53

51.17

2.9

2.3

2.65

2.89

mg/l

1.73

457

2489

Sequelae of other external causes

906

5666

1.94

51.16

2.9

2.2

2.89

2.79

mg/l

0.66

818

4884

Fall involving bed

646

3777

2.34

51.07

3.1

2.5

3.17

3.01

mg/l

0.66

558

3240

Juvenile arthritis (FINNGEN)

716

4189

2.09

50.96

3.5

2.3

2.92

2.54

mg/l

5.28

659

3633

Adenomyosis (Endometriosis of uterus)

1949

14157

1.54

50.67

2.5

2.3

2.68

2.82

mg/l

2.06

1679

12243

Vascular dementia

1711

11813

1.61

50.61

2.6

2.5

2.93

3.17

mg/l

2.68

1469

10102

Secondary uncertain malignant neoplasm

2015

14778

1.53

50.36

2.2

2.4

3.31

2.80

mg/l

12.82

1755

12696

Procreative management

4427

29350

1.32

50.16

2.5

2.4

2.53

2.69

mg/l

5.08

3913

25768

Mixed hyperlipidaemia

636

3640

2.21

50.02

3.0

2.2

3.23

2.94

mg/l

2.38

562

3113

Alcohol-induced acute pancreatitis

548

2994

2.35

49.99

2.7

2.2

2.73

2.83

mg/l

0.39

473

2592

Other/unspecified synovitis and tenosynovitis

1647

11636

1.59

49.94

2.6

2.2

2.77

2.81

mg/l

0.30

1443

10010

Systemic lupus erythematosus, unspecified

508

2746

2.52

49.94

3.1

2.2

2.93

2.80

mg/l

0.49

461

2369

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

517

2810

2.49

49.91

2.8

2.4

3.98

2.84

mg/l

9.80

468

2380

Chronic lymphocytic leukaemia, helper endpoint

517

2810

2.49

49.91

2.8

2.4

3.98

2.84

mg/l

9.80

468

2380

Chronic lymphocytic leukaemia

517

2810

2.49

49.91

2.8

2.4

3.98

2.84

mg/l

9.80

468

2380

Temporal arteritis

658

3892

2.29

49.83

2.9

2.4

3.01

2.99

mg/l

0.07

575

3309

Memory loss

1453

10200

1.69

49.56

2.6

2.4

2.38

2.98

mg/l

19.89

1230

8816

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1523

10701

1.64

49.36

2.3

2.4

3.15

2.81

mg/l

4.55

1317

9184

Personal history of other diseases and conditions

1710

12159

1.58

49.32

2.6

2.3

2.55

2.57

mg/l

0.11

1444

10627

Retinal detachments and breaks

5406

44933

1.29

49.25

2.6

2.4

2.84

2.89

mg/l

0.74

4674

38723

Other inflammation of eyelid, including avohilmo

6898

58412

1.25

49.14

2.4

2.3

2.50

2.72

mg/l

16.16

5891

50873

Nonhereditary hypogammaglobulinemia

226

892

4.40

49.14

3.7

2.1

3.19

2.77

mg/l

1.97

218

769

Adenocarcinoma and papilloma adenocarcinoma of rectum

1466

10241

1.65

49.02

2.3

2.4

3.17

2.82

mg/l

4.63

1263

8782

Other infectious diseases, including avohilmo

1434

10011

1.67

48.97

3.1

2.4

3.15

2.84

mg/l

4.63

1280

8651

Other and unspecified disorders of white blood cells

665

3916

2.19

48.95

3.1

2.3

3.10

2.83

mg/l

1.68

591

3359

Carcinoma in situ of skin of other and unspecified parts of face

1531

10957

1.68

48.85

2.8

2.5

3.05

3.02

mg/l

0.14

1314

9391

Uterine polyps

4086

19087

1.35

48.82

2.4

2.3

2.80

2.83

mg/l

0.38

3519

16538

Infection of intervertebral disc (pyogenic)

277

1209

3.72

48.81

3.6

2.2

2.93

2.96

mg/l

0.07

250

1031

Drug-induced cataract

411

2084

2.79

48.74

3.7

2.2

3.34

2.87

mg/l

3.01

373

1797

Other maternal disorders predominantly related to pregnancy

8130

43473

1.23

48.59

2.3

2.63

2.64

mg/l

0.18

7143

37781

Lung diseases due to external agents

2193

16427

1.50

48.53

2.8

2.4

3.25

2.92

mg/l

6.41

1906

14050

Other noninflammatory disorders of uterus, except cervix

3078

15935

1.41

48.48

2.6

2.4

3.03

2.93

mg/l

1.22

2682

13712

Other disorders of nervous system

1029

6733

1.83

48.35

2.7

2.3

2.89

2.85

mg/l

0.18

891

5810

Other and unspecified immunodeficiencies with predominantly antibody defects

248

1033

3.99

48.23

3.4

2.2

2.77

2.84

mg/l

0.17

236

889

Inguinal hernia

8608

49109

1.22

48.06

2.4

2.3

2.82

2.81

mg/l

0.12

7478

42302

Malignant neoplasm of urinary organs

1463

10257

1.64

48.00

2.4

3.15

2.81

mg/l

5.26

1275

8802

Anankastic personality disorder

612

3494

2.18

47.99

2.5

2.1

2.37

2.61

mg/l

2.75

544

3060

Other disorders of patella

2254

16799

1.46

47.98

2.4

2.2

2.71

2.66

mg/l

0.38

1944

14529

Discitis, unspecified

327

1536

3.21

47.87

3.1

2.2

3.25

2.92

mg/l

1.46

295

1304

IgA nephropathy (IgA glomerulonephritis)

396

1984

2.75

47.55

3.3

2.1

2.85

2.82

mg/l

0.08

363

1714

Female genital prolapse

4151

18515

1.34

47.51

2.4

2.3

2.79

2.88

mg/l

1.23

3619

15990

Carcinoma in situ of other and unspecified digestive organs

724

4413

2.11

47.47

3.0

2.3

2.86

2.89

mg/l

0.08

655

3793

Chronic myeloproliferative disease

288

1318

3.78

47.46

3.1

2.2

5.26

3.01

mg/l

7.93

263

1129

Crystal arthropathies, rheuma endpoint

373

1856

2.96

47.42

3.0

2.2

3.57

3.01

mg/l

2.98

323

1554

Acne, including avohilmo

3392

21639

1.37

47.19

2.4

2.2

2.45

2.50

mg/l

0.91

2931

18804

Oesophageal obstruction

582

3320

2.26

47.15

2.9

2.2

2.89

2.86

mg/l

0.11

508

2806

Brachial plexus disorders

1305

8929

1.66

47.06

2.4

2.2

2.60

2.66

mg/l

0.62

1176

7811

Sacroiliitis, not elsewhere classified

707

4196

2.01

46.96

2.6

2.1

2.58

2.66

mg/l

0.52

647

3650

Alzheimer disease

5802

34861

1.28

46.94

2.4

2.5

2.82

3.07

mg/l

12.59

4865

29759

Giant cell arteritis with polymyalgia rheumatica

658

3964

2.24

46.83

2.9

2.4

3.01

3.00

mg/l

0.06

575

3370

Pneumonia due to other infectious organisms, not elsewhere classified

545

3053

2.30

46.58

2.9

2.2

3.13

2.78

mg/l

3.01

500

2619

Female infertility

4021

19297

1.33

46.51

2.3

2.2

2.56

2.62

mg/l

1.14

3462

16783

Synovial cyst of popliteal space [Baker]

1105

7368

1.75

46.48

2.8

2.3

2.83

2.90

mg/l

0.46

961

6293

Infective dermatitis

1677

12097

1.57

46.40

2.7

2.3

2.93

2.77

mg/l

1.92

1483

10496

Cystic kidney disease

528

2949

2.36

46.34

3.2

2.3

2.72

2.82

mg/l

0.52

468

2560

Nail disorders

1251

8558

1.69

46.27

3.0

2.3

2.72

2.75

mg/l

0.20

1114

7443

Fracture at wrist and hand level

4948

40710

1.28

46.24

2.4

2.66

2.76

mg/l

2.34

4317

35512

Heart failure and hypertrophic cardiomyopathy

351

1740

3.09

46.01

4.0

2.4

3.45

3.01

mg/l

1.59

319

1486

Drug-induced osteoporosis

266

1176

3.72

45.97

3.7

2.2

3.28

3.00

mg/l

1.09

248

1003

Acute and transient psychotic disorders

1559

11067

1.58

45.91

2.4

2.3

2.66

2.71

mg/l

0.45

1363

9659

Tubulo-interstitial nephritis, not specified as acute or chronic

1074

7149

1.76

45.79

2.9

2.2

3.27

2.84

mg/l

5.26

947

6099

Bullous disorders

950

6228

1.87

45.72

2.9

2.4

2.80

2.89

mg/l

0.48

841

5358

Malignant neoplasm of rectum

1462

10344

1.62

45.51

2.3

2.4

3.13

2.81

mg/l

4.35

1257

8880

Pyothorax

699

4247

2.07

45.46

2.8

2.3

2.99

2.89

mg/l

0.53

618

3677

Speech and linguistic disorders

1288

8469

1.65

45.42

2.9

2.5

2.69

2.59

mg/l

0.72

1137

7434

Viral warts, including avohilmo

3191

25236

1.37

45.19

2.7

2.3

2.69

2.68

mg/l

0.07

2811

21991

Other crystal arthropathies

373

1897

2.87

44.90

3.0

2.2

3.57

2.95

mg/l

3.62

323

1599

Congenital malformations of the urinary system

886

5698

1.87

44.85

3.0

2.4

2.76

2.71

mg/l

0.27

778

4955

Other and unspecified acquired haemolytic anaemias

210

848

4.53

44.72

4.9

2.2

4.13

2.91

mg/l

4.22

198

736

Special screening examination for neoplasms

875

5515

1.81

44.70

2.9

2.0

2.80

2.79

mg/l

0.02

757

4720

Volvulus

466

2517

2.42

44.57

3.0

2.2

3.14

2.83

mg/l

1.16

404

2148

Speech disturbances, not elsewhere classified

1441

10267

1.63

44.45

2.8

2.4

2.98

2.90

mg/l

0.50

1208

8845

Assault by bodily force

1039

6839

1.72

44.28

2.4

2.2

2.62

2.63

mg/l

0.06

884

6018

Cystic kidney disease, including avohilmo

564

3256

2.24

44.28

3.2

2.3

2.71

2.83

mg/l

0.70

496

2829

Other and unspecified visual disturbances

1613

11680

1.57

44.28

2.8

2.3

2.49

2.79

mg/l

7.42

1420

10118

Neuralgia and neuritis, unspecified

774

4804

1.92

44.19

2.7

2.2

2.57

2.79

mg/l

2.46

693

4129

Vitamin D deficiency

338

1640

2.87

44.12

3.0

2.1

3.05

2.72

mg/l

1.63

308

1421

Right bundle-branch block

581

3349

2.14

43.92

3.0

2.1

3.04

2.75

mg/l

1.75

500

2820

Congenital malformations of the urinary system, including avohilmo

939

6153

1.82

43.72

3.0

2.4

2.75

2.71

mg/l

0.19

820

5348

Superficial injury of wrist and hand

3037

23953

1.37

43.67

2.6

2.3

2.64

2.67

mg/l

0.32

2617

20937

Herpesviral [herpes simplex] infections

1750

12848

1.53

43.64

2.8

2.3

2.83

2.74

mg/l

0.87

1542

11164

Hypertrophy of breast in women and men

2741

21392

1.40

43.52

2.5

2.3

2.63

2.72

mg/l

1.60

2422

18630

Emotional disorders starting during childhood or adolescence

784

4864

1.92

43.51

2.8

2.5

2.58

2.45

mg/l

1.10

688

4259

Arthropathic psoriasis

1567

11284

1.57

43.51

2.6

2.3

2.90

2.77

mg/l

1.23

1399

9843

Focal epilepsy

3123

24809

1.37

43.33

2.4

2.80

2.79

mg/l

0.09

2669

21544

Chronic diseases of tonsils and adenoids

11697

65140

1.17

43.30

2.3

2.58

2.74

mg/l

12.65

10230

56654

Female infertility, cervical, vaginal, other or unspecified origin

3670

18774

1.33

43.29

2.4

2.2

2.52

2.62

mg/l

2.26

3167

16335

Diseases of middle ear and mastoid

8844

62827

1.20

43.17

2.5

2.3

2.64

2.70

mg/l

2.06

7697

54668

Carbimazole or st.post thyroidectomy, condition for graves disease

3036

24066

1.37

43.12

2.5

2.3

2.67

2.75

mg/l

1.08

2643

20907

therapeutic use

541

3138

2.31

43.09

3.0

2.3

3.36

2.89

mg/l

3.84

446

2669

Asthma and opportunity respiratory infection

764

4843

1.99

43.06

2.9

2.3

2.96

2.88

mg/l

0.42

692

4133

Prurigo nodularis

429

2309

2.54

42.94

3.2

2.3

2.80

2.93

mg/l

0.54

373

1983

Other noninflammatory disorders of vulva and perineum

1431

10154

1.59

42.84

2.6

2.3

2.58

2.71

mg/l

1.78

1258

8844

Arterial embolism and thrombosis

923

6058

1.82

42.61

3.1

2.3

3.47

2.93

mg/l

6.55

827

5174

Other condition

2083

15730

1.46

42.58

2.8

2.4

3.17

2.74

mg/l

9.99

1889

13707

Mental disorders, not otherwise specified

1171

8016

1.67

42.53

2.5

2.2

2.44

2.61

mg/l

2.19

1013

6984

Other and unspecified aplastic anaemias

224

940

3.84

42.49

3.2

2.1

2.95

2.85

mg/l

0.20

198

816

Malignant neoplasm of kidney, except renal pelvis

1314

9242

1.63

42.44

2.5

2.4

3.17

2.80

mg/l

5.56

1149

7935

Tinnitus

3378

27139

1.35

42.44

2.4

2.58

2.79

mg/l

6.60

2891

23592

Sleep disorders, other/unspecified

568

3284

2.12

42.36

2.5

2.3

2.43

2.72

mg/l

2.78

479

2875

Ankylosing spondylitis, strict definition

602

3531

2.05

42.10

2.8

2.2

2.76

2.67

mg/l

0.48

546

3092

Other infectious diseases

1183

8217

1.68

41.74

3.2

2.3

3.13

2.86

mg/l

3.08

1052

7087

Systemic sclerosis (FG)

381

1966

2.58

41.73

3.8

2.1

2.90

2.81

mg/l

0.31

348

1664

Excessive vomiting in pregnancy

1200

8312

1.66

41.67

2.4

2.2

2.60

2.59

mg/l

0.08

1017

7233

Lateral epicondylitis

1695

12365

1.50

41.58

2.4

2.2

2.75

mg/l

0.01

1492

10753

Polycythaemia vera

543

3167

2.20

41.12

2.5

2.4

7.55

2.83

mg/l

30.80

474

2689

Ganglion

2899

22869

1.36

41.02

2.4

2.2

2.63

2.74

mg/l

2.37

2549

19821

Thyrotoxicosis with diffuse goitre

1979

14896

1.46

41.02

2.4

2.3

2.68

2.73

mg/l

0.36

1728

12994

Gestational diabetes (for exclusion)

5294

30498

1.26

40.97

2.3

2.2

2.62

2.51

mg/l

3.61

4611

26766

Other disorders of conjunctiva

2114

16153

1.46

40.96

2.6

2.4

2.93

2.87

mg/l

0.49

1871

13974

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1197

8385

1.67

40.74

3.0

2.3

3.08

2.81

mg/l

3.58

1064

7256

Late syphilis

248

1106

3.40

40.72

3.6

2.1

3.18

2.90

mg/l

0.85

219

974

Superficial injury of shoulder and upper arm

1786

13275

1.50

40.72

2.5

2.3

2.75

2.80

mg/l

0.28

1515

11536

Any prescribed medicine buy

8.44

40.68

1.9

1.8

2.56

2.59

mg/l

0.04

Other benign neoplasms of skin

5723

48642

1.25

40.64

2.5

2.4

2.86

2.85

mg/l

0.08

4948

41969

Carcinoma in situ of colon

490

2813

2.34

40.46

3.0

2.3

2.96

2.91

mg/l

0.15

443

2420

Seborrhoeic dermatitis

1459

10527

1.57

40.40

2.8

2.3

2.78

2.76

mg/l

0.07

1267

9124

Other/unspecified enthesopathies of lower limb, excluding foot

1016

6816

1.70

40.34

2.5

2.2

2.70

2.77

mg/l

0.46

884

5889

Any event in hilmo or specialist outpatient

11.03

40.29

1.8

1.3

2.52

2.74

mg/l

0.11

Pollen allergy

2642

20390

1.38

40.09

2.6

2.4

2.48

2.59

mg/l

2.31

2284

17881

Late syphilis, including avohilmo

293

1409

3.00

39.95

3.5

2.1

3.07

2.88

mg/l

0.62

254

1243

Acute suppurative otitis media

3736

28321

1.31

39.85

2.5

2.3

2.63

2.57

mg/l

1.21

3262

24703

Other abnormalities of plasma proteins

303

1495

3.04

39.82

2.9

2.2

3.17

3.00

mg/l

0.60

268

1282

Olecranon bursitis

861

5619

1.78

39.44

2.7

2.2

2.82

2.83

mg/l

0.05

756

4844

Autoimmune hyperthyroidism

856

5565

1.77

39.38

2.5

2.1

2.66

2.73

mg/l

0.43

760

4787

Disorders of refraction and accommodation

4063

33348

1.29

39.23

2.4

2.63

2.68

mg/l

0.71

3497

29114

Idiopathic thrombocytopenic purpura

503

2920

2.24

39.11

3.2

2.3

3.13

2.84

mg/l

1.46

461

2506

Secondary parkinsonism, excluding more controls

389

2046

2.40

39.06

2.5

2.2

2.85

2.88

mg/l

0.09

331

1747

Abnormal findings on examination of urine, without diagnosis

695

4382

1.96

39.03

3.0

2.4

3.15

2.80

mg/l

3.11

636

3764

Acute pharyngitis

2103

15841

1.42

38.99

2.6

2.2

2.58

2.56

mg/l

0.07

1836

13811

Car occupant injured in other and unspecified transport accidents

2676

21099

1.37

38.97

2.5

2.3

2.74

2.69

mg/l

0.55

2333

18399

Speech therapy

3824

31478

1.31

38.93

2.6

2.4

2.60

2.85

mg/l

9.05

3483

27197

conjunctival haemorrhage

1174

8265

1.66

38.89

2.8

2.4

3.02

2.89

mg/l

0.89

1051

7123

Vasculitis limited to skin, not elsewhere classified

443

2482

2.37

38.88

3.3

2.3

3.23

2.89

mg/l

1.81

401

2107

Orchitis and epididymitis

1223

8556

1.60

38.85

2.6

2.3

2.90

2.86

mg/l

0.22

1083

7440

Suppurative and unspecified otitis media

5271

39336

1.25

38.83

2.5

2.3

2.63

2.62

mg/l

0.23

4607

34278

Acne

1569

11404

1.51

38.82

2.5

2.3

2.51

mg/l

0.01

1372

9949

Psoriatic arthropathies, ICD10

1429

10341

1.56

38.68

2.6

2.3

2.89

2.76

mg/l

1.12

1275

9010

Cluster headache, strict

528

3058

2.09

38.65

2.9

2.1

2.50

2.68

mg/l

1.36

464

2648

Chronic nephritic syndrome

582

3506

2.07

38.61

3.2

2.3

2.96

2.86

mg/l

0.48

535

3010

Diffuse large B-cell lymphoma, including Hilmo

743

4766

1.90

38.61

2.3

2.4

3.32

2.81

mg/l

4.71

650

4077

Diffuse large B-cell lymphoma

743

4766

1.90

38.61

2.3

2.4

3.32

2.81

mg/l

4.71

650

4077

Diffuse large B-cell lymphoma, helper endpoint

743

4766

1.90

38.61

2.3

2.4

3.32

2.81

mg/l

4.71

650

4077

Sarcoidosis

1811

13618

1.48

38.49

2.7

2.3

3.00

2.81

mg/l

2.46

1629

11831

Plantar fascial fibromatosis

1347

9618

1.56

38.46

2.5

2.2

2.59

2.79

mg/l

3.62

1168

8277

Pneumocystosis

343

1797

2.78

38.42

3.0

2.3

3.20

2.94

mg/l

1.23

325

1529

Pneumocystosis, including avohilmo

343

1797

2.78

38.42

3.0

2.3

3.20

2.94

mg/l

1.23

325

1529

Cluster headache, wide

560

3305

2.03

38.27

2.9

2.1

2.54

2.69

mg/l

0.96

494

2864

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

4173

34548

1.28

38.27

2.5

2.3

2.77

2.79

mg/l

0.19

3643

30061

Other or ill-defined heart diseases

722

4521

1.83

38.17

3.0

2.2

2.90

2.69

mg/l

1.32

633

3846

Hypertension, Pulmonary Arterial

180

720

4.26

38.15

6.1

2.3

3.31

3.03

mg/l

0.57

172

601

Superficial injury of forearm

1501

10965

1.53

38.12

2.5

2.3

2.83

2.71

mg/l

1.43

1284

9546

Injury of unspecified body region

1187

8390

1.64

38.06

2.9

2.4

2.88

2.78

mg/l

0.60

1034

7253

Polycystic kidney disease

424

2355

2.38

38.00

3.3

2.3

2.68

2.85

mg/l

0.91

379

2042

Other aneurysm

840

5551

1.80

37.86

2.9

2.3

3.26

2.87

mg/l

3.59

748

4749

Other psoriatic arthropathies

1387

10039

1.55

37.49

2.6

2.3

2.91

2.76

mg/l

1.32

1238

8730

Gout due to impairment of renal function

223

1005

3.70

37.45

3.8

2.3

3.14

2.96

mg/l

0.54

209

873

Benign neoplasm: Rectosigmoid junction

656

4150

1.99

37.27

2.8

2.3

3.05

2.94

mg/l

0.41

579

3567

Amputation of ankle bones

382

2074

2.50

37.20

3.9

2.3

3.43

2.98

mg/l

2.81

347

1775

Otalgia

1260

9019

1.60

37.07

2.7

2.4

2.53

2.72

mg/l

2.84

1081

7877

Focal epilepsy, strict definition

2863

22943

1.35

37.06

2.4

2.81

2.80

mg/l

0.07

2446

19912

Other and unspecified abdominal hernia

644

4035

1.97

37.05

3.1

2.2

2.94

2.85

mg/l

0.49

570

3470

Corticotropin deficiency

182

749

4.26

37.05

3.2

2.3

2.88

mg/l

0.00

168

654

Benign neoplasm: Adrenal gland

1144

8093

1.64

36.83

2.8

2.4

3.13

2.84

mg/l

2.91

1018

7008

Diabetic retinopathy, strict definition

2705

19334

1.40

36.81

3.2

2.6

2.99

3.04

mg/l

0.53

2354

16981

Other specified/unspecified soft tissue disorders

742

4790

1.84

36.49

2.8

2.2

2.98

2.93

mg/l

0.27

668

4054

Rash and other nonspecific skin eruption

1413

10335

1.55

36.47

2.7

2.4

2.77

2.80

mg/l

0.22

1233

8952

Hyperhidrosis

495

2867

2.10

36.43

2.5

2.0

2.70

2.68

mg/l

0.09

419

2480

Female infertility, associated with anovulation

1125

7844

1.60

36.28

2.3

2.1

2.66

2.48

mg/l

2.85

988

6872

Endometriosis of ovary

2312

16984

1.39

36.16

2.5

2.3

2.73

2.75

mg/l

0.17

1993

14777

Traumatic subarachnoid haemorrhage

565

3411

2.00

36.04

2.6

2.2

3.11

2.88

mg/l

0.98

487

2921

Hidradenitis suppurativa

563

3400

2.00

36.00

3.1

2.2

2.90

2.59

mg/l

2.26

512

2987

Pyoderma gangrenosum

169

677

4.34

36.00

3.9

2.1

2.90

2.87

mg/l

0.06

159

582

Moderate visual impairment, binocular

544

3315

2.11

35.94

3.1

2.4

3.85

3.06

mg/l

7.56

421

2807

Ptosis of eyelid

1681

12697

1.49

35.92

2.6

2.4

2.58

2.90

mg/l

6.73

1478

10948

Hallux rigidus

1834

13921

1.44

35.69

2.5

2.2

2.74

2.86

mg/l

1.38

1519

11876

Congenital iodine-deficiency syndrome/hypothyroidism

486

2874

2.19

35.60

2.6

2.4

3.19

2.90

mg/l

1.24

438

2472

Corneal ulcer

2565

20371

1.36

35.22

2.5

2.3

2.70

2.75

mg/l

0.45

2246

17724

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

782

4996

1.76

35.21

2.5

2.6

2.60

2.49

mg/l

0.93

697

4394

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

2847

22849

1.33

35.15

2.3

2.2

2.57

2.58

mg/l

0.10

2438

19989

Urethral stricture

856

5761

1.75

35.10

2.4

2.3

2.86

2.89

mg/l

0.12

723

4951

Manic episode

442

2505

2.16

35.07

2.2

2.1

2.60

2.71

mg/l

0.40

388

2179

Other female pelvic inflammatory diseases

2216

17364

1.40

34.97

2.7

2.3

2.79

2.75

mg/l

0.24

1879

15084

Cramp and spasm

712

4616

1.85

34.90

2.8

2.3

2.75

2.77

mg/l

0.08

607

3989

Atrophic disorders of skin

2267

17810

1.39

34.82

2.6

2.3

2.72

2.79

mg/l

0.67

1997

15415

Hypertrophy of breast

2359

18597

1.38

34.77

2.5

2.3

2.61

2.71

mg/l

1.90

2083

16186

Other and unspecified tonsillitis

4547

31655

1.25

34.70

2.5

2.2

2.60

2.56

mg/l

0.45

4016

27668

Abnormal findings on antenatal screening of mother

1268

9168

1.56

34.54

2.2

2.32

2.44

mg/l

1.70

1165

7985

Use of biperiden

725

4709

1.81

34.54

2.4

2.3

2.74

2.82

mg/l

0.48

636

4068

Impotence

777

5118

1.77

34.48

2.5

2.3

2.67

2.85

mg/l

1.53

697

4449

Other endocrine disorders

777

4929

1.79

34.21

3.1

2.6

2.94

2.63

mg/l

3.17

692

4299

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

4075

34008

1.27

34.15

2.4

2.3

2.63

2.68

mg/l

0.85

3548

29709

Inflammatory diseases of prostate (prostatitis)

1665

12545

1.46

34.08

2.4

2.3

2.81

2.85

mg/l

0.36

1445

10875

N06DA Anticholinesterases

5945

39675

1.23

34.06

2.4

2.5

2.87

3.05

mg/l

6.77

4966

33888

Use of anticholinesterases

5945

39675

1.23

34.06

2.4

2.5

2.87

3.05

mg/l

6.77

4966

33888

Polyarthritis, unspecified

539

3274

2.00

33.99

2.9

2.2

2.90

2.77

mg/l

0.64

493

2785

Intentional self-harm by unspecified means

240

1131

2.99

33.88

2.7

2.1

2.68

2.61

mg/l

0.21

217

980

Mental and behavioural disorders due to use of other stimulants, including caffeine

380

2059

2.22

33.86

2.3

2.2

2.66

2.53

mg/l

0.45

318

1821

Other and unspecified vascular occlusions

1455

10874

1.52

33.81

2.7

2.4

3.02

2.94

mg/l

0.49

1271

9311

Malignant neoplasm of oesophagus, including Hilmo

539

3292

2.01

33.75

2.3

2.4

3.30

2.77

mg/l

3.61

485

2792

Other nutritional anaemias

191

822

3.52

33.68

3.3

2.0

3.04

2.89

mg/l

0.30

161

693

Tongue abnormality

919

6361

1.71

33.62

2.6

2.4

2.79

2.86

mg/l

0.31

788

5478

Carcinoma in situ of skin

1349

10017

1.56

33.60

2.8

2.4

2.95

mg/l

0.02

1197

8601

Other and unspecified vasculitis limited to skin

392

2213

2.33

33.54

3.2

2.3

3.30

2.92

mg/l

1.90

354

1877

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

735

4833

1.80

33.51

3.0

2.4

3.58

2.80

mg/l

11.13

653

4114

Chronic tubulo-interstitial nephritis

558

3435

1.97

33.48

3.2

2.2

3.02

2.89

mg/l

0.66

504

2906

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

957

6636

1.66

33.47

2.9

2.5

3.50

2.83

mg/l

9.35

857

5656

Ingrowing nail

757

4992

1.77

33.44

3.0

2.3

2.80

2.74

mg/l

0.33

671

4309

Cyst of kidney

1078

7695

1.63

33.36

2.8

2.3

2.92

2.88

mg/l

0.21

955

6620

Other and unspecified follicular disorders

613

3871

1.90

33.25

2.8

2.2

3.00

2.69

mg/l

1.96

542

3326

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

166

697

4.29

32.97

3.2

2.4

2.92

2.91

mg/l

0.02

149

589

Autoimmune hepatitis

170

699

3.72

32.93

3.8

2.0

2.73

2.79

mg/l

0.13

153

589

Cardiomyopathy, Hypertrophic obstructive

287

1457

2.60

32.74

3.7

2.1

3.25

2.83

mg/l

1.53

256

1228

Amputation of thigh

523

3229

2.06

32.73

3.5

2.4

3.68

3.03

mg/l

5.46

465

2756

Other and unspecified disorders of vitreous body

6101

51801

1.21

32.70

2.5

2.4

2.71

2.86

mg/l

6.12

5241

44778

Focal brain injury

860

5802

1.67

32.69

2.5

2.3

2.97

2.83

mg/l

0.72

732

5003

Hypotension due to drugs

282

1467

2.85

32.62

2.9

2.3

2.92

3.08

mg/l

0.51

243

1253

Algoneurodystrophy

483

2885

2.05

32.53

2.9

2.1

2.92

2.71

mg/l

0.98

417

2510

Postprocedural disorders of nervous system

993

6946

1.62

32.43

2.4

2.2

2.61

mg/l

0.00

900

6071

Lymphoid leukaemia

853

5873

1.73

32.42

2.7

2.5

3.50

2.88

mg/l

6.82

775

5054

Alzheimer’s disease (Late onset)

4127

28686

1.27

32.41

2.4

2.5

2.80

3.10

mg/l

12.74

3475

24462

Complications of cardiac and vascular prosthetic devices, implants and grafts

360

2010

2.41

32.39

3.9

2.3

3.45

2.93

mg/l

2.86

322

1726

Acquired absence of limb

189

831

3.48

32.20

4.0

2.2

3.08

2.86

mg/l

0.62

173

725

Drug-induced hypoglycaemia without coma

284

1463

2.68

32.15

2.8

2.2

2.90

2.92

mg/l

0.05

243

1260

Other disorders of penis

1229

8885

1.52

32.13

2.8

2.4

2.69

2.82

mg/l

1.34

1057

7763

Isolated proteinuria

440

2592

2.15

32.11

3.2

2.2

3.26

2.82

mg/l

3.39

400

2234

Clear cell adenocarcinoma of kidney

680

4454

1.83

32.05

2.5

2.4

3.09

2.76

mg/l

2.62

599

3796

Supervision of high-risk pregnancy

2728

13129

1.34

32.04

2.2

2.65

2.61

mg/l

0.45

2423

11556

Orthopaedic devices associated with adverse incidents

331

1832

2.59

31.99

2.9

2.3

3.69

3.01

mg/l

5.05

257

1571

Protein-energy malnutrition of moderate and mild degree

202

944

3.65

31.93

3.3

2.6

3.29

2.91

mg/l

1.01

179

818

Wide developmental disorders

512

3091

1.96

31.86

2.3

2.7

2.51

mg/l

0.00

442

2739

Open wound of abdomen, lower back and pelvis

467

2778

2.05

31.83

2.7

2.2

2.81

2.70

mg/l

0.43

417

2420

Chronic Coagulation defects

382

2167

2.27

31.73

3.8

2.3

2.67

2.70

mg/l

0.11

336

1886

Nummular dermatitis

1203

8774

1.55

31.67

2.6

2.3

2.65

2.79

mg/l

1.47

1053

7566

Other peripheral vascular diseases

1181

8587

1.56

31.64

3.0

2.3

2.76

mg/l

0.00

1049

7408

Adenocarcinoma and papillary adenocarcinoma of stomach

443

2604

2.09

31.62

2.8

2.3

3.19

2.85

mg/l

1.78

408

2213

Other and unspecified psoriasis

965

6784

1.64

31.52

2.8

2.3

2.88

2.79

mg/l

0.52

849

5877

Mental and behavioural disorders due to cannabinoids

373

2047

2.14

31.42

2.1

2.2

2.39

2.54

mg/l

0.65

303

1815

Other predominantly sexually transmitted diseases, not elsewhere classified

2302

18283

1.35

31.40

2.3

2.2

2.59

2.60

mg/l

0.10

1963

16025

Other epidermal thickening

695

4596

1.80

31.39

3.2

2.3

2.98

2.81

mg/l

1.05

635

3963

Protozoal diseases, including avohilmo

484

2956

2.07

31.33

2.9

2.3

3.02

2.88

mg/l

0.63

446

2546

Dronedarone medication

427

2509

2.15

31.24

2.8

2.2

3.14

2.79

mg/l

1.64

362

2086

Protozoal diseases

468

2838

2.10

31.24

2.9

2.3

3.06

2.88

mg/l

0.94

432

2440

Persistent delusional disorders

1050

7490

1.59

31.20

2.4

2.3

2.73

2.84

mg/l

0.83

905

6449

Acne vulgaris

1186

8571

1.53

31.16

2.5

2.3

2.49

2.51

mg/l

0.17

1035

7492

Other and unspecified injuries of lower leg

1123

8094

1.56

31.14

2.7

2.3

2.73

2.71

mg/l

0.10

982

7053

Other/unspecified reactive arthropathies

907

6309

1.65

31.13

2.7

2.3

2.57

2.74

mg/l

1.80

818

5469

Autism

402

2294

2.13

31.04

2.3

2.5

2.63

2.47

mg/l

1.15

342

2029

Unspecified jaundice

728

4844

1.75

31.03

2.9

2.3

3.22

2.89

mg/l

2.09

642

4139

Hypertrophic cardiomyopathy

626

4071

1.87

30.98

3.4

2.4

3.22

2.88

mg/l

1.91

562

3504

COPD, hospital admissions 1, only main diagnosis

5256

38956

1.23

30.97

2.8

2.4

3.32

2.89

mg/l

20.42

4525

33377

Hydrocele

1575

11940

1.44

30.87

2.6

2.4

2.92

2.90

mg/l

0.15

1374

10306

Tonsillectomy and adenotomy

7853

48131

1.18

30.72

2.3

2.49

2.63

mg/l

8.35

6937

42173

Focal epilepsy, mode (most common among epilepsy diagnosis)

2665

21636

1.33

30.69

2.3

2.4

2.84

2.80

mg/l

0.44

2269

18802

Complications of other internal prosthetic devices, implants and grafts

661

4360

1.83

30.60

2.8

2.3

2.96

2.85

mg/l

0.36

579

3737

Nontoxic multinodular goitre

2757

22513

1.32

30.52

2.5

2.4

2.98

2.91

mg/l

0.76

2382

19402

Haemorrhage in early pregnancy

3725

30292

1.26

30.52

2.3

2.59

2.63

mg/l

0.57

3272

26408

Lesion of lateral popliteal nerve

703

4671

1.77

30.47

2.8

2.2

2.82

2.78

mg/l

0.21

629

4035

Dependent personality disorder

312

1684

2.43

30.30

2.6

2.1

2.98

2.84

mg/l

0.51

284

1459

Left ventricular outflow tract obstruction, narrow definition

675

4447

1.78

30.20

2.7

2.5

3.06

2.70

mg/l

2.97

624

3856

Fracture of neck

916

6462

1.65

30.07

2.8

2.4

2.87

mg/l

0.01

808

5558

Explicit fungal Sepsis

146

596

4.21

30.06

4.4

2.0

3.36

2.89

mg/l

1.09

133

518

Explicit fungal Sepsis, including avohilmo

147

602

4.18

30.04

4.4

2.0

3.35

2.89

mg/l

1.05

134

522

Open wound of wrist and hand

6395

53978

1.19

30.00

2.4

2.3

2.69

2.73

mg/l

0.85

5488

47041

Other noninfective disorders of lymphatic vessels and lymph nodes

550

3482

1.91

29.90

3.0

2.2

2.87

2.76

mg/l

0.46

485

2982

Viral warts

1399

10520

1.47

29.78

3.1

2.3

2.78

2.70

mg/l

0.67

1260

9144

Gastrojejunal ulcer

216

1028

2.92

29.70

3.5

2.2

3.52

2.99

mg/l

2.14

195

870

Molar incisor enamel hypoplasia, with caries

171

752

3.73

29.66

4.5

3.8

2.86

2.28

mg/l

2.43

159

669

Acute laryngitis and tracheitis

1590

11893

1.42

29.64

2.7

2.2

2.62

2.57

mg/l

0.39

1396

10348

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

323

1801

2.45

29.58

3.1

2.4

3.33

3.09

mg/l

0.99

287

1534

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

1528

11557

1.44

29.52

2.8

2.5

2.57

2.63

mg/l

0.58

1320

10151

Dermatographic urticaria

966

6868

1.60

29.35

2.4

2.2

2.64

2.67

mg/l

0.18

837

5991

Alzheimer’s disease (Atypical or mixed)

1898

14842

1.41

29.32

2.4

2.5

3.01

3.18

mg/l

2.12

1601

12671

Systemic sclerosis

381

2217

2.21

29.32

3.8

2.2

2.90

2.86

mg/l

0.11

348

1898

Macular pucker

2336

18904

1.36

29.31

2.6

2.4

2.74

2.90

mg/l

2.61

1996

16281

Urolithiasis

4628

39702

1.23

29.30

2.6

2.4

2.95

2.84

mg/l

2.30

4016

34284

Panniculitis affecting regions of neck and back

514

3197

1.91

29.16

2.7

2.2

2.77

2.80

mg/l

0.13

461

2739

Malignant immunoproliferative diseases

201

969

3.36

29.12

3.1

2.2

3.04

2.94

mg/l

0.23

180

831

Nonalcoholic steatohepatitis

168

731

3.47

29.11

3.0

2.1

2.98

2.89

mg/l

0.16

151

635

Neuroendocrine tumor and carcinoma of small intestine

244

1240

2.78

29.11

2.8

2.2

2.95

2.84

mg/l

0.27

222

1039

Malignant neoplasm of bladder

1001

7158

1.58

29.09

2.5

2.4

2.99

2.87

mg/l

0.78

882

6059

Behavioural disorders, excluding more controls

269

1356

2.38

28.99

2.4

2.5

2.58

2.55

mg/l

0.06

242

1197

Ovarian dysfunction

1169

8603

1.53

28.97

2.5

2.1

2.51

mg/l

0.02

1049

7483

Suggestive for eosinophilic asthma

1249

9282

1.50

28.91

2.5

2.3

2.76

2.78

mg/l

0.10

1089

8012

Dermatitis due to substances taken internally

803

5547

1.67

28.78

3.1

2.3

3.01

2.77

mg/l

2.18

699

4813

Intentional self-harm by sharp object

393

2293

2.11

28.77

2.7

2.1

2.84

2.56

mg/l

1.91

346

2001

Tobacco use

761

5199

1.69

28.76

2.6

2.2

3.03

2.71

mg/l

3.88

676

4493

Event of undetermined intent

877

6131

1.62

28.75

2.5

2.3

2.69

mg/l

0.01

766

5327

Specific development disorders of scholastic skills

610

3871

1.78

28.61

2.8

2.6

2.58

2.47

mg/l

0.44

526

3423

Hypertension, portal

270

8.08

28.60

4.6

2.2

3.48

2.90

mg/l

0.96

243

Portal vein thrombosis

264

1377

2.58

28.57

4.2

2.2

3.79

2.89

mg/l

4.69

242

1173

Other disorders starting during childhood or adolescence

729

4871

1.70

28.52

2.5

2.7

2.59

2.46

mg/l

1.04

650

4290

Maternal care for known or suspected abnormality of pelvic organs

3470

19525

1.27

28.45

2.2

2.3

2.52

2.57

mg/l

0.77

3055

17098

Hepatocellular carcinoma, including Hilmo

448

2737

2.02

28.32

3.2

2.4

3.79

2.80

mg/l

10.13

401

2320

Bruxism

299

1627

2.39

28.23

2.7

2.1

2.56

2.66

mg/l

0.22

267

1412

Emphysema

1069

7797

1.55

28.19

2.6

2.3

3.18

2.84

mg/l

3.31

924

6645

Superficial injury of ankle and foot

1734

13493

1.39

28.15

2.6

2.3

2.57

2.64

mg/l

0.68

1504

11806

Atypical facial pain

739

5048

1.70

28.15

2.8

2.3

2.66

2.81

mg/l

1.30

642

4364

Erythema intertrigo

404

2417

2.11

28.09

3.2

2.2

3.12

2.90

mg/l

1.19

370

2059

Entropion and trichiasis of eyelid

1331

10097

1.49

28.07

2.6

2.4

2.92

2.99

mg/l

0.51

1128

8658

Autism spe

390

2277

2.07

28.04

2.3

2.4

2.60

2.45

mg/l

1.08

331

2010

Systemic sclerosis, icd10

378

2226

2.18

28.04

3.8

2.2

2.90

2.89

mg/l

0.04

346

1914

Congenital malformations of cardiac chambers and connections

121

460

4.44

28.04

4.3

3.7

3.35

2.40

mg/l

1.40

114

414

Drug-induced neutropenia

994

7191

1.58

28.02

2.4

2.3

3.16

2.81

mg/l

3.78

901

6215

Cluster headache, strict, including avohilmo

685

4593

1.72

28.01

2.7

2.2

2.53

2.67

mg/l

0.95

609

4014

Pre-eclampsia or poor fetal growth

4154

35253

1.24

27.93

2.5

2.2

2.72

2.59

mg/l

3.46

3659

30762

Use of levodopa decarboxylase inhibitor

2113

17011

1.37

27.86

2.4

2.5

2.76

2.97

mg/l

4.01

1783

14583

Pregnancy examination and test

2192

10810

1.35

27.72

2.1

2.3

2.44

2.57

mg/l

2.29

1883

9483

Other hereditary haemolytic anaemias

129

516

4.33

27.64

3.6

2.3

4.65

2.81

mg/l

3.25

118

446

Cerebral cysts

826

5776

1.64

27.60

2.9

2.3

2.88

2.74

mg/l

0.87

749

5013

Gingival hyperplasia

549

3556

1.87

27.50

3.3

2.5

2.72

2.78

mg/l

0.27

479

3070

Appendectomy

9391

80373

1.15

27.41

2.4

2.3

2.71

2.73

mg/l

0.52

8223

69939

Disorders of breast

7385

57733

1.17

27.39

2.4

2.3

2.66

2.76

mg/l

3.46

6453

50096

Abrasion of teeth

5027

43570

1.21

27.34

2.4

2.3

2.56

2.77

mg/l

11.39

4337

37888

Palmar fascial fibromatosis [Dupuytren]

2116

16963

1.35

27.34

2.5

2.3

2.72

2.96

mg/l

5.80

1829

14449

Diabetic maculopathy

1927

14607

1.40

27.31

3.2

2.6

2.94

3.02

mg/l

0.93

1704

12838

Vascular dementia (mixed)

368

2186

2.23

27.28

2.7

2.4

2.61

3.09

mg/l

3.55

328

1887

Strabismus

3703

31257

1.25

27.28

2.6

2.4

2.75

2.72

mg/l

0.34

3264

27217

Amyloidosis

368

2167

2.18

27.25

2.8

2.3

2.93

3.09

mg/l

0.63

328

1855

Arterial embolism and thrombosis of lower extremity artery

549

3562

1.86

27.22

3.0

2.3

3.61

2.88

mg/l

6.01

486

3026

Vascular dementia (subcortical)

609

4082

1.83

27.14

2.6

2.5

2.78

3.13

mg/l

2.01

542

3506

Other and unspecified rosacea

1271

9571

1.48

27.13

2.6

2.3

2.92

2.75

mg/l

1.20

1126

8338

Rosacea

1797

14157

1.38

27.12

2.6

2.3

2.84

2.74

mg/l

0.78

1576

12314

Dysplasia of cervi uteri

3193

18642

1.27

27.05

2.2

2.56

2.65

mg/l

1.82

2758

16250

Polycystic ovarian syndrome

894

6376

1.60

27.03

2.5

2.1

2.48

2.47

mg/l

0.08

805

5552

Raynaud syndrome

1264

9527

1.48

27.02

2.7

2.3

2.57

2.71

mg/l

1.61

1123

8297

Pemphigoid

466

2955

2.02

26.97

2.9

2.3

2.94

3.01

mg/l

0.19

414

2530

Follicular cysts of skin and subcutaneous tissue

2481

20256

1.31

26.87

2.6

2.3

2.71

2.77

mg/l

0.69

2177

17593

Cluster headache, wide,, including avohilmo

717

4894

1.68

26.87

2.7

2.2

2.57

2.69

mg/l

0.84

639

4263

Allergic bronchopulmonary aspergillosis (ABPA)

197

5.93

26.77

2.8

1.5

3.26

2.37

mg/l

2.27

166

Syphilis

365

2130

2.11

26.74

3.1

2.1

3.07

2.82

mg/l

1.16

319

1852

Syphilis, including avohilmo

365

2130

2.11

26.74

3.1

2.1

3.07

2.82

mg/l

1.16

319

1852

Testicular dysfunction

470

2892

1.86

26.73

2.5

2.2

3.01

2.71

mg/l

1.89

407

2537

Other renal tubulo-interstitial diseases

361

2106

2.13

26.70

2.8

2.1

2.96

2.84

mg/l

0.46

319

1793

Alzheimer’s disease, strict definition

4346

30204

1.24

26.66

2.4

2.5

2.79

3.09

mg/l

12.88

3648

25767

Allergic contact dermatitis

1828

14434

1.37

26.62

2.4

2.3

2.70

2.71

mg/l

0.05

1609

12551

Gangrene, not elsewhere classified

147

632

3.62

26.48

3.2

2.1

3.70

2.84

mg/l

3.70

132

538

Impacted cerumen

1713

13519

1.40

26.46

2.7

2.4

2.78

2.87

mg/l

0.85

1325

11710

Fluid overload

255

7.31

26.35

3.9

2.1

3.28

2.95

mg/l

0.75

224

Other/unspecified enthesopathies, not elsewhere classified

1128

8349

1.49

26.30

2.5

2.2

2.84

2.86

mg/l

0.06

990

7175

Pneumonia derived septicemia

525

3400

1.86

26.25

2.9

2.3

3.12

2.81

mg/l

1.77

464

2912

Microscopic polyangiitis

128

532

4.45

26.25

2.7

2.2

2.76

3.03

mg/l

0.74

115

456

Other noninflammatory disorders of vagina

1092

8055

1.51

26.21

2.7

2.3

2.82

2.76

mg/l

0.36

950

7007

Anorexia

257

1375

2.52

26.13

2.9

2.3

2.64

2.87

mg/l

0.87

229

1170

Non-Hodgkin lymphoma, all

652

4419

1.73

26.06

2.3

2.4

3.55

2.85

mg/l

6.53

574

3761

Pneumonia due to Streptococcus pneumoniae

577

3785

1.77

26.06

2.8

2.2

3.01

2.74

mg/l

1.68

509

3247

Degenerative macular diseases

1793

14264

1.39

26.04

2.7

2.4

2.95

mg/l

0.02

1519

12225

Carcinoma in situ of skin of trunk

562

3762

1.88

26.01

2.8

2.4

3.05

2.98

mg/l

0.24

486

3205

Calculus of kidney and ureter

4230

36384

1.23

25.96

2.6

2.4

2.93

2.83

mg/l

1.75

3677

31431

Hypoplasia of dental enamel

172

806

3.37

25.95

4.9

3.8

2.76

2.29

mg/l

2.07

161

725

Other neurotic disorders

652

4406

1.71

25.95

2.5

2.2

2.71

2.83

mg/l

0.71

558

3774

Other congenital malformations

1170

8743

1.48

25.88

2.7

2.4

2.60

2.63

mg/l

0.17

1023

7674

Colitis due to radiation

200

1002

3.05

25.88

3.0

2.2

3.07

2.91

mg/l

0.43

185

861

Sequelae of injuries of neck and trunk

421

2580

1.97

25.80

2.5

2.2

2.75

2.80

mg/l

0.16

367

2224

Other congenital malformations of the digestive system, including avohilmo

738

5092

1.66

25.76

3.7

2.5

2.77

2.70

mg/l

0.48

658

4433

Nasal polyp

2538

20861

1.30

25.63

2.4

2.3

2.73

2.82

mg/l

1.31

2180

18084

Other secondary gonarthrosis

732

5089

1.66

25.53

2.8

2.3

2.63

2.84

mg/l

1.96

663

4367

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

6275

48016

1.18

25.50

2.5

2.3

2.81

2.63

mg/l

9.91

5638

41678

Allergic urticaria

1151

8613

1.48

25.47

2.6

2.3

2.64

2.68

mg/l

0.26

984

7487

Symptoms and signs involving emotional state

452

2829

1.91

25.44

2.6

2.2

2.44

2.66

mg/l

1.28

395

2463

Otitis externa, unspecified

1581

12365

1.40

25.26

2.7

2.4

2.66

2.72

mg/l

0.54

1358

10793

Magnesium deficiency

274

6.88

25.24

3.3

2.0

2.84

3.15

mg/l

0.41

240

Eosinophilic disease (BM)

237

1236

2.50

25.15

3.3

2.2

2.82

2.77

mg/l

0.14

207

1046

Other specified/unspecified hearing loss

1299

9938

1.45

25.09

2.4

2.66

2.86

mg/l

2.00

1136

8604

Sacrococcygeal disorders, not elsewhere classified

435

2697

1.91

25.04

2.5

2.1

2.40

2.80

mg/l

4.65

388

2336

Malignant neoplasm of rectosigmoid junction, including Hilmo

429

2679

1.96

25.04

2.3

3.37

2.80

mg/l

2.34

392

2284

Spinal instabilities

379

2270

2.00

24.95

2.9

2.2

3.11

2.82

mg/l

1.82

341

1941

Other obstructive and reflux uropathy

621

4193

1.72

24.89

2.6

2.1

3.16

2.70

mg/l

4.07

551

3573

Infarction of spleen

134

581

4.01

24.88

3.3

2.2

4.17

3.06

mg/l

2.36

127

505

Renal tubulo-interstitial disorders in diseases classified elsewhere

170

799

3.12

24.85

3.0

2.1

3.19

2.95

mg/l

0.51

154

682

Pregnancy hypertension

5641

44273

1.19

24.84

2.5

2.3

2.81

2.61

mg/l

10.92

5049

38529

Anxious personality disorder

284

1567

2.24

24.83

2.5

2.1

2.44

2.58

mg/l

0.66

245

1364

Osteonecrosis due to drugs

260

1440

2.53

24.83

2.9

2.3

2.70

3.00

mg/l

1.40

240

1246

Scabies, including avohilmo

2008

16143

1.33

24.77

2.5

2.3

2.65

2.63

mg/l

0.19

1730

14151

Toxic effects of substances chiefly nonmedicinal as to source

1509

11747

1.40

24.73

2.5

2.3

2.70

2.72

mg/l

0.08

1325

10240

Myocardial infarction, with ST-elevation

2527

20918

1.30

24.67

2.7

2.4

3.12

2.95

mg/l

2.31

2189

17892

L02BX Other hormone antagonists and related agents

869

6350

1.62

24.63

2.2

2.4

3.04

2.85

mg/l

1.63

770

5473

Oligomenorrhoea

513

3325

1.80

24.62

2.7

2.2

2.65

2.62

mg/l

0.11

451

2901

Need for immunization against other single viral diseases

284

1588

2.29

24.60

5.3

2.2

2.18

2.87

mg/l

7.14

256

1383

Unspecified protein-energy malnutrition

129

553

4.11

24.60

3.4

2.5

3.40

2.89

mg/l

0.78

118

473

Chondrocostal junction syndrome [Tietze]

565

3774

1.78

24.60

2.8

2.3

2.64

2.79

mg/l

0.89

483

3256

Pure hyperglyceridaemia

333

1942

2.11

24.59

2.8

2.2

2.98

2.99

mg/l

0.03

294

1662

Congenital malformations of aortic and mitral valves

559

3699

1.76

24.55

2.6

2.5

3.10

2.72

mg/l

2.78

519

3205

Somnolence, stupor and coma

619

4190

1.71

24.49

2.8

2.2

2.84

2.85

mg/l

0.00

553

3586

Other chondrocalcinosis

236

1278

2.67

24.44

3.1

2.3

3.57

3.11

mg/l

1.99

209

1093

Congenital malformations of cardiac septa

907

6374

1.55

24.44

2.9

2.6

3.05

2.64

mg/l

3.74

807

5574

Cardiomyopathy in other diseases

114

453

4.18

24.41

2.8

2.1

3.05

2.96

mg/l

0.13

379

Injury of muscle and tendon at shoulder and upper arm level

4875

42531

1.20

24.38

2.5

2.4

2.77

2.84

mg/l

1.37

4282

36860

Primary open-angle glaucoma

4917

41403

1.21

24.37

2.5

2.98

2.99

mg/l

0.19

4204

35409

Anogenital herpesviral [herpes simplex] infection, including avohilmo

1560

12217

1.39

24.36

2.3

2.2

2.42

2.58

mg/l

2.86

1315

10703

Ethmoidectomy

1676

13252

1.37

24.30

2.6

2.3

2.72

2.73

mg/l

0.04

1450

11573

Bullous pemphigoid

371

2287

2.13

24.28

2.8

2.4

2.89

3.03

mg/l

0.38

330

1958

Mental retardation, excluding more controls

457

2763

1.83

24.21

2.6

2.7

2.82

2.63

mg/l

1.08

413

2437

Drug-induced obesity

160

740

3.14

24.11

3.1

2.1

2.84

2.80

mg/l

0.08

144

643

Visual field defects

1197

9117

1.46

24.06

2.7

2.4

2.92

2.87

mg/l

0.37

1033

7867

Assault by unspecified means

281

1555

2.19

23.97

2.2

2.1

2.76

2.61

mg/l

0.46

239

1365

Monoarthritis, not elsewhere classified

564

3747

1.73

23.94

2.7

2.2

2.95

2.72

mg/l

1.68

506

3206

Carcinoma in situ of skin of scalp and neck

486

3225

1.94

23.93

3.0

2.4

3.02

mg/l

0.00

428

2764

Sequelae of injuries of head

699

4855

1.64

23.93

2.4

2.2

2.76

mg/l

0.01

590

4212

Seborrhoeic keratosis

3614

30934

1.24

23.92

2.5

2.4

2.77

2.88

mg/l

2.01

3176

26624

Dislocation, sprain and strain of joint and ligaments of hip

570

3845

1.76

23.80

2.6

2.3

2.97

2.90

mg/l

0.30

506

3303

Morphin

348

2076

2.06

23.80

2.8

2.2

3.56

2.87

mg/l

5.35

306

1751

Other congenital malformations of the digestive system

632

4304

1.69

23.72

3.9

2.5

2.81

2.70

mg/l

0.66

571

3758

Kyphosis

220

1154

2.56

23.53

2.9

2.3

2.86

2.97

mg/l

0.17

196

982

Lactose intolerance

449

2861

1.86

23.47

2.8

2.2

2.66

2.81

mg/l

0.69

389

2460

Exposure to other and unspecified inanimate mechanical forces

1020

7577

1.49

23.45

2.8

2.3

2.52

2.71

mg/l

2.58

887

6595

Glaucoma suspect

5373

47372

1.19

23.43

2.5

2.4

2.79

2.91

mg/l

3.62

4721

40740

FESS (DNB20)

1611

12735

1.37

23.41

2.6

2.3

2.73

2.72

mg/l

0.11

1389

11130

Xerosis cutis

294

1708

2.27

23.40

3.4

2.3

3.03

2.98

mg/l

0.14

267

1463

Examination and encounter for administrative purposes

1053

7842

1.47

23.39

2.6

2.1

2.91

2.81

mg/l

0.78

959

6683

Endometriosis ASRM stages 1,2

2367

19536

1.30

23.32

2.4

2.3

2.55

2.65

mg/l

1.72

2039

17083

Early complications of trauma

620

4244

1.69

23.30

2.8

2.3

3.05

2.80

mg/l

1.84

558

3648

!Aliquae complicationes praecoces traumatis

620

4244

1.69

23.30

2.8

2.3

3.05

2.80

mg/l

1.84

558

3648

Other keratitis

1538

12099

1.38

23.28

2.7

2.3

2.66

2.72

mg/l

0.48

1345

10533

Ehlers-Danlos syndrome, including avohilmo

223

1188

2.56

23.21

3.2

2.2

2.31

2.53

mg/l

1.10

188

1026

Other specified congenital malformation syndromes affecting multiple systems

257

1421

2.33

23.15

3.1

2.9

2.87

2.57

mg/l

0.77

228

1270

Lichen ruber planus, wide definition including periferal and oral lichen planus

3077

26059

1.25

23.06

2.5

2.4

2.73

2.83

mg/l

1.65

2673

22640

Alcoholic gastritis

211

1087

2.51

23.02

2.7

2.0

3.26

2.91

mg/l

1.11

180

931

Nonsuppurative otitis media, including avohilmo

4536

34076

1.20

22.98

2.5

2.3

2.58

2.62

mg/l

0.74

3976

29592

Parkinson's disease, including avohilmo

2326

19284

1.31

22.98

2.4

2.5

2.82

2.96

mg/l

2.26

1960

16530

Gluteal tendinitis

595

4039

1.69

22.97

2.5

2.2

2.71

2.81

mg/l

0.62

518

3491

Malignant neoplasm of head and neck, including Hilmo

1288

9921

1.42

22.97

2.3

2.4

2.72

2.79

mg/l

0.50

1107

8517

Type 1 diabetes, definitions combined

1129

8454

1.44

22.96

2.5

2.4

2.57

2.49

mg/l

0.68

983

7415

Alcohol abuse counselling and surveillance

234

1250

2.37

22.88

2.4

2.1

3.22

2.79

mg/l

1.71

221

1093

Scabies

620

4241

1.66

22.88

2.6

2.2

2.89

2.68

mg/l

1.20

521

3687

Gastrointestinal stromal tumor and sarcoma

204

1063

2.69

22.88

2.4

2.3

3.19

2.86

mg/l

0.93

178

905

Early lumbar disc prolapse, operated

1095

8170

1.44

22.84

2.2

2.57

mg/l

0.02

970

7196

Astigmatism

887

6483

1.53

22.82

2.5

2.64

2.69

mg/l

0.32

756

5663

Polycystic ovarian syndrome, broad definition

1626

12932

1.37

22.78

2.4

2.1

2.59

2.47

mg/l

1.90

1449

11252

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

722

5116

1.61

22.59

3.0

2.4

3.57

2.83

mg/l

7.97

640

4346

Other strabismus

2947

24759

1.25

22.58

2.6

2.4

2.68

2.70

mg/l

0.17

2585

21621

Testicular hypofunction

411

2554

1.84

22.58

2.6

2.2

3.07

2.74

mg/l

1.85

357

2246

Fibrosis of liver

139

630

3.41

22.58

3.8

2.2

3.52

2.80

mg/l

2.63

129

549

Marginal zone B-cell lymphoma, including Hilmo

258

1453

2.35

22.55

2.6

2.3

3.03

2.83

mg/l

0.72

234

1231

Amyloidosis, other/unspecified

301

1773

2.19

22.54

2.7

2.3

2.90

3.12

mg/l

0.89

269

1512

Pneumococcal septicemia

495

3278

1.80

22.52

2.9

2.4

3.12

2.84

mg/l

1.38

436

2819

Type 1 diabetes, strict (exclude DM2)

1121

8414

1.43

22.48

2.5

2.4

2.56

2.49

mg/l

0.67

975

7381

Bell's palsy

1579

12524

1.37

22.46

2.6

2.3

2.94

2.79

mg/l

1.64

1358

10844

Other and specified injuries of hip and thigh

369

2290

2.01

22.46

2.9

2.3

2.80

2.96

mg/l

0.71

323

1960

Other bursitis of hip

320

1904

2.09

22.37

2.8

2.2

2.44

2.89

mg/l

3.39

282

1616

Primary adrenocortical insufficiency

190

972

2.73

22.29

3.4

2.3

2.77

2.93

mg/l

0.49

173

837

Inflammatory diseases of the central nervous system

1108

8415

1.46

22.24

2.6

2.3

2.94

2.76

mg/l

1.39

973

7280

Recurrent dislocation of patella

680

4743

1.60

22.20

2.4

2.1

2.70

2.54

mg/l

1.21

607

4114

Carrier of infectious disease

375

2334

1.97

22.19

3.0

2.2

3.20

2.81

mg/l

1.48

344

2036

Biomechanical lesions, not elsewhere classified

727

5199

1.61

22.17

2.5

2.3

2.38

2.87

mg/l

6.22

627

4487

Acute generalized exanthematous pustulosis

645

4513

1.66

22.11

3.1

2.3

2.95

2.82

mg/l

0.86

558

3881

Other and unspecified types of non-Hodgkin lymphoma, hilmo

602

4173

1.70

22.11

2.6

2.3

3.28

2.94

mg/l

2.24

537

3567

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

924

6779

1.48

21.99

2.5

2.2

2.77

2.66

mg/l

0.64

798

5880

Salpingitis and oophoritis

2201

18140

1.30

21.91

2.5

2.3

2.77

2.76

mg/l

0.08

1883

15756

Myositis

367

2270

1.95

21.90

2.5

2.2

2.89

2.83

mg/l

0.19

324

1931

Embolic stroke with flimmer

395

2488

1.91

21.90

2.9

2.3

2.98

2.87

mg/l

0.36

348

2095

Generalized skin eruption due to drugs and medicaments

569

3897

1.71

21.88

3.1

2.3

2.99

2.78

mg/l

1.45

495

3358

Injuries involving multiple body regions

541

3653

1.72

21.87

2.7

2.2

2.78

2.80

mg/l

0.06

469

3138

Heterophoria

1096

8332

1.45

21.81

2.6

2.4

2.65

2.67

mg/l

0.09

967

7273

Dementia in Alzheimer disease

2991

21248

1.26

21.80

2.4

2.5

3.22

3.10

mg/l

1.59

2411

18156

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

105

432

4.33

21.74

3.3

2.2

2.80

2.83

mg/l

0.05

369

Chronic iridocyclitis

676

4773

1.62

21.70

2.8

2.3

2.95

2.78

mg/l

1.04

614

4098

Paranoid personality disorder

272

1557

2.19

21.68

2.3

2.1

2.58

2.74

mg/l

0.50

245

1347

Juvenile rheumatoid arthirtis

311

1836

2.04

21.67

3.0

2.1

3.05

2.57

mg/l

3.16

284

1591

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1204

9310

1.43

21.53

2.5

2.3

2.86

mg/l

0.00

1036

8053

Status epilepticus

511

3419

1.74

21.46

2.6

2.3

2.93

2.80

mg/l

0.52

443

2930

Shock, not elsewhere classified

160

769

2.84

21.45

3.5

2.1

2.81

2.88

mg/l

0.09

144

656

Overexertion and strenuous or repetitive movements

1271

9867

1.40

21.44

2.5

2.3

2.48

2.73

mg/l

3.65

1095

8624

Postviral fatigue syndrome

151

713

2.97

21.42

3.2

2.3

2.14

2.59

mg/l

3.69

135

631

Pediculosis, acariasis and other infestations, including avohilmo

2330

19324

1.28

21.39

2.5

2.4

2.64

2.66

mg/l

0.11

2007

16938

Lichen planus

1753

14192

1.34

21.30

2.5

2.4

2.75

2.85

mg/l

0.94

1528

12262

Other specified disorders of kidney and ureter

465

3074

1.80

21.28

2.9

2.3

3.09

2.87

mg/l

1.06

421

2639

Sequelae of injuries of upper limb

1235

9553

1.41

21.27

2.4

2.3

2.60

2.76

mg/l

1.68

1085

8341

Foreign body in alimentary tract

763

5531

1.57

21.25

2.6

2.4

2.97

2.80

mg/l

1.07

649

4786

Cachexia

109

454

3.81

21.15

2.8

2.1

2.75

3.00

mg/l

0.65

389

Poisoning by narcotics and psychodysleptics [hallucinogens]

222

1190

2.29

21.05

2.5

2.1

2.76

2.63

mg/l

0.36

187

1031

Dementia due to Parkinsons disease, excluding more controls

353

2189

1.95

20.95

2.2

2.3

2.68

2.96

mg/l

1.65

278

1849

Other arterial embolism and thrombosis

418

2705

1.85

20.94

3.3

2.2

3.21

2.89

mg/l

1.81

375

2293

Hypogonadotropic hypogonadism

342

2066

1.90

20.91

2.3

2.2

3.07

2.71

mg/l

2.07

296

1820

Maltreatment syndromes

657

4607

1.59

20.89

2.4

2.2

2.59

2.56

mg/l

0.12

565

4033

Trigeminal neuralgia

809

5923

1.53

20.84

2.6

2.3

2.68

2.81

mg/l

0.86

712

5114

Abscess of lung

244

1378

2.28

20.76

3.1

2.2

3.00

2.91

mg/l

0.25

215

1191

Congenital malformations and deformations of the musculoskeletal system

1156

8845

1.42

20.76

2.9

2.4

2.58

2.60

mg/l

0.17

1012

7773

Mixed conductive and sensorineural hearing loss

1692

13692

1.34

20.74

2.6

2.4

2.89

2.85

mg/l

0.24

1421

11837

Unspecified nephritic syndrome

318

1930

2.03

20.73

3.2

2.2

3.03

2.89

mg/l

0.54

286

1664

Certolizumab pegol

287

1694

2.11

20.72

2.7

2.1

2.92

2.62

mg/l

1.48

263

1466

Other congenital malformations, including avohilmo

1717

13869

1.33

20.71

2.6

2.4

2.55

2.67

mg/l

1.29

1482

12131

Anomalies of dental arch relationship, including avohilmo

2654

20180

1.25

20.66

2.6

2.3

2.62

mg/l

0.01

2340

17620

Senility

183

921

2.48

20.64

2.9

2.2

2.79

3.24

mg/l

1.73

155

780

Disorder of the sleep-wake schedule

269

1554

2.14

20.63

2.9

2.2

2.60

2.75

mg/l

0.59

238

1337

Blood alcohol or alcohol intoxication level

327

1985

1.97

20.62

2.3

2.1

3.14

2.68

mg/l

2.27

284

1709

Hypersplenism

316

4.56

20.60

3.5

2.1

3.40

2.83

mg/l

1.18

277

Conotruncal defects

205

1098

2.46

20.60

3.5

3.4

3.20

2.47

mg/l

1.78

190

973

Other infective otitis externa

835

6164

1.52

20.58

2.6

2.3

2.82

2.74

mg/l

0.30

709

5345

Pediculosis, acariasis and other infestations

777

5647

1.53

20.57

2.6

2.3

2.83

2.71

mg/l

0.67

658

4914

Perforation of tympanic membrane

1364

10771

1.38

20.56

2.5

2.3

2.77

2.79

mg/l

0.14

1171

9326

Lichen planus, including avohilmo

2572

21676

1.26

20.52

2.5

2.4

2.76

2.83

mg/l

0.81

2239

18782

Scleritis and episcleritis

799

5842

1.53

20.51

2.6

2.3

2.64

2.76

mg/l

0.90

717

5067

Achilles tendinitis

1274

9918

1.38

20.50

2.6

2.3

2.84

2.78

mg/l

0.36

1103

8568

Benign neoplasm: Skin of eyelid, including canthus

2151

17870

1.29

20.46

2.6

2.4

2.91

2.86

mg/l

0.46

1866

15456

Schizoid personality disorder

230

1263

2.24

20.42

2.5

2.1

2.86

2.83

mg/l

0.08

207

1088

Necrotizing fasciitis

103

424

3.84

20.41

3.2

2.1

3.49

3.07

mg/l

0.83

361

Bronchitis, not specified as acute or chronic

1108

8491

1.42

20.34

2.8

2.3

3.01

2.76

mg/l

2.18

953

7302

Lactose intolerance, other/unspecified

389

2483

1.85

20.21

2.8

2.2

2.65

2.83

mg/l

0.86

338

2134

Chronic hepatitis NAS

203

1095

2.47

20.18

3.1

2.1

3.12

2.95

mg/l

0.38

185

943

Von Willebrand disease

210

1146

2.43

20.17

4.5

2.1

2.67

2.80

mg/l

0.29

188

986

Selective deficiency of immunoglobulin G [IgG] subclasses

120

531

3.36

20.13

4.0

2.4

3.62

2.79

mg/l

2.52

112

465

Other immunodeficiencies

186

978

2.60

20.13

4.6

2.4

2.74

2.84

mg/l

0.22

175

855

Rare circulating lymphoid malignancy, including Hilmo

419

2737

1.82

20.12

2.3

2.6

3.00

2.72

mg/l

1.35

372

2358

Benign neoplasm: Oesophagus

199

1075

2.53

20.10

3.0

2.1

2.82

3.01

mg/l

0.54

178

932

Other disorders of electrolyte and fluid balance, not elsewhere classified

161

805

2.81

20.10

3.1

2.2

2.76

3.17

mg/l

1.81

148

678

Diffuse brain injury

452

2957

1.72

20.03

2.3

2.1

2.91

2.73

mg/l

0.64

380

2570

Other peripheral vertigo

1285

10134

1.40

20.01

2.6

2.4

2.82

2.88

mg/l

0.53

1111

8750

Other retinal artery occlusion

366

2341

1.94

19.97

2.9

2.3

2.97

2.98

mg/l

0.02

317

2004

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

286

1712

2.10

19.96

3.7

2.2

2.41

2.59

mg/l

0.93

245

1485

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

986

7490

1.46

19.95

2.8

2.4

2.99

2.96

mg/l

0.15

865

6389

Other orthopaedic follow-up care

749

5445

1.53

19.86

2.5

2.2

2.63

2.77

mg/l

0.86

651

4646

Parkinson's disease

2211

18502

1.29

19.85

2.4

2.5

2.83

2.96

mg/l

1.99

1860

15870

Acquired pure red cell aplasia [erythroblastopenia]

337

4.47

19.84

3.5

2.1

3.02

2.77

mg/l

0.32

282

Benign neoplasm of mouth and pharynx

1444

11533

1.36

19.83

2.6

2.4

2.79

2.83

mg/l

0.30

1232

10006

Specific development disorders of speech and language

783

5514

1.52

19.82

2.9

2.6

2.71

2.65

mg/l

0.26

702

4832

Personal history of certain other diseases

303

1837

2.03

19.82

2.6

2.1

3.35

2.51

mg/l

4.98

268

1588

Nonsuppurative otitis media

3263

24282

1.22

19.79

2.6

2.3

2.60

mg/l

0.02

2852

21040

Postpartum care and examination

1920

9824

1.31

19.74

2.2

2.55

2.56

mg/l

0.08

1670

8615

Use of rivastigmine

2583

21919

1.27

19.67

2.4

2.5

2.82

3.08

mg/l

6.28

2203

18670

Mixed disorders of conduct and emotions, excluding more controls

280

1629

1.98

19.61

2.4

2.68

2.37

mg/l

1.32

249

1447

Impetigo

617

4348

1.60

19.59

3.1

2.3

2.68

2.67

mg/l

0.03

553

3801

Lichen sclerosus et atrophicus

1529

12297

1.35

19.58

2.6

2.3

2.77

2.83

mg/l

0.52

1343

10632

Other prurigo

189

1008

2.53

19.57

2.8

2.2

2.87

2.93

mg/l

0.11

168

868

Radial styloid tenosynovitis [de Quervain]

730

5282

1.53

19.56

2.5

2.2

2.61

2.70

mg/l

0.58

638

4569

ILD-related respiratory insufficiency

514

3563

1.74

19.51

3.1

2.4

3.45

2.96

mg/l

2.98

473

3067

329

2026

1.92

19.50

2.4

2.1

2.71

2.70

mg/l

0.01

292

1769

Effects of foreign body entering through natural orifice

3090

26486

1.22

19.35

2.4

2.67

2.74

mg/l

1.14

2656

23160

Hemiplegia

683

4923

1.56

19.33

2.8

2.3

2.97

2.83

mg/l

0.62

599

4232

Lichen simplex chronicus

458

3066

1.74

19.31

2.7

2.2

2.78

2.84

mg/l

0.21

417

2636

Parkinson's disease, strict definition

2067

17241

1.30

19.31

2.4

2.5

2.80

2.97

mg/l

2.83

1736

14793

Toxic liver disease

232

1317

2.24

19.30

3.5

2.2

2.57

2.95

mg/l

2.09

203

1135

Acquired absence of organs, not elsewhere classified

192

1028

2.45

19.26

3.3

2.3

2.98

2.96

mg/l

0.03

168

887

Dislocation, sprain and strain of joints and ligaments of thorax

494

3366

1.70

19.16

2.6

2.2

2.76

2.78

mg/l

0.10

441

2886

Schizotypal disorder

289

1723

1.98

19.14

2.3

2.1

2.72

2.64

mg/l

0.22

248

1500

Myeloid leukaemia

398

2614

1.84

19.11

2.7

2.3

2.90

2.98

mg/l

0.26

351

2241

Personal history of risk-factors, not elsewhere classified

220

1230

2.27

19.10

2.9

2.3

2.61

2.55

mg/l

0.17

202

1070

Other disorders of optic [2nd] nerve and visual pathways

881

6653

1.48

18.96

2.6

2.4

3.05

2.75

mg/l

2.81

788

5770

Nontoxic goitre/thyroid nodule

4136

36407

1.19

18.83

2.4

2.90

2.88

mg/l

0.28

3585

31417

Malignant neoplasm of liver and intrahepatic bile ducts

443

2967

1.75

18.81

3.2

2.4

3.73

2.82

mg/l

8.80

389

2511

Complications following infusion, transfusion and therapeutic injection

228

1300

2.24

18.80

3.4

2.2

3.01

2.91

mg/l

0.27

199

1114

Other acute viral hepatitis

189

1010

2.40

18.79

2.7

2.2

2.58

2.73

mg/l

0.45

168

881

Follow-up care involving plastic surgery

517

3564

1.66

18.77

2.5

2.2

3.21

2.75

mg/l

3.60

406

3050

Other misadventures during surgical and medical care

362

2339

1.89

18.75

2.9

2.2

3.01

2.91

mg/l

0.32

328

2023

Ehlers-Danlos syndrome

177

940

2.57

18.71

3.4

2.2

2.28

2.58

mg/l

1.63

149

818

Psoriasis (vulgaris), strict definition

436

2897

1.73

18.64

2.8

2.2

3.13

2.74

mg/l

2.75

386

2509

Mixed connective tissue disease

271

1631

2.09

18.62

3.2

2.2

3.15

2.88

mg/l

1.09

241

1408

Ectropion of eyelid

644

4671

1.60

18.59

2.7

2.4

3.02

3.04

mg/l

0.05

546

4003

327

2041

1.90

18.58

2.6

2.0

2.65

2.47

mg/l

1.42

301

1796

Secondary thrombocytopenia

195

1067

2.41

18.57

3.0

2.2

3.25

2.92

mg/l

1.00

183

940

Exclusion endpoint for clefts

289

1755

2.01

18.57

3.0

2.8

2.88

2.59

mg/l

0.83

257

1555

Other and unspecified glaucoma

1047

8151

1.44

18.56

2.6

2.5

2.98

3.01

mg/l

0.16

909

6987

Glaucoma secondary to other eye disorders

590

4196

1.62

18.55

3.0

2.3

3.11

2.94

mg/l

0.94

542

3602

Other salmonella infections, including avohilmo

571

4011

1.61

18.55

2.8

2.1

2.73

2.78

mg/l

0.23

474

3429

Collapsed vertebra, not elsewhere classified

144

716

2.90

18.53

3.0

2.3

2.95

3.09

mg/l

0.27

118

597

Lesion of radial nerve

500

3434

1.67

18.49

2.9

2.2

2.92

2.87

mg/l

0.15

431

2949

Infective bursitis

376

2429

1.81

18.47

2.9

2.3

2.85

2.87

mg/l

0.08

342

2083

Calcific tendinitis of shoulder

697

5052

1.52

18.46

2.5

2.2

2.78

2.80

mg/l

0.07

618

4367

Meralgia paraesthetica

462

3129

1.71

18.45

2.8

2.2

2.62

2.82

mg/l

1.49

407

2708

Malignant neoplasm of head and neck

1049

8105

1.41

18.45

2.3

2.4

2.66

2.79

mg/l

1.31

887

6950

Dissocial personality disorder

190

1005

2.28

18.45

2.2

2.1

3.00

2.74

mg/l

0.68

171

893

Disorders of phosphorus metabolism and phosphatases

403

3.79

18.44

4.0

2.5

3.16

2.95

mg/l

0.25

353

Cerebral aneurysm, nonruptured

1121

8754

1.40

18.44

2.6

2.3

3.00

2.79

mg/l

2.12

1006

7588

Cauda equina syndrome

209

1171

2.32

18.44

2.8

2.1

2.64

2.89

mg/l

0.74

190

1019

Operations for atrial fibrillation

231

1347

2.28

18.41

2.8

2.2

2.76

3.00

mg/l

0.84

207

1150

L02BB Anti-androgens

1358

10916

1.37

18.40

2.1

2.5

2.88

2.94

mg/l

0.50

1161

9313

Other bullous disorders

392

2583

1.82

18.37

2.4

2.3

2.76

2.87

mg/l

0.50

343

2245

Endocrine disorders, other/unspecified

280

1699

2.03

18.36

2.8

2.2

3.53

2.89

mg/l

3.42

245

1459

Neovascular glaucoma

587

4180

1.61

18.34

3.0

2.3

3.11

2.89

mg/l

1.36

540

3569

Other and unspecified haemorrhagic conditions

246

1447

2.16

18.34

3.7

2.3

3.85

2.94

mg/l

3.49

215

1259

Hepatocellular carcinoma

329

2077

1.91

18.34

3.2

2.3

3.89

2.77

mg/l

9.90

291

1758

Infection due to other mycobacteria

242

1414

2.16

18.32

2.9

2.2

3.04

2.93

mg/l

0.25

215

1185

Cervical polyps

1197

9397

1.37

18.30

2.3

2.75

2.79

mg/l

0.24

1033

8192

Respiratory disorders in diseases classified elsewhere

220

1261

2.29

18.29

3.3

2.2

3.40

2.97

mg/l

1.47

204

1091

malignant neoplasm of female genital organs, including Hilmo

2361

19006

1.26

18.29

2.3

2.5

3.06

2.84

mg/l

3.65

2029

16372

Carcinoma in situ of skin of ear and external auricular canal

276

1709

2.14

18.18

2.9

2.4

3.28

2.99

mg/l

0.56

236

1478

Burns and corrosions

1737

14232

1.30

18.15

2.4

2.3

2.69

2.70

mg/l

0.12

1509

12469

Other salmonella infections

483

3307

1.68

18.15

2.9

2.2

2.85

2.84

mg/l

0.01

399

2818

Other otitis externa (chronic)

911

6944

1.45

18.15

2.8

2.3

2.70

2.77

mg/l

0.47

764

6028

Thalassaemia

326

4.49

18.12

3.1

2.1

3.47

2.65

mg/l

2.09

283

Intussusception

297

1823

1.95

18.11

2.5

2.1

2.45

2.78

mg/l

2.60

273

1567

Dermatopolymyositis (FG)

201

1108

2.29

18.10

2.8

2.0

3.03

2.93

mg/l

0.22

181

922

Achalasia of cardia

256

1521

2.08

18.03

3.0

2.1

2.95

2.94

mg/l

0.02

233

1302

Sudden idiopathic hearing loss

1350

10826

1.36

17.99

2.6

2.4

2.94

2.80

mg/l

1.31

1154

9380

Pseudopolyposis of colon

203

5.45

17.97

2.8

2.1

2.76

3.09

mg/l

0.51

179

Common variable immunodeficiency

109

488

3.34

17.97

4.5

2.1

2.86

3.06

mg/l

0.43

102

432

L01XE Protein kinase inhibitors

713

5283

1.54

17.92

2.3

2.4

3.50

2.85

mg/l

5.03

647

4552

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

801

6029

1.50

17.90

2.5

2.4

2.82

2.88

mg/l

0.30

702

5216

Other fall from one level to another

3061

26402

1.22

17.89

2.5

2.4

2.70

2.72

mg/l

0.24

2657

22968

Other superficial mycoses, including avohilmo

1417

11386

1.33

17.87

2.4

2.3

2.60

2.64

mg/l

0.26

1183

9924

Dementia in other diseases classified elsewhere

675

4953

1.56

17.85

2.6

2.4

2.76

2.98

mg/l

1.30

543

4248

Superficial injuries involving multiple body regions

380

2493

1.80

17.77

2.8

2.2

2.86

2.85

mg/l

0.01

325

2153

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

523

3675

1.65

17.73

2.7

2.3

2.87

2.90

mg/l

0.12

464

3152

Benign lipomatous neoplasm

3939

34646

1.19

17.73

2.5

2.4

2.81

2.82

mg/l

0.06

3407

30058

Postzoster neuralgia

264

1609

2.10

17.73

2.9

2.3

3.01

mg/l

0.01

229

1376

Dystonia

718

5300

1.52

17.72

2.5

2.3

2.76

2.81

mg/l

0.19

611

4598

Iridocyclitis in diseases classified elsewhere

280

1717

2.00

17.67

3.0

2.3

3.23

2.90

mg/l

1.27

248

1485

Thyrotropin deficiency

179

969

2.45

17.66

3.0

2.1

2.76

2.73

mg/l

0.10

165

844

Failed induction of labour

860

6524

1.46

17.65

2.3

2.2

2.67

2.42

mg/l

3.93

748

5700

Abnormal blood-pressure reading, without diagnosis

590

4193

1.57

17.63

2.6

2.2

2.60

2.75

mg/l

0.67

505

3609

Intracranial and intraspinal abscess and granuloma

184

1006

2.42

17.61

3.3

2.1

3.17

3.03

mg/l

0.27

165

869

Other specified/unspecified dorsopathies

456

3100

1.68

17.59

2.6

2.2

2.50

2.86

mg/l

3.12

406

2655

Leiomyoma of uterus

8992

46202

1.12

17.55

2.4

2.94

2.78

mg/l

6.81

7718

40322

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

8702

61921

1.12

17.51

2.3

2.64

2.71

mg/l

2.43

7581

53854

CR(E)ST syndrome

237

1402

2.16

17.51

4.3

2.2

2.99

2.97

mg/l

0.03

221

1193

Pre-eclampsia or eclampsia

2746

23544

1.23

17.51

2.5

2.3

2.86

2.62

mg/l

7.12

2425

20462

Hyperosmolality and hypernatraemia

222

1286

2.20

17.49

2.7

2.2

3.08

3.23

mg/l

0.38

198

1096

Hypersomnia

206

1160

2.24

17.49

2.7

2.1

3.01

2.85

mg/l

0.29

191

1008

Medical abortion

9587

47680

1.12

17.47

2.4

2.3

2.72

2.74

mg/l

0.39

8185

41416

Atlantoaxial subluxation

116

540

3.14

17.46

3.1

2.2

3.60

3.01

mg/l

1.97

105

459

Other abnormal immunological findings in serum

306

1926

1.93

17.45

2.8

2.2

2.60

2.79

mg/l

0.80

279

1653

Other other unspecified disorders of the circulatory system

507

3554

1.66

17.41

3.0

2.3

2.94

2.92

mg/l

0.08

454

3070

Isolated proteinuria with specified morphological lesion

180

982

2.44

17.41

3.2

2.1

2.88

2.94

mg/l

0.15

168

852

Other forms of systemic lupus erythematosus

141

709

2.78

17.38

3.2

2.1

3.21

2.87

mg/l

0.51

132

612

Other sideroblastic anaemias

288

4.43

17.32

4.5

2.0

3.70

2.89

mg/l

1.72

245

Other diseases of gallbladder

633

4610

1.56

17.31

2.8

2.3

2.80

2.86

mg/l

0.25

551

3927

Bicuspidal aortic valve syndrome

467

3203

1.67

17.30

2.5

2.4

3.09

2.77

mg/l

1.77

432

2771

Disorders of optic nerve and visual pathways

1262

10082

1.36

17.29

2.6

2.4

2.94

2.71

mg/l

2.51

1123

8777

Other diseases of spinal cord

411

2760

1.74

17.29

2.7

2.3

2.93

2.85

mg/l

0.23

367

2376

Personal history of medical treatment

177

961

2.43

17.26

3.1

2.2

2.89

2.84

mg/l

0.08

156

834

Unspecified event, undetermined intent

345

2225

1.82

17.26

2.4

2.2

2.85

2.79

mg/l

0.13

298

1929

Use of antiglaucoma preparations and miotics

1170

9313

1.39

17.22

2.6

2.5

3.03

3.06

mg/l

0.14

1013

7967

Primary open-angle glaucoma, strict

3946

34793

1.19

17.19

2.5

2.96

2.99

mg/l

0.34

3385

29776

Pre-eclampsia

2549

21761

1.23

17.15

2.5

2.3

2.88

2.61

mg/l

8.02

2254

18931

Infection due to other mycobacteria, including avohilmo

255

1539

2.05

17.13

2.9

2.1

3.05

2.91

mg/l

0.34

228

1290

Burns and corrosions of external body surface, specified by site

1379

11105

1.33

17.12

2.4

2.3

2.69

2.73

mg/l

0.28

1207

9719

Endometriosis of rectovaginal septum and vagina

1008

7840

1.41

17.08

2.5

2.3

2.83

2.78

mg/l

0.34

870

6829

Campylobacter enteritis

374

2466

1.78

17.06

2.7

2.2

3.03

2.83

mg/l

0.62

323

2129

Malignant neoplasm of oesophagus

366

2405

1.79

17.03

2.2

2.4

3.40

2.78

mg/l

3.35

324

2038

Toxic effect of other and unspecified substances

186

1017

2.28

17.02

2.6

2.1

2.56

2.72

mg/l

0.46

166

892

Other secondary coxarthrosis

455

3128

1.68

17.02

3.0

2.2

2.96

2.89

mg/l

0.15

408

2675

Retinal haemorrhage

385

2580

1.79

16.94

3.0

2.3

2.81

2.91

mg/l

0.39

331

2183

Injury of other and unspecified intrathoracic organs

830

6296

1.45

16.93

2.5

2.3

2.95

2.84

mg/l

0.61

716

5419

Bursitis of shoulder

336

2160

1.82

16.87

2.5

2.2

2.61

2.86

mg/l

1.40

307

1856

Chondropathies

1946

16258

1.27

16.87

2.6

2.3

2.70

2.71

mg/l

0.14

1679

14206

Paraplegia, diplegia of upper limbs

313

2001

1.89

16.74

3.0

2.3

3.08

2.89

mg/l

0.55

270

1718

Hyperfunction of pituitary gland

652

4779

1.53

16.73

2.7

2.2

2.61

2.67

mg/l

0.36

559

4177

Open wound of shoulder and upper arm

286

1780

1.92

16.63

2.8

2.2

2.90

2.87

mg/l

0.08

243

1541

Melanocytic naevi

4314

38302

1.17

16.62

2.5

2.4

2.58

2.73

mg/l

5.04

3828

33312

Other disorders of cornea

1291

10389

1.34

16.56

2.6

2.4

2.84

2.83

mg/l

0.02

1123

8992

Post-traumatic wound infection, not elsewhere classified

379

2525

1.75

16.51

2.9

2.3

2.91

2.84

mg/l

0.24

342

2187

Other surgical follow-up care

472

3279

1.64

16.49

2.9

2.2

2.59

2.71

mg/l

0.71

413

2791

Septal defects

818

6091

1.45

16.48

2.8

2.6

3.04

2.64

mg/l

3.34

723

5338

Recurrent dislocation and subluxation of joint

777

5815

1.44

16.38

2.5

2.2

2.71

2.64

mg/l

0.41

670

5038

Alcohol induced polyneuropathy

163

881

2.49

16.35

2.8

2.2

2.98

2.93

mg/l

0.09

147

772

Benign neoplasm: Pituitary gland, craniopharyngeal duct

692

5152

1.50

16.33

2.4

2.3

2.78

2.77

mg/l

0.07

614

4459

Congenital malformations of the musculoskeletal system, not elsewhere classified

236

1419

2.09

16.32

4.0

2.2

2.38

2.62

mg/l

1.19

202

1240

Left hemicolectomy

338

2227

1.85

16.32

3.1

2.3

2.86

2.98

mg/l

0.44

307

1898

Disturbances of smell and taste

548

3923

1.58

16.31

2.5

2.2

2.73

2.79

mg/l

0.34

476

3385

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

952

7385

1.40

16.27

2.7

2.2

2.84

2.54

mg/l

4.53

855

6470

Other specified/unspecified necrotizing vasculopathies

211

1234

2.19

16.26

3.5

2.2

3.41

3.02

mg/l

0.85

186

1056

Anogenital herpesviral [herpes simplex] infection

839

6400

1.44

16.26

2.4

2.2

2.47

2.59

mg/l

1.09

700

5621

Asthma mixed form (mode), excluding more controls

627

4551

1.50

16.19

2.5

2.1

2.90

2.70

mg/l

1.44

570

3887

Other encephalitis

385

2591

1.74

16.15

2.6

2.3

2.96

2.81

mg/l

0.45

332

2226

Thyroiditis

941

7322

1.41

16.13

2.5

2.3

2.57

2.76

mg/l

1.81

812

6371

Degeneration of the brain due to alcohol

307

1974

1.88

16.07

2.6

2.3

3.17

2.88

mg/l

0.97

273

1700

290

1835

1.90

16.06

2.8

2.4

2.59

2.39

mg/l

1.01

258

1606

Drug-induced systemic lupus erythematosus

113

540

3.04

16.06

4.2

2.2

2.71

2.98

mg/l

0.52

105

465

Carcinoma in situ of skin of upper limb, including shoulder

419

2926

1.76

16.04

2.7

2.4

2.98

3.03

mg/l

0.14

362

2509

Hyperkinetic disorders (excl. ADHD)

261

1570

1.93

16.00

2.9

3.0

2.34

2.50

mg/l

0.64

230

1399

Other localized connective tissue disorders

283

1788

1.92

15.95

3.0

2.2

2.83

2.86

mg/l

0.08

250

1529

Other and unspecified iridocyclitis

633

4667

1.52

15.81

2.6

2.3

2.58

2.79

mg/l

1.75

565

4020

Encephalitis

404

2757

1.70

15.78

2.5

2.3

2.95

2.83

mg/l

0.36

348

2368

Vulvovaginal ulceration/inflammation in other diseases

947

7391

1.40

15.72

2.6

2.2

2.57

2.64

mg/l

0.51

800

6453

Varicose veins of other sites

769

5812

1.45

15.72

3.1

2.3

3.05

2.79

mg/l

2.25

665

5034

Combined immunodeficiencies

165

904

2.40

15.72

3.6

2.3

2.90

2.93

mg/l

0.06

148

785

Problems related to social environment

423

2917

1.68

15.63

2.8

2.3

3.07

2.86

mg/l

1.21

385

2515

Glaucoma, exfoliation

1641

13686

1.30

15.61

2.4

2.5

3.01

3.07

mg/l

0.46

1414

11656

Eosinophilia

238

1452

2.04

15.60

3.3

2.3

2.83

2.86

mg/l

0.08

208

1259

Fitting and adjustment of external prosthetic device

251

4.52

15.58

2.9

2.1

2.92

2.87

mg/l

0.07

215

Acute lymphadenitis

736

5544

1.46

15.58

2.4

2.2

2.78

2.68

mg/l

0.71

652

4808

Complex cardiac defects

104

487

3.13

15.53

4.3

3.4

3.33

2.64

mg/l

0.71

429

Dissection of aorta

447

3130

1.65

15.42

2.8

2.3

3.26

2.86

mg/l

2.19

380

2677

Episcleritis

665

4948

1.49

15.40

2.5

2.3

2.65

2.74

mg/l

0.51

593

4301

Disorders of myoneural junction and muscle in diseases classified elsewhere

134

695

2.70

15.39

3.5

2.1

3.44

2.95

mg/l

1.28

120

593

Malignant neoplasm of oral cavity, including Hilmo

561

4069

1.55

15.35

2.5

2.4

2.70

2.77

mg/l

0.29

492

3483

Graves disease, strict definition

1320

10733

1.32

15.33

2.3

2.57

2.71

mg/l

1.59

1153

9365

Other specified and unspecified disorders of eye and adnexa

504

3602

1.59

15.32

2.6

2.2

2.29

2.90

mg/l

6.89

425

3105

Disorders of speech understanding and production

588

4222

1.53

15.31

3.0

2.6

2.75

2.69

mg/l

0.25

531

3699

Secondary parkinsonism+Parkinsonism in other disease

398

2737

1.71

15.26

2.5

2.3

2.87

2.98

mg/l

0.46

337

2352

Later onset COPD

4474

32227

1.17

15.17

2.7

2.4

3.36

2.93

mg/l

17.01

3825

27456

366

2496

1.77

15.16

2.9

2.3

3.35

2.91

mg/l

2.09

316

2128

Other specified/unspecified spondylopathies

353

2369

1.75

15.12

3.0

2.2

3.33

3.02

mg/l

1.37

319

1999

Complications peculiar to reattachment and amputation

113

549

2.86

15.11

3.8

2.0

3.66

3.19

mg/l

0.93

105

472

Contusion of other and unspecified parts of foot

691

5181

1.47

15.06

2.7

2.2

2.57

2.63

mg/l

0.35

594

4528

Previous suicide attempt

170

949

2.29

15.05

2.9

2.3

2.55

2.66

mg/l

0.29

155

827

Nonpyogenic thrombosis of intracranial venous system

151

814

2.43

15.03

2.7

2.2

3.47

2.81

mg/l

1.18

124

711

Degeneration of nervous system due to alcohol

307

2007

1.84

15.02

2.6

2.3

3.17

2.88

mg/l

1.00

273

1735

Alopecia areata

375

2545

1.71

15.01

2.5

2.2

2.52

2.71

mg/l

1.17

339

2195

Encephalopathy

158

868

2.40

15.01

3.5

2.1

3.38

3.00

mg/l

0.79

149

749

Postpartum haemorrhage

3330

24101

1.19

14.99

2.2

2.3

2.59

2.54

mg/l

0.79

2879

21126

Scar conditions and fibrosis of skin

548

3980

1.55

14.98

2.5

2.2

2.63

2.73

mg/l

0.42

488

3442

Malignant melanoma, including Hilmo

2301

19730

1.23

14.97

2.4

2.87

2.78

mg/l

0.97

1967

17014

Carcinoma in situ of other and unspecified sites

582

4320

1.56

14.94

2.6

2.4

3.03

2.94

mg/l

0.36

492

3702

Femoral hernia

588

4333

1.53

14.92

2.4

2.3

2.98

2.86

mg/l

0.51

511

3712

Infections of genitourinary tract in pregnancy

1232

9977

1.33

14.91

2.4

2.3

2.88

2.62

mg/l

4.06

1111

8633

Panhypopituitarism

253

1583

1.95

14.90

2.4

2.3

2.86

2.91

mg/l

0.15

230

1382

Background retinopathy and retinal vascular changes

298

1934

1.84

14.87

3.2

2.2

2.97

2.96

mg/l

0.02

261

1660

Lupus nephritis

264

3.92

14.85

3.2

1.9

2.76

2.65

mg/l

0.18

224

Hypertrichosis

329

2184

1.78

14.83

2.3

2.1

2.66

2.49

mg/l

0.81

293

1893

Aspergillosis

143

767

2.54

14.82

2.9

2.2

3.16

3.06

mg/l

0.17

128

663

Tic and related disorders

174

964

2.16

14.80

2.8

2.57

2.60

mg/l

0.07

152

854

Other abnormal products of conception

4292

25063

1.16

14.75

2.2

2.49

2.56

mg/l

1.30

3791

22064

Cushing syndrome

173

980

2.26

14.73

3.0

2.1

2.99

2.88

mg/l

0.28

156

843

Carcinoma in situ, bladder

540

3974

1.58

14.72

2.7

2.4

2.98

2.93

mg/l

0.21

455

3405

Marginal zone B-cell lymphoma

159

886

2.40

14.66

2.6

2.2

3.04

2.88

mg/l

0.36

145

748

Habit and impulse disorders

202

1174

2.02

14.64

2.6

2.1

3.01

2.58

mg/l

1.41

172

1038

Additional codes for the location of defect, injury or illness

781

6018

1.44

14.62

2.6

2.3

2.52

2.79

mg/l

3.78

720

5218

Thiamine deficiency

451

3.09

14.58

2.9

2.0

2.74

2.79

mg/l

0.08

395

Other and unspecified epidermal thickening

371

2533

1.71

14.56

3.2

2.3

3.18

2.80

mg/l

1.98

343

2173

Secondary parkinsonism

389

2690

1.69

14.56

2.5

2.3

2.85

2.99

mg/l

0.62

331

2313

Sequelae of injuries of lower limb

1132

9087

1.34

14.55

2.6

2.3

2.62

2.74

mg/l

0.94

991

7906

Dermatopolymyositis

209

1250

2.07

14.55

2.8

2.2

3.03

2.96

mg/l

0.16

189

1070

Aspergillosis, including avohilmo

146

794

2.48

14.50

2.9

2.2

3.16

3.03

mg/l

0.23

131

687

Injury of eye and orbit

1719

14368

1.26

14.45

2.5

2.3

2.55

2.71

mg/l

2.72

1482

12566

Other or unspecified common variable immunodeficiency

262

4.25

14.43

3.7

2.1

3.18

2.91

mg/l

0.44

231

Alkalosis

181

5.19

14.38

4.1

2.0

2.96

2.84

mg/l

0.15

159

Malignant neoplasm of endocrine gland, including Hilmo

1019

8104

1.36

14.36

2.5

2.4

2.87

2.71

mg/l

1.36

891

7035

Neuroendocrine tumor and carcinoma of stomach

427

3.30

14.35

3.5

2.3

3.25

2.94

mg/l

0.57

359

Right ventricular outflow tract obstruction

131

688

2.58

14.33

3.6

3.5

2.96

2.45

mg/l

0.90

121

606

Bitten or struck by other mammals

1506

12489

1.28

14.28

2.4

2.3

2.85

2.66

mg/l

2.07

1272

10892

Other maltreatment syndromes

339

2248

1.69

14.26

2.3

2.2

2.46

2.66

mg/l

0.83

286

1983

Dislocation of lens

230

1417

1.97

14.24

2.8

2.2

2.98

2.96

mg/l

0.03

189

1199

Inguinal of femoral hernia, unilateral

375

2579

1.69

14.24

2.4

2.2

2.89

2.86

mg/l

0.09

328

2195

Femoral hernia, unilateral

375

2579

1.69

14.24

2.4

2.2

2.89

2.86

mg/l

0.09

328

2195

Inguinal hernia, unilateral

375

2579

1.69

14.24

2.4

2.2

2.89

2.86

mg/l

0.09

328

2195

Other and unspecified injuries of shoulder and upper arm

438

3090

1.61

14.22

2.6

2.2

2.83

2.82

mg/l

0.02

377

2658

Type 1 diabetes, wide definition, subgroup 2

1386

0.34

14.19

2.6

2.3

2.95

2.88

mg/l

0.09

1160

Other disorders of the genitourinary system

1695

14280

1.27

14.14

2.6

2.4

2.86

2.88

mg/l

0.08

1470

12349

Pregnancy with abortive outcome

10014

48432

1.10

14.12

2.4

2.3

2.72

2.75

mg/l

0.49

8623

42053

Chronic conjunctivitis

397

2758

1.65

14.08

2.4

2.3

2.52

2.85

mg/l

2.73

356

2391

Hirsutism in women

293

1921

1.82

14.07

2.4

2.1

2.61

2.48

mg/l

0.53

263

1675

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

856

6702

1.40

14.03

2.3

2.4

2.82

2.78

mg/l

0.19

736

5748

Other drug-induced secondary parkinsonism

151

835

2.37

14.03

2.6

2.2

3.00

3.12

mg/l

0.25

128

724

Complications predominantly related to the puerperium

3371

29800

1.18

14.03

2.3

2.57

2.61

mg/l

0.53

2939

25942

Benign neoplasm: Other and unspecified parts of small intestine

239

1510

1.98

13.97

3.5

2.2

3.26

3.06

mg/l

0.48

221

1294

Female infertility, tubal origin

552

4026

1.49

13.94

2.6

2.2

2.59

2.63

mg/l

0.13

490

3546

Causalgia

219

1337

1.97

13.85

2.8

2.0

2.50

2.74

mg/l

0.85

200

1168

Vascular dementia (undefined)

644

4808

1.47

13.84

2.7

2.5

3.19

3.24

mg/l

0.18

531

4108

Congenital malformations of great arteries

289

1860

1.81

13.81

3.4

3.1

2.88

2.57

mg/l

1.54

267

1656

Postpartum hemorraghe, parous women as controls

3330

24583

1.18

13.74

2.2

2.59

2.53

mg/l

0.94

2879

21601

Malignant melanoma

2035

17408

1.23

13.73

2.4

2.86

2.78

mg/l

0.73

1733

15020

Wegener granulomatosis

217

1336

2.00

13.70

2.9

2.2

2.93

2.92

mg/l

0.02

199

1153

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

2035

17403

1.24

13.70

2.3

2.4

2.54

2.77

mg/l

4.47

1808

15153

Acute appendicitis, no complications

7546

69078

1.11

13.66

2.4

2.3

2.66

2.72

mg/l

1.58

6651

60245

Other diseases of peritoneum

589

4410

1.50

13.65

3.1

2.3

2.97

2.83

mg/l

0.69

509

3813

Acute myeloid leukaemia, including Hilmo

197

1186

2.08

13.63

2.3

2.94

2.86

mg/l

0.16

166

1009

Acute myeloid leukaemia

197

1186

2.08

13.63

2.3

2.94

2.86

mg/l

0.16

166

1009

Acute myeloid leukaemia, helper endpoint

197

1186

2.08

13.63

2.3

2.94

2.86

mg/l

0.16

166

1009

Viral infections of the central nervous system, including avohilmo

977

7788

1.36

13.62

2.5

2.3

2.79

2.74

mg/l

0.26

859

6769

Urethritis and urethral syndrome

297

1955

1.77

13.61

2.7

2.2

2.65

2.88

mg/l

1.14

258

1682

Peptic ulcer

150

831

2.30

13.58

3.9

2.1

3.22

3.10

mg/l

0.23

140

705

Crushed, pushed or stepped on by crowd or human stampede

899

7068

1.36

13.56

2.7

2.3

2.44

2.67

mg/l

2.97

780

6174

Hordeolum and other deep inflammation of eyelid

785

6099

1.41

13.54

2.5

2.3

2.41

2.71

mg/l

4.45

680

5276

Pleural plaque

1365

11356

1.31

13.54

2.5

2.4

3.06

2.90

mg/l

1.70

1137

9631

Congenital malformations of gallbladder, bile ducts and liver

156

886

2.32

13.53

3.9

2.6

2.57

2.87

mg/l

1.16

135

770

Recurrent and persistent haematuria

134

719

2.44

13.52

2.5

2.1

2.77

2.82

mg/l

0.11

122

621

Childhood allergy (age < 16)

1933

13516

1.24

13.52

2.7

2.3

2.40

2.41

mg/l

0.06

1714

11724

Dependence on enabling machines and devices, not elsewhere classified

166

945

2.19

13.51

4.1

2.6

2.76

2.77

mg/l

0.03

154

828

Other specified and unspecified disorders of lens

150

847

2.40

13.50

2.5

2.3

2.98

3.04

mg/l

0.09

117

711

Other and unspecified paralytic syndromes

205

1246

2.02

13.49

2.4

2.2

2.66

2.94

mg/l

1.19

174

1085

Erectile dysfunction

1042

8425

1.35

13.46

3.3

2.4

2.84

2.87

mg/l

0.13

918

7275

Other ill-defined and unspecified causes of mortality

1307

10820

1.31

13.42

2.6

2.4

3.90

2.94

mg/l

24.76

1137

9258

Other puerperal infections

1068

8625

1.34

13.42

2.3

2.2

2.46

2.49

mg/l

0.14

913

7523

Polyglandular dysfunction

178

5.07

13.38

4.9

2.4

3.93

2.83

mg/l

1.42

160

Other and unspecified injuries of ankle and foot

559

4141

1.49

13.36

2.7

2.2

2.71

2.66

mg/l

0.19

488

3603

Erythema nodosum

399

2811

1.63

13.35

3.1

2.2

3.24

2.82

mg/l

2.21

352

2421

Injury of intra-abdominal organs

320

2146

1.71

13.34

2.4

2.2

3.20

2.79

mg/l

1.65

274

1871

Other acute skin changes due to ultraviolet radiation

452

3253

1.58

13.32

2.8

2.3

2.78

2.89

mg/l

0.39

395

2777

Nosocomial condition (hospital)

109

558

2.84

13.32

2.9

2.1

3.16

3.04

mg/l

0.14

483

Other secondary gout

276

4.12

13.30

3.5

2.1

3.94

3.13

mg/l

0.53

232

Systemic disorders of connective tissue in diseases classified elsewhere

295

3.65

13.29

4.1

2.0

2.85

mg/l

0.01

254

Malignant neoplasm of rectosigmoid junction

242

1543

1.90

13.28

2.2

2.3

3.45

2.87

mg/l

1.38

220

1305

Abnormal findings on diagnostic imaging of central nervous system

652

4959

1.45

13.25

2.6

2.2

2.81

2.70

mg/l

0.56

578

4289

Other and unspecified mononeuropathies, also in other diseases

388

2721

1.63

13.19

3.1

2.2

3.08

2.90

mg/l

0.57

335

2314

Restrictive cardiomyopathy

318

3.95

13.16

4.2

2.3

3.07

3.04

mg/l

0.04

279

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

2286

19785

1.21

13.15

2.4

2.57

2.78

mg/l

4.49

2037

17209

Malignant neoplasm of tongue, including Hilmo

335

2283

1.69

13.14

2.4

2.3

2.72

2.81

mg/l

0.22

293

1958

Syndrome of inappropriate secretion of antidiuretic hormone

101

506

2.96

13.14

3.2

2.1

2.66

3.01

mg/l

1.00

434

Other menopausal disorders

3372

16583

1.18

13.13

2.3

2.52

2.81

mg/l

12.02

2899

14429

Lesion of plantar nerve

754

5862

1.41

13.12

2.5

2.3

2.69

2.88

mg/l

1.35

664

5073

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

448

3215

1.56

13.09

2.3

2.2

2.38

2.71

mg/l

3.66

396

2817

Somnolence

190

1143

2.06

13.08

2.7

2.1

2.76

2.75

mg/l

0.01

172

995

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

406

2859

1.60

13.06

3.0

2.6

2.75

2.56

mg/l

0.64

364

2526

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

150

855

2.34

13.04

2.3

2.2

2.89

2.94

mg/l

0.11

133

737

Aneurysms, operations, SAH

2126

18322

1.22

13.03

2.6

2.4

3.07

2.86

mg/l

3.07

1885

15797

Mantle cell lymphoma, including Hilmo

204

1255

2.01

13.02

2.3

2.99

2.74

mg/l

0.92

178

1062

Small cell lung cancer, helper endpoint

154

2642

0.52

13.01

2.5

2.3

3.27

2.96

mg/l

1.03

137

2258

Abnormality of white blood cells, not elsewhere classified

140

776

2.37

13.00

3.0

2.2

2.45

2.92

mg/l

2.35

125

679

Atrial septal defect

486

3530

1.54

12.95

3.0

2.6

3.09

2.69

mg/l

2.34

437

3094

Autonomic disorders

333

2278

1.69

12.94

2.7

2.2

2.74

2.85

mg/l

0.40

292

1964

Herpesviral keratitis and keratoconjunctivitis

564

4224

1.49

12.93

2.7

2.3

2.91

2.87

mg/l

0.18

510

3623

Open bite

700

5388

1.42

12.89

2.6

2.5

2.59

2.57

mg/l

0.13

625

4723

Malignant neoplasm of endocrine gland

882

6990

1.36

12.88

2.5

2.4

2.82

2.70

mg/l

0.81

771

6077

Oral lichen planus

363

2536

1.66

12.87

2.7

2.2

2.78

2.92

mg/l

0.34

310

2178

Open wound of neck

116

598

2.46

12.74

2.9

2.0

2.86

2.82

mg/l

0.06

106

526

Conduct disorder

269

1747

1.76

12.73

2.4

2.5

2.56

2.53

mg/l

0.09

242

1521

Premature rupture of membranes

2838

17712

1.19

12.69

2.1

2.2

2.60

2.55

mg/l

0.78

2451

15475

Idiopathic pulmonary fibrosis

1094

8961

1.33

12.68

2.6

2.4

3.05

2.96

mg/l

0.65

962

7660

Abdominal aortic aneurysm (AAA)

1393

11524

1.28

12.65

2.6

2.3

3.36

2.93

mg/l

6.84

1216

9702

Corneal scars and opacities

380

2682

1.63

12.62

2.8

2.3

2.90

2.91

mg/l

0.04

326

2302

Other and unspecified nail disorders

316

2151

1.71

12.60

3.2

2.2

2.78

2.82

mg/l

0.11

286

1853

Benign neoplasm of other and unspecified intrathoracic organs

163

955

2.18

12.59

3.1

2.1

3.01

mg/l

0.00

144

825

Tracheo-bronchomalasia

235

3.32

12.58

2.6

1.5

3.04

2.47

mg/l

1.48

194

Prepatellar bursitis

530

3922

1.48

12.58

2.5

2.2

2.80

2.76

mg/l

0.15

472

3388

Myopia

1640

13854

1.25

12.54

2.5

2.3

2.58

2.64

mg/l

0.47

1411

12114

Abnormal findings in secretions and smears from cervix uteri vagina vulva

6913

46826

1.11

12.53

2.3

2.51

2.66

mg/l

8.31

6080

40805

Spinal osteochondrosis

145

807

2.19

12.50

2.6

2.1

2.58

2.84

mg/l

0.91

127

703

Type 1 diabetes, strict definition

844

6613

1.35

12.50

2.4

2.54

2.44

mg/l

0.81

727

5844

Cardiomyopathies, Secondary/extrinsic

101

500

2.62

12.48

2.8

2.0

2.62

2.86

mg/l

0.47

426

Otitis media, unspecified

1481

11418

1.26

12.45

2.7

2.4

2.55

2.60

mg/l

0.46

1334

9915

Malignant neoplasm of other connective and soft tissue, including Hilmo

533

3979

1.49

12.44

2.3

2.4

2.74

2.77

mg/l

0.10

452

3385

Residual foreign body in soft tissue

608

4595

1.44

12.43

2.4

2.2

2.78

2.71

mg/l

0.29

518

3960

Carcinoma in situ of rectum

197

1224

2.03

12.42

2.7

2.2

2.59

2.99

mg/l

1.84

179

1069

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

179

1066

2.03

12.42

3.0

2.3

2.98

2.83

mg/l

0.43

163

920

Other disorders of iris and ciliary body

381

2698

1.62

12.41

2.9

2.3

2.85

2.94

mg/l

0.29

331

2300

Complications of genitourinary prosthetic devices, implants and grafts

355

2483

1.65

12.41

2.6

2.1

2.74

2.83

mg/l

0.32

312

2124

Type 1 diabetes, strict definition, subgroup 1

802

6252

1.36

12.40

2.4

2.52

2.44

mg/l

0.59

690

5519

Vertigo of central origin

242

1575

1.87

12.40

2.8

2.3

3.13

3.01

mg/l

0.25

201

1359

Unspecified visual impairment (binocular)

225

1433

1.90

12.39

3.3

2.4

2.51

2.88

mg/l

1.77

196

1240

Other and unspecified trigeminal disorders

220

1391

1.90

12.37

2.7

2.2

2.64

2.83

mg/l

0.82

196

1198

Striae atrophicae

164

960

2.12

12.35

2.8

2.2

2.54

2.69

mg/l

0.55

146

823

Other congenital malformations of upper alimentary tract

118

634

2.56

12.35

3.2

2.3

3.67

2.81

mg/l

3.58

107

557

Chronic myeloid leukaemia, including Hilmo

136

756

2.31

12.34

3.0

2.2

2.63

2.79

mg/l

0.40

129

645

Adenocarcinoma and Papillary adenocarcinoma of kidney

163

957

2.14

12.30

2.5

2.3

3.02

2.73

mg/l

0.79

144

816

Diastasis of muscle

143

806

2.24

12.30

3.2

2.0

2.92

2.69

mg/l

0.83

124

708

Disorder of external ear, unspecified

435

3153

1.56

12.24

2.7

2.3

2.91

2.86

mg/l

0.16

381

2706

Defects in the complement system

112

589

2.57

12.24

5.3

2.5

2.79

2.78

mg/l

0.03

104

514

Severe visual impairment, binocular

466

2.86

12.23

3.2

2.4

3.95

3.06

mg/l

2.04

418

Viral infections of the central nervous system

892

7129

1.35

12.22

2.5

2.3

2.82

2.75

mg/l

0.45

782

6191

Other congenital malformations of heart

108

559

2.59

12.21

3.7

3.0

2.74

2.77

mg/l

0.05

102

503

Other erythematous conditions

465

3412

1.53

12.20

3.1

2.3

2.67

2.84

mg/l

0.93

412

2933

Unspecified contracted kidney

479

2.79

12.19

4.0

2.2

3.23

2.96

mg/l

0.46

422

Evidence of alcohol involvement determined by blood alcohol level

197

1210

1.94

12.19

2.3

2.1

3.08

2.78

mg/l

0.80

171

1056

Other disorders of breast

1799

15395

1.23

12.18

2.3

2.63

2.73

mg/l

1.16

1544

13352

Antepartum haemorrhage, not elsewhere classified

1081

8816

1.31

12.17

2.1

2.3

2.48

2.53

mg/l

0.36

965

7768

malignant neoplasm of female genital organs

2028

17139

1.22

12.15

2.3

2.5

3.05

2.85

mg/l

3.04

1748

14789

Carcinoid syndrome

145

835

2.28

12.12

2.5

2.2

3.14

3.03

mg/l

0.18

125

726

Embedded and impacted teeth

3579

25921

1.16

12.08

2.3

2.55

2.52

mg/l

0.43

3197

22537

Pedestrian injured in transport accident

896

7177

1.35

12.08

2.4

2.3

2.60

2.78

mg/l

1.71

779

6208

Acute bronchiolitis

769

5436

1.38

12.07

2.9

2.6

2.69

2.59

mg/l

0.73

693

4732

Benign neoplasm of meninges

1362

11422

1.28

12.05

2.6

2.4

2.81

2.90

mg/l

0.74

1170

9857

Cystic disease of liver

111

588

2.57

12.00

3.1

2.3

2.47

3.07

mg/l

2.33

507

Medial epicondylitis

432

3113

1.53

11.98

2.3

2.2

2.59

2.75

mg/l

0.87

379

2702

Other bursitis of elbow

132

735

2.30

11.91

2.5

2.2

2.53

3.01

mg/l

1.02

122

634

Evidence of alcohol involvement determined by level of intoxication

144

815

2.16

11.90

2.4

2.1

3.16

2.63

mg/l

1.55

126

706

Open wound of hip and thigh

410

2944

1.55

11.86

2.4

2.3

2.86

2.71

mg/l

0.62

360

2533

Granulomatous disorders of skin and subcutaneous tissue

355

2502

1.62

11.84

2.7

2.2

2.81

2.78

mg/l

0.07

321

2142

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

175

1058

2.04

11.83

2.7

2.1

2.85

2.82

mg/l

0.06

148

913

Abnormal findings in nipple discharge synovial fluid wound secretions

210

1332

1.91

11.77

3.1

2.2

2.60

2.84

mg/l

0.63

185

1152

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

276

1855

1.74

11.75

2.4

2.3

2.49

2.82

mg/l

2.08

245

1580

Disorders of orbit

548

4140

1.46

11.74

2.6

2.2

2.62

2.81

mg/l

1.44

495

3580

Fistulae involving female genital tract

217

1380

1.86

11.74

3.3

2.2

2.86

mg/l

0.01

192

1194

Behavioural disorders

269

1783

1.72

11.72

2.4

2.5

2.58

2.54

mg/l

0.08

242

1557

Inguinal or femoral hernia, bilateral

1362

11426

1.27

11.72

2.5

2.3

2.79

2.86

mg/l

0.60

1179

9792

Car occupant injured in noncollision transport accident

449

3287

1.52

11.68

2.4

2.2

2.72

2.71

mg/l

0.03

396

2853

Short Achilles tendon (acquired)

336

2333

1.62

11.67

2.6

2.1

1.83

2.75

mg/l

27.11

325

2008

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

934

7402

1.33

11.67

2.7

2.4

2.57

2.54

mg/l

0.22

819

6484

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

221

1416

1.85

11.66

3.4

2.7

2.70

2.71

mg/l

0.01

195

1236

Otorrhagia

119

652

2.45

11.66

2.6

2.3

2.52

3.05

mg/l

1.83

107

571

Postmenopausal atrophic vaginitis

3243

15684

1.17

11.65

2.4

2.71

2.91

mg/l

5.15

2834

13568

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

544

4086

1.45

11.64

2.6

2.2

2.86

2.70

mg/l

0.90

484

3526

Seronegative juvenile rheumatoid arthritis

260

1733

1.77

11.63

3.3

2.4

2.99

2.49

mg/l

3.44

236

1508

Hypermetropia

935

7553

1.33

11.62

2.4

2.5

2.72

2.71

mg/l

0.01

809

6598

Malignant neoplasm of oral cavity

426

3101

1.54

11.60

2.4

2.62

2.79

mg/l

0.94

371

2648

Impaction of intestines

108

567

2.48

11.60

2.9

2.1

3.06

2.95

mg/l

0.14

486

Surgical ablation of atrial fibrillation

442

2.85

11.56

2.7

2.2

2.44

2.93

mg/l

1.46

385

Bacterial, viral and other infectious agents, including avohilmo

1053

8606

1.30

11.48

2.7

2.3

2.74

2.69

mg/l

0.35

940

7503

Systemic sclerosis,strict definition

137

783

2.24

11.47

3.8

2.2

3.20

2.87

mg/l

0.79

130

670

Other and unspecified acne

198

1237

1.90

11.46

3.0

2.1

2.64

2.63

mg/l

0.03

172

1077

Cystic fibrosis with pulmonary manifestations

7.63

11.42

4.5

2.0

2.82

2.48

mg/l

0.46

Other nonscarring hair loss

173

1058

2.04

11.40

2.6

2.1

2.52

2.74

mg/l

0.55

155

901

Endometriosis ASRM stages 3,4

3025

26963

1.17

11.38

2.5

2.3

2.74

2.73

mg/l

0.09

2612

23528

Hodgkin lymphoma, hilmo

366

2614

1.59

11.34

2.5

2.2

3.16

2.82

mg/l

1.85

331

2266

Asthma mixed form (mode)

627

4819

1.40

11.34

2.5

2.2

2.90

2.75

mg/l

0.96

570

4136

Other contact dermatitis

1008

8223

1.31

11.33

2.5

2.3

2.84

2.74

mg/l

0.85

880

7140

Congenital malformations of pulmonary and tricuspid valves

117

642

2.41

11.31

3.6

3.3

2.99

2.53

mg/l

0.70

108

563

Vascular syndromes of brain in cerebrovascular disorders

598

4622

1.44

11.28

2.8

2.4

3.15

2.99

mg/l

0.78

539

3989

Other protozoal intestinal diseases

197

1237

1.89

11.27

2.8

2.2

2.48

2.78

mg/l

1.16

174

1077

Other and unspecified erythematous conditions

420

3074

1.54

11.27

3.2

2.3

2.65

2.85

mg/l

1.09

370

2636

Dislocation, sprain and strain of joints and ligaments of knee

8416

70865

1.09

11.26

2.3

2.66

2.69

mg/l

0.55

7370

61798

Vascular dementia (other)

129

739

2.37

11.25

2.8

2.5

2.67

3.07

mg/l

1.26

102

631

Biological medicines for asthma

277

1872

1.70

11.25

2.7

2.1

2.70

2.76

mg/l

0.20

258

1616

Dyshidrosis [pompholyx]

216

1385

1.83

11.25

2.2

2.1

2.71

2.67

mg/l

0.09

177

1190

Lung cancer and mesothelioma

2497

18604

1.18

11.25

2.3

2.2

3.11

2.83

mg/l

4.99

2173

15759

Other/unspecified crystal arthropathies

114

632

2.55

11.24

3.0

2.3

3.49

3.06

mg/l

0.52

545

Progressive systemic sclerosis

411

3.01

11.20

4.7

2.2

3.55

3.19

mg/l

0.54

357

Other and unspecified medical devices associated with adverse incidents

489

2.81

11.15

3.0

2.1

2.96

3.06

mg/l

0.14

426

Papilloedema, unspecified

316

2209

1.65

11.15

2.8

2.2

3.06

2.78

mg/l

1.35

288

1927

Other and unspecified bullous disorders

164

997

2.07

11.14

2.7

2.2

3.07

2.97

mg/l

0.21

146

871

Hypothyroidism due to medicaments and other exogenous substances

178

1104

2.00

11.13

3.1

2.2

2.69

2.94

mg/l

0.57

155

956

Factitial dermatitis

427

2.81

11.09

2.9

2.2

3.32

2.76

mg/l

0.48

364

Atypical mycobacterium lung infection

177

1099

2.00

11.09

2.6

2.3

3.00

mg/l

0.00

155

932

Embolic stroke

648

5058

1.41

11.09

2.7

2.4

3.04

3.01

mg/l

0.12

573

4295

Injury of muscle and tendon at hip and thigh level

1236

10310

1.27

11.08

2.4

2.3

2.76

2.75

mg/l

0.06

1075

8993

Family history of certain disabilities and chronic diseases leading to disablement

617

4759

1.41

11.08

2.7

2.1

2.63

2.58

mg/l

0.28

535

4164

Paralytic strabismus

906

7359

1.33

11.07

2.6

2.4

3.00

2.87

mg/l

0.89

816

6328

Other factor of the environment

179

1108

1.97

11.06

3.8

2.2

3.08

2.95

mg/l

0.30

164

966

Other abnormal findings in urine

236

1568

1.81

11.05

2.7

2.2

3.00

2.94

mg/l

0.12

218

1330

Injury of muscle and tendon at wrist and hand level

1591

13559

1.23

11.00

2.4

2.3

2.67

2.76

mg/l

0.92

1412

11882

Other/unspecified disorders of vestibular function

562

4323

1.45

10.99

2.6

2.3

2.58

2.91

mg/l

3.59

491

3703

Central retinal artery occlusion

320

2260

1.66

10.99

3.1

2.3

3.21

3.01

mg/l

0.77

282

1924

Hyphaema and other vascular disorders of iris and ciliary body

290

2003

1.69

10.97

3.1

2.3

2.94

3.00

mg/l

0.16

256

1702

Melanocytic naevi of trunk

1581

13515

1.24

10.88

2.6

2.3

2.58

2.74

mg/l

1.95

1408

11771

Monoplegia

217

1417

1.84

10.84

2.7

2.2

2.69

2.94

mg/l

0.92

191

1231

Disorders of synovium and tendon in diseases classified elsewhere

267

1805

1.69

10.81

2.8

2.2

2.76

2.87

mg/l

0.30

232

1533

ILD and respiratory illness in diseases classified elsewhere

462

2.75

10.81

3.6

2.1

3.94

2.98

mg/l

1.64

396

Inguinal hernia, bilateral

1329

11209

1.26

10.81

2.5

2.3

2.79

2.87

mg/l

0.58

1150

9603

Hyposplenism

134

5.87

10.75

2.9

2.0

3.20

2.42

mg/l

0.76

117

Benign intracranial hypertension

160

973

2.04

10.73

2.7

2.1

3.21

2.48

mg/l

2.41

148

845

Hyperprolactinaemia

435

3217

1.50

10.72

2.7

2.2

2.56

2.61

mg/l

0.21

371

2843

Human immunodeficiency virus [HIV] disease, including avohilmo

205

1302

1.80

10.70

2.3

2.1

2.41

2.77

mg/l

1.37

182

1154

Contact with and exposure to communicable diseases

3965

35725

1.14

10.67

2.4

2.3

2.76

2.56

mg/l

8.49

3500

31259

Assault by blunt object

172

1048

1.90

10.64

2.0

2.1

2.47

2.66

mg/l

0.63

137

928

Other and unspecified mononeuropathies of upper limb

364

2615

1.56

10.64

2.4

2.2

2.74

2.80

mg/l

0.24

320

2272

Other nonthrombocytopenic purpura

146

872

2.13

10.64

3.1

2.2

2.93

2.98

mg/l

0.10

134

748

Allergic purpura

387

2819

1.54

10.63

3.0

2.2

2.86

2.77

mg/l

0.26

347

2450

Bacterial, viral and other infectious agents

958

7818

1.30

10.61

2.7

2.3

2.78

2.69

mg/l

0.66

860

6825

Maternal care for known or suspected malpresentation of fetus

2427

15211

1.18

10.61

2.2

2.3

2.50

2.51

mg/l

0.06

2136

13336

Livedoid vasculitis

344

3.16

10.60

3.4

2.1

2.71

3.08

mg/l

0.68

293

Dermatitis herpetiformis

239

1600

1.77

10.60

2.3

2.54

2.97

mg/l

2.72

206

1386

Malignant neoplasm of anus and anal canal, including Hilmo

175

1090

1.95

10.60

2.5

2.3

3.24

2.84

mg/l

0.92

153

928

Drug-induced headache, not elsewhere classified

476

2.62

10.59

2.8

2.1

3.12

2.76

mg/l

0.54

415

Pleural plaque with presence of asbestos

1007

8350

1.32

10.58

2.6

2.4

3.18

2.93

mg/l

2.62

849

7138

Postpartum hemorraghe, all women as controls

3330

29177

1.15

10.56

2.2

2.59

2.53

mg/l

0.96

2879

25552

Benign neoplasm: Skin of ear and external auricular canal

535

4114

1.45

10.55

2.5

2.3

3.10

2.92

mg/l

0.75

460

3533

Toxic effect of carbon monoxide

237

1581

1.76

10.55

2.5

2.2

3.00

2.93

mg/l

0.18

215

1368

Ill-defined and unknown causes of mortality

1396

11886

1.25

10.54

2.6

2.4

3.88

2.95

mg/l

25.91

1217

10156

Pustular psoriasis

567

4373

1.42

10.53

2.5

2.3

2.97

2.83

mg/l

0.62

496

3791

Benign neoplasm: Cerebral meninges

1229

10346

1.27

10.51

2.5

2.4

2.77

2.89

mg/l

1.04

1051

8941

Poor fetal growth

1608

13796

1.23

10.51

2.3

2.2

2.46

2.48

mg/l

0.26

1411

12076

Other injuries of lower limb, level unspecified

143

847

2.10

10.50

2.8

2.2

2.27

2.91

mg/l

2.82

126

738

Hypertrophic disorders of skin

720

5720

1.36

10.44

2.6

2.2

2.55

2.69

mg/l

1.26

644

4963

Blindness, monocular

145

867

2.10

10.44

2.9

2.3

3.44

3.17

mg/l

0.56

122

758

Other protozoal intestinal diseases, including avohilmo

287

1985

1.64

10.42

2.6

2.1

2.43

2.70

mg/l

1.44

253

1718

Viral meningitis, including avohilmo

449

3348

1.48

10.40

2.5

2.2

2.68

2.67

mg/l

0.04

399

2929

Other and/or unspecified nontoxic goitre

1004

8284

1.30

10.37

2.3

2.4

2.69

2.86

mg/l

1.38

862

7167

Maternal care related to the fetus and amniotic cavity and possible delivery problems

5620

30257

1.12

10.37

2.1

2.3

2.57

2.62

mg/l

0.96

4935

26415

Shoulder region

203

1317

1.84

10.33

2.9

2.2

2.19

3.00

mg/l

7.88

185

1141

Macular hole

772

6235

1.36

10.30

2.6

2.4

2.88

2.93

mg/l

0.24

676

5331

Other hyperalimentation

253

3.45

10.30

2.8

2.0

3.00

mg/l

0.00

224

Spermatocele

901

7344

1.31

10.27

2.4

2.3

2.77

2.89

mg/l

0.89

783

6359

Oral lichen planus, including avohilmo , including avohilmo

862

7016

1.32

10.24

2.5

2.3

2.62

2.82

mg/l

1.64

743

6104

Peritonsillar abscess

2542

22497

1.17

10.19

2.4

2.3

2.66

2.69

mg/l

0.29

2234

19632

Other deformities of toe(s)

435

3243

1.48

10.16

2.8

2.2

2.81

2.80

mg/l

0.04

360

2762

Benign neoplasm: Anus and anal canal

378

2779

1.55

10.15

2.8

2.3

3.02

2.97

mg/l

0.12

328

2370

Stenosis and insufficiency of lacrimal passages

1235

10424

1.26

10.12

2.5

2.4

2.76

2.88

mg/l

1.11

1080

9003

Benign neoplasm: Skin of other and unspecified parts of face

1401

11962

1.24

10.07

2.6

2.4

2.93

2.86

mg/l

0.45

1195

10309

Panniculitis, unspecified

144

860

2.03

10.06

3.2

2.2

3.10

3.04

mg/l

0.09

131

725

Maternal care for known or suspected fetal abnormality and damage

2016

14901

1.19

10.05

2.2

2.41

2.52

mg/l

1.59

1755

13055

Premenstrual syndrome

198

1273

1.80

10.05

2.5

2.0

2.49

2.45

mg/l

0.07

174

1127

Disorders of parathyroid gland, other and/or unspecified

110

618

2.36

10.04

3.0

2.2

3.66

3.13

mg/l

0.73

533

Other injuries of upper limb, level unspecified

179

1138

1.90

10.01

3.2

2.2

2.78

2.80

mg/l

0.03

157

982

Use of ropinirole

456

3464

1.49

10.00

2.5

2.3

2.75

2.88

mg/l

0.75

397

2962

Congenital malformations of the respiratory system, including avohilmo

252

1722

1.70

10.00

2.8

2.6

2.73

2.81

mg/l

0.15

223

1508

Intestinal helminthiases, other/unspecified, including avohilmo

264

3.71

9.97

2.7

2.2

2.80

2.88

mg/l

0.09

228

Implicit parasitic Sepsis, including avohilmo

515

2.47

9.94

3.2

1.9

2.54

2.86

mg/l

0.85

441

Other mycoses, not elsewhere classified/unspecified, including avohilmo

242

1642

1.71

9.93

3.1

2.1

2.49

2.83

mg/l

1.88

217

1425

Pneumothorax

869

7097

1.31

9.93

2.5

2.3

3.03

2.82

mg/l

1.41

745

6106

Pulmonary oedema

258

1778

1.69

9.91

3.4

2.3

3.11

3.09

mg/l

0.03

240

1506

Oral lichen planus and hypothyroidism or thyroxine medication

253

1739

1.70

9.91

2.5

2.2

2.98

2.92

mg/l

0.09

213

1490

Family history of malignant neoplasm

1360

11552

1.24

9.89

2.4

2.2

2.56

2.66

mg/l

0.89

1197

10046

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

180

1129

1.82

9.88

2.3

2.1

2.41

2.74

mg/l

1.04

160

1003

Molar incisor enamel hypoplasia

493

3594

1.44

9.88

3.8

2.8

2.53

2.46

mg/l

0.35

443

3190

Viral meningitis

426

3178

1.48

9.86

2.5

2.2

2.69

mg/l

0.02

378

2773

Malignant neoplasm of thyroid gland, including Hilmo

879

7185

1.31

9.85

2.4

2.86

2.71

mg/l

1.08

768

6230

Leukaemia of unspecified cell type

139

836

2.09

9.83

2.2

2.3

3.01

2.88

mg/l

0.32

124

732

422

2.73

9.82

3.5

2.1

4.08

2.89

mg/l

2.08

362

Atopic conjunctivitis

561

4355

1.40

9.81

2.5

2.2

2.71

mg/l

0.01

497

3793

Endometriosis of intestine

209

1367

1.75

9.81

2.4

2.1

2.54

2.51

mg/l

0.12

178

1217

Human immunodeficiency virus [HIV] disease

198

1275

1.76

9.77

2.3

2.2

2.45

2.76

mg/l

1.04

176

1130

Other haemoglobinopathies

163

4.47

9.75

2.9

2.1

3.93

2.70

mg/l

1.12

138

Lack of expected normal physiological development

272

1637

1.63

9.72

2.9

2.50

2.40

mg/l

0.39

248

1442

Sequelae of other and unspecified effects of external causes

452

2.53

9.72

2.6

2.2

2.37

2.85

mg/l

1.29

397

Ménière disease

1209

10235

1.26

9.69

2.6

2.4

2.78

2.91

mg/l

1.44

1054

8817

Cerebral palsy

204

1334

1.76

9.67

2.7

2.6

2.85

2.61

mg/l

0.72

177

1175

Acute appendicitis

9806

85672

1.08

9.67

2.4

2.3

2.71

2.75

mg/l

0.99

8632

74389

Symptoms and signs involving appearance and behaviour

123

714

2.14

9.66

2.7

2.1

3.08

2.70

mg/l

1.54

111

614

Hypertrophic scar

655

5199

1.36

9.62

2.6

2.2

2.52

2.69

mg/l

1.54

587

4519

Malignant neoplasm of tongue

247

1691

1.68

9.61

2.4

2.3

2.50

2.81

mg/l

1.65

218

1439

Pustulosis palmaris et plantaris

507

3901

1.42

9.59

2.4

2.3

2.93

2.82

mg/l

0.41

443

3373

Human immunodeficiency virus [HIV] disease resulting in other conditions

178

1122

1.80

9.58

2.3

2.1

2.41

2.74

mg/l

0.99

158

997

Complications associated with artificial fertilization

226

1512

1.70

9.54

2.5

2.0

2.61

2.48

mg/l

0.46

203

1344

Other intracranial haemorrhages

449

3424

1.47

9.53

2.4

3.32

2.96

mg/l

1.71

384

2917

Short stature, not elsewhere classified

298

1963

1.61

9.52

3.7

3.1

2.38

2.35

mg/l

0.08

273

1746

Carcinoma in situ of skin of lower limb, including hip

332

2442

1.61

9.52

2.6

2.4

2.75

3.02

mg/l

1.56

286

2078

Other specified and unspecified retinal disorders

459

3501

1.46

9.50

2.8

2.2

2.96

2.88

mg/l

0.20

399

2988

Contraceptive management

4702

30059

1.12

9.50

2.3

2.56

2.67

mg/l

3.54

4158

26388

Abnormality of red blood cells

429

2.57

9.48

3.0

2.2

3.01

2.89

mg/l

0.14

381

Use of rotigotine

156

977

1.97

9.46

2.9

2.2

2.91

3.09

mg/l

0.30

131

842

Spontaneous abortion

6201

38499

1.10

9.45

2.3

2.64

2.67

mg/l

0.53

5437

33530

Helminthiases, including avohilmo

543

4233

1.41

9.43

2.6

2.3

2.42

2.66

mg/l

2.31

480

3665

Pyoderma

243

1665

1.68

9.41

3.3

2.1

2.95

2.84

mg/l

0.27

207

1432

Malignant melanoma of skin, including Hilmo

1833

16021

1.20

9.40

2.3

2.4

2.86

2.78

mg/l

0.65

1573

13838

Thyroiditis, unspecified

198

1302

1.78

9.38

2.5

2.2

2.73

2.79

mg/l

0.14

170

1124

Other and unspecified pemphigoid

148

929

2.05

9.34

3.2

2.3

3.06

3.21

mg/l

0.30

128

797

Listeriosis, including avohilmo

444

2.61

9.32

3.4

2.1

3.84

3.04

mg/l

1.59

370

Dermatopolymyositis, unspecified

450

2.57

9.30

3.3

2.0

3.15

2.79

mg/l

0.85

393

Malignant neoplasm of renal pelvis, including Hilmo

165

1048

1.90

9.30

2.3

2.95

2.91

mg/l

0.09

145

879

Inflammatory disorders of male genital organs, not elsewhere classified

166

1043

1.85

9.30

2.7

2.2

3.24

2.87

mg/l

0.93

154

908

Disorders of purine and pyrimidine metabolism

484

2.47

9.30

3.1

2.1

3.95

3.12

mg/l

1.65

423

Embedded teeth, including avohilmo

1143

9621

1.25

9.29

2.4

2.3

2.42

2.57

mg/l

1.98

1030

8369

Benign neoplasm of urinary organs

616

4903

1.38

9.24

2.5

2.3

2.71

2.89

mg/l

1.11

535

4219

Retinal detachment with retinal break

1625

14115

1.21

9.20

2.4

2.80

2.85

mg/l

0.39

1403

12202

Mantle cell lymphoma

136

830

2.05

9.18

2.1

2.2

2.93

2.73

mg/l

0.52

117

700

Disorder of pancreatic internal secretion, other and/or unspecified

106

600

2.24

9.18

3.4

2.2

2.61

2.92

mg/l

0.61

528

Alzheimer’s disease (undefined)

979

0.37

9.14

2.2

2.5

2.78

3.33

mg/l

1.26

835

Mental and behavioural disorders due to hallucinogens

324

2.63

9.11

2.4

2.1

2.15

2.64

mg/l

1.42

290

Vasomotor rhinitis (mode)

901

7462

1.29

9.11

2.6

2.3

2.91

2.77

mg/l

0.93

777

6490

Thrombotic microangiopathy

516

2.39

9.10

3.7

2.1

3.17

2.83

mg/l

0.69

454

Benign neoplasm: Liver/bile ducts

345

2538

1.53

9.09

2.7

2.2

2.68

2.75

mg/l

0.21

296

2201

Injury of nerves at lower leg level

137

831

1.99

9.09

2.6

2.1

2.60

2.92

mg/l

0.77

123

728

Lifestyle-related condition

163

1039

1.89

9.07

3.8

2.1

3.03

2.94

mg/l

0.20

148

908

Implicit parasitic Sepsis

425

2.58

9.05

3.4

2.0

2.70

2.81

mg/l

0.20

360

Enteritis due to Yersinia enterocolitica

422

2.52

9.01

3.1

2.0

2.64

2.95

mg/l

0.64

369

Gestational [pregnancy-induced] hypertension

3265

29511

1.14

9.01

2.4

2.3

2.76

2.57

mg/l

7.13

2953

25689

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

223

3.38

8.99

3.5

2.1

3.15

2.88

mg/l

0.27

192

Listeriosis

429

2.59

8.93

3.5

2.1

3.97

3.06

mg/l

1.88

358

Foreign body in respiratory tract

637

5096

1.35

8.93

2.4

2.65

2.80

mg/l

1.06

542

4407

Toxic effect of ethanol

453

3456

1.43

8.93

2.7

2.2

2.64

2.68

mg/l

0.13

399

2999

Allergic contact dermatitis due to drugs in contact with skin

286

2049

1.59

8.91

2.6

2.2

2.71

2.83

mg/l

0.40

252

1764

Acute epiglottitis

192

1264

1.75

8.91

2.6

2.0

2.91

2.76

mg/l

0.32

159

1086

Benign neoplasm: Pancreas

373

2803

1.51

8.90

2.9

2.3

3.30

2.93

mg/l

1.51

344

2410

Endometriosis diagnosis and infertility diagnosis occurring together

1310

11216

1.23

8.90

2.4

2.2

2.53

2.58

mg/l

0.41

1131

9831

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

142

870

1.92

8.89

1.9

2.0

2.65

2.49

mg/l

0.49

126

754

Other disorders of peripheral nervous system

549

2.31

8.89

2.6

2.1

2.28

3.11

mg/l

4.23

478

Appendicitis, broad definition

10500

89093

1.07

8.87

2.4

2.3

2.71

2.75

mg/l

1.01

9238

77319

Separation of retinal layers (serosa)

474

3645

1.41

8.87

2.8

2.2

2.68

2.79

mg/l

0.51

411

3123

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

407

2.60

8.86

3.0

2.0

3.87

3.14

mg/l

1.42

355

Diabetes insipidus

128

771

2.03

8.85

2.4

2.0

2.69

2.94

mg/l

0.61

116

674

Malignant neoplasm of anus and anal canal

435

2.52

8.85

2.6

2.2

3.23

2.89

mg/l

0.38

369

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

183

1198

1.78

8.83

2.4

2.1

2.74

2.92

mg/l

0.47

165

1021

Tetraplegia

108

623

2.19

8.83

2.7

2.2

3.09

2.87

mg/l

0.36

545

Thyrotoxicosis with toxic multinodular goitre

786

6462

1.32

8.82

2.6

2.4

2.88

2.93

mg/l

0.25

689

5559

Diseases of appendix

10593

89599

1.07

8.82

2.4

2.3

2.72

2.75

mg/l

0.88

9320

77747

Habitual aborter

257

1792

1.60

8.80

2.3

2.1

2.48

2.47

mg/l

0.02

225

1586

Hypothermia

242

1685

1.65

8.79

2.7

2.3

3.13

2.95

mg/l

0.37

212

1438

Other and unspecified vaccines and biological substances

101

575

2.27

8.76

3.1

2.2

2.77

2.81

mg/l

0.06

506

Certain conditions originating in the perinatal period

1036

7702

1.26

8.75

2.8

2.5

2.56

2.52

mg/l

0.24

909

6723

Pedal cyclist injured in other and unspecified transport accidents

1388

11946

1.22

8.75

2.3

2.69

2.74

mg/l

0.38

1192

10401

Other and unspecified injuries of wrist and hand

488

3781

1.41

8.74

2.4

2.3

2.50

2.67

mg/l

1.25

421

3291

Tooth eruption problems

1895

16075

1.18

8.74

2.6

2.3

2.42

2.51

mg/l

1.47

1686

13996

Secondary polycythaemia

288

2063

1.57

8.74

2.8

2.2

5.00

2.93

mg/l

7.41

248

1777

Sexual dysfunction

214

1441

1.67

8.73

2.2

2.55

2.72

mg/l

0.67

196

1272

Motor disorders, excluding more controls

164

970

1.79

8.71

4.0

3.5

2.56

2.38

mg/l

0.62

149

877

Malignant neoplasm of other and unspecified parts of tongue

191

1270

1.76

8.71

2.3

2.40

2.83

mg/l

2.58

172

1068

Measles

123

723

1.97

8.71

2.7

2.1

2.81

2.74

mg/l

0.17

107

635

Postpartum haemorrhage due to anatomy

1400

12075

1.22

8.71

2.2

2.1

2.72

2.43

mg/l

5.79

1188

10548

Hypoplasia of dental enamel , including avohilmo

457

3379

1.43

8.68

3.8

2.8

2.55

2.46

mg/l

0.44

410

2998

Other acquired deformities of ankle and foot

115

675

2.09

8.67

2.3

2.1

2.77

2.81

mg/l

0.08

563

Use of rasagiline

333

2473

1.54

8.66

2.4

2.3

2.91

2.93

mg/l

0.06

269

2114

Measles, including avohilmo

125

740

1.96

8.65

2.7

2.1

2.81

2.75

mg/l

0.14

109

650

Other/unspecified soft tissue disorders related to use, overuse and pressure

347

2559

1.49

8.63

2.3

2.1

2.61

2.77

mg/l

0.79

304

2195

Other disorders of amniotic fluid and membranes

1708

14408

1.19

8.60

2.3

2.62

2.52

mg/l

1.51

1492

12611

Benign neoplasm: Liver

309

2255

1.55

8.59

2.7

2.2

2.63

2.75

mg/l

0.43

266

1952

Spondylopathies in diseases classified elsewhere

173

1135

1.82

8.55

2.3

2.1

3.42

2.95

mg/l

1.15

158

962

Cardiomyopathy due to drugs and other external agents

169

4.10

8.54

2.3

2.2

2.69

3.07

mg/l

0.45

151

Other specified/unspecified nutritional deficiencies

100

567

2.21

8.54

3.1

2.1

2.62

2.91

mg/l

0.74

497

Exfoliative dermatitis

146

918

1.91

8.53

2.7

2.1

2.81

3.04

mg/l

0.61

127

790

Malignant neoplasm of thyroid gland

789

6479

1.30

8.53

2.5

2.4

2.83

2.71

mg/l

0.74

690

5638

Bicipital tendinitis

537

4216

1.37

8.52

2.4

2.2

2.69

2.80

mg/l

0.58

471

3648

Torsion of ovary, ovarian pedicle and fallopian tube

278

1982

1.56

8.50

2.3

2.2

2.61

2.62

mg/l

0.04

245

1739

Malignant melanoma of skin

1500

13030

1.21

8.48

2.3

2.4

2.85

2.78

mg/l

0.44

1282

11232

Vitamin A deficiency

363

2.64

8.48

4.0

2.0

3.33

2.82

mg/l

1.01

319

Guillain-Barre syndrome

204

1382

1.71

8.48

2.6

2.2

3.09

2.92

mg/l

0.42

166

1186

156

994

1.85

8.47

2.3

2.1

3.11

2.86

mg/l

0.66

137

862

Other and unspecified mononeuropathies of lower limb

347

2585

1.50

8.44

2.5

2.2

2.69

2.87

mg/l

0.94

296

2228

Hereditary deficiency of other clotting factors

131

807

1.99

8.44

3.5

2.1

2.57

2.67

mg/l

0.21

111

712

Benign neoplasm: Tongue

345

2571

1.50

8.43

2.8

2.3

2.65

2.93

mg/l

1.48

297

2215

Traumatic ischaemia of muscle

167

1081

1.80

8.42

2.7

2.1

3.10

2.90

mg/l

0.50

149

933

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

265

1892

1.60

8.41

2.2

2.3

2.77

2.91

mg/l

0.49

224

1634

Ductal carcinoma of pancreas

115

688

2.11

8.41

2.2

2.3

3.03

2.89

mg/l

0.25

107

583

Other lesions of median nerve

362

2723

1.49

8.41

2.8

2.3

2.94

2.99

mg/l

0.17

314

2324

Other specified disorders of muscle

345

2556

1.49

8.40

2.9

2.2

2.53

2.87

mg/l

2.43

313

2185

Cutaneous lupus erythematosus

303

2213

1.55

8.40

2.8

2.2

2.94

2.89

mg/l

0.11

267

1897

Flatulence and related conditions

143

895

1.90

8.40

3.0

2.1

2.72

2.77

mg/l

0.14

127

760

Muscle strain

394

2975

1.44

8.37

2.5

2.1

2.66

2.74

mg/l

0.32

343

2547

Hypertrophy of tongue papillae

185

1234

1.76

8.37

2.3

2.2

2.87

2.94

mg/l

0.13

161

1080

Malignant neoplasm of ureter, including Hilmo

128

792

2.04

8.36

2.4

2.3

2.81

2.85

mg/l

0.07

112

671

Nutritional marasmus

179

4.11

8.36

2.9

2.1

2.72

2.73

mg/l

0.01

162

Other and unspecified intracranial injuries

385

2912

1.46

8.35

2.6

2.3

2.73

2.85

mg/l

0.54

339

2500

Malignant neoplasm of floor of mouth, including Hilmo

115

685

2.07

8.33

2.6

2.2

2.79

2.88

mg/l

0.16

102

576

Other and unspecified acute skin changes due to ultraviolet radiation

319

2355

1.53

8.33

2.8

2.3

2.85

2.99

mg/l

0.42

273

1998

Carcinoma in situ of skin, other sites/unspecified

239

1704

1.68

8.31

2.6

2.4

3.13

3.03

mg/l

0.25

213

1448

Nonspecific lymphadenitis

667

5387

1.32

8.31

2.5

2.2

2.54

2.66

mg/l

0.92

585

4711

Disorders in reading

204

1381

1.68

8.29

2.7

2.9

2.52

2.46

mg/l

0.14

182

1224

Mental retardation

460

3529

1.41

8.29

2.6

2.8

2.82

2.62

mg/l

1.29

416

3131

Early lumbar disc prolapse operation

1115

9437

1.23

8.28

2.2

2.56

2.57

mg/l

0.05

990

8332

Superficial injury of neck

251

1769

1.59

8.27

2.2

2.79

2.68

mg/l

0.23

218

1554

Allergic colitis

280

2010

1.55

8.27

3.5

2.0

2.63

2.49

mg/l

0.65

254

1756

Multifocal fibrosclerosis

567

2.28

8.25

2.7

2.2

3.17

3.15

mg/l

0.03

487

Haemorrhagic disorder due to circulating anticoagulants

210

1457

1.72

8.25

3.5

2.4

3.68

3.12

mg/l

1.63

183

1241

Traction detachment of retina

117

702

2.04

8.24

2.9

2.1

3.15

2.99

mg/l

0.25

105

611

Tic disorders

167

1085

1.78

8.24

2.9

2.7

2.56

2.57

mg/l

0.02

146

941

Ectopic pregnancy

2030

18005

1.17

8.21

2.4

2.3

2.65

2.66

mg/l

0.06

1768

15765

Varicella [chickenpox], including avohilmo

583

4638

1.34

8.20

2.7

2.4

2.81

2.62

mg/l

1.23

525

4073

Osteomyelitis of vertebra

267

3.00

8.15

3.4

2.0

3.17

2.90

mg/l

0.34

230

Injury of nerves and spinal cord at neck level

276

1994

1.56

8.14

2.5

2.2

2.71

2.92

mg/l

0.59

239

1722

Amblyopia ex anopsia

520

4110

1.38

8.13

2.4

2.6

2.77

2.72

mg/l

0.17

445

3578

Malignant neoplasm of bone and articular cartilage, including Hilmo

230

1606

1.63

8.11

2.4

3.02

2.77

mg/l

0.75

204

1375

Benign neoplasm of middle ear and respiratory system

953

8022

1.26

8.10

2.6

2.3

2.88

2.85

mg/l

0.15

841

6939

Coarctation of the aorta

136

850

1.91

8.10

2.6

2.9

2.78

2.70

mg/l

0.19

125

751

Polyarteritis nodosa and related conditions

182

1218

1.74

8.09

3.3

2.2

2.98

2.94

mg/l

0.09

169

1053

Marfan's syndrome

387

2.46

8.09

2.7

2.1

2.71

2.69

mg/l

0.02

347

Maze procedure for atrial fibrillation

396

2.61

8.08

3.0

2.1

2.91

3.06

mg/l

0.20

344

Localized scleroderma [morphea]

192

1301

1.72

8.07

2.6

2.2

2.83

2.92

mg/l

0.19

169

1107

Other disorders of bone density and structure

316

2330

1.51

8.07

2.6

2.2

2.69

2.78

mg/l

0.35

268

2007

Other and unspecified disorders of adult personality and behaviour

452

2.32

8.05

2.4

1.9

2.68

2.61

mg/l

0.11

397

Other articular cartilage disorders

271

1945

1.55

8.04

2.5

2.1

2.95

2.76

mg/l

0.54

241

1627

Congenital malformations of the nervous system

277

2005

1.55

7.95

2.5

2.87

2.60

mg/l

1.06

243

1761

Polyhydramnios

581

4657

1.34

7.95

2.5

2.2

2.58

2.52

mg/l

0.37

525

4069

Intermittent heterotropia

723

5922

1.30

7.94

2.4

2.5

2.72

2.61

mg/l

0.59

622

5191

Tetralogy of Fallot, a congenital heart defect.

302

2.75

7.94

2.8

3.4

3.45

2.50

mg/l

0.73

274

Idiopathic urticaria

286

2086

1.54

7.94

2.4

2.1

2.43

2.77

mg/l

2.43

249

1796

Malignant neoplasm of adrenal gland, including Hilmo

104

612

2.11

7.92

2.4

2.3

2.84

2.78

mg/l

0.10

529

All dysplastic lesions of the vulva

522

4146

1.37

7.90

2.6

2.3

2.98

2.78

mg/l

0.88

463

3600

Dislocation, sprain and strain of joints and ligaments of head

493

3875

1.37

7.88

2.5

2.3

2.98

2.65

mg/l

1.98

430

3400

Liver disorders in diseases classified elsewhere

216

3.15

7.88

2.5

2.1

2.31

2.76

mg/l

0.93

195

Malignant neoplasm of pancreas, including Hilmo

1085

9254

1.24

7.87

2.3

2.5

3.02

2.83

mg/l

1.48

959

7917

Subacute thyroiditis

434

3362

1.41

7.87

2.3

2.48

2.81

mg/l

2.99

377

2928

Pedal cyclist injured in transport accident

2807

25408

1.14

7.85

2.3

2.4

2.70

2.72

mg/l

0.22

2425

22181

Exposure to other and unspecified forces of nature

571

2.18

7.85

2.3

2.1

2.85

2.78

mg/l

0.06

507

Disorders of plasma-protein metabolism, not elsewhere classified

536

2.17

7.84

2.9

2.0

3.27

2.97

mg/l

0.45

467

Congenital malformations of trachea and bronchus

139

891

1.91

7.81

3.2

2.2

2.97

2.95

mg/l

0.01

126

775

Drug-induced polyneuropathy

127

797

1.98

7.80

2.6

2.72

2.94

mg/l

0.33

116

689

Small cell lung cancer

154

2344

0.60

7.79

2.5

2.3

3.27

2.85

mg/l

1.64

137

1980

Small cell lung cancer, including Hilmo

154

2344

0.60

7.79

2.5

2.3

3.27

2.85

mg/l

1.64

137

1980

Congenital malformations of the respiratory system

223

1567

1.63

7.77

2.9

2.6

2.77

2.83

mg/l

0.09

199

1368

Deep endometriosis

1228

10609

1.23

7.77

2.5

2.3

2.80

2.74

mg/l

0.46

1061

9213

Other disorders of binocular movement

288

2111

1.53

7.77

2.6

2.2

2.41

2.69

mg/l

1.37

262

1832

Other injuries of spine and trunk, level unspecified

123

760

1.95

7.72

3.0

2.1

2.76

2.74

mg/l

0.04

107

664

Viral encephalitis, not elsewhere classified/unspecified

256

1846

1.57

7.71

2.3

2.80

2.92

mg/l

0.39

216

1598

Disorders of optic nerve, not elsewhere classified

272

1989

1.56

7.69

2.5

2.3

2.99

2.96

mg/l

0.08

247

1713

Mental retardation, wide definition

484

3779

1.37

7.68

2.6

2.8

2.84

2.66

mg/l

1.06

437

3334

Polyarteritis nodosa

565

2.14

7.67

3.3

2.2

3.09

3.00

mg/l

0.13

488

Fourth [trochlear] nerve palsy

290

2143

1.54

7.67

2.5

2.3

3.12

2.93

mg/l

0.62

265

1836

Acute nephritic syndrome

251

1802

1.57

7.65

3.0

2.3

2.85

2.89

mg/l

0.07

229

1548

Vestibular neuronitis

1078

9219

1.24

7.64

2.5

2.4

2.80

2.85

mg/l

0.33

917

7983

Other disorders of choroid

192

1317

1.69

7.62

2.7

2.2

2.80

3.06

mg/l

0.66

166

1125

Burn and corrosion of trunk

361

2743

1.45

7.62

2.4

2.3

2.74

2.82

mg/l

0.32

318

2374

Periodontal disease, other/unspecified

330

2475

1.47

7.58

2.4

2.3

2.39

2.82

mg/l

4.75

291

2144

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

110

665

2.02

7.57

3.0

2.2

2.71

2.83

mg/l

0.21

100

584

Preterm labour and delivery

2965

26963

1.13

7.56

2.3

2.83

2.63

mg/l

4.81

2584

23553

Haemangioma, any site

1047

8939

1.24

7.56

2.9

2.3

2.88

2.77

mg/l

0.64

923

7763

Generalized epilepsy

497

3935

1.36

7.55

2.3

2.4

2.63

2.66

mg/l

0.13

422

3438

Other and unspecified injuries of thorax

227

1602

1.60

7.55

2.6

2.1

2.93

2.82

mg/l

0.26

197

1380

Disorders of eyelid in diseases classified elsewhere

398

3071

1.42

7.55

2.5

2.2

3.05

2.87

mg/l

0.51

352

2620

All dysplastic lesions of the cervix uteri, vagina or vulva

3814

34230

1.12

7.53

2.3

2.57

2.61

mg/l

0.58

3313

29959

Pulmonary eosinophilia, not elsewhere classified

161

1072

1.78

7.52

2.9

2.2

2.88

3.01

mg/l

0.31

143

920

Assault by sharp object

175

1162

1.67

7.51

2.1

2.78

2.67

mg/l

0.25

154

1024

Perforation of oesophagus

423

2.37

7.50

2.9

2.0

2.91

2.99

mg/l

0.12

364

Contusion of toe(s) without damage to nail

336

2531

1.46

7.49

2.7

2.2

2.42

2.66

mg/l

1.77

301

2218

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

327

2446

1.46

7.48

2.2

2.73

2.67

mg/l

0.18

292

2137

Other primary thrombocytopenia

355

2.60

7.46

3.6

1.9

2.98

2.82

mg/l

0.22

308

Chalazion

1398

12195

1.20

7.43

2.3

2.72

2.77

mg/l

0.37

1206

10621

Papillary adenocarcinoma of thyroid gland

596

4832

1.32

7.39

2.5

2.4

2.80

2.71

mg/l

0.42

521

4195

Non-small cell lung cancer, squamous, helper endpoint

424

5404

0.74

7.37

2.3

2.4

3.21

3.02

mg/l

0.66

374

4590

Varicella [chickenpox]

485

3827

1.36

7.37

2.8

2.3

2.86

2.65

mg/l

1.22

437

3371

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

581

4688

1.32

7.34

2.7

2.3

2.81

2.76

mg/l

0.23

515

4094

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

379

2.51

7.33

2.3

3.12

3.00

mg/l

0.17

336

Personality and behavioural disorders due to brain disease, damage and dysfunction

180

1222

1.68

7.32

2.4

2.3

2.67

2.94

mg/l

0.91

150

1052

Other papulosquamous disorders

158

1053

1.77

7.30

2.9

2.1

2.84

2.86

mg/l

0.03

139

900

Malignant neoplasm of adrenal gland

361

2.47

7.29

2.3

2.58

2.63

mg/l

0.07

311

Unspecified human immunodeficiency virus [HIV] disease

110

663

1.93

7.28

2.3

2.1

2.47

2.89

mg/l

1.21

101

587

Haemangioma and lymphangioma, any site

1117

9615

1.22

7.27

2.9

2.4

2.88

2.76

mg/l

0.76

990

8353

Assault by other specified means

123

765

1.87

7.26

2.1

2.74

2.66

mg/l

0.13

101

665

Universal erythroderma, KELA reimbursement

170

1145

1.71

7.26

2.6

2.1

3.34

2.91

mg/l

1.28

139

1003

Hypoplasia of dental enamel, prenatal

180

3.91

7.24

5.3

4.7

2.99

2.24

mg/l

1.62

168

Inflammatory disorders of breast

827

6949

1.27

7.23

2.3

2.2

2.53

2.62

mg/l

0.72

733

6012

Scleritis

169

1140

1.71

7.22

2.9

2.2

2.60

2.92

mg/l

1.17

157

988

Malignant neoplasm of mesothelium and soft tissue

492

3924

1.36

7.22

2.2

2.4

2.84

2.79

mg/l

0.20

421

3342

Contact with heat and hot substances

637

5214

1.30

7.20

2.5

2.3

2.60

2.72

mg/l

0.77

543

4518

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

494

2.20

7.20

3.2

2.1

2.91

2.89

mg/l

0.03

435

Other disorders of prostate

416

3244

1.39

7.20

2.6

2.3

2.73

2.92

mg/l

1.06

381

2812

Other disorders of Eustachian tube

379

2928

1.42

7.20

2.8

2.2

2.46

2.82

mg/l

3.66

340

2520

Ventricular septal defect, a heart condition

282

2085

1.51

7.16

3.1

2.8

3.01

2.57

mg/l

1.19

252

1842

Other and unspecified nonscarring hair loss

124

789

1.92

7.15

2.7

2.1

2.64

2.70

mg/l

0.08

111

674

Nontoxic single thyroid nodule

854

7199

1.26

7.15

2.4

2.3

2.78

2.83

mg/l

0.33

746

6239

Acute nasopharyngitis (common cold)

1175

10023

1.20

7.13

2.5

2.2

2.68

2.67

mg/l

0.04

1031

8779

Necrobiosis lipoidica, not elsewhere classified

481

2.20

7.10

3.4

2.1

2.77

2.70

mg/l

0.12

414

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

115

706

1.88

7.10

2.3

2.1

2.45

2.86

mg/l

1.26

105

625

Aphakia

178

1205

1.65

7.07

2.5

2.1

2.75

3.00

mg/l

0.77

154

1020

Fasciculation

153

1016

1.75

7.06

2.2

2.1

2.24

2.70

mg/l

3.57

128

894

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

947

8072

1.24

7.03

2.6

2.3

2.92

2.79

mg/l

0.81

800

6996

Intracerebral haemorrhage

1719

15280

1.17

7.02

2.4

3.15

2.99

mg/l

1.31

1463

13018

Sequelae of other and unspecified infectious and parasitic diseases

574

4650

1.31

7.02

2.7

2.3

2.82

2.76

mg/l

0.27

508

4059

Arnold-Chiari syndrome

128

822

1.87

7.01

2.3

2.78

2.57

mg/l

0.60

110

718

Melanocytic naevi, other sites/unspecified

1022

8761

1.23

6.99

2.5

2.3

2.76

2.72

mg/l

0.34

929

7620

Other congenital malformations of skin

477

3802

1.36

6.99

2.8

2.3

2.56

2.74

mg/l

0.81

416

3292

Malignant neoplasm of tonsil and base of tongue

235

1694

1.55

6.98

2.2

2.3

2.59

2.80

mg/l

0.73

197

1455

Malignant neoplasm of thymus

261

2.72

6.96

2.0

2.79

2.64

mg/l

0.17

223

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

423

3321

1.38

6.96

2.7

2.2

2.35

2.71

mg/l

3.13

373

2886

Other and unspecified injuries of forearm

108

662

1.95

6.96

2.3

2.1

3.64

2.78

mg/l

1.54

572

Eustachian salpingitis and obstruction

888

7503

1.24

6.95

2.4

2.3

2.57

2.65

mg/l

0.71

766

6584

Other congenital malformations of integument, including avohilmo

272

2.80

6.95

2.8

2.1

2.71

2.76

mg/l

0.05

238

Tuberculosis, IBD comorbidity

887

7528

1.25

6.93

2.8

2.4

2.91

2.97

mg/l

0.34

771

6418

Social disorders starting during childhood or adolecense, excluding more controls

558

2.00

6.93

3.1

2.61

2.29

mg/l

0.89

489

Drug-induced tremor

585

2.07

6.93

2.5

2.2

2.95

2.98

mg/l

0.04

510

Disorders of porphyrin and bilirubin metabolism

139

904

1.78

6.92

3.2

2.2

3.21

2.95

mg/l

0.36

124

783

Biliary cirrhosis, NAS

291

2.87

6.91

3.8

2.3

5.38

3.01

mg/l

1.42

255

Pyogenic granuloma

224

1607

1.57

6.90

2.8

2.3

2.86

2.80

mg/l

0.14

205

1383

Injury of urinary and pelvic organs

248

1807

1.53

6.89

2.5

2.2

3.28

2.81

mg/l

1.39

213

1566

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

335

2569

1.45

6.88

1.9

2.5

2.62

2.86

mg/l

1.13

284

2200

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

473

3779

1.36

6.87

2.7

2.3

2.86

2.88

mg/l

0.04

416

3257

Nontraumatic intracranial haemmorrhage

2716

24754

1.13

6.87

2.5

2.4

3.17

2.95

mg/l

3.56

2339

21219

Brain meningioma, including Hilmo

605

4960

1.31

6.85

2.4

2.82

2.79

mg/l

0.13

524

4268

Other facial nerve disorders

345

2647

1.43

6.84

2.5

2.2

2.70

2.84

mg/l

0.61

290

2273

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1601

14185

1.18

6.81

2.4

2.73

2.80

mg/l

0.66

1411

12330

Malignant neoplasm of ovary, including Hilmo

745

6241

1.27

6.79

2.1

2.5

2.97

2.79

mg/l

1.01

654

5418

Benign lipomatous neoplasm of other sites/unspecified

1068

9225

1.22

6.79

2.5

2.4

2.85

2.90

mg/l

0.27

917

7977

Myasthenia gravis

221

1596

1.59

6.78

2.6

2.2

3.00

2.91

mg/l

0.23

190

1366

Other bursitis of knee

167

1133

1.67

6.77

2.6

2.1

2.46

2.88

mg/l

2.18

148

979

Disorders of adrenal gland, other and/or unspecified

429

2.25

6.75

3.2

2.1

2.80

2.86

mg/l

0.09

372

Other and unspecified degenerative diseases of nervous system

371

2899

1.42

6.75

2.3

2.4

2.65

3.03

mg/l

2.39

311

2474

Malignant neoplasm of tonsil

177

1221

1.65

6.74

2.1

2.2

2.48

2.76

mg/l

0.94

149

1047

Tic and related disorders

174

1196

1.66

6.74

2.8

2.6

2.57

2.61

mg/l

0.10

152

1043

Benign leiomyoma with endometriosis

1930

17328

1.16

6.73

2.5

2.4

2.91

2.88

mg/l

0.21

1624

15048

Spasmodic torticollis

378

2947

1.40

6.71

2.6

2.3

2.86

2.83

mg/l

0.10

325

2558

Conductive hearing loss, unspecified

1001

8597

1.23

6.71

2.5

2.4

2.76

2.74

mg/l

0.08

878

7462

Other deformity of hallux (acquired)

108

672

1.94

6.71

2.6

2.1

2.63

2.94

mg/l

0.96

558

Respiratory tuberculosis, confirmed, including avohilmo

236

1718

1.54

6.69

3.0

2.3

2.83

3.03

mg/l

0.66

207

1481

Pedestrian injured in collision with pedal cycle

363

2812

1.41

6.68

2.4

2.2

2.52

2.87

mg/l

2.43

326

2421

Epileptic seizures related to drugs

196

2.91

6.68

2.4

2.0

3.16

2.92

mg/l

0.32

167

Torticollis

194

1357

1.59

6.67

2.5

2.1

2.60

2.79

mg/l

0.56

168

1163

Other and unspecified injuries of neck

117

741

1.87

6.67

2.3

2.1

2.45

2.63

mg/l

0.57

104

649

Other disorders of carbohydrate metabolism

341

2.38

6.67

2.3

3.03

3.01

mg/l

0.03

300

Ankylosing hyperostosis [Forestier]

169

1161

1.68

6.66

2.9

2.1

2.95

2.94

mg/l

0.02

152

981

Poisoning by medicine, drug-induced

155

1043

1.70

6.65

2.7

2.1

2.85

2.90

mg/l

0.10

134

903

Malignant neoplasm of corpus uteri, including Hilmo

1142

9931

1.21

6.65

2.4

2.5

3.15

2.88

mg/l

2.91

976

8582

Benign neoplasm: Parathyroid gland

148

997

1.76

6.64

3.7

2.2

2.43

3.12

mg/l

4.40

133

863

Serous carcinoma of ovary, including Hilmo

394

3097

1.39

6.63

2.1

2.5

2.80

2.84

mg/l

0.13

351

2666

Brain meningioma

585

4797

1.31

6.63

2.4

2.78

mg/l

0.00

506

4121

Malignant neoplasm of tonsil and base of tongue, including Hilmo

271

2016

1.49

6.63

2.2

2.3

2.79

2.78

mg/l

0.01

232

1725

Severe combined immunodeficiency [SCID] with reticular dysgenesis

242

2.86

6.62

3.6

2.1

3.30

2.93

mg/l

0.50

219

Calculus of lower urinary tract

667

5557

1.29

6.62

2.4

3.15

2.90

mg/l

1.27

570

4791

Other and unspecified disorders of psychological development

143

915

1.74

6.61

2.9

3.2

2.83

2.48

mg/l

0.56

131

825

Mild mental retardation

293

2205

1.46

6.60

2.6

2.70

2.68

mg/l

0.07

269

1937

Normotensive glaucoma

1165

10178

1.21

6.60

2.5

2.68

2.98

mg/l

5.24

977

8709

Hypersensitivity angiitis

436

2.27

6.58

2.7

2.1

2.58

2.99

mg/l

1.12

378

Other lack of coordination

220

1594

1.57

6.58

2.6

2.3

2.98

2.92

mg/l

0.13

200

1363

Other disorders of binocular vision

168

1154

1.67

6.57

2.6

2.1

2.19

2.66

mg/l

2.65

157

994

Benign neoplasm: Larynx

372

2903

1.40

6.57

2.5

2.3

2.86

2.92

mg/l

0.14

333

2495

Congenital aortic valve stenosis

358

2.33

6.55

2.7

3.1

3.33

2.59

mg/l

1.37

317

Ulcer of vagina/vulva

373

2921

1.41

6.55

2.5

2.2

2.71

2.70

mg/l

0.03

335

2503

Localized adiposity

395

2.26

6.53

3.3

2.1

3.23

2.87

mg/l

0.35

339

Autoimmune thyroiditis

233

1699

1.53

6.52

2.3

2.2

2.38

2.70

mg/l

1.73

197

1469

Polymyositis

108

677

1.92

6.52

2.7

2.1

2.73

2.99

mg/l

0.65

582

Acute alcohol intoxication ICD-9

377

2942

1.39

6.50

2.6

2.3

3.00

2.86

mg/l

0.46

336

2520

Other congenital malformations of peripheral vascular system

174

1206

1.64

6.50

4.0

2.3

2.82

2.69

mg/l

0.18

157

1047

Malignant neoplasm of thymus, including Hilmo

324

2.42

6.48

1.9

2.0

2.99

2.74

mg/l

0.32

276

Paget disease

464

2.24

6.45

2.5

2.1

2.92

2.75

mg/l

0.30

411

Other vitreous opacities

518

4217

1.33

6.44

2.5

2.3

2.80

2.84

mg/l

0.12

444

3624

Other congenital malformations of nervous system

137

911

1.77

6.43

2.5

2.3

2.85

2.60

mg/l

0.78

118

789

Malignant neoplasm of oropharynx

193

1367

1.59

6.41

2.1

2.3

2.43

2.80

mg/l

1.54

164

1177

Other disorders of central nervous system

157

1071

1.68

6.39

3.2

2.3

2.91

2.85

mg/l

0.11

132

937

Malignant neoplasm of breast, HER2-negative, including Hilmo

5411

32456

1.09

6.37

2.2

2.4

2.82

2.75

mg/l

1.30

4639

28190

Malignant neoplasm of breast, including Hilmo

5411

32453

1.09

6.37

2.2

2.4

2.82

2.75

mg/l

1.30

4639

28188

Other superficial mycoses

268

2001

1.47

6.35

2.6

2.2

2.74

2.72

mg/l

0.04

236

1737

Other disorders of amino-acid metabolism

386

2.28

6.35

3.6

2.0

3.77

2.94

mg/l

1.57

345

Other corneal oedema

121

791

1.86

6.34

2.6

2.2

3.04

3.09

mg/l

0.07

105

678

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.87

6.34

4.8

2.2

2.67

2.57

mg/l

0.08

Other and unspecified corneal deformities and disorders

374

2931

1.38

6.30

2.7

2.2

2.68

2.87

mg/l

0.90

336

2537

Follicular lymphoma, hilmo

516

4218

1.33

6.30

2.3

2.95

2.92

mg/l

0.11

462

3615

Sequelae of infectious and parasitic diseases, including avohilmo

878

7494

1.23

6.29

2.7

2.3

2.91

2.84

mg/l

0.40

777

6464

Foreign body entering into or through eye or natural orifice

903

7727

1.23

6.26

2.4

2.3

2.57

2.76

mg/l

2.01

769

6714

Other disorders of male genital organs

392

3072

1.36

6.25

2.4

2.3

2.50

2.80

mg/l

2.98

342

2700

Toxic colitis

289

2.57

6.25

2.6

2.1

2.88

2.71

mg/l

0.24

256

Hyperaldosteronism

343

2673

1.41

6.25

2.7

2.2

2.74

2.92

mg/l

0.78

296

2300

Benign neoplasm: Parotid gland

949

8181

1.23

6.23

2.4

2.3

2.92

2.84

mg/l

0.47

806

7084

Severe visual impairment, monocular

140

944

1.75

6.22

2.9

2.3

3.23

3.10

mg/l

0.20

115

820

Other specified and unspecified disorders of eyelid

181

1279

1.62

6.22

2.5

2.2

2.55

2.97

mg/l

1.46

160

1107

Other disorders of pigmentation

558

4592

1.30

6.21

2.7

2.3

2.69

2.83

mg/l

0.59

488

3937

Drug-induced dystonia

231

2.70

6.21

2.6

1.9

2.97

2.74

mg/l

0.33

205

Androgenic alopecia

128

847

1.79

6.20

2.5

2.1

2.70

2.82

mg/l

0.19

117

726

Injury of nerves and spinal cord at thorax level

378

2.22

6.20

2.6

2.1

3.20

2.94

mg/l

0.39

329

Single delivery by caesarean section

2363

12221

1.14

6.19

2.2

2.4

2.53

2.58

mg/l

0.63

2076

10693

Malignant neoplasm of oropharynx, including Hilmo

237

1749

1.51

6.19

2.2

2.3

2.47

2.80

mg/l

1.67

207

1498

Other congenital malformations, not elsewhere classified

110

700

1.86

6.19

2.8

2.6

2.62

2.64

mg/l

0.02

608

Contracture of joint

148

999

1.68

6.18

2.5

2.0

2.85

2.82

mg/l

0.04

132

836

Other specific arthropathies, wide

239

1759

1.49

6.18

2.6

2.1

3.03

2.81

mg/l

0.85

215

1477

Alzheimer’s disease (undefined), excluding more controls

815

0.44

6.16

2.2

2.4

2.78

3.38

mg/l

1.41

662

Malignant neoplasm of other connective and soft tissue

305

2342

1.44

6.15

2.3

2.81

2.82

mg/l

0.02

258

1993

Persons encountering health services in circumstances related to reproduction

6839

43240

1.08

6.15

2.3

2.4

2.58

2.70

mg/l

4.93

6027

37874

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

151

1032

1.69

6.14

2.4

2.3

3.01

2.81

mg/l

0.38

132

882

Tuberculosis, wide, including avohilmo

925

7963

1.22

6.13

2.7

2.4

2.90

2.97

mg/l

0.40

805

6790

Abscess of Bartholin gland

340

2649

1.40

6.11

2.9

2.1

2.70

2.66

mg/l

0.13

304

2301

Pemphigus

606

1.97

6.11

3.0

2.0

2.53

2.96

mg/l

1.49

521

Viral agents as the cause of diseases classified to other chapters, including avohilmo

307

2361

1.43

6.10

2.5

2.3

2.63

2.78

mg/l

0.63

271

2061

Unspecified dementia

1605

12847

1.16

6.08

2.5

3.34

3.18

mg/l

1.30

1338

10943

Contusion of ankle

483

3913

1.32

6.06

2.5

2.3

2.63

2.69

mg/l

0.27

416

3418

Respiratory tuberculosis, confirmed

228

1681

1.51

6.02

3.1

2.3

2.83

3.05

mg/l

0.71

200

1446

Other and unspecified diseases of spleen

349

2.32

6.02

3.0

2.1

4.00

2.82

mg/l

2.28

306

Respiratory conditions due to other external agents

262

1984

1.48

6.00

2.9

2.3

3.17

2.99

mg/l

0.57

242

1680

Routine general health check-up of defined subpopulation

225

1636

1.48

5.99

2.0

2.67

2.61

mg/l

0.20

202

1415

Sequelae of infectious and parasitic diseases

851

7276

1.23

5.99

2.7

2.3

2.90

2.83

mg/l

0.42

751

6278

Erythema multiforme

278

2116

1.45

5.97

2.5

2.2

2.76

2.91

mg/l

0.55

241

1811

Mixed disorders of conduct and emotions

280

2123

1.44

5.96

2.4

2.68

2.37

mg/l

1.31

249

1865

Struck by thrown, projected or falling objec

589

4876

1.28

5.95

2.4

2.3

2.68

2.72

mg/l

0.18

528

4220

Oral leukoplakia, including avohilmo

323

2510

1.41

5.94

2.3

2.2

2.77

2.94

mg/l

0.51

272

2167

Malignant neoplasm of tonsil, including Hilmo

195

1403

1.56

5.94

2.1

2.3

2.50

2.77

mg/l

1.00

167

1204

Unspecified multiple injuries

249

2.57

5.93

2.1

2.3

2.47

2.71

mg/l

0.38

215

Convergence insufficiency and excess

174

1231

1.60

5.90

2.3

2.1

2.09

2.61

mg/l

4.05

160

1067

Migraine, unspecified, drug-induced

569

1.95

5.90

2.5

2.1

2.84

2.73

mg/l

0.17

487

Benign neoplasm: salivary glands, exclude unknown (D119)

1047

9129

1.21

5.89

2.4

2.3

2.90

2.84

mg/l

0.33

891

7888

Open wound of thorax

171

1199

1.59

5.88

2.5

2.1

2.83

2.84

mg/l

0.02

152

1045

Impacted teeth

2559

20058

1.12

5.86

2.3

2.59

2.50

mg/l

1.53

2284

17403

Burn and corrosion of ankle and foot

170

1198

1.60

5.84

2.5

2.3

3.32

2.90

mg/l

1.19

143

1050

Benign neoplasm of major salivary glands

1174

10323

1.19

5.83

2.4

2.95

2.85

mg/l

0.75

1004

8931

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

213

1565

1.53

5.83

2.3

3.08

2.86

mg/l

0.66

187

1328

Dermatitis due to ingested food

418

3198

1.34

5.82

3.1

2.7

2.37

2.50

mg/l

0.90

370

2837

Abscess of external ear

161

1122

1.62

5.82

2.8

2.2

2.69

2.90

mg/l

0.56

142

958

Other inflammation of vagina/vulva

471

3835

1.32

5.80

2.3

2.2

2.41

2.62

mg/l

1.86

403

3355

Mental and behavioural disorders associated with the puerperium

142

969

1.68

5.80

1.9

2.1

2.65

2.56

mg/l

0.21

126

843

Respiratory tuberculosis, bacteriologically and histologically confirmed

234

1743

1.49

5.79

3.0

2.3

2.83

3.06

mg/l

0.75

205

1496

Other acquired deformities of musculoskeletal system and connective tissue

499

4082

1.30

5.78

2.6

2.3

2.72

2.84

mg/l

0.60

433

3520

Disorders of lacrimal system and orbit in diseases classified elsewhere

290

2229

1.43

5.78

2.7

2.2

2.47

2.86

mg/l

3.00

259

1917

Contact with sharp object, undetermined intent

273

2073

1.43

5.77

2.4

2.1

2.32

2.71

mg/l

3.56

239

1808

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

260

1972

1.46

5.76

2.6

2.4

3.28

2.83

mg/l

1.15

236

1681

Psoas tendinitis

448

2.06

5.76

2.6

2.1

2.51

2.93

mg/l

1.33

372

Venous complications and haemorrhoids in pregnancy

219

1614

1.50

5.76

2.3

2.2

2.21

2.46

mg/l

1.62

191

1414

128

856

1.72

5.76

2.3

2.2

2.73

2.61

mg/l

0.24

115

743

Thyrotoxicosis factitia

277

2.54

5.74

2.7

2.1

2.81

2.92

mg/l

0.14

232

Tuberculosis, wide

910

7867

1.22

5.74

2.8

2.4

2.90

2.97

mg/l

0.41

792

6704

Sequelae of malnutrition and other nutritional deficiencies

180

3.03

5.73

3.6

2.2

2.62

2.77

mg/l

0.18

156

Unspecified chronic bronchitis

424

3410

1.33

5.72

2.8

2.2

2.82

2.88

mg/l

0.22

373

2892

Chronic suppurative otitis media, including avohilmo

950

8239

1.21

5.71

2.5

2.4

2.68

2.74

mg/l

0.43

810

7142

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

169

1203

1.62

5.70

3.6

2.1

3.02

2.91

mg/l

0.23

151

1037

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

209

1540

1.53

5.70

2.3

2.58

2.88

mg/l

1.24

182

1308

Phantom limb syndrome with pain

191

2.80

5.69

3.9

2.2

3.46

2.86

mg/l

0.53

163

Type1 diabetes, definitions combined, early onset

682

5712

1.25

5.69

2.5

2.6

2.51

2.48

mg/l

0.16

596

5074

Spinal enthesopathy

350

2737

1.36

5.68

2.4

2.3

3.19

3.16

mg/l

0.06

307

2279

Effects of heat and light

103

661

1.85

5.67

2.7

2.2

2.79

mg/l

0.00

576

Epiphora

284

2191

1.44

5.67

2.5

2.2

2.80

2.96

mg/l

0.54

240

1869

Other bacterial agents as the cause of diseases classified to other chapters

140

965

1.70

5.65

3.8

2.1

3.21

2.93

mg/l

0.57

124

835

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

999

8703

1.20

5.64

2.6

2.3

2.83

2.70

mg/l

0.92

912

7505

Lesion of femoral nerve

101

647

1.86

5.63

2.1

2.0

2.62

2.76

mg/l

0.41

560

Colorectal neuroendocrine tumor and carcinoma

172

1226

1.59

5.61

2.7

2.2

2.96

2.72

mg/l

0.75

155

1045

Congenital stenosis of pulmonary valve

560

1.92

5.59

3.8

2.8

3.19

2.59

mg/l

0.72

492

Brain glioblastoma, helper endpoint

1278

0.55

5.59

1.6

2.2

3.13

2.98

mg/l

0.16

1107

Exposure to sunlight

217

2.79

5.57

3.2

2.4

3.51

2.86

mg/l

0.68

190

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

423

3413

1.33

5.57

2.8

2.4

2.64

2.56

mg/l

0.37

375

3001

Benign neoplasm: Bladder

132

904

1.73

5.57

2.6

2.2

2.75

3.03

mg/l

0.80

114

776

Intercostal neuropathy

103

665

1.84

5.55

2.8

2.1

2.70

2.90

mg/l

0.50

564

Nystagmus and other irregular eye movements

179

1290

1.57

5.53

2.4

2.3

3.19

2.76

mg/l

0.74

155

1128

Malignant neoplasm of breast

5279

32012

1.08

5.51

2.2

2.4

2.84

2.75

mg/l

1.81

4522

27802

Deep bite

1358

10588

1.17

5.50

2.7

2.5

2.60

2.65

mg/l

0.29

1202

9269

Pervasive developmental disorders excl. Autism + Asperger

161

1119

1.59

5.50

2.3

3.3

2.15

2.49

mg/l

1.72

142

1005

Alpha thalassaemia

116

4.32

5.49

3.0

2.2

3.83

2.47

mg/l

1.40

107

Malignant neoplasm of breast, HER2-negative

5271

31974

1.08

5.49

2.2

2.4

2.84

2.75

mg/l

1.82

4514

27767

Migraine without aura, drug-induced

134

914

1.67

5.48

2.6

2.0

2.62

2.85

mg/l

0.70

125

784

Perioral dermatitis

293

2274

1.41

5.47

2.7

2.1

2.69

2.64

mg/l

0.14

250

1970

Phantom limb syndrome

209

2.69

5.46

4.1

2.0

3.44

3.00

mg/l

0.37

179

Viral agents as the cause of diseases classified to other chapters

264

2023

1.44

5.46

2.6

2.3

2.63

2.80

mg/l

0.63

239

1774

Other congenital malformations of urinary system

417

2.07

5.46

2.7

2.5

2.73

2.79

mg/l

0.07

373

Male infertility

342

2665

1.34

5.45

2.4

2.2

2.89

2.68

mg/l

1.12

310

2354

Malignant neoplasm of bone and articular cartilage

124

837

1.72

5.45

2.3

2.4

2.63

2.75

mg/l

0.28

107

724

Congenital deformities of hip, including avohilmo

251

1905

1.45

5.45

2.5

2.50

2.60

mg/l

0.41

216

1659

Benign neoplasm: Skin of trunk

504

4164

1.30

5.44

2.5

2.3

2.73

2.79

mg/l

0.17

436

3577

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

235

1768

1.46

5.40

2.3

2.1

2.42

2.49

mg/l

0.20

208

1558

Atrial septal defect, secundum type

335

2643

1.38

5.39

3.1

2.8

2.98

2.68

mg/l

1.62

299

2331

Idiopathic peripheral autonomic neuropathy

319

2.33

5.38

2.8

2.2

3.08

2.77

mg/l

0.52

278

Malignant neoplasm of corpus uteri

1032

9058

1.20

5.38

2.4

2.5

3.19

2.88

mg/l

3.33

882

7822

Perichondritis of external ear

223

1678

1.49

5.37

2.7

2.3

2.98

3.03

mg/l

0.14

198

1444

Helminthiases

211

1569

1.50

5.37

3.0

2.2

2.73

2.86

mg/l

0.39

184

1359

Lumbosacral root disorders, not elsewhere classified

147

1029

1.63

5.36

2.2

2.1

2.60

2.79

mg/l

0.45

135

885

Other and unspecified disorders of pigmentation

597

1.85

5.36

2.6

2.1

2.76

2.86

mg/l

0.09

523

Localized skin eruption due to drugs and medicaments

151

1065

1.63

5.34

3.3

2.2

2.91

2.90

mg/l

0.01

133

925

1169

10325

1.18

5.34

2.1

2.2

2.14

2.47

mg/l

7.51

961

9094

Other and unspecified papulosquamous disorders

563

1.92

5.34

3.4

2.1

2.83

2.96

mg/l

0.17

490

Benign neoplasm: Appendix

144

1010

1.66

5.33

3.1

2.2

2.62

2.95

mg/l

1.31

134

868

Findings of drugs and other substances, not normally found in blood

356

2.21

5.33

3.0

2.1

3.03

2.86

mg/l

0.23

306

Patent foramen ovale

252

1922

1.44

5.32

3.1

2.6

3.05

2.73

mg/l

1.12

221

1699

727

6179

1.23

5.29

2.7

2.3

3.21

3.01

mg/l

1.11

657

5234

Exposure to smoke, fire and flames

273

2103

1.41

5.28

2.2

2.3

2.67

2.82

mg/l

0.51

239

1825

Other disorders of optic disc

175

1268

1.56

5.28

2.3

2.2

2.61

2.89

mg/l

0.65

159

1094

Anomalies of pupillary function

255

1956

1.43

5.21

2.3

2.2

2.28

2.81

mg/l

4.44

226

1699

Behçet disease

227

2.55

5.21

3.2

2.1

2.70

2.69

mg/l

0.00

198

Benign neoplasm of bone and articular cartilage

960

8384

1.20

5.19

2.4

2.3

2.71

2.73

mg/l

0.09

835

7318

Other bursitis, not elsewhere classified

118

793

1.70

5.19

2.1

2.93

3.07

mg/l

0.19

103

689

Renal agenesis and other reduction defects of kidney

413

2.09

5.17

3.1

2.7

2.73

2.76

mg/l

0.05

367

Benign neoplasm: Kidney

433

3552

1.32

5.16

2.6

2.3

2.72

2.91

mg/l

0.86

376

3052

Optic atrophy, wide definition

220

1657

1.47

5.16

2.7

2.4

3.10

2.87

mg/l

0.84

191

1427

Contracture of muscle

374

2.13

5.15

2.5

1.8

2.51

2.96

mg/l

0.78

328

Complications following abortion and ectopic and molar pregnancy

390

3161

1.33

5.14

2.4

2.86

2.79

mg/l

0.22

324

2769

Malignant neoplasm, without specification of site, including Hilmo

566

4742

1.26

5.12

2.4

3.27

2.87

mg/l

2.96

479

4031

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

994

8714

1.19

5.12

2.5

2.2

2.43

2.57

mg/l

1.66

877

7650

Enduring personality changes

298

2.24

5.10

2.5

2.1

2.87

2.62

mg/l

0.32

260

Contact with sharp glass

416

3378

1.31

5.10

2.4

2.2

2.52

2.62

mg/l

0.53

352

2963

Lagophthalmos

168

1223

1.57

5.08

3.2

2.3

2.84

3.00

mg/l

0.34

144

1056

Hypertensive encephalopathy

350

2.25

5.08

3.0

2.2

2.99

3.09

mg/l

0.11

298

Retinal breaks without detachment

1914

17425

1.13

5.08

2.4

2.3

2.62

2.82

mg/l

3.56

1623

15113

Renal agenesis and other reduction defects of kidney, including avohilmo

469

1.99

5.05

3.0

2.6

2.68

2.79

mg/l

0.22

412

Adult-onset Still disease

299

2.22

5.04

3.8

2.0

2.72

2.98

mg/l

0.41

257

Rheumatic fever incl heart disease

371

2994

1.34

5.03

3.2

2.3

3.33

3.00

mg/l

1.71

334

2551

Sequelae of intentional self-harm, assault and events of undetermined intent

527

1.87

5.01

2.5

2.0

2.70

2.73

mg/l

0.04

469

Frostbite

130

898

1.64

5.01

2.3

2.1

2.97

2.77

mg/l

0.40

116

788

Corneal degeneration

213

1608

1.48

5.01

2.5

2.3

2.54

2.97

mg/l

2.06

183

1378

Whooping cough, including avohilmo

204

1522

1.48

4.99

2.2

2.25

2.55

mg/l

2.11

170

1317

Tuberculosis of other organs

261

2030

1.42

4.98

3.0

2.3

2.94

3.07

mg/l

0.35

231

1730

LSIL lesion of the vulva

326

2596

1.36

4.98

2.3

2.2

2.99

2.77

mg/l

0.65

298

2255

Optic atrophy

210

1580

1.48

4.98

2.7

2.4

3.11

2.87

mg/l

0.87

182

1366

Use of levodopa decarbox-comt-inhibitor

405

3323

1.33

4.98

2.5

2.4

3.21

2.96

mg/l

0.99

351

2843

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

479

1.96

4.97

2.1

2.44

2.63

mg/l

0.46

415

Other and unspecified injuries of abdomen, lower back and pelvis

192

1424

1.50

4.96

2.9

2.2

2.66

2.80

mg/l

0.40

165

1233

Nightmares

225

2.54

4.96

2.6

2.0

2.24

2.67

mg/l

0.86

206

Congenital malformations of genital organs

1100

9662

1.18

4.94

2.7

2.4

2.59

2.60

mg/l

0.01

969

8491

Mature T/NK-cell lymphomas, hilmo

169

1235

1.55

4.94

2.7

2.3

3.20

3.00

mg/l

0.43

159

1067

Cysts of oral region, not elsewhere classified

668

5705

1.23

4.94

2.5

2.3

2.87

2.76

mg/l

0.54

579

4931

Myotonic disorders

641

1.77

4.94

2.4

2.1

2.99

2.90

mg/l

0.10

562

Congenital lactase deficiency

212

2.59

4.90

2.1

1.9

2.93

2.73

mg/l

0.23

179

Organ-limited amyloidosis

451

2.00

4.89

2.6

2.2

3.21

3.19

mg/l

0.02

390

Burns classified according to extent of body surface involved

117

796

1.68

4.88

2.7

2.1

2.50

2.96

mg/l

1.20

102

699

Asymptomatic human immunodeficiency virus [HIV] infection status

335

2.05

4.87

2.3

2.1

2.62

2.89

mg/l

0.36

300

Isolated patent ductus arteriosus

136

949

1.64

4.86

4.2

3.3

2.94

2.44

mg/l

1.78

128

850

Liposarcoma, including Hilmo

120

824

1.67

4.85

2.4

2.1

2.89

2.83

mg/l

0.08

105

708

Abscess of tendon sheath

492

1.88

4.85

3.2

1.9

2.54

2.93

mg/l

1.08

421

Epidural haemorrhage

102

669

1.71

4.85

2.7

2.3

2.68

2.73

mg/l

0.09

577

Chorioretinal inflammation

327

2614

1.35

4.82

2.7

2.2

3.08

2.82

mg/l

0.97

291

2232

Renal cell carcinoma of kidney

380

3090

1.32

4.82

2.5

2.3

3.44

2.83

mg/l

4.07

327

2635

Pityriasis rubra pilaris

192

2.64

4.80

2.1

3.09

2.74

mg/l

0.28

171

Congenital deformities of feet, including avohilmo

444

3663

1.29

4.79

2.5

2.2

2.64

mg/l

0.02

371

3216

Ulcer of oesophagus, drug-induced

424

2.04

4.79

2.7

2.2

3.00

2.93

mg/l

0.08

365

Other congenital malformations of skin, including avohilmo

948

8325

1.19

4.79

2.5

2.3

2.49

2.69

mg/l

1.86

808

7247

Lower leg

628

1.81

4.79

2.5

2.2

1.92

2.89

mg/l

7.49

542

Crossbite

829

6628

1.20

4.78

3.4

2.6

2.57

2.60

mg/l

0.16

741

5827

296

2.17

4.78

2.8

2.0

2.53

2.86

mg/l

0.65

261

Benign neoplasm: Other and unspecified parts of mouth

387

3162

1.32

4.78

2.8

2.3

2.83

2.90

mg/l

0.27

339

2709

Carcinoma in situ of oral cavity, oesophagus and stomach

535

1.91

4.76

3.7

2.2

3.01

3.14

mg/l

0.19

460

Acute inflammation of orbit

519

1.85

4.75

2.9

2.2

2.86

2.89

mg/l

0.04

456

Nail dystrophy

522

1.87

4.75

3.3

2.1

2.21

3.02

mg/l

2.80

448

Exposure to unspecified smoke, fire and flames

117

802

1.67

4.75

2.2

2.57

2.92

mg/l

1.08

106

692

Congenital malformations of spine and bony thorax, including avohilmo

561

1.83

4.74

3.4

2.8

2.97

2.64

mg/l

0.67

491

Benign neoplasm of eye and adnexa

1305

11712

1.16

4.74

2.5

2.4

2.63

2.85

mg/l

2.52

1114

10132

Major anomalies of jaw size

287

2259

1.37

4.73

2.6

2.2

2.70

2.72

mg/l

0.08

254

1971

Intrahepatic Cholestasis of Pregnancy (ICP)

816

7099

1.20

4.72

2.4

2.2

2.39

2.53

mg/l

1.40

723

6215

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

816

7099

1.20

4.72

2.4

2.1

2.39

2.50

mg/l

1.06

723

6259

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

994

8767

1.18

4.72

2.5

2.2

2.43

2.60

mg/l

2.16

877

7654

Toxic effect of organic solvents

292

2.20

4.71

2.3

2.2

2.67

2.91

mg/l

0.39

253

Telogen effluvium

174

2.80

4.71

2.5

2.3

1.95

2.78

mg/l

2.36

146

Osteopathy in diseases classified elsewhere

627

1.78

4.71

2.4

2.2

3.33

2.97

mg/l

0.51

536

Glaucoma-related operations

739

6419

1.22

4.71

2.4

2.76

2.98

mg/l

1.53

643

5514

Arteriovenous malformation of peripheral vessels

412

1.97

4.70

4.7

2.4

2.47

2.73

mg/l

0.50

370

Other congenital malformations of intestine

109

741

1.70

4.69

5.0

2.5

2.73

2.74

mg/l

0.01

102

639

Other conjunctival vascular disorders and cysts

274

2159

1.39

4.66

2.7

2.3

2.97

2.89

mg/l

0.20

239

1860

Demyelinating diseases of the central nervous system

952

8373

1.18

4.65

2.4

2.3

2.68

2.67

mg/l

0.03

824

7324

All dysplastic lesions of the vagina

317

2541

1.35

4.64

2.8

2.2

2.69

2.80

mg/l

0.46

275

2204

Benign neoplasm of ovary

2079

19104

1.12

4.63

2.5

2.4

2.87

2.86

mg/l

0.06

1826

16523

Benign neoplasm: Heart

323

2.25

4.63

3.8

2.1

2.97

2.92

mg/l

0.06

283

Abnormal reflex

400

1.99

4.61

2.4

2.1

2.66

2.73

mg/l

0.11

353

Isolated growth hormone deficiency

600

1.80

4.61

3.6

3.8

2.47

2.45

mg/l

0.05

547

Nezelof syndrome

342

2.13

4.60

3.9

2.1

2.90

3.06

mg/l

0.20

304

Pilonidal cyst

854

7440

1.19

4.59

2.4

2.2

2.71

2.60

mg/l

0.87

777

6508

Pigmented purpuric dermatosis

131

927

1.61

4.59

2.7

2.2

2.55

2.82

mg/l

0.74

115

798

Histrionic personality disorder

411

2.00

4.59

2.1

2.87

3.09

mg/l

0.29

358

Other and unspecified localized connective tissue disorders

253

2.35

4.58

3.7

2.2

2.99

2.82

mg/l

0.23

219

Sickle-cell disorders

218

2.51

4.58

3.5

2.2

3.37

2.81

mg/l

0.82

198

Cerebral atherosclerosis

176

1306

1.51

4.57

3.0

2.3

2.75

3.18

mg/l

1.75

159

1109

Acute hepatitis B

316

2.10

4.57

3.2

2.0

2.82

2.94

mg/l

0.13

274

Graves ophthalmopathy

283

2243

1.37

4.56

2.7

2.2

2.44

2.84

mg/l

3.08

252

1925

Chronic suppurative otitis media

786

6843

1.20

4.55

2.5

2.4

2.67

2.77

mg/l

0.59

668

5904

Benign neoplasm: Skin of lower limb, including hip

326

2629

1.34

4.54

2.6

2.3

2.73

2.86

mg/l

0.60

285

2277

Other congenital malformations of intestine, including avohilmo

138

988

1.59

4.53

4.4

2.4

2.81

2.84

mg/l

0.06

123

857

Injury of muscle and tendon at ankle and foot level

277

2185

1.37

4.52

2.2

2.1

2.44

2.75

mg/l

2.23

243

1898

Congenital deformities of hip

223

1714

1.43

4.51

2.5

2.52

2.60

mg/l

0.26

195

1495

Disorders of other and unspecified cranial nerves

434

1.93

4.51

2.8

2.2

2.74

2.85

mg/l

0.19

378

Testicular dysfunction, other/unspecified

321

2.02

4.51

2.4

2.2

2.57

2.93

mg/l

0.68

282

Other operation for atrial fibrillation

457

1.98

4.50

2.9

2.2

2.99

2.96

mg/l

0.03

399

Esophageal diverticulum (pouch), including avohilmo

319

2.25

4.50

2.7

2.2

2.53

2.93

mg/l

0.58

275

Other benign neoplasms of connective and other soft tissue

1144

10213

1.16

4.49

2.6

2.3

2.75

2.79

mg/l

0.23

992

8845

Exposure to other specified electric current

142

1967

0.67

4.49

2.2

2.60

2.61

mg/l

0.01

131

1709

Neuroendocrine tumor and carcinoma of pancreas

512

1.84

4.49

3.0

2.1

3.10

2.78

mg/l

0.41

430

Benign neoplasm: Hypopharynx

375

2.04

4.48

2.0

2.50

2.89

mg/l

0.92

331

Mandibular retrognathia

724

6247

1.21

4.48

2.3

2.4

2.60

2.61

mg/l

0.05

662

5486

Contact with other hot fluids

353

2870

1.32

4.47

2.3

2.52

2.74

mg/l

1.17

293

2501

Exposure to other and unspecified animate mechanical forces

360

2932

1.31

4.45

2.6

2.3

2.56

2.65

mg/l

0.29

310

2568

Cerebral amyloid angiopathy

515

1.91

4.45

2.0

2.1

2.71

2.95

mg/l

0.32

444

Unspecified threat to breathing

123

865

1.62

4.44

2.5

2.2

2.76

mg/l

0.01

112

757

Labour and delivery complicated by fetal stress [distress]

3105

18819

1.10

4.42

2.1

2.2

2.51

2.47

mg/l

0.60

2703

16481

Effects of other external causes

305

2436

1.33

4.39

2.5

2.1

2.48

2.64

mg/l

0.83

275

2121

Whooping cough

514

1.81

4.39

2.3

2.2

2.53

2.40

mg/l

0.34

449

Malignant neoplasm of breast, ER-negative, including Hilmo

2614

22698

1.10

4.39

2.3

2.4

2.87

2.82

mg/l

0.43

2204

19595

Defect, injury or illness of neck

534

1.82

4.38

2.4

2.0

2.34

2.77

mg/l

1.54

452

Choroidal haemorrhage and rupture

264

2.26

4.38

2.6

2.1

3.09

3.25

mg/l

0.24

228

Abnormal spermatozoa

1500

13633

1.14

4.37

2.4

3.23

2.85

mg/l

8.87

1239

11785

Iliotibial band syndrome

129

912

1.57

4.36

2.2

2.1

2.33

3.00

mg/l

4.21

118

778

Tarsal tunnel syndrome

123

869

1.61

4.34

2.9

2.1

2.95

2.92

mg/l

0.04

114

743

Third [oculomotor] nerve palsy

222

1723

1.42

4.34

2.8

2.4

2.99

3.01

mg/l

0.04

198

1478

Foreign body or object entering through skin

668

5761

1.21

4.33

2.5

2.3

2.71

2.69

mg/l

0.07

582

5000

Dementia due to Parkinson's disease

353

2910

1.33

4.32

2.2

2.4

2.68

3.01

mg/l

2.14

278

2480

Malignant neoplasm of bronchus and lung

2070

18788

0.90

4.31

2.3

2.4

3.15

2.81

mg/l

6.12

1794

16060

Infectious mononucleosis

940

8296

1.17

4.29

2.3

2.2

2.56

2.54

mg/l

0.13

814

7248

Infectious mononucleosis, including avohilmo

940

8296

1.17

4.29

2.3

2.2

2.56

2.54

mg/l

0.13

814

7248

Contusion of toe(s) with damage to nail

138

994

1.55

4.29

2.6

2.3

2.73

2.78

mg/l

0.07

121

870

Nontoxic diffuse goitre

365

2999

1.31

4.28

2.4

2.3

3.08

2.89

mg/l

0.86

314

2588

Malignant neoplasm of breast, ER-positive, including Hilmo

4022

28161

1.08

4.27

2.3

2.4

2.83

2.77

mg/l

0.72

3440

24386

Other noninflammatory disorders of cervix uteri

542

4611

1.24

4.27

2.6

2.4

3.11

2.88

mg/l

1.33

469

3985

Chronic mastoiditis

308

2492

1.34

4.27

2.6

2.3

2.96

2.93

mg/l

0.06

260

2125

Carcinoma in situ of skin of eyelid, including canthus

213

2.60

4.26

2.6

2.3

3.36

2.99

mg/l

0.20

186

Deaf mutism, not elsewhere classified

385

1.95

4.26

3.5

2.1

3.22

3.06

mg/l

0.17

336

HSIL lesion of the vulva

218

1694

1.42

4.26

3.0

2.3

2.92

2.89

mg/l

0.07

184

1453

Other abnormal auditory perceptions

139

1005

1.55

4.25

2.4

2.1

2.60

2.90

mg/l

0.81

124

867

Hereditary ataxia

155

1143

1.51

4.25

2.4

2.3

2.76

2.97

mg/l

0.54

134

984

Burns and corrosions of multiple and unspecified body regions

252

1983

1.37

4.25

2.6

2.2

2.72

2.78

mg/l

0.15

220

1721

Alzheimer’s disease (Early onset)

414

4966

0.79

4.25

2.2

2.4

3.10

mg/l

0.01

334

4209

Hypertrophy of (infrapatellar) fat pad

109

751

1.63

4.24

2.5

2.0

3.16

2.74

mg/l

1.07

653

Dissection of cerebral arteries, nonruptured

573

1.73

4.23

2.2

2.0

2.81

2.94

mg/l

0.20

503

Henoch-Schönlein purpura nephritis (HSPN)

312

2.11

4.23

3.5

2.1

2.53

2.69

mg/l

0.28

271

Malignant neoplasm of other and unspecified parts of biliary tract

183

1385

1.46

4.21

2.5

2.3

3.33

2.86

mg/l

0.81

163

1171

Congenital malformations of spine and bony thorax

500

1.83

4.17

3.2

2.8

2.98

2.60

mg/l

0.70

441

Lesion of medial popliteal nerve

320

2.06

4.16

2.4

2.1

2.65

2.93

mg/l

0.42

275

Amoebiasis, including avohilmo

667

1.67

4.14

2.3

2.2

2.28

2.74

mg/l

1.68

571

Malignant neoplasm of breast, HER-positive

4007

28119

1.08

4.13

2.3

2.4

2.83

2.78

mg/l

0.72

3429

24349

Tuberculosis of other organs, strict

290

2339

1.35

4.13

2.9

2.4

2.92

3.03

mg/l

0.32

257

1986

Mental and behavioural disorders of puerperium, not classified elsewhere

142

1039

1.54

4.12

1.9

2.1

2.65

2.58

mg/l

0.16

126

896

Hereditary erythropoietic porphyria

4.79

4.12

2.9

2.2

2.54

3.20

mg/l

0.61

Anuria and oliguria

633

1.72

4.09

2.6

2.2

2.94

3.05

mg/l

0.16

550

Procedures for purposes other than remedying health state

270

2153

1.35

4.09

2.3

2.1

2.37

2.75

mg/l

2.77

231

1846

Other sexually transmitted chlamydial diseases

704

6116

1.20

4.08

2.2

2.1

2.38

2.49

mg/l

0.93

559

5355

All dysplastic lesions of the cervix uteri

3275

30246

1.09

4.07

2.3

2.52

2.58

mg/l

1.09

2840

26505

Guttate psoriasis

164

1226

1.48

4.07

2.9

2.1

2.99

2.82

mg/l

0.43

146

1067

Congenital malformations of eye, ear, face and neck

734

6412

1.19

4.06

2.5

2.4

2.69

2.65

mg/l

0.19

649

5605

Unspecified lump in breast

1922

17708

1.12

4.06

2.4

2.61

2.80

mg/l

2.60

1689

15357

Leiomyosarcoma, including Hilmo

112

789

1.62

4.05

2.1

2.3

2.80

2.86

mg/l

0.13

672

Keratoconus

249

1964

1.36

4.04

2.4

2.2

2.89

2.82

mg/l

0.18

209

1706

Injury of muscle and tendon at lower leg level

1708

15638

1.12

4.03

2.5

2.3

2.82

2.76

mg/l

0.48

1465

13645

Crowding of teeth, including avohilmo

1116

8273

1.15

4.01

2.8

2.4

2.48

2.52

mg/l

0.24

981

7261

Puerperal sepsis

1372

12444

1.14

4.01

2.4

2.3

2.72

2.74

mg/l

0.13

1185

10812

Myelofibrosis

5.04

4.01

1.6

2.0

2.84

2.66

mg/l

0.10

Tuberculosis of other organs, strict, including avohilmo

294

2384

1.34

4.01

2.9

2.4

2.91

3.02

mg/l

0.32

259

2025

Benign neoplasm: Pharynx, unspecified

104

726

1.65

4.00

2.1

2.93

2.91

mg/l

0.03

627

HSIL lesion of the cervix uteri, vagina or vulva

2498

23249

1.10

4.00

2.3

2.55

2.59

mg/l

0.47

2155

20396

Malignant neoplasm of retroperitoneum and peritoneum

668

1.68

4.00

2.1

2.2

2.35

2.94

mg/l

1.72

567

Cryoglobulinemia

130

2.96

4.00

3.1

2.4

3.03

2.99

mg/l

0.03

122

Brain glioblastoma

1184

0.61

3.99

1.6

2.3

3.13

2.80

mg/l

0.40

1007

Foreign body in ear

233

1836

1.38

3.99

2.2

2.3

2.62

2.77

mg/l

0.48

199

1592

Intentional self-harm by jumping from a high place

397

1.86

3.98

1.7

2.0

2.45

2.72

mg/l

0.66

351

Disorder of thyroid, unspecified

160

1200

1.48

3.98

2.2

2.54

2.90

mg/l

1.25

138

1033

Acute mastoiditis

101

696

1.63

3.98

2.7

2.2

2.95

2.81

mg/l

0.13

611

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

235

1855

1.38

3.98

2.9

2.4

2.87

2.70

mg/l

0.34

204

1614

Pedestrian injured in collision with car, pick-up truck or van

290

2345

1.33

3.97

2.3

2.2

2.63

2.87

mg/l

1.27

241

2021

Family history of other specific disorders

163

1223

1.47

3.97

2.5

2.3

2.51

2.65

mg/l

0.46

142

1056

Acute hepatitis B, including avohilmo

338

1.97

3.96

3.1

2.1

2.83

2.91

mg/l

0.08

296

Injury of nerves at forearm level

147

1084

1.49

3.96

2.9

2.1

2.57

2.80

mg/l

0.81

131

940

Graves ophthalmopathy, strict

250

1990

1.36

3.95

2.7

2.2

2.49

2.87

mg/l

2.45

220

1698

Meningitis

541

4633

1.23

3.94

2.5

2.3

2.82

2.79

mg/l

0.09

481

3997

Injury of cranial nerves

514

1.76

3.90

2.5

2.0

2.83

2.61

mg/l

0.40

446

Chronic thyroiditis

336

2.01

3.88

2.4

2.2

2.53

2.77

mg/l

0.36

283

Postdysenteric arthropathy

110

777

1.60

3.87

2.3

2.0

2.68

2.82

mg/l

0.36

660

Esophageal diverticulum (pouch)

234

2.37

3.87

3.0

2.2

2.60

2.94

mg/l

0.39

209

Burn and corrosion of wrist and hand

409

3423

1.26

3.87

2.4

2.3

2.51

2.69

mg/l

1.20

359

2975

Sequelae of burns, corrosions and frostbite

380

1.90

3.86

2.4

2.50

2.74

mg/l

0.39

333

Contact with other hot metals

176

1341

1.44

3.86

2.6

2.3

2.45

2.87

mg/l

1.88

154

1163

Other specified and unspecified strabismus

143

1058

1.50

3.86

3.0

2.4

2.79

2.94

mg/l

0.36

124

919

Other bursal cyst

174

1323

1.44

3.86

2.3

2.1

2.66

2.93

mg/l

0.87

145

1128

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

113

803

1.58

3.85

2.6

2.3

3.15

2.75

mg/l

0.72

101

694

Bacterial agents resistant to antibiotics

3.80

3.84

4.9

2.2

3.72

2.86

mg/l

0.72

Benign neoplasm of other and unspecified sites

372

3100

1.28

3.83

2.6

2.3

2.95

2.85

mg/l

0.31

311

2672

Parapsoriasis

221

1740

1.38

3.81

2.5

2.2

2.55

2.84

mg/l

1.23

196

1506

Benign neoplasm: Other/unspecified site

182

1400

1.43

3.81

2.5

2.2

3.00

2.91

mg/l

0.18

146

1209

Lumbosacral plexus disorders

253

2.16

3.80

2.9

2.1

2.87

2.98

mg/l

0.14

221

Benign neoplasm: Skin, unspecified

457

3879

1.25

3.80

2.8

2.2

2.86

2.83

mg/l

0.09

406

3330

Bacterial meningitis

366

3042

1.28

3.80

2.5

2.2

2.89

2.85

mg/l

0.10

321

2634

Palindromic rheumatism

116

829

1.56

3.80

2.6

2.0

3.12

2.93

mg/l

0.42

107

701

Desensitization to allergens

587

5067

1.21

3.79

2.3

2.38

2.58

mg/l

1.93

496

4450

Inflammatory disease of cervix uteri

715

6283

1.19

3.78

2.6

2.4

3.25

2.86

mg/l

3.80

612

5438

Calcaneal spur

146

1085

1.48

3.78

2.6

2.1

2.66

2.92

mg/l

1.04

134

917

Malignant neoplasm of other and unspecified female genital organs

195

1521

1.42

3.77

1.8

2.4

2.49

2.87

mg/l

1.73

168

1301

Granuloma annulare

182

1402

1.43

3.77

2.6

2.1

2.82

2.83

mg/l

0.03

164

1197

Other infective (teno)synovitis

328

1.96

3.76

2.9

1.9

3.44

3.12

mg/l

0.35

277

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

669

1.66

3.76

2.6

2.3

2.99

2.76

mg/l

0.47

560

Benign neoplasm: Pelvic bones, sacrum and coccyx

353

1.94

3.76

1.8

2.1

2.82

2.76

mg/l

0.10

307

Generalized epilepsy, mode (most common among epilepsy diagnosis)

338

2790

1.29

3.74

2.3

2.63

2.69

mg/l

0.20

293

2424

Urticaria due to cold and heat

105

743

1.61

3.74

2.3

2.1

2.48

2.71

mg/l

0.51

649

Toxic effect of corrosive substances

390

1.84

3.72

2.2

1.9

2.71

2.63

mg/l

0.09

337

Injury of nerves at shoulder and upper arm level

125

909

1.53

3.72

2.2

2.58

2.92

mg/l

0.73

110

795

Cholesteatoma of external ear

100

705

1.64

3.72

2.3

2.50

3.02

mg/l

1.62

618

Other and unspecified myoneural disorders

325

2.01

3.71

3.1

2.2

2.70

2.93

mg/l

0.28

278

Melanoma in situ

557

4832

1.22

3.70

2.4

2.73

2.94

mg/l

1.27

461

4149

Pneumonia due to Haemophilus influenzae

307

1.99

3.70

1.7

2.1

3.62

2.78

mg/l

0.94

265

Generalized pustular psoriasis

310

2.03

3.69

3.0

2.1

3.29

2.87

mg/l

0.42

266

LSIL lesion of the cervix uteri, vagina or vulva

1705

15691

1.12

3.69

2.3

2.61

mg/l

0.00

1500

13720

Peroneal tendinitis

184

1415

1.40

3.68

2.3

2.0

2.30

2.81

mg/l

3.84

165

1226

Simple and mucopurulent chronic bronchitis

484

4136

1.23

3.67

2.7

2.3

3.04

2.85

mg/l

0.90

416

3500

Vitiligo

136

1005

1.49

3.66

2.6

2.2

2.85

2.71

mg/l

0.26

119

869

Porphyria cutanea tarda

3.85

3.66

3.3

1.9

3.29

3.05

mg/l

0.16

813

9156

0.86

3.66

2.6

2.4

3.71

2.88

mg/l

9.61

711

7899

Injury of nerves at wrist and hand level

392

3285

1.26

3.65

2.5

2.2

2.55

2.76

mg/l

1.52

348

2842

Congenital malformation of biliary tract

278

2.21

3.65

6.0

3.4

2.78

2.48

mg/l

0.58

254

Dacryoadenitis

101

716

1.62

3.64

2.5

2.2

2.88

3.05

mg/l

0.37

612

Other osteochondrodysplasias, including avohilmo

139

1035

1.49

3.63

2.7

2.3

2.52

2.85

mg/l

1.32

115

900

Mental and behavioural disorders due to use of volatile solvents

180

2.28

3.63

1.8

1.9

3.77

2.62

mg/l

0.81

158

Congenital malformation syndromes predominantly affecting facial appearance

260

2.18

3.62

2.2

3.2

2.99

2.51

mg/l

0.94

232

Malignant neoplasm of larynx, including Hilmo

220

1741

1.36

3.61

2.3

2.58

2.80

mg/l

0.90

190

1482

Hereditary corneal dystrophies

413

3502

1.26

3.61

2.6

2.3

2.83

2.91

mg/l

0.26

354

2989

Congenital malformations of oesophagus, including avohilmo

503

1.76

3.61

2.5

2.67

2.86

mg/l

0.28

440

Deformity of finger(s)

508

1.73

3.60

2.8

1.9

2.49

2.77

mg/l

0.58

432

Blindness or visual impairment, binocular

396

1.84

3.59

3.0

2.2

3.14

2.99

mg/l

0.20

348

Aortic stenosis, including avohilmo

210

2.40

3.59

2.9

2.52

2.81

mg/l

0.35

185

Malignant neoplasm of renal pelvis

561

1.71

3.58

2.1

2.3

2.70

2.94

mg/l

0.47

464

Need for immunization against other single infectious diseases

109

3.06

3.58

18.2

1.9

1.77

2.73

mg/l

2.90

Other degenerative diseases of the basal ganglia

235

1895

1.37

3.57

2.5

2.3

2.74

2.99

mg/l

1.04

197

1637

Exophthalmic conditions

123

901

1.52

3.56

2.4

2.2

2.78

2.94

mg/l

0.33

113

780

Adrenogenital disorders

383

1.87

3.55

2.7

2.2

2.87

3.01

mg/l

0.13

328

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

313

1.98

3.53

2.7

2.0

2.97

2.78

mg/l

0.16

266

Other specified disorders of external ear

434

3700

1.25

3.53

2.4

2.3

2.74

2.87

mg/l

0.65

365

3210

Other specified/unspecified deforming dorsopathies

184

1424

1.39

3.53

2.6

2.2

2.79

2.90

mg/l

0.28

161

1230

Onycholysis

585

1.67

3.53

2.7

2.3

2.47

2.84

mg/l

1.52

505

Other and unspecified syphilis, including avohilmo

209

2.10

3.52

1.8

1.9

2.58

2.91

mg/l

0.42

187

Other/unspecified mastoiditis and related conditions

432

1.81

3.52

2.6

2.2

3.13

2.85

mg/l

0.38

380

Other disorders affecting eyelid function

115

838

1.55

3.51

2.4

2.2

1.90

3.01

mg/l

8.17

110

739

Benign neoplasm: Conjunctiva

376

3167

1.26

3.50

2.5

2.2

2.73

2.87

mg/l

0.46

313

2717

Melanoma in situ of trunk

195

1540

1.40

3.49

2.5

2.3

2.71

2.99

mg/l

0.72

161

1338

Other specified and unspecified disorders of conjunctiva

118

861

1.53

3.49

2.3

2.1

2.43

2.91

mg/l

2.19

103

758

Accidental poisoning by and exposure to other gases and vapours

415

1.80

3.49

2.5

2.1

3.40

3.00

mg/l

0.74

367

Secondary sideroblastic anaemia

222

2.17

3.48

2.8

1.9

3.09

2.84

mg/l

0.31

195

Sclerosis of liver

5.27

3.48

4.4

2.5

3.71

2.78

mg/l

0.87

Liposarcoma

602

1.64

3.48

2.3

2.1

2.62

2.81

mg/l

0.34

523

Narcolepsy and cataplexy

551

1.67

3.48

2.7

2.0

2.66

2.61

mg/l

0.12

478

Meckel's diverticulum

496

1.72

3.47

2.9

2.3

2.54

2.78

mg/l

0.52

444

Acute thyroiditis

329

1.92

3.47

3.4

2.2

2.75

2.69

mg/l

0.06

287

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

394

3332

1.25

3.46

2.3

2.4

2.52

2.75

mg/l

1.74

340

2890

Benign neoplasm: Tonsil

142

1070

1.47

3.46

2.5

2.2

3.15

3.03

mg/l

0.18

120

932

Pedestrian injured in collision with heavy transport vehicle or bus

275

2.02

3.46

2.3

2.4

2.90

2.87

mg/l

0.03

246

Congenital malformations of uterus and cervix

256

2080

1.33

3.45

2.7

2.1

2.70

2.51

mg/l

0.78

226

1807

Varus deformity, not elsewhere classified

122

895

1.50

3.44

2.6

2.1

2.69

2.93

mg/l

0.71

112

755

Brain glioblastoma and astrocytoma

109

1499

0.68

3.44

1.7

2.2

2.78

2.77

mg/l

0.01

1282

Epileptic seizures related to alcohol

456

1.75

3.43

2.9

2.1

2.31

2.92

mg/l

2.04

409

Exposure to excessive natural heat

197

2.37

3.43

2.7

2.1

2.82

2.95

mg/l

0.12

170

Acute otitis externa, noninfective

195

1535

1.38

3.42

3.0

2.2

3.03

2.89

mg/l

0.45

169

1333

Sixth [abducent] nerve palsy

395

3352

1.25

3.42

2.7

2.3

2.93

mg/l

0.01

349

2872

Malignant neoplasm of testis

137

1015

1.44

3.42

2.5

2.2

2.93

2.74

mg/l

0.41

118

868

Benign neoplasm of brain and other parts of central nervous system

736

6527

1.18

3.40

2.5

2.3

2.85

2.82

mg/l

0.15

622

5651

Increased muscle tone

659

1.62

3.38

2.6

2.1

2.39

2.76

mg/l

1.01

569

Supervision of normal pregnancy

2549

13586

1.09

3.37

2.0

2.3

2.47

2.60

mg/l

2.68

2215

11950

Shigellosis, including avohilmo

571

1.64

3.37

2.3

2.0

2.13

2.76

mg/l

2.28

487

Benign neoplasm: Nasopharynx

108

785

1.56

3.37

2.5

2.2

2.61

3.01

mg/l

1.05

679

Enterobiasis, including avohilmo

271

2219

1.31

3.37

2.5

2.4

2.33

2.51

mg/l

0.99

236

1949

Abnormal findings on diagnostic imaging of breast

177

1383

1.40

3.36

2.4

2.3

2.75

2.91

mg/l

0.44

153

1188

Malignant neoplasm of hypopharynx, including Hilmo

558

1.66

3.35

2.2

2.70

2.72

mg/l

0.03

469

Cicatricial alopecia [scarring hair loss]

102

734

1.57

3.35

2.5

2.1

2.46

3.02

mg/l

2.19

638

Fatigue fracture of vertebra

472

1.76

3.33

2.5

2.39

2.80

mg/l

1.15

409

Acute lymphocytic leukaemia, helper endpoint

567

1.65

3.31

2.2

3.2

2.34

2.51

mg/l

0.37

501

Acute lymphocytic leukaemia, including Hilmo

567

1.65

3.31

2.2

3.2

2.34

2.51

mg/l

0.37

501

Acute lymphocytic leukaemia

567

1.65

3.31

2.2

3.2

2.34

2.51

mg/l

0.37

501

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

103

746

1.57

3.30

2.5

2.2

2.93

3.01

mg/l

0.11

645

Injury of muscle and tendon at forearm level

192

1510

1.36

3.30

2.4

2.1

2.80

2.74

mg/l

0.10

172

1319

Atypical virus infections of central nervous system

103

742

1.55

3.29

2.4

2.1

3.14

3.10

mg/l

0.05

647

Inflammation of lacrimal passages (acute and unspecified)

207

1651

1.36

3.28

2.7

2.3

2.73

2.94

mg/l

0.88

193

1406

Antenatal screening

2675

14022

1.09

3.28

2.0

2.3

2.45

2.60

mg/l

3.30

2354

12343

Acute poliomyelitis

147

1124

1.44

3.27

2.4

2.2

3.25

3.04

mg/l

0.49

127

971

Melanocytic naevi of lower limb, including hip

513

4454

1.21

3.26

2.7

2.3

2.53

2.77

mg/l

2.22

453

3860

Use of selegiline

532

4639

1.21

3.26

2.5

2.4

2.88

2.94

mg/l

0.24

424

3974

Benign neoplasm: Short bones of upper limb

168

1305

1.40

3.25

2.5

2.1

2.69

2.82

mg/l

0.28

143

1141

Carcinoma in situ of penis

164

2.48

3.24

2.7

2.0

3.47

2.70

mg/l

0.69

153

Medical treatment for female infertility

2552

23734

1.09

3.22

2.3

2.2

2.55

2.51

mg/l

0.40

2237

20884

Malignant neoplasm of breast, HER-negative

2385

21461

1.09

3.22

2.3

2.5

2.89

2.83

mg/l

0.51

2004

18492

Rheumatic valve diseases

261

2140

1.30

3.21

3.2

2.3

3.45

3.08

mg/l

1.50

232

1837

Malignant neoplasm of larynx

172

1342

1.39

3.20

2.3

2.53

2.80

mg/l

1.02

147

1137

Dengue, including avohilmo

171

2.39

3.20

2.5

2.2

2.09

3.00

mg/l

1.51

154

Acute poliomyelitis, including avohilmo

147

1128

1.44

3.20

2.4

2.2

3.25

3.04

mg/l

0.47

127

974

Benign neoplasm of breast

1424

13112

1.12

3.20

2.4

2.79

2.81

mg/l

0.08

1214

11353

Acquired clawhand, clubhand, clawfoot and clubfoot

389

1.76

3.20

2.8

1.9

2.44

2.84

mg/l

0.79

333

LSIL lesion of the vagina

178

1400

1.38

3.19

2.6

2.2

2.74

2.76

mg/l

0.07

147

1211

Unspecified abortion

493

4263

1.21

3.19

2.3

2.54

2.69

mg/l

0.98

437

3770

Injury of blood vessels at abdomen, lower back and pelvis level

354

1.85

3.18

3.0

2.0

3.45

2.86

mg/l

0.94

314

Optic neuritis

458

3949

1.22

3.17

2.5

2.2

2.74

2.68

mg/l

0.22

403

3457

Burn and corrosion of hip and lower limb, except ankle and foot

261

2143

1.30

3.15

2.5

2.2

2.78

2.73

mg/l

0.13

229

1857

Horner syndrome

140

1069

1.44

3.14

2.5

2.1

2.73

2.90

mg/l

0.34

121

935

Cyst of spleen

157

2.42

3.14

3.7

2.1

3.19

2.42

mg/l

2.31

138

Malignant neoplasm of brain, including Hilmo

384

4510

0.82

3.13

2.2

2.4

2.80

2.71

mg/l

0.29

331

3882

Superficial frostbite

547

1.63

3.13

2.4

2.0

2.91

2.81

mg/l

0.16

477

Adrenomedullary hyperfunction

230

2.07

3.13

2.8

2.1

2.96

2.72

mg/l

0.33

204

Other acute disseminated demyelination

112

826

1.50

3.13

2.6

2.1

3.03

2.71

mg/l

0.65

102

723

Other congenital malformations of circulatory system

284

2356

1.29

3.12

2.5

2.3

2.59

2.84

mg/l

1.42

239

2045

Amoebiasis

442

1.71

3.12

2.5

2.1

2.47

2.78

mg/l

0.74

379

693

1.56

3.11

2.6

2.4

2.67

3.16

mg/l

1.06

592

Mild or no visual impairment, binocular

429

1.75

3.10

2.7

2.2

2.96

3.04

mg/l

0.10

375

Acne conglobata

400

1.73

3.09

2.6

2.1

2.65

2.59

mg/l

0.09

349

Valgus deformity, not elsewhere classified

624

1.58

3.09

2.6

2.2

2.78

2.81

mg/l

0.06

522

Congenital hypothyroidism without goiter

498

1.71

3.09

2.4

2.7

2.81

2.67

mg/l

0.24

426

Vertical strabismus

387

3304

1.24

3.09

2.6

2.3

2.65

2.81

mg/l

0.83

327

2848

Burn and corrosion of head and neck

218

1757

1.32

3.08

2.1

2.2

2.61

2.73

mg/l

0.41

192

1532

Other specified/unspecified disorders of bone/cartilage

284

2355

1.28

3.07

2.9

2.2

2.85

2.86

mg/l

0.03

249

2026

Calcification and ossification of muscle

186

2.18

3.05

2.3

1.9

2.34

2.94

mg/l

1.24

161

Disorders of globe

296

2474

1.28

3.05

2.7

2.3

2.88

2.96

mg/l

0.21

264

2115

Other and unspecified disorders of autonomic nervous system

383

1.80

3.04

2.9

1.9

2.48

2.71

mg/l

0.44

332

Overjet

283

2339

1.28

3.04

3.2

3.0

2.66

2.52

mg/l

0.51

252

2075

Use of galantamine

1125

10306

1.14

3.03

2.3

2.5

2.82

3.07

mg/l

3.36

931

8797

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

153

1184

1.39

3.01

2.4

2.2

2.64

2.66

mg/l

0.04

133

1031

Injury of nerves at ankle and foot level

586

1.59

3.01

2.8

2.1

3.06

2.83

mg/l

0.30

509

Congenital malformations of great veins

289

1.97

3.00

4.2

3.4

3.30

2.41

mg/l

1.38

266

Adult respiratory distress syndrome

149

1157

1.41

2.99

3.1

2.3

3.18

2.95

mg/l

0.58

131

1003

Polymorphous light eruption

664

1.56

2.99

2.5

2.1

2.38

2.79

mg/l

1.40

574

Contact with other and unspecified heat and hot substances

545

1.61

2.98

2.8

2.2

2.89

2.78

mg/l

0.14

476

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

168

1332

1.39

2.98

2.4

3.18

3.08

mg/l

0.24

149

1144

Other complications of labour and delivery, not elsewhere classified

1528

12522

1.11

2.97

2.1

2.2

2.50

2.41

mg/l

1.19

1319

10927

Gonococcal infection

319

2679

1.25

2.97

2.2

2.71

2.80

mg/l

0.28

263

2332

Viral conjunctivitis, including avohilmo

434

3747

1.21

2.97

2.7

2.2

2.65

2.71

mg/l

0.21

386

3257

Primary ovarian failure

215

1743

1.32

2.96

2.4

2.1

2.65

2.52

mg/l

0.40

193

1532

Other and unspecified primary disorders of muscles

624

1.57

2.95

3.1

2.4

3.07

2.94

mg/l

0.13

540

Other disorders of thyroid

163

1285

1.39

2.95

2.4

2.2

2.64

2.94

mg/l

0.82

141

1100

Acute hepatitis A, including avohilmo

359

1.77

2.94

2.9

2.2

2.83

3.01

mg/l

0.24

308

Juvenile osteochondrosis

348

2953

1.24

2.93

2.5

2.2

2.54

2.61

mg/l

0.28

300

2581

Mixed specific developmental disorders

234

1765

1.30

2.93

2.7

3.3

2.84

2.45

mg/l

2.22

209

1590

Changes in corneal membranes

321

1.84

2.93

2.5

2.1

2.78

mg/l

0.01

275

Osteitis due to dental implant

722

1.54

2.92

2.7

2.2

2.75

3.03

mg/l

0.72

625

Bullous keratopathy

108

809

1.51

2.91

2.6

2.3

3.32

3.16

mg/l

0.28

695

Certain zoonotic bacterial diseases, including avohilmo

339

2879

1.25

2.91

2.5

2.2

2.70

2.83

mg/l

0.53

296

2482

Atypical virus infections of central nervous system, including avohilmo

103

759

1.50

2.91

2.4

2.2

3.14

3.10

mg/l

0.05

661

Foreign body in genitourinary tract

121

918

1.46

2.91

2.4

2.1

2.68

2.78

mg/l

0.21

105

795

Other sexually transmitted chlamydial diseases, including avohilmo

1163

10636

1.12

2.90

2.1

2.2

2.34

2.50

mg/l

2.35

945

9300

Congenital dislocation of hip, unilateral

603

1.59

2.89

2.7

2.6

2.61

2.55

mg/l

0.10

521

Congenital malformations of nose, including avohilmo

174

2.17

2.89

2.5

2.0

2.18

2.71

mg/l

1.09

157

Other demyelinating diseases of the central nervous system

388

3326

1.22

2.89

2.5

2.2

2.68

2.66

mg/l

0.05

344

2926

Benign neoplasm: Skin of upper limb, including shoulder

226

1851

1.31

2.88

2.4

2.2

2.72

2.88

mg/l

0.47

195

1603

Benign neoplasm: Mediastinum

284

1.91

2.87

3.0

2.2

2.40

2.87

mg/l

0.66

251

Carcinoma in situ of vagina

493

1.64

2.87

3.4

2.2

2.78

2.91

mg/l

0.16

427

Chronic constrictive pericarditis

231

2.06

2.86

3.0

2.2

3.54

3.03

mg/l

0.55

205

Congenital malformations of oesophagus

421

1.72

2.86

2.7

2.5

2.74

2.85

mg/l

0.13

373

Disorders of brain, other and unspecified

109

814

1.48

2.86

2.7

2.1

3.28

3.05

mg/l

0.35

104

701

Loose body in joint

240

1971

1.29

2.85

2.3

2.1

2.88

2.78

mg/l

0.32

216

1671

Malignant neoplasm of brain

250

3021

0.79

2.85

1.9

2.3

2.69

2.71

mg/l

0.04

211

2578

Other and unspecified mental retardation

173

1361

1.36

2.85

2.4

3.3

2.72

2.54

mg/l

0.47

150

1223

Thyrotoxicosis with toxic single thyroid nodule

106

792

1.50

2.85

2.5

2.2

2.49

2.97

mg/l

1.63

683

Benign lipomatous neoplasm of of intra-abdominal organs

270

1.93

2.81

2.5

2.3

2.87

2.94

mg/l

0.07

238

Migraine with aura, drug-induced

118

895

1.45

2.81

2.6

2.2

2.69

2.80

mg/l

0.18

110

777

Respiratory tuberculosis, confirmed and not-confirmed

622

5531

1.17

2.80

2.7

2.4

2.88

2.97

mg/l

0.47

537

4712

Respiratory tuberculosis

622

5531

1.17

2.80

2.7

2.4

2.88

2.97

mg/l

0.47

537

4713

Spirochaetal infections, other/unspecified

1026

9373

1.13

2.80

2.4

2.60

2.84

mg/l

2.81

830

8165

Combined immunodeficiency, unspecified

3.08

2.78

3.9

2.5

2.44

2.34

mg/l

0.11

Social disorders starting during childhood or adolescence

698

1.51

2.78

3.1

3.0

2.61

2.38

mg/l

0.57

610

Personal history of allergy to drugs, medicaments and biological substances

128

981

1.42

2.77

2.6

2.0

2.72

2.68

mg/l

0.07

114

851

Enterobiasis

384

1.75

2.76

3.8

2.1

2.94

2.60

mg/l

0.64

337

Personal history of malignant neoplasm

928

8431

1.13

2.75

2.2

2.3

2.33

2.75

mg/l

7.24

781

7296

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

607

1.55

2.73

2.2

2.68

2.77

mg/l

0.18

515

Occupant of pick-up truck or van injured in other and unspecified transport accidents

422

1.67

2.73

2.6

2.1

2.87

2.77

mg/l

0.13

377

Mechanical strabismus

234

2.01

2.72

2.0

2.1

2.65

2.79

mg/l

0.15

209

Endometriosis of fallopian tube

588

1.54

2.71

2.6

2.1

2.55

2.74

mg/l

0.48

512

Use of donepezil

3146

28563

1.07

2.71

2.3

2.5

2.97

3.08

mg/l

1.99

2579

24381

Benign neoplasm: Spinal meninges

126

974

1.43

2.71

3.0

2.2

3.16

3.03

mg/l

0.25

109

836

Disorder of carbohydrate metabolism, other/unspecified

215

1.96

2.70

2.1

2.5

2.57

3.23

mg/l

1.04

189

Pedal cyclist injured in noncollision transport accidents

1291

11914

1.11

2.70

2.4

2.3

2.69

2.72

mg/l

0.26

1130

10405

Specific developmental disorder of motor function

166

1284

1.35

2.69

4.0

3.5

2.58

2.41

mg/l

0.61

151

1152

Malignant neoplasm of lip

711

1.50

2.69

2.2

2.3

3.28

2.87

mg/l

0.92

605

Leiomyosarcoma

627

1.54

2.69

2.1

2.3

2.93

2.83

mg/l

0.18

537

Malignant neoplasm of testis, including Hilmo

152

1189

1.35

2.67

2.6

2.2

3.03

2.74

mg/l

0.78

133

1014

Macular cyst

374

3237

1.23

2.67

2.4

2.3

2.73

2.89

mg/l

0.72

311

2760

Fall on and from ladder

835

7571

1.14

2.67

2.3

2.85

2.83

mg/l

0.09

718

6559

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

202

1637

1.31

2.67

3.3

2.6

2.43

2.53

mg/l

0.36

183

1443

Secondary malignant neoplasm of other and unspecified sites

213

1754

1.31

2.66

1.7

2.3

3.81

2.78

mg/l

4.36

188

1498

Pathological resorption of teeth

411

3572

1.21

2.65

2.6

2.3

2.78

2.77

mg/l

0.03

367

3087

Carcinoma in situ of vulva

106

802

1.47

2.65

2.8

2.3

3.13

2.97

mg/l

0.20

695

Malignant neoplasm of floor of mouth

418

1.67

2.65

2.7

2.1

2.97

2.78

mg/l

0.23

353

Endovascular or surgical operations to intracerebral aneurysms

654

5854

1.16

2.64

2.5

2.3

3.31

2.83

mg/l

4.90

597

5035

Disorders of puberty

170

1361

1.34

2.64

2.7

2.67

2.40

mg/l

0.86

141

1190

Unequal limb length (acquired)

710

1.47

2.62

2.4

2.1

2.44

2.50

mg/l

0.12

608

Burn and corrosion of shoulder and upper limb, except wrist and hand

223

1839

1.29

2.62

2.3

2.2

2.53

2.83

mg/l

1.74

194

1594

Patellar tendinitis

160

1266

1.34

2.61

1.9

2.1

2.68

2.65

mg/l

0.05

142

1095

Gonococcal infection, including avohilmo

346

2964

1.22

2.60

2.2

2.66

2.76

mg/l

0.34

285

2582

Secondary malignant neoplasm of respiratory and digestive organs

202

1658

1.31

2.58

2.0

2.4

3.88

2.79

mg/l

6.21

167

1411

Other acantholytic disorders

272

1.93

2.57

5.1

2.2

2.27

2.82

mg/l

1.36

239

Other and unspecified disorders of orbit

439

1.65

2.57

2.4

2.2

2.99

2.93

mg/l

0.06

385

Other specified/unspecified disorders of ear

259

1.86

2.57

2.9

2.2

2.39

2.64

mg/l

0.38

229

Other and unspecified disorders of lacrimal system

152

2.20

2.57

1.9

2.1

2.42

3.12

mg/l

0.99

131

Ovarian hyperstimulation (induction)

209

1722

1.30

2.57

2.5

2.1

2.61

2.46

mg/l

0.53

187

1524

Contact with blunt object, undetermined intent

494

1.58

2.56

1.7

2.1

2.50

2.75

mg/l

0.54

442

Presbyopia

807

7308

1.14

2.56

2.4

2.3

2.56

2.77

mg/l

2.13

702

6415

Malignant neoplasm of pancreas

818

7425

1.14

2.56

2.2

2.4

3.00

2.84

mg/l

1.23

727

6354

Glaucoma secondary to eye trauma

575

1.56

2.55

2.8

2.2

3.22

3.18

mg/l

0.04

498

Pemphigus foliaceus

2.79

2.54

2.2

2.3

2.34

2.90

mg/l

0.99

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

103

2.61

2.54

7.2

2.3

2.74

2.53

mg/l

0.23

Benign neoplasm: Spinal cord

155

1237

1.35

2.53

2.5

2.2

2.97

2.94

mg/l

0.05

132

1061

Ankylosis of joint

412

1.63

2.52

2.1

1.9

2.48

3.22

mg/l

1.64

347

Phakomatoses, not elsewhere classified

119

917

1.41

2.52

2.8

2.2

2.80

2.76

mg/l

0.06

108

790

Dislocation, sprain and strain of joints and ligaments of elbow

700

6301

1.15

2.52

2.6

2.3

2.62

2.67

mg/l

0.26

610

5504

Unspecified transport accident

347

1.69

2.51

2.7

2.1

2.25

2.91

mg/l

1.66

303

Retained placenta and membranes, without haemorrhage

1315

12192

1.10

2.51

2.3

2.74

2.65

mg/l

0.62

1132

10622

Granuloma faciale [eosinophilic granuloma of skin]

3.67

2.50

2.1

1.92

2.76

mg/l

1.16

hereditary angioödema type 3

2.99

2.50

5.7

1.8

3.15

2.71

mg/l

0.51

Drug-induced myopathy

239

1.92

2.50

2.8

2.0

3.38

2.88

mg/l

0.51

209

Arthropod-borne viral fevers and viral haemorrhagic fevers

1024

9403

1.12

2.49

2.4

2.3

2.88

2.80

mg/l

0.47

932

8172

Small kidney of unknown cause

193

2.06

2.49

4.1

2.2

2.61

2.97

mg/l

0.54

173

Tuberculosis

729

6592

1.14

2.49

2.7

2.4

2.93

2.98

mg/l

0.25

630

5608

Other osteochondropathies

721

6507

1.14

2.48

2.6

2.2

2.79

2.72

mg/l

0.40

636

5668

Anisometropia and aniseikonia

360

3119

1.21

2.47

2.5

2.4

2.81

2.84

mg/l

0.07

281

2691

Carcinoma in situ of other and unspecified genital organs

228

1905

1.28

2.46

2.9

2.3

3.30

2.90

mg/l

1.26

201

1634

Sleep terrors [night terrors]

185

2.05

2.46

2.1

2.2

2.21

2.43

mg/l

0.34

158

Convergent concomitant strabismus

600

5362

1.16

2.46

2.5

2.3

2.55

2.64

mg/l

0.51

529

4703

Benign neoplasm: Lip

237

1987

1.27

2.46

2.5

2.3

2.80

2.98

mg/l

0.63

187

1691

Acute myringitis

628

1.50

2.45

3.0

2.4

2.35

2.81

mg/l

1.61

550

Primary angle-closure glaucoma

523

4656

1.18

2.45

2.4

3.03

3.00

mg/l

0.11

453

3981

HSIL lesion of the cervix uteri

2226

21026

1.08

2.45

2.2

2.51

2.56

mg/l

0.56

1921

18458

Malignant neoplasm of other and ill-defined digestive organs

100

759

1.46

2.44

2.4

2.3

3.00

2.97

mg/l

0.05

645

Chromomycosis and phaeomycotic abscess, including avohilmo

328

1.73

2.42

2.4

2.2

2.80

2.78

mg/l

0.01

279

Malignant neoplasm of base of tongue, including Hilmo

689

1.47

2.41

2.5

2.2

3.39

2.76

mg/l

0.63

586

Melanocytic naevi of scalp and neck

270

2291

1.25

2.41

2.5

2.2

2.61

2.75

mg/l

0.47

238

1978

Retinoschisis and retinal cysts

267

2269

1.25

2.40

2.6

2.3

2.89

2.91

mg/l

0.06

239

1933

Felty syndrome

489

1.59

2.39

3.3

2.2

3.19

3.07

mg/l

0.18

416

Biliary cirrhosis, secondary

3.31

2.38

7.4

3.1

3.47

2.86

mg/l

0.42

Juvenile cataract

321

1.71

2.36

2.2

2.4

3.33

2.62

mg/l

1.40

285

Caught, crushed, jammed or pinched in or between objects

557

4974

1.16

2.34

2.4

2.3

2.52

2.70

mg/l

1.36

487

4315

Carcinoma in situ of skin of lip

277

1.84

2.34

3.2

2.3

3.04

2.93

mg/l

0.09

243

Bus occupant injured in other and unspecified transport accidents

618

1.50

2.34

3.2

2.2

2.67

2.91

mg/l

0.32

530

Cicatricial pemphigoid

198

2.04

2.34

2.7

2.1

3.06

2.91

mg/l

0.13

178

Scarlet fever

450

1.55

2.33

3.4

2.0

2.87

2.59

mg/l

0.56

391

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

457

1.60

2.33

3.0

2.2

2.61

2.95

mg/l

0.69

393

Exposure to controlled fire, not in building or structure

209

1.89

2.33

2.0

2.1

2.63

2.76

mg/l

0.16

183

Other benign neoplasm of uterus: Corpus uteri

100

768

1.45

2.31

2.4

2.2

2.62

3.05

mg/l

1.36

653

Congenital deformities of feet

270

2296

1.23

2.31

2.6

2.2

2.79

2.61

mg/l

0.69

231

1996

Corneal pigmentations and deposits

341

1.69

2.29

3.4

2.2

2.86

3.00

mg/l

0.18

309

Malignant neoplasm, without specification of site

369

3219

1.20

2.28

2.3

2.4

3.39

2.90

mg/l

2.68

307

2726

Other and unspecified neuropathies

375

1.66

2.28

2.3

2.1

3.36

2.95

mg/l

0.22

326

Mandibular prognathia

169

1378

1.31

2.28

2.7

2.5

2.43

2.63

mg/l

0.65

153

1216

Operations 1 for CAVS

245

1.85

2.28

2.7

3.1

2.73

3.05

mg/l

0.38

212

Single spontaneous delivery

5282

28900

0.95

2.27

2.2

2.5

2.76

2.82

mg/l

0.96

4604

24956

Blepharospasm

107

830

1.41

2.26

2.1

2.51

3.10

mg/l

2.18

717

Malignant neoplasm of ovary

525

4694

1.16

2.25

2.1

2.4

2.90

2.81

mg/l

0.35

466

4062

Absence of one kidney, including avohilmo

287

1.78

2.25

2.6

2.5

2.65

2.73

mg/l

0.11

247

Bacterial sepsis of newborn

547

1.54

2.24

4.4

3.7

2.60

2.38

mg/l

0.51

486

Diving or jumping into water causing injury other than drowning or submersion

339

1.64

2.24

2.1

2.45

2.82

mg/l

0.75

296

Congenital lens malformations

400

1.61

2.24

2.3

2.4

2.97

2.70

mg/l

0.40

348

Other meningitis

171

1399

1.30

2.24

2.5

2.2

2.87

2.82

mg/l

0.09

156

1214

Other osteochondrodysplasias

724

1.43

2.23

2.9

2.4

2.47

2.84

mg/l

1.30

630

Use of apomorphine

3.55

2.23

2.5

1.8

2.59

3.82

mg/l

—

Malignant neoplasm of palate, including Hilmo

501

1.53

2.23

2.0

2.2

2.46

2.79

mg/l

0.79

422

Benign neoplasm: Carotid body

246

1.83

2.23

2.5

2.87

2.81

mg/l

0.05

210

HSIL lesion of the vagina

158

1287

1.32

2.22

3.2

2.3

2.67

2.84

mg/l

0.44

143

1107

Acute hepatitis A

334

1.67

2.22

3.1

2.1

3.03

2.95

mg/l

0.09

288

Pleural plaque without asbestos

459

4092

1.18

2.22

2.5

2.4

2.80

3.00

mg/l

1.04

369

3492

Benign neoplasm: Lower jaw bone

360

1.65

2.22

2.6

2.1

2.65

2.78

mg/l

0.16

316

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

3.84

2.21

10.5

2.1

2.60

3.03

mg/l

0.40

Malignant neoplasm of eye, brain and central nervous system

345

3960

0.84

2.20

2.0

2.3

2.71

mg/l

0.01

298

3397

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS